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Abstract 
Background and aims: Prior to gender affirming medical interventions, transgender people 
often experience high levels of body dissatisfaction and poor mental health in comparison to 
the cisgender (i.e., non-transgender) population. Body dissatisfaction and poor mental health 
have been associated with eating disorder psychopathology within the cisgender population. 
Transgender people are therefore an important group to target for intervention development. 
Participating in physical activity and/or sport within the cisgender population has been 
associated with body satisfaction and mental well-being. The overarching aim for the 
research reported on in this thesis was therefore to explore the role of body (dis)satisfaction, 
mental health and medical transition on physical (in)activity and eating disorder symptoms 
within the transgender population. Studies that have evaluated gender affirming medical 
interventions have been limited by the outcome tools used and therefore this thesis also aimed 
to develop and validate a new measure to assess intervention and treatment outcomes. 
 
Participants: Treatment seeking transgender people were invited to take part in all of the 
empirical studies reported on in this thesis. For some studies, transgender people from the 
community and/or cisgender participants were also recruited.  
 
Main findings: Despite being motivated, many transgender people reported having negative 
experiences engaging in physical activity and/or sport due to numerous internal and external 
barriers. Many of these barriers are directly or indirectly related to body dissatisfaction. 
Cross-sex hormones appeared to increase physical activity participation, possibly by 
alleviating body dissatisfaction and increasing mental well-being. It was also found that body 
dissatisfaction played a key role in the existence of eating disorder symptoms. Transgender 
people who had taken cross-sex hormones reported lower levels of eating disorder symptoms, 
possibly due to an increase in body satisfaction. Finally, this thesis successfully developed a 
new outcome measure in collaboration with transgender people and experts working in 
transgender healthcare. This measure was named the Gender Congruence and Life 
Satisfaction Scale (GCLS) and was found to be valid and reliable. 
 
Implications: Spreading awareness of the barriers that transgender people face in relation to 
physical activity and sport engagement may help this population to become more active. 
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Being more active is important for transgender people as it may have body image and mental 
health benefits. Cross-sex hormones appear to be crucial in reducing body dissatisfaction and 
increasing mental well-being. Possibly because of this, physical activity levels are higher 
among people who have taken cross-sex hormones. Additionally, cross-sex hormones also 
appear to reduce eating disorder symptoms. However, the research in this thesis is cross-
sectional. Future research should adopt a longitudinal research design, particularly now that a 
new tool to evaluate intervention and treatment outcomes (the GCLS) has been developed. 
This tool is likely to make important advances in research which will contribute towards 
increasing the well-being of the transgender population.  
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Glossary of key terms used within this thesis  
Body dissatisfaction: A complex interaction between psychological and social factors which 
leads to subjective negative evaluation of one’s body image.  
Body image: A person’s subjective perception of their body, which can be positive or 
negative.  
Body satisfaction: Subjective positive evaluation of one’s body image.  
Chest surgery6F*: This is a gender neutral term which describes a surgical intervention that 
some transgender people may choose to undergo. Transgender males (or non-binary people 
assigned female at birth) may choose to undergo a mastectomy and chest reconstructive 
surgery to remove breast tissue and create a flat chest. Transgender females (or non-binary 
people assigned male at birth) may choose to undergo breast augmentation to increase the 
size of their chest.  
Cisgender: A person who does not experience incongruence between their gender assigned 
at birth and their gender identity. 
Competitive elite sport: The highest level of national and international sporting competition 
where the emphasis is on winning prestigious competitions for career gains. Elite or 
professional athletes are a minority in terms of their exceptional sporting ability.  
Competitive recreational sport: Activity that involves physical exertion and skill in which 
an individual or team competes against another or others for entertainment, leisure and fitness.  
Cross-sex hormone treatment (sometimes abbreviated to CHT): Sex hormones 
(oestrogens or testosterone) that initiate the development of secondary sex characteristics.  
Disordered eating: Unhealthy eating attitudes and behaviours (e.g., restrictive eating, binge 
eating, compensatory behaviours) that do not necessarily fulfil a clinical eating-related 
diagnosis.  
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Eating disorder psychopathology: Maladaptive and dysfunctional thoughts and/or 
behaviours relating to eating, body shape or weight.   
Eating disorder symptoms: Unhealthy eating attitudes, behaviours and psychopathology 
that do not necessarily fulfil a clinical eating-related diagnosis.  
Gender: Comprises a person’s sex, gender expression and gender identity.  
Gender affirming medical interventions7F †: Medical treatments used to align a person’s 
body with their gender identity.  
Gender affirming surgery8F‡: Surgeries to align a person’s body with their gender identity.  
Gender assigned at birth9F§: The gender a person is assigned at birth based on their sex.  
Gender confirming medical interventions†: See gender affirming medical interventions.  
Gender confirming surgery‡: See gender affirming surgery.   
Gender expression: A person’s expression of their gender identity through their clothing, 
mannerisms, behaviour, hairstyle, voice, and body characteristics.  
Gender dysphoria: The distress a person experiences as a result of their gender assigned at 
birth and gender identity being incongruent.   
Gender identity: The internal sense of how a person feels and identifies in relation to their 
gender (e.g., male, female, non-binary). 
Gender neutral: A person who consider themselves to have no gender and will present their 
gender in an ambiguous manner. Gender neutral people fall under the umbrella term of non-
binary people. 
Gender queer: A person who identifies and presents in a way that is outside the gender 
dichotomy of male and female. Gender queer people fall under the umbrella term of non-
binary people.  
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Gender role: The social gender role a person learns and performs which is appropriate to 
their gender identity according to social and cultural ‘rules’ (i.e., their mannerisms, 
demeanour, play preferences, recreational interests, clothing, speech).  
LGBT: An acronym that refers to people who are lesbian, gay, bisexual and/or transgender. 
LGBTQI: An acronym that refers to people who are lesbian, gay, bisexual, transgender, 
queer and/or intersex. 
Medical transition: See gender affirming medical interventions.  
Natal gender§: See gender assigned at birth. 
Non-binary: An umbrella term used to describe people who identify (and present) outside 
the binary gender system (i.e., neither male nor female). 
Non-gender: See gender neutral.  
Physical activity10F **: Any activity that involves muscular-skeletal movement and energy 
expenditure (e.g., while working, playing, carrying out household chores, or engaging in 
recreational pursuits such as football, swimming, gymnastics, running or walking).  
Primary sex characteristics: Body structures that are directly related to reproduction such as 
the testes and ovaries.  
Sex: The biological differences between males and females such as sex chromosomes (i.e., 
XX, XY), reproductive organs (e.g., ovaries, testes) and secondary sex characteristics. 
Sex assigned at birth§: See gender assigned at birth.  
Sex reassignment surgery‡: See gender affirming surgery. 
Sexual reassignment†: See gender affirming medical interventions. 
Secondary sex characteristics: Physical characteristics that are developed at puberty which 
differentiate between the male and female sex but are not directly involved in reproduction 
(e.g., development of breasts, distribution of fat tissue, and muscularity).  
Sex-specific body parts: See secondary sex characteristics. 
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Sexual characteristics: Traits and behaviours that differentiate the male and female sex.  
Social transition: The social change that a person goes through (i.e., through clothing and 
appearance) in accordance with their gender identity and not with their gender assigned at 
birth.   
Sport-related physical activity**: See physical activity.  
Transgender (sometimes abbreviated to trans): A person who experiences incongruence 
between their gender assigned at birth and gender identity. 
Treatment seeking transgender people: A person who wishes to undergo, or is undergoing, 
gender affirming medical interventions.  
 
                                            
 
* In chapters 6, 7, & 9 the word mastectomy is used to describe the surgical intervention that some transgender 
men or non-binary people (assigned female at birth) may choose to undergo to reduce breast tissue. As part of 
this intervention, the chest is also reconstructed (to create a flatter chest), although it should be noted that this 
isn’t explicitly stated within these chapters. In other chapters within this thesis, the phrase “mastectomy and 
chest reconstructive surgery” is used. This is a reflection of changes to accepted terminology which have 
occurred over time.  
† In chapter 3, the term sexual reassignment is used. In chapters 2 & 6 gender confirming medical interventions 
is used. In chapters 1, 4, 5, 7, 8, 9, & 10 gender affirming medical interventions is used. This is a reflection of 
how accepted terminology has changed over time and to satisfy requirements of journals. The meaning of these 
terms is the same. 
‡ In chapter 3, sex reassignment surgery is used. In chapters 2, 6, & 9 gender confirming surgery is used. In 
chapters 1, 4, 5, 8, & 10, gender affirming surgery is used. This is a reflection of how accepted terminology has 
changed over time and to satisfy requirements of journals. The meaning of these terms is the same. 
§ In chapter 3, natal gender and sex assigned at birth are used. In chapter 7, sex assigned at birth is used. In 
chapters, 1, 2, 4, 5, 6, 8, & 9, gender assigned at birth is used. This is a reflection of how accepted terminology 
has change over time and to satisfy requirements of journals. The meaning of these terms is the same. 
** In chapter 2, sport-related physical activity is used. However, in the other chapters of this thesis physical 
activity is used. The difference in this terminology is a reflection of journal requirements. The meaning of these 
terms is the same. 
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Chapter 1 
General introduction 
1.1. Introduction 
This chapter will begin by describing who transgender people are followed by a discussion 
about the prevalence of transgender people and the diagnostic classification systems used by 
clinicians working within the field of transgender health. The treatment pathway followed at 
transgender health services in the United Kingdom (UK) will then be described and a brief 
overview will be provided of support organisations available for transgender people within 
the UK. The chapter will then present a discussion of the prevalence of mental health 
problems within the transgender population and will close by outlining the initial aims of this 
thesis. The information presented in this chapter will be discussed with reference to 
transgender adults as the research reported on in this thesis is conducted with transgender 
people aged 17 and over.  
 
1.2. Who are transgender people? 
Sex encompasses the biological differences between males and females, such as sex 
chromosomes (i.e., XX, XY), reproductive organs (e.g., ovaries, testes), and secondary sex 
characteristics (e.g., penis, vagina). Gender is the internal sense of being a man or woman. 
Gender is presumed at birth based on the biological sex of the baby which is determined from 
sex characteristics (i.e., genitals). Babies born with a penis are gendered as a boy (male) and 
babies born with a vagina are gendered as a girl (female). In Western society, the gender 
assigned to a child (based on its sex characteristics) can determine the name parents give to 
the baby, the clothes the child is dressed in, and the toys the child is given. Many parents will 
expect their child’s gender role (which is defined as the behaviour a person learns and 
performs appropriate to their gender and society; i.e., their mannerisms, demeanour, play 
preferences, recreational interests, clothing, speech; Arcelus & Bouman, 2017a) to be 
consistent with the gender they were assigned at birth (based on their sex characteristics) 
throughout their life. This is true for the majority of people who will give little consideration 
to or concern for their gender. However, there are some people who, even from a young age, 
will experience incongruence (i.e., a discrepancy) between the gender they were assigned at 
birth and their gender identity. These people are called transgender (sometimes abbreviated 
to trans). Transgender is an umbrella term used to describe people whose gender identity is 
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felt to be different from the gender they were assigned at birth (Arcelus & Bouman, 2017a). 
Under this umbrella, transgender males are people who were assigned female at birth (based 
on sex characteristics) but identify as male. Transgender females are people who were 
assigned male at birth (based on sex characteristics) but identify as female. Over the years, 
professionals working in the field of transgender health have become more aware that gender 
isn’t a binary concept (i.e., male and female) but that it is better described on a continuum. 
There are now an increasing number of people who identify outside the binary gender system 
(Richards et al., 2016). For example, these people may choose to identify as gender neutral 
(feeling one is neither male nor female), non-gender (having no gender in relation to 
presentation), or gender queer (identifying and presenting in a way that is outside the gender 
dichotomy of male and female) (Richards et al., 2016). Some people may also be more fluid 
with their gender identity whereby they do not have a fixed gender and it can therefore vary 
over time. Although it is acknowledged that the term transgender may not capture everyone’s 
experiences due to the diversity in gender identities experienced (Arcelus & Bouman, 2017a), 
in this thesis, transgender will be used to describe people who experience incongruence 
between their gender assigned at birth and their current gender identity. The term cisgender 
will be used to describe people who do not experience incongruence between their gender 
assigned at birth and the gender they identify with. 
 
Many transgender people will choose to transition from the gender they were assigned at 
birth to the gender they identify with. This will usually include a social gender role transition, 
where the individual will transition so that they socially present (i.e., through clothing and 
appearance) their gender in accordance with how they identify (and not in accordance with 
their gender assigned at birth). For many people it is necessary to make a social gender role 
transition in all aspects of their lives when at home, with friends, family and at work (if the 
person is currently employed). This will usually involve people ‘coming out’ as transgender, 
asking people to use different pronouns (i.e., he, she or they) and using a different name. As 
part of a social gender role transition, many people will change their name to one that the 
individual feels better reflects their gender identity (e.g., from Jessica to Andy). Name change 
can be done officially in the UK via a legal document known as a deed poll. Transgender 
people will usually also change their name and gender signifier (i.e., Ms, Mr, Mx (when 
possible)) on legal documents such as their passport, bank cards, and driving licence. As part 
of this transition, many transgender people will also wish to undergo gender affirming 
medical interventions which may include cross-sex hormone treatment and also sometimes 
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surgeries to align their body with their gender identity. This is referred to within this thesis as 
a medical transition. Interventions that may comprise a medical transition can be accessed at 
transgender health services. It is agreed by professionals working in the field of transgender 
health that no irreversible interventions should be offered to children (Steensma & Risori, 
2017). Undergoing a medical transition is a personal preference, which not every person will 
feel is necessary for their body to feel congruent with their gender identity (Arcelus & 
Bouman, 2017a; Beek, Kreukels, Cohen-Kettenis, & Steensma, 2015). The specifics of the 
different gender affirming medical interventions that people may choose to undergo as part of 
a medical transition will be discussed in more detail in section 1.5. To distinguish between 
people who do and do not wish to undergo a medical transition, the former group will be 
described as treatment seeking transgender people throughout this thesis. 
 
1.3. The global prevalence of being transgender 
Determining the prevalence of transgender people is important for predicting how many 
people might need to access transgender health services so that provisions can be prepared. 
Prevalence studies of transgender people have been conducted all over the world and usually 
use clinical data (i.e., data from people who have accessed transgender health services). In the 
United States of America (USA), the first epidemiological study to be conducted reported a 
prevalence of 0.45 per 100,000 people (Pauly, 1968). In more recent years, a prevalence of 
5.91 per 100,000 people has been reported in Sweden (Olsson & Möller, 2003), 3.88 per 
100,000 in Spain (Gómez-Gill et al., 2006), 4.28 per 100,000 in Belgium (De Cuypere et al., 
2007), and 6.77 per 100,000 in Ireland (Judge, O’Donovan, Callaghanm, Gaoatswe, & 
O’Shea, 2014). In an effort to synthesise these findings, a systematic review and meta-
analysis of the clinical transgender epidemiological literature was recently conducted which 
concluded the prevalence rate to be 4.6 per 100,000 people (Arcelus, Bouman, Witcomb, Van 
De Noortgate, & Fernandez-Aranda, 2015). This study also concluded that the prevalence of 
transgender people has increased considerably over the last 50 years (Arcelus et al., 2015). 
This is likely to be related to the increase in visibility of transgender people (especially in the 
media and on the internet) which has contributed towards a reduction in the stigmatisation, 
discrimination and prejudice of transgender people (i.e., transphobia) and, consequently, 
means that people feel more comfortable and confident identifying as transgender (Arcelus & 
Bouman, 2017b). For instance, Caitlyn Jenner, a former Olympic medallist, came out as 
transgender during a television interview which was viewed all over the world (Dooley et al., 
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2015). In addition, there is an increasing amount of information freely available on the 
internet about gender diversity.   
 
However, not every transgender person will wish to undergo gender affirming medical 
interventions or access transgender health services (e.g., Arcelus & Bouman, 2017b; Beek et 
al., 2015) and, for this reason, clinical prevalence studies may be seen as unreliable at 
estimating the number of transgender people. In response to this, more recent research has 
been concerned with people who identify as transgender within the community (not just those 
accessing clinical services). In the Netherlands, a survey on gender incongruence was 
conducted and a prevalence of 110 per 100,000 people assigned male at birth and 80 per 
100,000 people assigned female at birth was reported (Kuyper & Wijsen, 2014). In a study 
conducted in Belgium, a prevalence of 70 per 100,000 people assigned male at birth and 60 
per 100,000 people assigned female at birth was reported (Van Caenegem et al., 2015). These 
data indicate that when community samples are also included, the prevalence of transgender 
people is considerably higher than when only clinical samples are used. 
 
Another threat to the reliability of these prevalence studies is that the terminology used to 
describe transgender people has changed over the years. As discussed in section 1.2., the term 
transgender has widened in recent years to include people who identify outside the binary 
gender system (as well as those who do). The way transgender people are defined in a given 
study will determine the participants who are recruited into the study and this will, in turn, 
affect the conclusions drawn regarding the prevalence of transgender people and the 
generalisability of the findings. Prevalence rates can also be affected by the geographical 
location that the data are collected from. Some countries are more tolerant of transgender 
people than others which will impact how comfortable people feel in identifying as 
transgender. This is reflected in studies that have been conducted in different parts of the 
world. For instance, the prevalence of transgender females in Sweden (a country accepting of 
transgender people) was found to be 16.6 per 100,000 people (Dhejne, Öberg, Arver, & 
Landén, 2014) which contrasts with a prevalence of 0.7 per 100,000 people reported in a 
study from Iran (a country not accepting of transgender people) (Ahmadzad-Asl et al., 2010). 
The time period when the research was conducted can also impact prevalence rates. A 
prevalence rate of 23.60 per 100,000 people reported in Singapore in the 1970s (Tsoi, 1988) 
can be explained by the fact that during the 1970s Singapore was known for its large 
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transgender community and, hence, people were likely to feel more comfortable identifying 
as transgender during the time when Tsoi’s study was conducted.  
 
In light of the issues discussed above, calculating prevalence rates of transgender people is 
evidently extremely complex and therefore it is difficult to determine exactly how many 
people identify as transgender. The findings from prevalence studies need to be considered in 
light of whether the data were collected from a clinical or community sample, the 
geographical location and time period the data were collected from, and the terminology used 
to define the population recruited. All of these factors are likely to contribute towards the 
prevalence rate of transgender people found in a given study.  
 
1.4. Diagnostic classification for transgender people: Revisions and current debates 
As mentioned in section 1.2., some transgender people may wish to make their body 
congruous with their gender identity by undergoing a medical transition (e.g., cross-sex 
hormones and surgeries). In some parts of the world (including the UK), healthcare funding 
systems are configured in such a way that transgender people cannot access gender affirming 
interventions without a related diagnosis (Beek et al., 2016; Richards et al., 2015). There are 
two classification systems that include diagnosis relating to transgender people: (1) the 
Diagnostic and Statistical Manual of Mental Disorders (DSM; American Psychiatric 
Association (APA)); and, (2) the International Classification of Diseases (ICD; World Health 
Organization (WHO)). The DSM is used most popularly in the USA to diagnose mental 
disorders and is in its fifth edition (DSM-5; APA, 2013) having been most recently updated 
in 2013. The DSM-5 classifies the distress that is experienced as a result of gender assigned 
at birth and gender identity not being congruent as Gender Dysphoria (APA, 2013). The 
DSM-5 defines this diagnosis as a marked incongruence between one’s gender assigned at 
birth and gender identity, lasting for at least six months. A strong desire to have the primary 
and/or secondary sex characteristics of, and to live and behave as, another gender must also 
be present. In Europe, the ICD is most commonly used to diagnose health conditions 
(physical and mental) and is currently in its 10th edition (ICD-10). It was last updated in 1992 
and the new edition is expected in 2019 (ICD-11). The ICD-10 uses the diagnostic label of 
Transsexualism (WHO, 1992) and defines this as “a desire to live and be accepted as a 
member of the opposite sex, usually accompanied by a sense of discomfort with, or 
inappropriateness of, one’s anatomic sex, and a wish to have surgery and hormonal treatment 
to make one’s body as congruent as possible with one’s preferred sex”. This desire must be 
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persistently present for a minimum of two years. These classification systems (ICD and 
DSM) are an integral part of providing transgender healthcare within the UK and around the 
world but having a diagnosis of Transsexualism (WHO, 1992) or Gender Dysphoria (APA, 
2013) can be heavily stigmatising for the individual (e.g., Bouman & Richards, 2013; 
Richards et al., 2015).  
 
Gender Dysphoria in the DSM-5 is a revision of Gender Identity Disorder (DSM-IV; APA, 
1994). Although it is one of the most contested entries in the DSM-5, the revision is seen to 
be greatly improved from the DSM-IV diagnosis of Gender Identity Disorder (APA, 1994) as 
it has attempted to remove the connotation that the individual is disordered thereby aiming to 
avoid the stigmatisation of transgender people. The DSM-5 working group encouraged the 
change from ‘disorder’ to ‘dysphoria’ in the diagnostic label (Knudson, De Cuypere, & 
Bockting, 2010). The diagnosis ‘Gender Dysphoria’ also now has its own chapter in the 
DSM-5 (APA, 2013) and has been removed from the chapter that included Sexual 
Dysfunctions and Paraphilic Disorders in the DSM-IV (APA, 1994). In addition, the DSM-5 
(APA, 2013) has changed the language used to encapsulate people with non-binary gender 
identities (e.g., gender neutral, non-gender, gender queer) as well as people who wish to 
transition to the opposite gender (i.e., male or female).  
 
Although the ICD revision has not been synchronised with the DSM-5 release, the new 
edition, ICD-11, is due in 2019 and is expected to remove the diagnosis of Transsexualism 
from the psychiatric section and rename this Gender Incongruence. The language used within 
the new ICD-11 Gender Incongruence diagnosis is expected to be inclusive of individuals 
who do not identify within the binary gender system (i.e., male or female). It is also expected 
to remove the presence of distress and impairment of functioning as a requirement of the 
Gender Incongruence ICD-11 diagnosis. It is important to note that people who experience 
incongruence between their gender assigned at birth and gender identity may or may not 
experience associated distress (i.e., a profound state of unease and dissatisfaction) and 
therefore this will allow people who experience gender incongruence but not gender distress 
(dysphoria) to have access to the treatment offered at transgender health services. When 
transgender people, their relatives and healthcare providers from the Netherlands, Belgium 
and the UK were asked about the proposed new diagnosis of Gender Incongruence within 
ICD-11, the majority were in agreement with these changes (Beek et al., 2016).  
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Although the revisions made to the DSM-5, and the proposed revisions to the ICD in 2019 
(ICD-11), are likely to help to minimise the stigmatisation associated with these diagnoses, it 
cannot be ignored that these diagnoses are included within classification systems intended for 
the diagnosis of mental health disorders. Therefore, it is possible that the very presence of 
these diagnoses as part of these classification systems will mean that some transgender 
individuals will potentially still incur (or that individuals will perceive) stigmatisation from 
others. It has been established that experiencing incongruence between one’s gender assigned 
at birth and gender identity is not a mental health disorder (e.g., Richards et al., 2015). In 
light of this, it could therefore be seen as inappropriate to have a gender-related diagnosis in 
the DSM and the ICD. However, the current consensus remains that the DSM and ICD 
should continue to include diagnoses relating to gender identity so that transgender people 
can access the treatment offered at transgender health services if they wish to (Beek et al., 
2016; Megeri & Khoosal, 2007; Richards et al., 2015). The recent changes in this school of 
thought relating to diagnostic classification systems are reflected within the chapters of this 
thesis. In chapter 3, reference to Gender Dysphoria (APA, 2013) and Transsexualism (WHO, 
1992) is made. However, for chapters 2 and 4 to 10 this is not the case as, during the course 
of this PhD, changes in thinking about diagnoses resulted in a widely held view that a 
diagnosis of Gender Dysphoria (APA, 2013) or Transsexualism (WHO, 1992) is only 
relevant for clinical pragmatic reasons. Only the individual truly knows how they feel in 
relation to their gender. In light of this, no participants were required to have a diagnosis of 
Gender Dysphoria (APA, 2013) or Transsexualism (WHO, 1992) to be included within the 
empirical studies of this thesis (chapters 6 to 9). Instead, participants were required to self-
identify as transgender.  
 
1.5. The treatment pathway in the National Health Service: A UK perspective  
Within the UK, treatment for transgender people is offered by the National Health Service 
(NHS) and is free at the point of access. Transgender health services are funded by NHS 
England rather than by local commissioning groups. It is important to acknowledge that not 
every transgender person will have a desire to undergo a medical transition to feel congruent 
with their gender identity or require any support regarding their transition and, therefore, not 
everyone will wish to access transgender health services (Arcelus & Bouman, 2017a; Beek et 
al., 2015). As the majority of the data for this thesis were collected from a transgender health 
service within the UK (the Nottingham Centre for Transgender Health), the sections that 
follow outline the typical treatment pathway for transgender health services within the UK. 
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The Nottingham Centre for Transgender Health is an adult service which accepts referrals for 
people aged 17 and over and, therefore, the treatment pathway discussed in this section refers 
to the procedures followed with adults (i.e., people aged 17 and over). There are seven 
national transgender health services for adults in England and Wales. The Nottingham Centre 
for Transgender Health is the second largest service within the UK and one of the largest in 
Europe in relation to the number of referrals it receives annually (approximately 1000 per 
year).  
 
1.5.1. Referral to a transgender health service 
To access transgender health services within the NHS, a person must first be referred by their 
general practitioner (GP) or secondary care service. People cannot self-refer to transgender 
health services in the UK. 
 
1.5.2. Waiting time at transgender health services after referral  
The waiting time to access a NHS funded transgender health service after referral is currently 
between 12-24 months (Bouman & Richards, 2013; UK Trans Info, 2016). This is a 
consequence of a recent surge in demand for these services, which is likely to be at least 
partially linked to the increase in visibility and acceptability of transgender people (Arcelus 
& Bouman, 2017b; see section 1.3.).  
 
1.5.3. Stage of transition at the point of referral  
Patients are not required to have initiated a social or medical transition for a referral to be 
made to a transgender health service. Consequently, when referred to a transgender health 
service, people will be at varying stages of social and medical transition. For instance, some 
people may be questioning their gender identity and therefore have not made a social gender 
role transition, whereas other people might have made a full social gender role transition and 
be taking cross-sex hormone treatment obtained through a private provider or via the internet 
(Mepham, Bouman, Arcelus, Hayter, & Wylie, 2014). Obtaining hormone treatment through 
these sources is usually fuelled by the extensive waiting times experienced by many 
transgender people accessing care through the NHS. There are some health risks associated 
with cross-sex hormone treatment such as high haematocrit (high proportion of red blood 
cells) which can occur with testosterone therapy and venous thromboembolism (blood 
clotting disorder) which can be a side effect of oestrogen therapy. However, when this 
treatment is monitored by a healthcare professional, risk is greatly minimised (Mepham et al., 
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2014; Seal, 2017). Oestrogen and testosterone therapy will be discussed in more detail in 
sections 1.5.6.1. and 1.5.6.2. 
 
1.5.4. Initial assessment at a transgender health service  
During the first appointment at a transgender health service, the initial assessment will 
commence. At the Nottingham Centre for Transgender Health the assessment will usually 
span three separate appointments; the first two appointments with different clinicians and the 
final appointment involving the two clinicians from the previous appointments, the patient 
and a person of the patient’s choice (usually a family member or friend who knows the 
individual well). It is not compulsory for the patient to bring a person of support to the final 
assessment appointment. During the assessment, the clinician(s) involved with the patient’s 
care will collect a gender history to help determine whether a diagnosis (usually 
Transsexualism (WHO, 1992), although some clinicians may use Gender Dysphoria (APA, 
2013)) can be confirmed. Confirmation of a diagnosis is sought for pragmatic reasons (see 
section 1.4.) as only the individual truly knows how they feel in relation to their gender. It is 
also important during the assessment process to collect information that confirms that a social 
gender role transition has been made, including a name change and ensuring that changes 
have been made to official documentation such as bank details or driving licence. During the 
initial assessment process, the presence of any mental health issues will also be determined. It 
is not uncommon for transgender people to present with mental health problems, such as 
anxiety, depression and self-harm (e.g., Arcelus, Claes, Witcomb, Marshall, & Bouman, 
2016; Bouman, Davey, Meyer, Witcomb, & Arcelus, 2016a; Dhejne, Van Vlerken, Heylens, 
& Arcelus, 2016; Reisner et al., 2016; see section 1.7.) and these symptoms do not prevent a 
person from accessing transgender health care (Wylie et al., 2014). In fact, poor mental health 
within the transgender population has been found to reduce once a medical transition has 
been initiated (Davis & Meier, 2014; De Cuypere, Elaut, Heylens, & Monstrey, 2006; Fisher 
et al., 2014; Gorin-Lazard et al., 2012; Heylens, Verroken, De Cock, T’Sjoen, & De Cuypere, 
2014; Lindqvist et al., 2017; Murad et al., 2010; Ruppin & Pfäfflin 2015; van de Grift et al., 
2017a; van de Grift, Elaut, Cerwenka, Cohen-Kettenis, & Kreukels, 2017b). However, for 
people experiencing severe mental health problems, such as schizophrenia or bipolar 
disorder, it is important that these conditions are stabilised prior to any gender affirming 
interventions to ensure the individual can understand the irreversibility of these interventions 
and is able to provide informed consent.  
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At the end of the initial assessment process, typically lasting six months, a decision regarding 
the initiation of cross-sex hormones will be made (if this is what the patient wishes). For 
some patients, it may be necessary to extend the assessment process. For instance, a small but 
growing number of transgender patients also present with autism spectrum disorder (ASD 
(DSM-5; APA, 2013)) which can make the assessment process more complex due to 
communication difficulties, rigid thinking, limited self-awareness, and problems with 
executive functioning associated with ASD (Glidden, Bouman, Jones, & Arcelus, 2016; van 
der Miesen & de Vries, 2017).  
 
1.5.5. Ongoing assessment at a transgender health service 
After the initial assessment process has ended, it is necessary throughout the treatment 
process for the patient to have ongoing assessment at the transgender health service. Patients 
can usually expect to have three or four appointments a year. During these appointments, 
gender affirming medical interventions will be offered, if appropriate, and outcomes 
evaluated. Support on issues relating to social, occupational, family and relationship issues 
will also be offered. Some transgender people may wish to obtain a Gender Recognition 
Certificate (GRC) which allows the individual to change their name and gender on their birth 
certificate. It is not possible to make such changes without a GRC and the clinician(s) 
involved in the patient’s care can facilitate and support the individual with obtaining a GRC.  
 
1.5.6. Cross-sex hormone treatment  
Cross-sex hormone treatment refers to the administration of sex hormones that are different 
to the naturally occurring sex hormones associated with a person’s sex. Cross-sex hormones 
will facilitate the development of the secondary sex characteristics (e.g., hair, fat and muscle 
distribution) associated with the person’s gender identity (Seal, 2017). To achieve this, 
transgender males will be prescribed testosterone and transgender females will be prescribed 
oestrogen. Some people who identify outside the binary gender system may also request sex 
hormones that are different from the sex hormones that are associated with their gender 
assigned at birth. Cross-sex hormone treatment in the UK is funded by the NHS. Prior to the 
prescription of cross-sex hormone treatment, discussions about the negative effects on 
fertility and potential health risks should be discussed at length and, following this, informed 
consent obtained (Wylie et al., 2014).  
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1.5.6.1. Cross-sex hormone treatment: Testosterone 
Treatment seeking transgender males, as well as some transgender people who identify 
outside the binary gender system (but were assigned female at birth), will usually request the 
prescription of testosterone. Testosterone therapy will induce the development of facial hair 
after six to nine months and is maximal after 48-56 months (Hembree et al., 2009). 
Testosterone therapy will also encourage body hair to grow in a male pattern (i.e., chest, 
abdomen, back; Meyer et al., 1986). At the same time, testosterone therapy may induce male 
baldness (Seal, 2017). Testosterone therapy will also increase muscle mass in a male pattern 
and decrease body fat, especially around the hips and buttocks (Meyer et al., 1986). After 
three to four months of testosterone therapy, the clitoris will increase in size and 
approximately two to three cycles after the administration of testosterone, cessation of 
menses (amenorrhea) will occur (Seal, 2017). About nine to 12 months into testosterone 
treatment the voice will start to break and deepen (Hembree et al., 2009). To maintain these 
changes, testosterone is prescribed for life. In some circumstances, transgender males (or 
non-binary people) may pause their testosterone treatment for child birth (if the uterus hasn't 
been removed).  
 
1.5.6.2. Cross-sex hormone treatment: Oestrogen   
Treatment seeking transgender females, as well as some transgender people who identify 
outside the binary gender system (but were assigned male at birth), will usually request the 
prescription of oestrogen. Oestrogen therapy induces the development of breasts after about 
two to three months and full breast growth will be achieved after approximately two years 
(Seal, 2017). Oestrogen therapy will also soften the skin and reduce the production of facial 
hair. The effects of oestrogen therapy on facial hair are maximal after four months and many 
people will seek further treatment, such as electrolysis or laser therapy (Seal, 2017). 
Oestrogen therapy will reduce muscle mass and increase body fat (average weight gain 3.8 
kg) mainly around the hips and buttocks (Elbers et al., 2003). Oestrogen therapy will also 
reduce penile function and libido (Seal, 2017), but oestrogen therapy does not change the 
tone or pitch of the voice. As with testosterone therapy, oestrogen therapy is prescribed for 
life. However, oestrogen therapy is paused approximately 6 months prior to undergoing any 
non-emergency surgery (not just gender affirming surgery), so as to minimise the risk of deep 
vein thrombosis (i.e., blood clots).  
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1.5.6.3. Testosterone blockers 
People who are prescribed oestrogen will also sometimes be prescribed testosterone blockers 
(i.e., GnRH analogues). The aim of this intervention is to suppress the production of 
testosterone. Testosterone blockers do not change secondary sex characteristics. If the testes 
(where testosterone is produced) are removed, it is no longer necessary to take GnRH 
analogues. However, not every individual will wish to undergo genital affirming surgery.  
 
1.5.7. Surgical interventions  
Some transgender people will feel that cross-sex hormone treatment alone is sufficient to 
align their body with their gender identity and therefore choose not to undergo gender 
affirming surgeries. Others may be concerned about surgical outcomes or be fearful of 
undergoing such procedures and therefore choose not to. However, there are a significant 
proportion of transgender people who will choose to undergo surgeries to align their body 
with their gender identity. The amount of surgery a person chooses to undergo is a personal 
choice. The different surgeries transgender people may choose to undergo are discussed 
below separately for people who were assigned female at birth and male at birth.  
 
1.5.7.1. Surgical interventions for people assigned female at birth 
As testosterone therapy has little effect on the breast tissue, many transgender males or 
people with a non-binary gender identity (who were assigned female at birth) will wish to 
undergo a mastectomy (where the breast tissue is removed) and chest reconstructive surgery 
(Yelland, 2017). People can be referred for these interventions six months after the initiation 
of testosterone therapy (Wylie et al., 2014). Some patients may wish to undergo a 
phalloplasty which is a series of complex operations to create a phallus usually undertaken in 
three stages (although more than one operation may be required per stage) which can span 
approximately 18 months as operations are scheduled at least three months apart for adequate 
healing to take place (Christopher et al., 2017). This procedure will create a cosmetically 
acceptable phallus which can be used for penetrative sexual intercourse (Christopher et al., 
2017). If a patient does not wish to use their penis for penetrative sexual intercourse, they 
may choose to undergo a metoidioplasty to create a phallus. This is a much less complex and 
risky procedure than a phalloplasty and can usually be completed in two or three operations 
(Christopher et al., 2017). People can be referred for phalloplasty 12-18 months after social 
gender role transition and cross-sex hormone treatment (Christopher, Ralph, & Garaffa, 2017; 
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Wylie et al., 2014).  Both chest and genital surgery for transgender people assigned female at 
birth is funded by the NHS. 
 
1.5.7.2. Surgical interventions for people assigned male at birth 
Some transgender females or people with a non-binary gender identity (who were assigned 
male at birth) may also wish to be considered for genital surgery to create a vagina, labia and 
clitoris (vaginoplasty) which is recommended at least 12 months after a social gender role 
transition has been made (Wylie et al., 2014). In this UK, this treatment is funded by the 
NHS. When speech and language therapy has not been successful, patients may be referred 
for phonosurgery (vocal cord surgery) to change the tone and pitch of the voice. This 
intervention is not funded by the NHS. Due to insufficient breast growth, some transgender 
women (or non-binary people) may seek breast augmentation, although this treatment is 
currently not funded on the NHS (Yelland, 2017). Some transgender women (or non-binary 
people) may also seek facial feminisation surgery and/or a cricothyroid (Adam’s apple) 
shave; neither of which are funded by the NHS. Although the latter four treatments are not 
funded by the NHS they are associated with positive outcomes, such as an increase in 
perceived gender congruence and mental well-being (e.g., Wylie et al., 2014), and therefore 
people may seek to undergo these treatments privately. 
 
1.5.8. Aftercare 
After the patient feels that they have reached the end of their transition (i.e., they feel their 
body aligns with their gender identity) and no longer require support, they can be discharged 
from the transgender health service. The service will provide information and guidance to the 
individual’s GP so that they can take responsibility for the patient’s care thereafter. As noted 
above, patients who are taking cross-sex hormones will do so for the rest of their lives and 
therefore it is important that this is monitored in the long term to minimise the health risks 
associated with this type of intervention (Seal, 2017; Unger, 2016; Wylie et al., 2014). 
 
1.6. Support organisations for transgender people within the UK 
Transgender people may also seek support though dedicated organisations. Across the UK 
there are several support organisations and charities specifically for transgender people (e.g., 
Gender Trust, Gendered Intelligence, Nottingham Chameleons). Some support networks 
operate through the internet, while others organise support meetings and events within the 
local community. The type and level of support offered by these organisations and charities 
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can differ greatly. Some support organisations will solely offer an opportunity to socialise 
with other transgender people while others will provide peer support or formal information 
and advice about various aspects of being transgender, making a social gender role and 
medical transition, and mental health. These support organisations are usually open to anyone 
who identifies as transgender, including people who identify outside the binary gender 
system (although some groups may be dedicated to transgender males or females only, for 
example). Some organisations are also open to the family and friends of transgender people 
so that they themselves can seek advice and support. Some transgender people may seek 
support (in various forms) through these organisations and never attend a transgender health 
service, while others may have been in contact with both outlets. Some transgender people 
may never access a support organisation. As not all transgender people will wish to undergo 
gender affirming medical interventions, transgender support organisations are likely to be in 
contact with a broader range of transgender people than transgender health services. In 
recognising this, transgender support organisations within the UK were contacted to facilitate 
the recruitment of transgender people for some of the studies reported on in this thesis.  
 
1.7. Mental health within the transgender population 
1.7.1. General mental health  
Although being transgender is not considered a mental health problem (as discussed in 
section 1.4.), treatment seeking transgender people who have not initiated a medical 
transition have been found to report higher levels of depression, anxiety and non-suicidal 
self-injury in comparison to the cisgender population (e.g., Arcelus et al., 2016; Bouman et 
al., 2016a; Dhejne et al., 2016; Reisner et al., 2016). Several academics have attributed the 
high levels of mental health problems in the transgender population to minority stress. 
Hendricks and Testa (2012) and Meyer (2003) stated that people with minority identities 
(e.g., transgender, gay, lesbian) may experience stigma, prejudice and discrimination (i.e., 
transphobia) as a result of their identity which can put them at risk of mental health problems. 
Internalising these negative attitudes can also lower self-esteem (Hendricks & Testa, 2012; 
Meyer, 2003). It is, however, important to note that a recent systematic review of the mental 
health and transgender literature concluded that serious psychiatric and mental health 
disorders (e.g., bipolar, schizophrenia) in the transgender population are no higher than in the 
cisgender population (Dhejne et al., 2016). 
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1.7.2. Body dissatisfaction and disordered eating  
Treatment seeking transgender people often report very high levels of body dissatisfaction; 
much higher than levels of body dissatisfaction typically found within the cisgender 
population (e.g., Kozee, Tylka, & Bauerband, 2012; Witcomb et al., 2015). The majority of 
research concerned with body dissatisfaction in transgender individuals has focused on sex 
characteristics that are associated with gender assigned at birth (e.g., genitals) which this 
population is unsurprisingly often severely dissatisfied with (e.g., van de Grift et al., 2016a; 
2016b; 2016c). Body dissatisfaction within the transgender population has been associated 
with disordered eating attitudes and behaviour (e.g., Ålgars, Alanko, Santtila, & Sandnabba, 
2012). This is not surprising as body dissatisfaction has also been associated with disordered 
eating attitudes and behaviour within the cisgender population (Stice & Shaw, 2002). It has 
been hypothesised that transgender people engage in disordered eating to suppress body 
features associated with the gender assigned at birth and to accentuate features associated 
with their gender identity (Ålgars et al., 2012). When body dissatisfaction in transgender 
people has been compared to people with eating disorders and to controls (cisgender people 
with no eating disorders), transgender people who had not undergone gender affirming 
surgery were found to report levels of body dissatisfaction that were much higher than 
controls and were similar to people with an eating disorder (Bandini et al., 2013). In contrast, 
for transgender people who had undergone gender affirming surgery, body dissatisfaction 
was significantly lower than for people with an eating disorder but was not as low as for 
those in the control group (Bandini et al., 2013). Why transgender people still report levels of 
body dissatisfaction that are higher than the cisgender population after gender affirming 
surgery might be explained by the fact that transgender people often report dissatisfaction 
with all body parts and not just sex-specific body parts that are affected by gender affirming 
medical interventions (e.g., Becker et al., 2016; van de Grift et al., 2017a; 2017b; Witcomb et 
al., 2015). In some ways, body dissatisfaction is likely to be similar to dissatisfaction 
experienced by the cisgender population (i.e., dissatisfaction with general body shape). At the 
same time, dissatisfaction with shape and weight within the transgender population might 
differ from the shape and weight dissatisfaction experienced by cisgender people. 
Transgender people may be dissatisfied with parts of their body they feel do not align with 
their gender identity. For instance, transgender males may feel they are too curvaceous or are 
lacking muscle on their upper torso. In contrast, transgender females might feel that they are 
too muscular on their upper torso and would prefer a more curvaceous body shape. Taking 
cross-sex hormones (if this is want a person wishes) will change body shape in accordance 
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with gender identity to a certain degree. However, there is no medical or physical 
intervention that can, for example, increase the size of the pelvis (to give a feminine 
hourglass shape) or decrease the size of the pelvis (to diminish a feminine hourglass shape) 
(Elbers et al., 2003; Meyer et al., 1986). It is therefore evident that interventions other than 
gender affirming medical treatments need to be considered to help alleviate broader body 
dissatisfaction within the transgender population. 
 
1.7.3. Alleviation of mental health problems and body dissatisfaction 
1.7.3.1. Gender affirming medical interventions  
There has been very little research which has considered the effects that gender affirming 
medical interventions might have on gender incongruence and gender distress. This is 
concerning seeing as this is the primary reason transgender people access transgender health 
services and seek gender affirming medical interventions. The lack of empirical data on these 
important outcomes can be attributed to the lack of measures available to assess such 
outcomes. To compensate for this, research has tended to focus on mental health and body 
dissatisfaction as an outcome of gender affirming medical interventions. While this is still 
important to assess due to the high prevalence of mental health problems and body 
dissatisfaction experienced within this population (e.g., Dhejne et al., 2016; Witcomb et al., 
2015; see sections 1.7.1. and 1.7.2.), alleviating poor mental health and body dissatisfaction is 
not the primary aim of gender affirming medical interventions and interventions that address 
poor mental health and body dissatisfaction are not usually offered at transgender health 
services (Arcelus & Bouman, 2015; Dhejne et al., 2016).  
 
Although the literature is limited, on the whole studies that have explored outcomes of gender 
affirming medical interventions have reported improvements in mental health (Davis & 
Meier, 2014; De Cuypere et al., 2006; Gorin-Lazard et al., 2012; Heylens et al., 2014; 
Lindqvist et al., 2017; Murad et al., 2010; Ruppin & Pfäfflin 2015). Gender affirming 
medical interventions have also been found to be successful at alleviating dissatisfaction with 
sex-specific body parts (Fisher et al., 2014; Kraemer, Delsignore, Schnyder, & Hepp, 2008; 
Smith, Van Goozen, Kuiper, & Cohen-Kettenis, 2005; van de Grift et al., 2017a). It could be 
assumed that if body dissatisfaction is associated with disordered eating within the 
transgender population (Ålgars et al., 2012), then eating disorder symptoms would also 
alleviate following gender affirming medical interventions. However, research concerned 
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with disordered eating and gender affirming medical interventions is scarce and therefore 
conclusions cannot be drawn.  
 
Although these findings on the most part are positive, it is important to consider that not 
every transgender person will wish to undergo a medical transition with cross-sex hormones 
and gender affirming surgeries and therefore these interventions are not suitable to alleviate 
mental health problems and body dissatisfaction in all circumstances. In addition, for 
transgender people who are treatment seeking, accessing transgender health services can be a 
lengthy process (see section 1.5.2.) and therefore it may be necessary to recommend mental 
health and body dissatisfaction interventions that can take immediate effect. For some 
treatment seeking transgender people, poor mental health and body dissatisfaction may also 
continue even after they have undergone a medical transition. For instance, higher levels of 
body dissatisfaction when first referred to a transgender health service have been associated 
with higher levels after gender affirming medical interventions (van de Grift et al., 2017a). In 
such circumstances, frequent physical activity and/or sport engagement may be a particularly 
beneficial intervention in order to address poor mental health and body dissatisfaction in the 
transgender population.  
 
1.7.3.2. Physical activity and sport 
Within the cisgender literature, it is well established that engaging in regular physical activity 
and/or sport is associated with alleviating mental health problems, especially symptoms of 
anxiety and depression (e.g., Carter, Morres, Meade, & Callaghan, 2016; Herring, Jacob, 
Suveg, & O’Conner, 2011; McMahon et al., 2017; Rebar et al., 2016). The NHS also 
currently recommends engaging in frequent physical activity (at least three times a week) to 
alleviate mild to moderate levels of depression (National Institute for Health and Care 
Excellence (NICE), 2016). Body satisfaction has also been positively associated with 
physical activity and/or sport engagement in cisgender individuals (e.g., Cox, Ullrich-French, 
Howe, & Cole, 2017; Kruger, Lee, Ainsworth, & Macera, 2008; Lantz, Hardy, & Ainsworth, 
1997). In light of this, it would seem that populations who are particularly vulnerable to poor 
mental health and body dissatisfaction, such as transgender people, would benefit from 
frequent engagement in physical activity and/or sport. However, research conducted with the 
transgender population in relation to physical activity and sport is scarce and there are several 
limitations with the small amount of research that has been conducted (this is discussed in 
more detail in section 1.7.5.2.). Considering this, determining whether physical activity 
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and/or sport would be a feasible mechanism to alleviate poor mental health and body 
dissatisfaction within the transgender population is currently difficult.  
 
1.7.4. Physical health of the transgender population  
In addition to the mental health benefits that physical activity and/or sport participation are 
likely to have for transgender people, physical activity and/or sport may also be beneficial for 
physical health, especially for people who choose to medically transition with cross-sex 
hormones and gender affirming surgeries. Prior to undergoing gender affirming surgeries, it 
is necessary for transgender people to have a suitable Body Mass Index (BMI). A suitable 
BMI is usually considered 30 or below. However, in some circumstances, surgeons may 
accept patients with BMIs greater than 30. In addition, cross-sex hormones may put 
transgender females (or people taking oestrogen therapy) at risk of cardiovascular disease, 
and transgender males (or people who take testosterone therapy) might be more susceptible to 
factors associated with cardiovascular disease (Unger, 2016). Therefore, to maintain a 
suitable BMI for gender affirming surgery and a healthy heart, physical activity and/or sport 
engagement is likely to be essential for the treatment seeking transgender population.  
 
1.7.5. Limitations of the extant transgender physical activity, body dissatisfaction and mental 
health literature  
1.7.5.1. Measurement issues  
The challenges encountered by transgender people which put them at greater risk of mental 
health problems and body dissatisfaction need to be addressed. However, research within 
these areas has largely used self-report measures that have been developed and validated with 
the cisgender population (e.g., the Hospital Anxiety and Depression Scale; Zigmond & 
Snaith, 1983), or other specific populations, such as people with eating disorders (e.g., the 
Eating Disorder Inventory-2; Garner, 1991). This is somewhat problematic as these measures 
are unlikely to be specific enough to be used with the transgender population (i.e., because 
they do not assess mental health and body dissatisfaction in relation to gender identity 
issues). The use of such measures might have limited the current understanding of mental 
health problems and body dissatisfaction within the transgender population and, in particular, 
how and why these might differ from experiences of the cisgender population. Without 
understanding mental health issues and body dissatisfaction specifically among transgender 
people, targeted interventions to better support this population cannot be identified and 
developed. The research concerned with mental health problems and body dissatisfaction in 
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the transgender population is also inconsistent in relation to the measures employed across 
studies. This is problematic because the results are not comparable across studies and this 
then limits the ability to draw conclusions from research concerned with mental health 
problems and body dissatisfaction within the transgender population. After systematically 
reviewing the mental health literature, Dhejne et al. (2016) concluded that the findings within 
this area are limited by such measurement issues. However, an important omission is that the 
literature concerning body dissatisfaction was not synthesised. The body dissatisfaction 
literature would benefit from its findings being drawn together so that a current 
knowledgebase can be developed and so that limitations and areas for future research can be 
identified.   
 
1.7.5.2. Sample issues  
For the most part, research investigating physical activity, body dissatisfaction and mental 
health within the transgender population has recruited very small sample sizes. While this 
research has made important inroads, the generalisability of such findings is limited. 
Research in these fields has also recruited transgender people who are at varying stages of 
social and medical transition. This is significant as the stage of social and medical transition, 
and whether or not a person is treatment seeking, will likely impact physical activity levels, 
body dissatisfaction and mental health. After reviewing the literature, Dhejne et al. (2016) 
concluded that mental health symptoms in transgender people dissipate to levels found within 
the cisgender population following gender affirming medical interventions. However, the 
findings regarding body dissatisfaction need to be unpacked further and subsequently 
synthesised in order to establish at what stage of social and medical transition transgender 
people are most vulnerable to body dissatisfaction and which gender affirming medical 
interventions are associated with good outcomes.  
 
The evidence that has been presented in sections 1.7.3.2. and 1.7.4. shows that physical 
activity and/or sport engagement is likely to have benefits for transgender people’s mental 
and physical health. Physical activity and sport research is extremely limited. To date, 
research has been conducted with both transgender people who engage recreationally in 
physical activity and/or sport for leisure and fitness, as well as transgender people who 
engage in competitive sport at an elite level. As the experiences of people who engage in 
physical activity and/or sport recreationally compared to those who engage at an elite level 
are likely to greatly differ, it is very difficult to determine from the existing literature whether 
Chapter 1: General introduction 
 
20 
 
physical activity and/or sport would be a feasible mechanism to improve mental and physical 
health within the transgender population. Synthesising the research in this area would 
facilitate a better understanding of whether physical activity and/or sport can feasibly be used 
to alleviate poor mental health and body dissatisfaction within the transgender population. 
Additionally, the physical activity and sport literature would benefit from being drawn 
together so it can be determined at what point of a transition physical activity and/or sport 
might be able to alleviate mental health problems and body dissatisfaction, whether physical 
activity and sport are accessible to the transgender population and, if necessary, how physical 
activity and sport can be made more accessible to transgender people.   
 
1.8. Chapter summary 
Poor mental health, body dissatisfaction and subsequent vulnerability to disordered eating 
impose significant challenges for the treatment seeking transgender population. Research 
suggests gender affirming medical interventions (for transgender people who are treatment 
seeking) may be particularly beneficial in alleviating mental health problems and body 
dissatisfaction (as well as vulnerability to disordered eating). In addition, physical activity 
and/or sport may be beneficial for the mental and physical health of the transgender 
population. However, the conclusions drawn from this literature concerned with physical 
activity, body dissatisfaction and mental health are limited due to that fact that self-report 
measures do not assess these constructs in relation to gender incongruence. There is also 
variability in the self-report measures employed which makes it hard to compare findings 
across studies. In addition to this, research to date has tended to employ small samples who 
are heterogeneous in relation to the stage of transition which has affected research findings. 
For these reasons, it is evident that conducting a systematic review of literature that pertains 
to physical activity and sport, as well as systematically reviewing literature related to body 
dissatisfaction and disordered eating, is required to advance the field. Conducting such 
reviews of the existing literature will serve to synthesise the current knowledge and establish 
areas for future research so that challenges relating to physical activity engagement, body 
dissatisfaction and poor mental health can be addressed within the transgender population.  
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1.9. Initial aims of the thesis 
Based on the limitations with past research outlined above, including the use of numerous 
different measures with different samples in existing research with the transgender 
population, the initial aims of this thesis are to:  
1) Systematically review the literature concerned with physical activity and sport in 
the transgender population. 
2) Systematically review the literature concerned with body dissatisfaction and 
disordered eating within the transgender population.  
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Chapter 2 
Sport in transgender people: A systematic review of the literature relating 
to sport participation and competitive sport policies 
 
This chapter has been published in Sports Medicine (impact factor: 6.84) as:  
Jones, B. A., Arcelus, J., Bouman, W. P., & Haycraft, E. (2016). Sport and transgender 
people: a systematic review of the literature relating to sport participation and competitive 
sport policies. Sports Medicine, 47(4), 701-716.  
36Thttps://link.springer.com/article/10.1007/s40279-016-0621-y 36T  
 
The content of chapter 2 is largely the same as the published paper, however some small 
changes have been made to the formatting and presentation to ensure it is consistent with the 
rest of the chapters that comprise this thesis.  
 
Statement of authorship 
Research conception and design: BJ, JA & EH. 
Data collection: BJ. 
Data analysis and interpretation: BJ, JA & EH. 
Drafting of article: BJ. 
Article editing and revisions: BJ, JA, WB & EH. 
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2.1. Abstract 
Whether transgender people should be able to compete in sport in accordance with their 
gender identity is a widely contested question within the literature and among sport 
organisations, fellow competitors, and spectators. Due to concerns surrounding transgender 
people (especially transgender females) having an athletic advantage, several sport 
organisations place restrictions on transgender competitors (e.g., must have undergone gender 
confirming surgery). In addition, some transgender people who engage in sport, both 
competitively and for leisure, report discrimination and victimisation. To the authors’ 
knowledge, there has been no systematic review of the literature pertaining to sport 
participation and competitive sport policies in transgender people. Therefore, this review 
aimed to address this gap in the literature. Eight research articles and 31 sport policies were 
reviewed. In relation to sport-related physical activity, this review found the lack of inclusive 
and comfortable environments to be the primary barrier to participation for transgender 
people. This review also found transgender people had a mostly negative experience in 
competitive sport due to the restrictions sport policy placed on them. The majority of 
transgender competitive sport policies that were reviewed were not evidence-based. In 
conclusion, currently there is no direct or consistent research that suggests transgender 
females (or males) have an athletic advantage at any stage of their transition (e.g., cross-sex 
hormones, gender confirming surgery) and, therefore, competitive sport policies that place 
restrictions on transgender people needs to be considered and potentially revised.  
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2.2. Introduction 
Transgender people are those who experience incongruence between the gender that they 
were assigned at birth (based on the appearance of their genitals) and their gender 
identity/experienced gender. Gender identity, or experienced gender, can be defined as a 
person’s internal sense of gender, whether this be male, female, neither or somewhere along 
the gender continuum. Some transgender people, but not all, will choose to affirm their 
gender identity by socially transitioning (i.e., living as their experienced gender socially, at 
work or education, with friends and family, outside the house) and some in addition will 
choose to medically transition with cross-sex hormones and gender confirming surgeries 
(Coleman et al., 2012; Wylie et al., 2014). Although over time various different terms have 
been used, the term transgender female will be used to describe individuals assigned male at 
birth, based on their genital appearance, but who later identify as female. Transgender male 
will be used to describe people who are assigned female at birth, based on their genital 
appearance, but later identify as male. Cisgender will be used to describe people who do not 
experience incongruence between their gender assigned at birth and their gender identity. 
 
Recent reports indicate that the number of transgender individuals who attend transgender 
health services has increased substantially over the years in many European countries 
(Arcelus et al., 2015; Aitken et al., 2015; de Vries, Kreukels, T’Sjoen, Ålgars, & Mattila, 
2015). There has also been a significant increase in the number of people who self-identify as 
transgender and do not necessarily attend transgender health services (Kuyper & Wijsen, 
2014). For example, Kuyper and Wijsen (2014) found that 4.6% of people who were assigned 
male at birth and 3.2% of people who were assigned female at birth in their Dutch population 
sample reported an ambivalent gender identity (equal identification with the other gender as 
with the gender they were assigned at birth). The authors also reported that 1.1% of the 
people who were assigned male at birth and 0.8% of the people who were assigned female at 
birth identified as transgender. It remains unknown how many of these people will seek 
treatment through a transgender health service. The increase in people who identify as 
transgender may be at least partly explained by the increase in visibility of transgender 
people within Western society (Aitken et al., 2015; de Vries et al., 2015). For example, 
Caitlyn Jenner, a former athlete and current television personality, recently came out as 
transgender during a television interview which was viewed all over the world (Dooley et al., 
2015). Increases in visibility may have prompted some people to reflect and question their 
gender identity (Bouman, de Vries, & T’Sjoen, 2016).  
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Some transgender people experience stigma, transphobia, prejudice, discrimination and 
violence as a consequence of their gender identity (i.e., transphobia) (Claes et al., 2015; Hill 
& Willoughby, 2005; Mizock & Mueser, 2014). Ellis, McNeil and Bailey (2014) found that 
transgender people were more likely to avoid situations when they were afraid of being 
harassed, identified as transgender, or ‘outed’, such as clothes shops, public toilets and gyms. 
Gyms are a popular outlet to engage in sport-related physical activities (i.e., gym fitness 
exercises) and therefore it is important to create an inclusive environment given the 
established mental and physical health benefits of physical activity and sport (De Moor, 
Beem, Stubbe, Boomsma, & De Geus, 2006; Maltby & Day, 2001). This is particularly 
important for transgender people as they have been found to report a high prevalence of 
depression and anxiety (Dhejne et al., 2011; Hepp, Kraemer, Schnyder, Miller, & Delsignore, 
2005), which could be managed with physical activity. Furthermore, physical activity and 
sport can also contribute towards maintaining the appropriate weight necessary to undergo 
gender confirmation surgery, acknowledging that not every transgender person will wish to 
do so (Beek, Kreukels, Cohen-Kettenis, & Steensma, 2015; Coleman et al., 2012; Wylie et 
al., 2014).   
 
The premise of competitive sport is fairness (i.e., inclusion in the absence of advantage) and, 
due to fears surrounding the perceived athletic advantage of transgender people, the question 
of whether or not transgender people should be permitted to compete in accordance with their 
gender identity has been raised and greatly contested within the literature, among sport 
organisations, fellow competitors and spectators. It is a commonly held belief that androgenic 
hormones (especially testosterone) confer an athletic advantage in competitive sport. 
Therefore transgender females, because of high endogenous testosterone levels, are perceived 
to hold an advantage in sport (when testosterone has not been blocked to a cisgender female 
level). Transgender men are not thought to possess an athletic advantage, despite being 
injected with testosterone if they chose to medically transition with cross-sex hormones. 
However, there has been a paucity of research that has directly explored how androgenic 
hormone levels are associated with athletic competence in both cisgender and transgender 
populations (e.g., running time).  
 
To facilitate the inclusion of transgender competitors, in 2004, the International Olympic 
Committee (IOC) announced that transgender people could participate in all future Olympic 
games providing they had fully medically transitioned (i.e., had been prescribed cross-sex 
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hormone treatment for 2 years and undergone gender confirming surgery). Although the 
requirements of this policy appear to concur with the commonly held belief that transgender 
people hold an athletic advantage, they have been criticised for not being underpinned by 
evidence-based rationale (Cavanagh & Sykes, 2006). The IOC (2016a) has recently updated 
its policy to be more inclusive of transgender athletes (i.e., fewer restrictions); however the 
2004 policy has been extremely influential on other sport organisations’ policy development. 
The new (2016a) IOC policy will be considered in the results section of this review. 
 
In an attempt to draw a consensus as to whether transgender people should be able to 
compete in accordance with their gender identity or not, Reeser (2005) conducted a review in 
2005 of the literature pertaining to gender identity issues in competitive (elite) sport. Reeser 
paid particular attention to the evolution of gender verification in competitive sport and 
whether current competitive sport policies for transgender people are fair. He concluded that, 
while gender verification has made significant advances, there is a lack of physiological 
performance-related data in transgender people. This is preventing an overall consensus from 
being made as to whether transgender sport policies are fair or not (i.e., fairness in the 
absence of advantage). Reeser’s review, although important, has some limitations. He did not 
adopt a systematic methodology and therefore did not include the majority of transgender 
sport policies. Additionally, Reeser only considered the implications of such policies in 
relation to elite competitive sport and did not consider the experiences of transgender people 
who engage in sport or sport-related physical activity for leisure or fitness (e.g., gym fitness 
activities, jogging).  
 
With the intention of addressing the limitations of the previous literature review, this 
systematic review has two aims. First, to systematically analyse and critically review the 
available literature regarding transgender people’s experiences in relation to competitive 
sport (elite and recreational) and sport-related physical activity participation (e.g., jogging, 
gym fitness activities). Second, to systematically review the available transgender 
competitive sport policies regarding their fairness (i.e., competition in the absence of 
advantage). It is hoped that this systematic review will further enhance the understanding of 
sport participation and competition amongst transgender people. It may be expected that, as 
more people define themselves as transgender, the issues that transgender people experience 
in competitive sport and sport-related physical activity will become more pronounced. It is 
therefore important that those who work to facilitate and promote sport and develop policies 
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for their own sport organisations (e.g., sport medicine specialists, sport policy makers) are 
informed about the issues that this vulnerable population face. This will allow for a non-
discriminatory atmosphere in sport, whilst ensuring a fair system for all participants and 
competitors (regardless of their gender identity).   
 
2.3. Method 
2.3.1. Search strategy  
PRISMA guidelines were followed to undertake this systematic review (Moher, Liberati, 
Tetzlaff, Altman, & PRISMA Group, 2009). To obtain relevant peer reviewed articles, an 
electronic search of literature published between January 1966 and August 2015 was 
conducted using the following search engines: ScienceDirect, Web of Science, Scopus, and 
PubMed. Within each search engine, the following search terms were entered: gender 
dysphoria, gender identity disorder, trans people, trans individual, transgender, and 
transsexual. These terms were combined with three terms relating to sport (physical activity, 
exercise and sport) using the “AND” operator. The reference lists of eligible papers were 
searched for potentially relevant publications. Sport policies were obtained through a Google 
search using the above search terms with the addition of “policy” at the end of all sport 
related terms.   
 
2.3.2. Inclusion and exclusion criteria 
To address the first aim, articles that were selected were concerned with the experiences and 
issues surrounding physical activity and sport participation for transgender people. This 
systematic review only considered articles eligible if they were research articles, as opposed 
to discussion papers. Case studies were also considered eligible, as research articles were 
limited. Peer reviewed articles that were written in English only were included. For the 
second aim, all available national and international policies on competitive sport in 
transgender people were selected and reviewed. 
 
2.3.3. Study selection 
Thirty-one research articles were considered potentially relevant to the remit of this review. 
The search also identified 31 competitive sport policies for transgender people. After 
screening the abstracts, 10 research articles were excluded as six were concerned with LGBT 
(lesbian, gay, bisexual and transgender) sport, one was a Scottish non-academic survey, one 
was a book chapter, one was concerned with an irrelevant topic, and another with cisgender 
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participants. The remaining 21 articles were downloaded for full text review and 13 papers 
were excluded as they were discussion papers, as opposed to research articles. Therefore, 
eight research articles fulfilled the inclusion criteria and were consequently included within 
this systematic review (see Figure 2.1.). All 31 competitive sport policies for transgender 
people were reviewed and included within this systematic review.  
 
31 potentially relevant 
papers identified from 
literature review
13 papers excluded because:
• Discussion papers (not 
research articles)
21 papers 
selected for 
full text 
retrieval
10 papers excluded based on 
screening the abstract because:
• LGBT (n=6)
• Scottish survey (n=1)
• Book chapter (n=1)
• Irrelevant topic (n=1)
• Cisgender participants (n=1)
8 papers met 
the full 
inclusion 
criteria
Selection stage
Eligibility stage
Eligible papers
 
Figure 2.1. The process of identifying eligible research articles 
LGBT: Lesbian, gay, bisexual, transgender 
 
2.4. Results 
This section presents the findings from the research articles and sport policies included within 
this systematic review. First, the findings from the research articles that explored 
participation in sports (both elite and recreational standards) and sport-related physical 
activities (i.e., gym fitness activities, jogging) are provided. Second, findings from the 
reviewed competitive sport policies relating to transgender inclusion are given.  
 
2.4.1. Transgender people and sport participation  
2.4.1.1. Characteristics of the eligible research studies 
The oldest research article included was published in 2004 (Gooren & Bunck, 2004) and the 
most recent publication was from 2015 (Hargie, Mitchell, & Somerville, 2015). The majority 
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of the studies were qualitative in nature, all of which employed interviews (Caudewell, 2012; 
Cohen & Semerjian, 2008; Hargie et al., 2015; Semerjian & Cohen, 2006; Tagg, 2012; 
Travers & Deri, 2011). The remaining two research articles included an experimental study 
(Gooren & Bunck, 2004) and a cross-sectional survey (Muchicko, Lepp, & Barkley, 2014). 
Most of the studies were concerned with transgender people who participated in sport 
competitively, at an elite or recreational level (Reeser, 2005; Gooren & Bunck, 2004; 
Caudwell, 2012; Cohen & Semerjian, 2008; Semerjian & Cohen, 2006; Tagg, 2012; Travers 
& Deri, 2011). Some authors focused on a specific sport; ice hockey, netball and softball 
(Cohen & Semerjian, 2008; Tagg, 2012; Travers & Deri, 2011) while others were concerned 
with transgender people engaging in any sport (Caudwell, 2012; Semerjian & Cohen, 2006; 
Travers & Deri, 2011). Broadly across all sports, Gooren and Bunck (2004) explored whether 
transgender athletes have a physiological advantage in competitive sport. One study explored 
participation in competitive sports and sport-related physical activity (Hargie et al., 2015) and 
another study discussed participation in sport-related physical activity only (Muchicko et al., 
2014). Details of all of the research articles included within this systematic review can be 
found in Table 2.1.  
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Table 2.1. Study characteristics of research articles included within the review 
Reference Year Country Aim(s) Sample size (N) Study design  Main finding(s)  
Caudwell  2012 UK To explore two transgender males’ 
experience of sport in an educational 
and recreational environment 
2 Qualitative (semi-
structured interviews) and 
a narrative review 
Four themes emerged: school sport, their 
embodied subjectivities, transitioning and sport 
participation.   
Cohen & Semerjian  2008 USA To explore the experience of a 
transgender female participating in 
women’s national ice hockey 
tournaments 
1 Qualitative (four open-
ended interviews) 
Five main themes: policed identity, internal 
conflict, traits of masculinity, affirmation and 
creating gender norms.  
Gooren & Bunck  2004 Netherlands To explore androgen deprivation and  
androgen administration in 
transgender people   
36 Retrospective study  Androgen deprivation in transgender females 
increases the overlap in muscles mass with 
women but does not reverse it.  
Hargie et al. 2015 UK To explore transgender people’s 
experiences of sport in relation to 
social exclusion and minority stress 
theory  
10  Qualitative study (semi-
structured interviews) 
Four themes emerged: intimidating nature of 
locker rooms, the impact of alienating sport 
experiences at school, fear of public space, and 
being denied the social, health and well-being 
aspects of sport.  
Muchicko et al. 2014 USA To explore the relationship between 
gender identity and physical activity  
80 Cross-sectional survey Transgender people reported less physical 
activity and reported lower social support and 
physical self-perception than the cisgender 
participants.  
Semerjian & Cohen  2006 USA To explore the experiences of 
transgender athletes, paying particular 
attention to whether gender identity or 
performance was related to 
participation  
4 Qualitative (semi-
structured interviews) 
Athletes discussed a number of barriers and 
challenges in relation to their sport participation 
(i.e., incorrect pronouns use, discomfort in 
changing rooms).  
Tagg  2012 Australia and 
New Zealand 
To understand the issues surrounding 
transgender athletes sport 
participation, specifically in relation 
to men’s netball in New Zealand 
2 Qualitative (semi-
structured interview) and a 
narrative review 
Transgender inclusive policies have medicalised 
gender. Instead of being protective they have 
done little to make sport fair for transgender 
participators. Transgender people who are 
undergoing physical transition have no place to 
openly participate in netball in New Zealand.   
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Reference Year Country Aim(s) Sample size (N)  Study design  Main finding(s)  
Travers & Deri  2011 Canada To examine the re-negotiation of sex 
based boundaries within the context of 
transgender inclusion in North 
American lesbian softball leagues 
12 Qualitative (semi-
structured interviews) 
Positive experiences were more often reported by 
transgender women than transgender men in 
relation to inclusion despite the re-negotiation of 
sex boundaries. 
Several participants perceived testosterone as an 
athletic advantage in transgender males (when 
injected) and females (endogenous).   
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2.4.1.2. Review of transgender people and competitive sport participation (elite and 
recreational): Research articles 
The same data were extracted from all research articles reviewed (see Table 2.1.). Below, we 
provide the most prominent findings in relation to competitive sport participation from each 
of these articles. Six research articles were concerned with competitive sport participation 
within this systematic review (Gooren & Bunck, 2004; Caudwell, 2012; Cohen & Semerjian, 
2008; Semerjian & Cohen, 2006; Tragg, 2012; Travers & Deri, 2011). The only experimental 
study was by Gooren and Bunck (2004) who aimed to explore whether transgender people on 
cross-sex hormone treatment can fairly compete in sport. The authors measured transgender 
people’s muscle mass (via magnetic resonance imaging) and hormone levels (via urine and 
blood analysis) before and one year after cross-sex hormone treatment. They found that one 
year after transgender males had been administered cross-sex hormone treatment, 
testosterone levels significantly increased and these levels were within a cisgender male 
range. They also found that one year after cross-sex hormone treatment, transgender males’ 
muscle mass had increased and was within the same range as transgender females (assigned 
male at birth) who had not been prescribed cross-sex hormone treatment. In relation to 
transgender females, Gooren and Bunck found testosterone levels had significantly reduced 
to castration levels after one year of cross-sex hormone treatment. Muscle mass had also 
reduced after one year of cross-sex hormone treatment. However, muscle mass remained 
significantly greater than in transgender males (assigned female at birth) who had not been 
prescribed cross-sex hormone treatment. Therefore, Gooren and Bunck concluded that 
transgender males are likely to be able to compete without an athletic advantage one year 
after cross-sex hormone treatment. To a certain extent this also applies to transgender 
females, however there still remains a level of uncertainty due to a large muscle mass one 
year after cross-sex hormones. While this study was the first to explore, experimentally, 
whether transgender people can compete fairly, the sample size was relatively small (N=36). 
Additionally, they did not explore the role of testosterone blockers and did not directly 
measure the effect cross-sex hormones had on athletic performance (e.g., running time). 
Many, but not all, transgender females are prescribed testosterone blockers in order to help 
them to reach cisgender female testosterone levels, when administration of oestrogen alone is 
not enough to reduce testosterone levels. This is particularly important if the person aims to 
undergo gender confirming surgery as six months of testosterone suppression is a 
requirement for such procedures. However, if a transgender woman does not wish to undergo 
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surgery or does not wish to have their testosterone blocked to cisgender female levels (e.g., as 
they wish to use their penis), their testosterone levels will be above cisgender female levels. 
Differentiating not only between those on cross-sex hormones and not on cross-sex 
hormones, but also transgender females on testosterone blockers, may be necessary when 
discussing athletic advantage.  
 
The remaining studies considered within this section are qualitative, and although they have 
provided insight into the experiences of transgender people participating in competitive sport, 
the findings cannot be generalised. Semerjian and Cohen’s (2006) narrative account provides 
a good overview of how diverse and individual the issues and experiences of transgender 
people participating in competitive sport can be. Some participants felt anxious when 
engaging in sport because they felt their genitals may be revealed (e.g., when changing). In 
contrast, one participant used sport as a safe space to escape from the harassment he received 
at school. It must be considered though, that participants within the study engaged in 
different sports and their experiences could therefore be associated with the specific sport 
(i.e., some sports could be more inclusive then others). 
 
Three qualitative studies described the implications that sport policies had on the experiences 
of transgender people who engaged in sport (Cohen & Semerjian, 2008; Tagg, 2012; Travers 
& Deri, 2011). Cohen and Semerjian (2008) published a case study about a transgender 
woman (before gender confirming surgery) who was playing in the women’s national ice 
hockey tournament, but who was eventually banned from playing in the tournament because 
it was felt she had an athletic advantage. She described how she felt under constant 
surveillance when she was playing and at times felt ambivalent about what gendered team 
she should play on. It was apparent that although teammates were supportive, the issues she 
experienced in relation to inclusion in the tournament were primarily related to constraints 
put in place by competitive sport policies. Similarly, the discussions held by two former New 
Zealand transgender female netball players in Tagg’s (2012) study gave the impression that 
although transgender sport policies were supposedly implemented to increase the inclusivity 
of transgender people, this was not always the case. They discussed how policy would allow 
a transgender women who had not under gone gender confirming surgery to compete in a 
male or mixed gender netball team only and they must obey male dress codes. However, the 
participants in this study were former netball players and therefore their discussions may not 
have been based on the current state of netball in relation to transgender participation. In 
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contrast to the previously mentioned studies, all of the participants (N=12) in Travers and 
Deri’s (2011) study discussed the positive experiences they had in relation to transgender 
participation in competitive sport. However, some of the transgender men did discuss how 
they had hostile experiences (e.g., incorrect pronoun use). Several of the participants in this 
study also felt that testosterone gave transgender women (endogenous) and men (when 
injected) an athletic advantage.  
 
For the two young transgender males in Caudwell’s (2012) study, the stage of transition 
appeared to be instrumental in disengagement from participation in competitive sport. The 
discussion held by the participants highlighted how accessing sport during their transitional 
period was difficult as they would not be accepted or feel comfortable on either a male or 
female team during this period. However, this study again discussed sport very broadly and 
therefore it is unknown whether the participants’ experiences were associated with specific 
sports or whether they are generalisable across other sports.  
 
In summary, there is limited research from which to draw any conclusion about whether 
transgender people have an athletic advantage in competitive sport or not. The limited 
physiological research conducted to date has informed the development of transgender sport 
policies that are implemented by sporting organisations all over the world. It is these sport 
policies that appear to be instrumental in transgender people’s experiences with competitive 
sport, most of which are negative.  
 
2.4.1.3. Review of transgender people and sport-related physical activities: Research 
articles 
Within this systematic review, only two studies explored sport-related physical activities 
Hargie et al., 2015; Muchicko et al., 2014). Muchicko et al. (2014) set out to quantitatively 
explore the relationship between gender identity and physical activity. They compared levels 
of physical activity between cisgender and transgender people. The study found that self-
identified transgender participants (n=33) reported engaging in less physical activity than 
cisgender participants (n=47). Social support and self-perception were found to mediate the 
relationship between gender identity and physical activity. The authors suggested that their 
study highlights how leisure centres need to be more inclusive, and transgender people need 
to be given more social support to encourage physical activity. However, this study was 
limited by the sampling methods employed. The cisgender participants were recruited from a 
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university campus where they potentially had more opportunity to walk around campus, and 
opportunity for discounted gym memberships, whereas the transgender participants were 
recruited from a support group for transgender people and were not associated with the 
university.  
 
As with transgender people who engage in sport at a competitive level, transgender people 
who engage in sport-related physical activity also appear to experience a range of different 
barriers. Hargie et al. (2015) found in their qualitative study that transgender people prefer to 
engage in individual, as opposed to group, sport-related physical activities. This was 
reportedly due to their fear of being ‘outed’. Regardless of whether sport-related physical 
activities are engaged in individually or in a group, changing rooms appeared to be a 
significant barrier. Being excluded from sport-related physical activities was distressing for 
participants, as they could not maintain physical fitness, which they felt was important in 
preparation for gender confirming surgery. Despite these interesting findings, the study is 
limited by the lack of socio-demographic information provided about participants. Within 
qualitative research, because of the small sample size, it is often desirable to provide a large 
amount of socio-demographic detail about participants so that the findings can be interpreted 
in relation to this information. For instance, in the context of sport-related physical activities, 
the stage of transition may be an important factor when interpreting the individuals’ current 
experiences of sport-related physical activities.   
 
The limited research studies concerned with sport-related physical activities suggest that 
inclusive environments are not created for transgender people engaging in such activities, 
which may deter engagement.  
 
2.4.2. Transgender inclusive sport policies 
2.4.2.1. Characteristic of the eligible sport policies 
Out of the 31 transgender inclusive policies reviewed, 13 were from the USA (Ladies 
Professional Golf Association, 2010; National Collegiate Athletic Association, 2011; The 
Association of Boxing Commissions, 2012; USA Gymnastics, 2015; USA Senior Softball, 
2014; USA Triathlon, n.d; USA Boxing, 2013; USA Sailing, 2013; USA Track and Field, 
2005; USA Swimming, 2013; US Soccer Federation, 2013; US Rowing, 2015; World Out 
Games, 2015). Ten of the policies reviewed were from the UK (Amateur Swimming 
Association, 2015; Badminton England, 2013; British Universities and Colleges Sport, 2012; 
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British Rowing, 2013; Rugby Football Union, n.d; Scottish Football Association, 2008; The 
Football Association, 2014; The Lawn Tennis Association, n.d; UK Roller Derby 
Association, 2014; Women’s Flat Track Derby Association n.d). One policy was from 
Australia (Disability Sport Australia, 2014). The rest of the policies (n=7) were international 
(Federation International de Volleyball, 2014; IOC, 2004, 2016a; International Association of 
Athletics Federation, 2011; International Gay and Lesbian Football Association, 2014; 
International Tennis Federation, n.d; International Quidditch Association, 2015). Details of 
all of the sport policies included within this review can be found in Table 2.2. 
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Table 2.2. Transgender inclusive sport policies included within this systematic review  
Organisation Pre-puberty Post-puberty 
International Olympic Committee (2004)  If had GCS then may complete in line with gender identity.  Provide legal recognition of their gender. 
Had GCS. 
Been on CHT for at least two years. 
Lived in their newly assigned gender for at least two years.  
International Olympic Committee (2016)  
 
Transgender males: no restrictions. 
Transgender females: declared gender as female for at least four years and have 
testosterone levels below 10nmol/L for at least 12 months prior to competition.  
Transgender males: no restrictions. 
Transgender females: declared gender as female for at least four years and have 
testosterone levels below 10nmol/L for at least 12 months prior to competition. 
Amateur Swimming Association (UK; 
2015)  
IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
Association of Boxing Commissions 
(2012)  
Allowed to complete in line with gender identity providing they have had GCS.   Transsexual females must comply with the IOC. 
Transsexual males must provide legal evidence of their gender and be prescribed 
CHT.  
Transgender females who are receiving a testosterone suppressant must compete as a 
man until two years of medical treatment has been prescribed.  
Transgender  males must be being prescribed CHT.  
Badminton England (UK; 2013)  IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
 
British Rowing (UK; 2013)  If hormone treatment has not been started a transgender female may compete as a 
male.  
A transgender girl pre-puberty may compete as a female or in mixed competition. 
Transgender males may compete as a male or in mixed competition. 
Transgender females may compete as female or in mixed competitions providing 
testosterone levels are within the normal range for a female or they have had a 
gonadectomy. 
If a transgender female has not started treatment then they may compete as a man or 
in mixed competition. 
British Universities & Colleges Sport 
(UK; 2012)  
Not applicable.  Recommended  that when transgender issues arise, then the policy of each national 
governing body for that sport should be adopted. 
Disability Sport Australia (2014)  Encourages participation in line with experienced gender but suggests completion 
of a TUE form if necessary.  
Encourages participation in line with experienced gender but suggests completion of 
a TUE form if necessary. 
Fédération Internationale de Volleyball 
(2014)  
Gender must be confirmed via birth certificate. 
Female players may be required to submit a gender certificate and/or medical 
examination. 
Gender must be confirmed via birth certificate. 
Female players may be required to submit a gender certificate and/or undergo a 
medical examination.  
International Tennis Federation (n.d)  IOC 2004 policy is adopted. IOC 2004 policy is adopted.  
International Quidditch Association 
(2015)  
Allows players to self-identify.  Allows players to self-identify. 
International Gay and Lesbian Football 
Association (2014)  
Provide legal recognition of their gender. 
Undergo uninterrupted hormone treatment for at least one year prior to competition. 
Provide legal recognition of their gender. 
Undergo uninterrupted hormone treatment for at least one year prior to competition. 
International Association of Athletics 
Federations (2011)  
Endocrine assessment. 
Evidence of GCS.  
Details of post-surgery treatment and monitoring to date. 
Endocrine assessment. 
Evidence of GCS.  
Details of post-surgery treatment and monitoring to date.  
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Organisation  Pre-puberty Post-puberty 
Ladies Professional Golf Association 
(USA; 2010)  
A transgender female may compete as a female if they have undergone GCS. 
Or, a transgender female who is treated with testosterone suppression must compete 
as a man until they have completed hormone treatment for one year. After this time 
they may compete as a female.  
A transgender male who is treated with testosterone may compete in a men’s event 
but not in a women’s. 
 
A transgender female may compete as a female if they have undergone GCS. 
Or, a transgender female who is treated with testosterone suppression must compete 
as a man until they have completed hormone treatment for one year. After this time 
they may compete as a female.  
A transgender male who is treated with testosterone may compete in a men’s event 
but not in a women’s. 
Lawn Tennis Association (UK; n.d)  Allowed to play in line with gender identity providing they have undergone GCS. Surgical anatomical changes have been completed, including external genitalia 
changes and gonadectomy (removal of ovaries or testes). 
Legal recognition of their assigned sex has been conferred by the appropriate official 
authorities. 
CHT has been administered for a sufficient length of time to minimise gender-related 
advantages in sport competitions. 
Eligibility should begin no sooner than two years after gonadectomy. 
 
National Collegiate Athletic Association 
(2011)  
To compete on a men’s team, a transgender male must be taking CHT and have a 
diagnosis of gender dysphoria. They are not allowed to play on a women’s team.  
Transgender females must be taking CHT and have a diagnosis of gender 
dysphoria. They are allowed to play on a men’s team until they have completed one 
year of CHT. 
A transgender  male who is not taking CHT may participate on a women’s or men’s 
team.  
A transgender female who is not taking CHT may not compete on a women’s team. 
To compete on a men’s team, a transgender male must be taking CHT and have a 
diagnosis of gender dysphoria. They are not allowed to play on a women’s team.  
Transgender females must be taking CHT and have a diagnosis of gender dysphoria. 
They are allowed to play on a men’s team until they have completed one year of 
CHT. 
A transgender male who is not taking CHT may participate on a women’s or men’s 
team.  
A transgender female who is not taking CHT may not compete on a women’s team.  
Rugby Football Union (UK; n.d.)  IOC 2004 policy is adopted. IOC 2004 policy is adopted.  
 
Scottish Football Association (UK; 2008)  IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
The Football Association (UK; 2014)  Under the age of 16, players may play with boys and girls (no GCS required).  Transgender males: must have hormone results within a cisgender male range. 
Undergone CHT for a sufficient amount of time. 
Legal recognition of gender. 
Transgender females: undergone CHT or gonadectomy (removal of  testes).  
Blood results must be within a cisgender female range. 
Legal recognition of gender.  
 
UK Roller Derby Association (2014)  No evidence of gender identity or hormone levels is required to participate. 
Must be living full time as their chosen gender. 
No evidence of gender identity or hormone levels is required to participate. 
Must be living full time as their chosen gender. 
 
US Rowing (2015) All rowers in men’s events are male and all rowers in women’s events are female. 
Gender is determined by legal recognition of gender.  
 
All rowers in men’s events are male and all rowers in women’s events are female. 
Gender is determined by legal recognition of gender.  
 
US Soccer Federation (2013)  
 
Transgender people are asked to provide legal or another form of documentation to 
reflect that the athlete’s gender identity is sincerely held and part of their core 
identity. 
 
Transgender people are asked to provide legal or another form of documentation to 
reflect that the athlete’s gender identity is sincerely held and part of their core 
identity. 
USA Gymnastics (2015)  
 
IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
USA Senior Softball (2014)  IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
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Organisation  Pre-puberty Post-puberty 
USA Triathlon (n.d)  Follows the United States Anti-Doping Agency rules regarding the use of 
testosterone, which is a banned substance which requires a TUE in order to avoid 
violating policy. 
Follows the United States Anti-Doping Agency rules regarding the use of 
testosterone, which is a banned substance which requires a TUE in order to avoid 
violating policy. 
USA Boxing (2013)  
 
IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
USA Sailing (2013)  
 
IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
USA Track & Field (2005)  
 
IOC 2004 policy is adopted. IOC 2004 policy is adopted. 
USA Swimming (2013)  Discrimination against any member or participant on the basis of gender, sexual 
orientation, and gender expression is prohibited. 
Discrimination against any member or participant on the basis of gender, sexual 
orientation, and gender expression is prohibited. 
Women’s Flat Track Derby Association 
(UK; n.d)  
Transgender women are allowed to compete as a woman as long as their hormone 
levels are within a typical female range.  
Information about healthcare provided must be submitted.  
Transgender males may not participate. 
Transgender women are allowed to compete as a woman as long as their hormone 
levels are within a typical female range.  
Information about healthcare provided must be submitted.  
Transgender males may not participate. 
World Outgames (USA; 2015)  Transgender people are asked to provide legal or another form of documentation to 
reflect that the athlete’s gender identity is sincerely held and part of their core 
identity.  
Transgender people are asked to provide legal or another form of documentation to 
reflect that the athlete’s gender identity is sincerely held and part of their core 
identity. 
Note: GCS (gender confirming surgery); CHT (cross-sex hormone treatment); IOC (International Olympic Committee); TUE (Therapeutic Use 
Exemption); n.d (no date); gender dysphoria is the diagnostic name included within the Diagnostic and Statistical Manual for Mental Health, 
fifth edition for people who experience an incongruence between their gender assigned at birth and gender identity.  
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2.4.2.2. Review of the sport policies 
Policies within this section were systematically reviewed in relation to their inclusiveness of 
transgender competitors (i.e., maintaining fairness in the absence of advantage for all 
competitors). The fairness of the policy requirements was judged against the available 
physiological research that has explored athletic advantage. The time restrictions associated 
with each requirement were also reviewed (e.g., cross-sex hormones must have been 
administered for at least 2 years prior to competition). The requirements from each policy are 
summarised within Table 2.2. and the most salient points of these policies are then presented 
in the section that follows.  
 
In 2004, the IOC (2004) announced that transgender people who transition after puberty are 
permitted to compete in sport in line with their experienced gender identity providing they 
have had gender confirming surgery, can provide legal recognition of their gender, have been 
prescribed cross-sex hormone treatment for at least 2 years, and have lived in their 
experienced gender for the same amount of time (IOC, 2004). Additionally, transgender 
people who had undergone gender confirming surgery pre-puberty are eligible to compete in 
sport in line with their experienced gender identity (IOC, 2004). This is an international 
policy and has been adopted by sport organisations all over the world.  
 
While the 2004 IOC policy has been praised for its efforts to address the inclusion of 
transgender athletes (Carroll, 2014), several flaws have been identified (Teetzel, 2006). First, 
the policy excludes transgender people who choose not to have gender confirming surgery 
due to a lack of genital dysphoria (distress), for medical reasons, fears about risk during 
operations, and/or for other personal reasons (Lucas-Carr & Krane, 2011; Tagg, 2012; 
Teetzel, 2006). The 2004 IOC policy also excludes transgender people who are in the process 
of transitioning. For instance, a transgender athlete may be prescribed cross-sex hormone 
treatment, but be yet to undergo gender confirming surgery. The 2004 IOC policy therefore 
adopts a very narrow definition and excludes a large proportion of transgender people 
(Cavanagh & Sykes, 2006). In addition to this, the policy appears to have been developed 
with only transgender females in mind, possibly as transgender males are not thought to 
possess athletic advantages in the majority of sports, and therefore the policy discriminates 
against transgender males (Reeser, 2005). Moreover, the 2004 IOC policy fails to take into 
consideration the regional, national, and international differences in accessing cross-sex 
hormone treatment and gender confirming surgery (IOC, 2004; Lucas-Carr & Krane, 2011; 
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Pieper, 2012; Sykes, 2006). Within this policy there also appears to be a lack of evidence-
based rationale as to why a period of 2 years was chosen as the length of time cross-sex 
hormone treatment must be administered prior to sport competition and why individual 
differences in blood hormone levels are not considered (Sullivan, 2011). As mentioned 
previously, the role of testosterone blockers in transgender women is also not considered. 
Although the rationale for the 2 year time period is not made explicit, it may be related to the 
fact that this time period was imposed by the IOC in 2004, when banning athletes from 
competitive sport to discipline them for doping violations. The evidence-based rationale for 
gender confirming surgery is also not clear (Carroll, 2014); whether an athlete has a penis or 
vagina appears irrelevant as this will not change the physiology of the body or the 
physiological advantage of the person (Lucas-Carr & Krane, 2011). 
 
Approximately 200 days before the 2016 Rio Olympic Games, the IOC announced changes 
to their competitive sport policy for transgender people. The new 2016 IOC policy suggests 
that transgender male athletes are able to compete in a male category without any restrictions. 
Transgender females may compete in a female category if they have declared their gender as 
female for at least 4 years and their blood testosterone levels are below 10 nmol/L for at least 
12 months prior to competition. However, the latter requirement is a general guideline, and 
each case will be reviewed individually to determine whether 12 months is a sufficient 
amount of time or not to suppress testosterone levels to an appropriate level. If transgender 
females do not meet these requirements, they will be able to compete in a male category. This 
is a great improvement in sport policy which considers gender assigned at birth, individual 
difference in relation to blood hormone levels and moves away from the requirement of 
surgery to compete in their experienced gender category. However, we could not find any 
evidence to support the requirement for testosterone to be below 10nmol/L for at least 12 
months.  
 
Despite its flaws, the 2004 IOC policy has been adopted by several other sport organisations. 
Within this systematic review, 11 sport organisations adopted the policy outlined by the IOC 
in 2004 (Amateur Swimming Association, 2015; Badminton England, 2013; International 
Tennis Federation, n.d; Rugby Football Union, n.d; Scottish Football Association, 2008; The 
Lawn Tennis Association, n.d; USA Sailing, 2013; USA Boxing, 2013; USA Senior Softball, 
2014; USA Track and Field, 2005; USA Gymnastics, 2015). All but one (the International 
Tennis Federation) of these sport organisation policies are employed at a national level. Not 
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only is it problematic that other sport organisations adopted the 2004 IOC policy, but 
elements of the 2004 IOC policy concerning children pre-puberty are not applicable to sport 
organisations in the UK and many other countries. Within the UK (and many other 
countries), children presenting with gender incongruence cannot undergo gender confirming 
surgery before the age of 18, by which time puberty has usually started.  
 
Three policies stated that it is only necessary to provide legal recognition of gender and to be 
prescribed cross-sex hormone treatment for a ‘sufficient amount of time’ (international 
policy) (International Gay and Lesbian Football Association, 2014) or so that hormone blood 
levels are within cisgender female or male ranges (national policy) (The Football 
Association, 2014; Women’s Flat Track Derby Association, 2015). Policies from the 
National Collegiate Athletic Association (2011) and British Rowing (2013) also state that 
only cross-sex hormone treatment is required, however the specifics of this requirement differ 
for both transgender males and females. With both of these policies, transgender females 
have to provide more evidence of cross-sex hormone treatment and their blood hormone 
levels in comparison to transgender men. Similarly, the Association of Boxing Commissions 
(2012) in its national policy has different cross-sex hormone treatment requirements 
dependent on gender assigned at birth and how the athlete identifies themselves (transgender 
or transsexual). The language used within the Association of Boxing Commissions’ policy 
(2012) may be seen as offensive by some transgender people and the difference between 
“transsexuals” and “transgender” people remains unclear. Policies held by the Ladies 
Professional Golf Association (international policy) (2010) and the International Association 
of Athletics Federations (2011) differ dramatically in relation to gender and gender 
confirming surgery as a requirement. In both cases it is necessary for transgender females to 
have undergone this procedure, but not for transgender males. Although some of the 
requirements of these policies are unreasonable and not evidence based (e.g., gender 
confirming surgery), the gender difference in relation to the amount of evidence that is 
required about their gender change seems acceptable considering that only transgender 
females (and not transgender males) are currently seen to potentially have an athletic 
advantage (Gooren & Bunck, 2004).  
 
The more inclusive sport policies reviewed here only required legal or medical recognition or 
do not ask for any evidence of gender; thus they encourage competition in line with 
experienced gender (five were national policies and two were international) (Disability Sport 
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Australia, 2014; International Quidditch Association, 2015; US Soccer Federation, 2013; US 
Rowing, 2015; UK Roller Derby Association, 2014; USA Swimming, 2013; World Out 
Games, 2015). The Fédération Internationale de Volleyball (2014) had the most invasive 
policy considered within this systematic review. They ask players to provide a birth 
certificate to verify gender. Additionally, female players may be asked to provide a gender 
certificate or submit themselves to a medical examination if the medical evidence is not 
sufficient. Both British Universities & Colleges Sport (2012) and USA Triathlon (n.d.) do not 
have their own policies, but suggest the adoption of other policies (i.e., those relevant to the 
sport in question or guidelines of the United States Anti-Doping Agency, respectively).  
 
Currently, the majority of sport policies unfairly exclude transgender people from 
competitive sport as the requirements they place on them are not underpinned by evidence-
based medicine. Until (and if) there is consistent and direct evidence to demonstrate 
transgender people have an athletic advantage it seems unreasonable to exclude them on any 
basis.  
 
2.5. Discussion 
The first aim of this systematic review was to explore the experiences of transgender people 
in relation to competitive sport participation (elite and recreational) and sport-related physical 
activity. The majority of the studies within this body of literature are qualitative in nature, 
which may be at least partly a reflection of the low numbers of transgender people in the 
general population. It is therefore difficult to draw any definite conclusions due to the lack of 
quantitative research. By its very nature, the findings from qualitative research cannot be 
generalised but the findings can be used to form a platform from which generalisations can be 
made. The research articles reviewed here described a generally negative experience of sport 
participation and sport-related physical activity for transgender individuals. It was evident 
from these studies that transgender people are facing barriers when engaging in competitive 
sport and sport-related physical activity. In relation to sport-related physical activity, lack of 
accessibility to an inclusive and comfortable environment appeared to be the primary barrier 
to participation. Charities and support organisations working with transgender people should 
consider developing campaigns to raise awareness about different gender identities. Leisure 
centres should also be made more aware of potential gender differences (i.e., via training and 
greater information provision) and be given advice on how to make such environments more 
inclusive of transgender people (e.g., gender neutral changing facilities with cubicles). In 
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relation to competitive sport participation, the findings from this systematic review suggest 
that the requirements that transgender competitive sport policies place on competitors were 
instrumental in transgender athletes’ negative experiences.  
 
While a distinction needs to be made between the issues and experiences transgender people 
have with regard to participation in sport and competitive sport, it also needs to be 
acknowledged that there is an overlap. Transgender males and females have anecdotally 
discussed that access to sport participation (such as becoming part of the local football team) 
is restricted as even community and local sport organisations who play at a recreational level 
implement transgender competitive sport policies. 
 
The second aim was to review the available sport policies regarding the fairness for 
transgender people in competitive sport (i.e., fairness in the absence of advantage). Due to 
over interpretation and fear of the athletic advantage in transgender athletes, the majority of 
the policies reviewed were discriminatory against transgender people, especially transgender 
males (i.e., exclusion in the absence of advantage). Although the updated IOC policy may be 
perceived as more inclusive then the 2004 version, there are still flaws. The requirement for a 
transgender female to have declared their gender as female for at least 4 years is excessive. In 
the UK and many other countries, once a transgender person has accessed a transgender 
health service, it is likely to be less than 4 years before a person legally changes their name, 
undergoes irreversible treatments and, hence, fully commits to their experienced gender. 
There appears to be a lack of rationale regarding the 4 year time period for transgender 
athletes, although this time restriction is consistent with the current disciplinary action for 
cisgender athletes when a doping incident occurs (IOC, 2016b). The 2016 IOC transgender 
policy also states that to avoid discrimination against transgender females, they are allowed 
to complete in a male category if they do not meet the requirements for transgender female 
athletes. For most transgender females, competing in a male category, when their experienced 
gender is female, would be distressing and may deter engagement in competitive sport 
altogether. This particular requirement may be promoting exclusion of transgender females in 
competitive sport, rather than avoiding discrimination.   
 
Several sport policies, including the recently updated IOC 2016 policy, have based their 
requirements for transgender competitors on indirect, inconsistent and unambiguous 
evidence. Physiological research involving cisgender people has shown that testosterone 
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deficiency in young men is associated with a decrease in muscle strength (Mauras et al., 
1998) and testosterone injections in cisgender men are associated with an increase in some 
aspects of muscle strength (Storer et al., 2003). However, this research did not determine 
whether these decreases and increases in muscle mass are within ranges for cisgender females 
and males and the time required to reach cisgender male or female levels. Elbers, Asscheman, 
Seidell and Gooren (1999) expanded on this research by explored the effects of oestrogen 
supplements and androgen deprivation on fat distribution and thigh muscle mass (by using 
magnetic resonance imaging) in 20 transgender females. They found 12 months after cross-
sex hormone treatment, transgender females had a more feminine pattern of adiposity and 
their thigh muscles had decreased. Other research has found that transgender female athletes 
who have hormonally and surgically transitioned have reported feeling weaker and their 
testosterone levels tend to be lower than average compared to cisgender women (Cavanagh & 
Sykes, 2006; Schultz, 2011). However, this research does not tell us anything about the 
relationship between androgenic hormones and athletic ability. To date, Harper’s (2015) 
study is the only one to directly explore androgenic hormones and athletic ability. The aim of 
the study was to explore the long distance (5 km to 42 km) running times of eight transgender 
females before and after testosterone suppression. It was found that after testosterone 
suppression, running times were significantly slower in comparison to before testosterone 
suppression. Harper stated that due to reductions in testosterone and haemoglobin, 
transgender females who had undergone transition would have the same endurance 
capabilities as a cisgender female. However, the sample size was very small (N=8) and 
participants were asked to self-report their race times which might have been subject to recall 
or social desirability bias. 
 
On average, men perform better than women in sport, however no empirical research has 
identified the specific reason(s) why. Based mainly on indirect research with cisgender 
people, it is commonly believed that androgenic hormones (specifically high testosterone 
levels) confer an advantage in competitive sports (i.e., enhance endurance, increase muscle 
mass) and, while this belief has informed several sporting policies, testosterone may not be 
the primary, or even a helpful, marker in determining athletic advantage (Karkazis, Jordan-
Young, Davis, & Camporesi, 2012). Karkazis et al. (2012) have argued that there is no 
evidence to suggest that endogenous testosterone levels are predictive of athletic performance 
(apart from doping), as there is variation in how bodies make and respond to the hormone. 
Testosterone is only one part of a person’s physiology and there are other important factors 
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(both biological and environmental) that should be considered if fairness (the absence of 
advantage) is the aim in competitive sport. For instance, having large hands is key for 
manipulation in some sports (e.g., basketball), but this is not seen as an unfair advantage. 
Establishing what an athletic advantage is in competitive sport would facilitate inclusion of 
all athletes (regardless of their gender identity) on the premise of fairness.   
 
The Canadian Centre for Ethics in Sport (2016) recently released a document which offers 
guidance to sport organisations on how to develop inclusive competitive sport policies for 
transgender people. An expert panel maintained the viewpoint that everyone has the right to 
compete in accordance with their gender identity at a recreational and elite level. Cross-sex 
hormones and gender confirming surgeries should not be a requirement at any level of sport. 
If any sport organisation requires transgender competitors to take cross-sex hormones for a 
specified time, they will have to provide evidence to support that this is reasonable. The panel 
suggests that when sporting organisations are concerned about safety, based on the size or 
strength of competitors, such organisations should develop skill and size categories, such as 
in wrestling. 
 
The issues and challenges that transgender people experience when engaging in competitive 
sport and sport-related physical activity will undoubtedly become more prominent as the 
visibility and prevalence of transgender people becomes more pronounced. Consequently, 
health professionals working in sport will need to become more familiar with the specific 
issues and challenges that a transgender person may experience when engaging in sport. By 
doing this, these professionals will be able to ensure transgender people can start or continue 
to engage in sport in a safe and inclusive manner. The most common question of people 
working within the sport domain will likely be: When it is safe and fair to permit a 
transgender person to compete in sport in line with their experienced gender? At the current 
time, this is going to be a difficult issue to address considering that there is a lack of direct 
and consistent physiological performance-related data with transgender people, which is 
preventing a consensus from being made as to whether transgender people (especially 
transgender females) do or do not have an athletic advantage. It may be sensible to suggest 
that until there is direct and consistent scientific data to suggest that transgender competitors 
have an advantage, transgender people should be allowed to compete in accordance with their 
gender identity with no restrictions (e.g., no requirement to have cross-sex hormones, gender 
confirming surgery). The athletic advantage transgender females are perceived to have (based 
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on indirect and ambiguous evidence) may be no greater than widely accepted physiological 
(e.g., large hands) and financial (e.g., training opportunities) advantages that some cisgender 
people possess in competitive sport. Sport organisations wanting to exclude a transgender 
person from competing in their experienced gender category would need to demonstrate that 
the sport is gender-affected and that exclusion is necessary for fair and safe competition 
(Canadian Centre for Ethics in Sport, 2016; House of Commons, 2016). At the current time, 
this would be difficult considering there is no evidence to suggest that androgenic hormone 
levels consistently confer competitive advantage (Canadian Centre for Ethics in Sport, 2016; 
House of Commons, 2016). 
 
2.5.1. Limitations of the area and directions for future research 
Within the area of sport, physical activity and transgender individuals, research is limited and 
mainly qualitative. More quantitative research needs to be conducted to increase the 
applicability and generalisability of the research findings and so that conclusions about 
transgender people and sport can be drawn. At a medical level, more physiological research 
is needed with the transgender population to accurately determine whether transgender 
people have an advantage in competitive sport or not. Future studies should investigate when 
a person can be considered physiologically as their experienced gender. This in turn should 
aid more inclusive (i.e., inclusion in the absence of advantage) sport policies for transgender 
individuals and a fair system for all. To date, the few studies which have explored the 
experiences of transgender people have mainly been concerned with exploring experiences in 
relation to competitive sport. This research now needs to be extended to those who participate 
in sport-related physical activity for leisure and fitness. It is also important to understand 
transgender people’s experiences in the context of different sports. The barriers to, and 
facilitators of, football participation, for example, may greatly differ to those experienced 
when engaging in gymnastics, athletics, swimming or aquatic activities. For the latter four 
sports, clothing may be revealing and an indication of one’s gender. For example, feeling 
comfortable in swimwear may be an issue for transgender people, especially when they are in 
the process of transitioning, as the body is often more exposed than in other sportswear (e.g., 
a football kit) and swimwear is heavily gendered (i.e., swimming trunks are worn by males 
and swimming costumes by females). In light of this, it would be interesting to explore the 
experiences of transgender people who have previously participated, or are currently 
participating, in aquatic activities, gymnastics and/or athletics.   
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2.5.2. Conclusion 
Overall, it appears that the majority of transgender people have a negative experience of 
competitive sport and sport-related physical activities. Accessibility to sport-related physical 
activity needs to be improved. Within competitive sport, the athletic advantage transgender 
athletes are perceived to have appears to have been over interpreted by many sport 
organisations around the world, which has had a negative effect on the experiences of this 
population. When the indirect and ambiguous physiological evidence is dissected, it is only 
transgender females who are perceived to potentially have an advantage due to androgenic 
hormones. Within the literature, it has been questioned as to whether androgenic hormones 
should be the only marker of athletic advantage or, indeed, if they are even a useful marker of 
athletic advantage. Given the established mental and physical health benefits of engaging in 
physical activity and sport (De Moor et al., 2006; Maltby & Day, 2001) the barriers 
transgender people experience are a significant limitation to the promotion of healthy 
behaviours in transgender individuals. There are several areas of future research that are 
required to significantly improve our knowledge of transgender people’s experiences in sport, 
inform the development of more inclusive sport policies, and most importantly, enhance the 
lives of transgender people, both physically and psychosocially. 
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Chapter 3 
Body dissatisfaction and disordered eating in transgender people: A 
systematic review of the literature 
 
This chapter has been published in the International Review of Psychiatry (impact factor: 
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3.1. Abstract  
Body dissatisfaction plays a prominent role in gender dysphoria. Body dissatisfaction, in 
some individuals, appears to manifest disordered eating in order to supress bodily features of 
natal gender and accentuate features of gender identity. To date, there has been no systematic 
review of the literature pertaining to body dissatisfaction and disordered eating in trans 
individuals. Such a review may highlight important implications for clinicians working with 
trans people. Therefore, the aim was to critically and systematically review the available 
literature examining body dissatisfaction or disordered eating in a trans population, and also 
the literature pertaining to how body dissatisfaction and disordered eating are related in trans 
people. This review found three studies that explored disordered eating in trans people, five 
studies that explored body image and disordered eating in trans people, and 18 studies that 
explored body image in trans people. The findings from this review suggest that body 
dissatisfaction is core to the distress trans people experience and that this dissatisfaction may 
also put some individuals at risk of developing disordered eating. Additionally, the findings 
appear to suggest that gender dysphoria treatment is successful at increasing body satisfaction 
and improving body image. The clinical implications are discussed. 
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3.2. Introduction 
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; American 
Psychiatric Association, 2013) classifies the incongruence that trans individuals experience 
between their assigned sex at birth (and the associated gender role and/or primary and 
secondary sex characteristic) and gender identity (how they see themselves with respect to 
gender) as Gender Dysphoria. Transsexualism is defined by the International Classification 
of Diseases, edition 10 (ICD-10; World Health Organization, 1992) as a desire to live and be 
accepted as a member of the opposite sex, usually accompanied by a sense of discomfort with, 
or inappropriateness of, one's anatomic sex, and a wish to have surgery and hormonal 
treatment to make one's body as congruent as possible with one's preferred sex. The new 
edition, ICD-11, is expected to acknowledge individuals who do not necessarily wish to 
transition from one binary gender to the other (male to female or female to male). Although 
there are several different terms used within the literature to describe people who feel an 
incongruence between their assigned sex at birth and gender identity, throughout this chapter 
the terms trans people/individuals, trans women and trans men will be used. Trans women 
are those who were assigned male at birth on the basis of genital appearance but who later 
identify themselves as female. Trans men are those who were assigned female at birth based 
on their genital appearance but identify as male. Recent studies have reported an overall 
meta-analytical prevalence for transsexualism of 4.6 in 100,000 individuals; 6.8 for trans 
women and 2.6 for trans men, which is primarily based on studies looking at individuals 
attending clinical services (Arcelus et al., 2015). 
 
Body dissatisfaction is referred to as the negative evaluation of one’s appearance and it is 
central to the distress and unhappiness that trans individuals experience (Bandini et al., 2013). 
It is not surprising that this distress is particularly related to body parts that are a reminder of 
the individual’s unwanted assigned sex (e.g., Becker et al., 2016). Much of the research in the 
area of gender dysphoria and body image has focused on sex-specific body parts which may 
be transformed by cross-sex hormone treatment (CHT) and surgical treatment. Several 
studies have found that such treatment is capable of relieving body dissatisfaction (e.g., de 
Vries, Steensma, Doreleijers, & Cohen-Kettenis, 2011; de Vries et al., 2014).  
Body dissatisfaction is also thought to be central to the distress experienced by those with an 
eating disorder (e.g., Fairburn, 2008) and it has been shown to be one of the main 
contributors towards the onset and maintenance of eating disorder psychopathology (Stice & 
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Shaw, 2002). Within the trans literature, Ålgars, Alanko, Santtila, and Sandnabba (2012) 
discuss the role of eating restriction in trans women as a way to strive for thinness in order to 
suppress features of their birth sex or to accentuate features of their desired gender. In 
addition, trans women may internalise the message portrayed by the Western media that thin 
is beautiful (Witcomb et al., 2015). The internalisation of this message is thought to be a risk 
factor for the development of disordered eating in cisgender (non-trans) women (Kroon Van 
Diest & Perez, 2013; Witcomb, Arcelus, & Chen, 2013) and therefore it may put trans 
women at a particular risk for developing disordered eating (e.g., Ålgars, Santtila, & 
Sandnabba, 2010).  
To date, the literature suggests that body dissatisfaction plays a prominent role in gender 
dysphoria, and in some cases body dissatisfaction appears to be a risk factor for the 
development of disordered eating. To the authors’ knowledge, there has been no systematic 
review of the available literature pertaining to trans people, body dissatisfaction and 
disordered eating. Such a review will likely highlight important implications for clinicians 
working with trans people. In light of this, the aim is to critically and systematically review 
the available literature examining body dissatisfaction or disordered eating in a trans 
population, and also the literature pertaining to how body dissatisfaction and disordered 
eating are related in trans people. 
 
3.3. Method 
3.3.1. Inclusion and exclusion criteria  
Articles selected were those that explored body dissatisfaction and/or disordered eating in 
trans people, as well as articles that explored how body dissatisfaction and disordered eating 
are related in trans individuals. Articles that may have not explored body dissatisfaction 
and/or disordered eating as a main outcome, but included a measure of body dissatisfaction 
and/or disordered eating, were included. Peer reviewed studies that were written in English, 
Spanish or Dutch languages were considered eligible. Studies were excluded if they were a 
case study or if they recruited participants who were intersex (i.e., people in which 
development of chromosomal, gonadal, or anatomical sex is atypical). 
 
3.3.2. Search strategy  
The PRISMA guidelines (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009) were 
followed to undertake this review. An electronic literature search was conducted using Web 
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of Science, PubMed and PsychInfo search engines. The searches included papers published 
from 1966 to April 2015. To obtain potentially relevant papers the following search terms 
were used in relation to trans people: gender dysphoria, gender identity disorder, transgender, 
transsexual, LGBT. Within each search engine, these terms were combined with terms 
relating to disordered eating using the “AND” operator: Anorexia Nervosa, Bulimia Nervosa, 
disordered eating, Eating Disorders not Otherwise Specified, eating concerns, eating 
problems. Additionally, the trans terms were combined (using “AND”) with body image 
terms: body image, body uneasiness, body dissatisfaction, body satisfaction. The reference 
lists of relevant papers were also searched to identify any additional papers and 
corresponding authors were contacted for unpublished data.  
 
3.3.3. Article selection 
Seventy-four publications were identified from the literature search as being potentially 
relevant to the aims of this review (see Figure 3.1.). Of these papers, 47 related to body image 
and trans people, 19 related to eating disorders and trans people, and eight related to body 
image, eating disorders and trans people. After screening the abstracts of these articles, 45 
were excluded as they were a dissertation, conference paper, case study, or included 
participants who were intersex. Twenty-nine papers were then downloaded and, after full text 
review, 26 papers were included, all of which were peer reviewed and written in English (see 
Figure 3.1.).  
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74 potentially relevant 
papers identified from 
literature review
8 relevant to 
body image 
and eating 
disorders
47 relevant to 
body image
19 relevant to 
eating disorders
3 papers were excluded because:
• Provisional data (n=1)
• Papers did not directly explore the 
association between body image and/ 
or disordered eating in trans people 
(n=2)
29 papers 
selected for full 
text retrieval
45 papers excluded based on 
screening the abstract because: 
• Dissertation
• Conference papers
• Case studies 
• Disorders of sex development 
26 papers met 
the full 
inclusion 
criteria
Screening stage
Eligibility stage
Included papers
 
Figure 3.1. The process of identifying eligible studies for inclusion within this review 
 
3.3.4. Quality assessment  
To determine the methodological quality of the studies included in this review, the National 
Institute of Health and Clinical Excellence (NICE, 2007) checklists for cohort studies and 
qualitative studies were utilised (see Table 3.1.). To complement the NICE (2007) checklist, 
Gilbert's (2009) checklist for assessing cross-sectional studies was also employed as there are 
no NICE guidelines for studies using this methodology (see Table 3.1.). The NICE (2007) 
and Gilbert (2009) guidelines were consulted for each study in turn and each criterion was 
rated as: well covered, adequately covered, poorly covered, not addressed, not reported, or 
not applicable. Additionally, each study was rated using NICE (2007) guidelines from good 
quality (++) (when most of the criteria have been satisfied), reasonable quality (+) (when 
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some of the criteria have been satisfied), or poor quality (-) (when few or no criteria have 
been satisfied) (see Table 3.2.). Based on the NICE (2007) and Gilbert (2009) guidelines, 
most studies (n=17) were rated poor quality (-). Most studies failed to recruit a representative 
sample as most samples were consecutive referrals to a gender clinic or recruited through an 
LGBT organisation. The majority of studies provided good coverage of the 
inclusion/exclusion criteria and sample characteristics which aided the interpretation of 
findings.  
 
Table 3.1. Gilbert (2009) and NICE (2007) methodological criteria used for rating the quality 
of the studies considered in the systematic review 
Gilbert (2009) Criteria 
Section 1: Internal 
Validity 
1.1 The study assessed an appropriate and clearly focused question 
 
Selection of Subjects 
1.2 Recruitment is appropriate to the aims of the research 
1.3 Representative cases from relevant population 
1.4  The study indicates how many of the people asked to take part did so 
1.5 Comparison is made between participants and non-participants 
1.6 Inclusion criteria are made explicit and sample characteristics sufficiently 
described 
1.7 Were subjects recruited over the same period of time? 
Data Collection 1.8 Confidence in the quality of individual responses 
1.9 Outcome is measured in an objective, standard, valid and reliable way 
1.10 Reliance on real information rather than recall/hypothetical scenarios 
Confounding 1.11 The main potential confounders are identified and taken into account in 
the design and analysis 
1.12 Minimisation of bias – (e.g., participant bias observer bias, halo effect) 
Statistical Analysis 1.13 Appropriate use of statistical analysis 
1.14 Actual p value reported 
 
Section 2: Overall 
assessment of the 
study 
 
2.1 Taking into account clinical considerations, your evaluation of the 
methodology used and the statistical power of the study, are you certain the 
findings could be replicated? 
 
NICE (2007) rating 
criteria  
++ The majority of criteria have been satisfied and where they have not, 
the conclusions from the study are unlikely to change.  
 
+ Some of the criteria have been satisfied and those criteria that are not 
satisfied are not thought to alter the conclusions of the study. 
 
- Very few or none of the criteria are satisfied. The conclusions of the 
study are thought to alter. 
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Table 3.2. Methodological quality of studies in accordance with NICE (2007) and Gilbert (2009) 
Study 1.1  1.2  1.3  1.4   1.5  1.6  1.7  1.8  1.9  1.10  1.11  1.12  1.13  1.14  2.1   NICE(2007) 
Ålgars et al. (2012) WC  AC  NR NA NA WC  WC  AC  AC  AC  NA NR PR NR  No  - 
Ålgars et al. (2010) WC AC AX NR NR  AC WC AC AC AC NA NR NR  WC  No - 
Bandini et al. (2013) WC AC PA WC NA WC  NR  AC AC WC WC NR  AC NA No + 
Becker et al. (2016) WC AC AC AC NA AC AC AC AC AC AC NA WC AC Yes ++ 
Bozkurt et al. (2006) WC  AC  PA NR NR  PA NR AC AC AC PA NR AC  NA No  - 
Cella et al. (2013) WC  AC  PA  PA NR AC  NR AC  AC  AC  NR NR  WC  WC  No  - 
Colizzi et al.  (2015) WC AC PA WC NA WC AC AC AC WC WC NR WC AC No + 
de Vries et al. (2014)  WC  AC PA WC  NR WC   WC  AC AC  AC  WA NR WC  PA No  + 
de Vries et al. (2011) WC  AC PA WC NA AC AC AC  AC  AC AC NR AC  WC  No + 
Fisher et al. (2013) WC  AC PA WA WC AC WC AC AC AC  WC  NR AC  WC  No + 
Fisher et al. (2014)  WC AC PA WC  NR WC WC AC  AC  AC  WC  NR  WC  WC No + 
Fleming et al. (1982) WC  NR PA NR  NR  AC  NR  AC  AC  AC  NA  NR  AC  NA No - 
Khoosal et al. (2009)  WC  AC PA NR  NR  WC  WC  AC  AC  AC  PA  NR  WC  WC No  - 
Kozee et al. (2012) WC  AC AC  WC NA  AC  WC  AC  AC  AC  NA NR  AC  NA No  - 
Kraemer et al. (2008) WC  AC  PA NA NA AC  PA AC  AC  AC  NA NR AC  -NA  No  - 
Lai et al. (2010) WC PA AC WC  NA AC  AC  AC  AC  AC  WC  NR AC  WC No + 
Lindgen & Pauly (1975) WC AC  PA NR NR PA NR AC PA WC PA NR AC  NA No  - 
Marone et al. (1998) WC  AC  PA NA NA PA NA PA PA AC NA  NR  NR  NR No  - 
Pauly & Lindgen (1976) WC AC  PA NR NR PA  NR AC PA WC  PA  NA  PA NA No  - 
Silverstein et al. (1990) WC  AC  AC  NA  NA NA NR AC  AC  AC  NA  NR AC  AC No  - 
Smith et al. (2005) WC   AC  PA AC  NA AC  NA AC  AC  AC  NA NA WC  AC  No  - 
Steensma et al. (2013) WC  AC  PA AC  NA WC  WC  AC  AC  AC  NA NR  AC  NA No  - 
Vocks et al. (2009)  WC  AC PA NR NA WC  NR AC AC WC PA NR AC  NC No  - 
Wiseman & Moradi (2010)  WC  AC  AC  NA  NA  AC  NR  AC  AC  AC  NA NA WC   NR No  - 
Witcomb et al. (2015) WC  AC  PA WC NA AC NR AC AC AC AC  NR AC  WC  No + 
Wolfradt & Neumann (2001)  WC  AC PA NA  NA AC  NA AC  AC  AC  NA  NR  AC  NR No  - 
Note: AC (Adequately covered), NA (not addressed, NA (not applicable), NR (not reported), PA (poorly addressed), WC (well covered). ++ 
(when most the criteria have been satisfied), + (when some of the criteria have been satisfied), - (when few or no criteria have been satisfied).
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3.4. Results 
What follows is a presentation of the findings from the studies included within this systematic 
review. Study characteristics will be explored and, following this, studies exploring firstly 
body dissatisfaction in a trans population, secondly disordered eating in a trans population, 
and lastly body dissatisfaction and disordered eating in a trans population will be discussed. 
At the start of each section, the measures employed to assess these constructs will be outlined.  
A summary of all the studies included within this review can be found in Table 3.3. 
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Table 3.3. Body dissatisfaction and/or disordered eating in trans people  
Author(s) Year Country that the 
study was 
conducted in 
Participants Outcome measures (relevant) Classification 
System  
Stage of Transition Main finding(s) 
Ålgars et al. 2012 Finland N=20 (n=11 trans males, 
n=9 trans females) 
EDI 
 
None Four participants had no 
medical intervention, 16 had 
undergone CHT (12/16 had 
undergone SRS).  
No trans people report clinically 
significant eating disorders  
Ålgars et al. 2010 Finland N=1,142 (Gender Conflict 
n=571, cisgender  n=571) 
 EAT None Information not collected Trans females > disordered eating 
than controls 
Bandini et al.  2013 Italy N=295 (Gender Dysphoria 
n=100, Eating Disorder 
n=88, Controls n=107) 
BUT 
 
DSM Before SRS. Eating disorder 
participants were at the 
assessment stage 
Trans individuals without SRS 
had > body uneasiness, similar to 
those with eating disorders 
 
Becker et al. 2016 Germany N=250 (n=135 trans males, 
n=115 trans females) 
Hamburg Body Drawing Scale  DSM Assessment stage  Trans males reported body 
dissatisfaction regarding all female 
body parts 
Trans females= dissatisfied with 
sex-specific body parts  
Bozkurt et al.  2006 Turkey N=160 (n=52 trans 
females, n=36 
homosexuals, n=72 
controls) 
BCS  DSM Not reported  Trans people are not more 
dissatisfied with their bodies in 
comparison to homosexuals and 
controls  
Cella et al.  2013 Italy N=325 (n=132 
homosexuals, n=178 
heterosexuals, n=15 
Gender Dysphoria) 
EDI-2  
BUT 
 
None Assessment stage  Trans participants > body 
dissatisfaction and eating disorder 
behaviour and attitudes in 
comparison to homosexuals and 
heterosexuals  
Colizzi et al. 2015 Italy N=118 (n=82 trans 
females, n=36 trans males) 
BUT 
 
DSM All CHT (n=22 SRS) Trans patients with a dissociative 
disorder >body uneasiness in 
comparison to trans patients who 
did not report a dissociative 
disorder 
de Vries et al. 2014  Netherlands N=55 (n= 22 transwomen,  
n=33 transmen) 
BIS  DSM Participants were assessed at 
intake before treatment (T0),  
during  treatment (T1, initiation 
of CHT) and post-treatment 
(T2, one year after SRS) 
Body image concerns continued to 
remit after SRS 
de Vries et al. 2011 Netherlands N=70 (n=33 natal males, 
n= 37 natal females) 
BIS  DSM Participants were assessed 
twice: once shortly after their 
first visit (T0) and shortly 
before starting CHT (T1). 
During T0 and T1 participants 
started on puberty suppression 
(GnRHa) 
GnRHa does not significantly 
reduce levels of body dissatisfaction 
between T0 and T1 
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Author(s) Year Country that the 
study was 
conducted in 
Participants Outcome measures (relevant) Classification 
System  
Stage of Transition Main finding(s) 
Fisher et al. 2013 Italy N=140 (n= 92 trans 
females, n= 48 trans males) 
BUT 
 
 
DSM, ICD All had not undergone SRS  There was a prevalence of 0.7% of 
eating disorders. Trans females 
dislike more body parts then trans 
men  
Fisher et al. 2014 Italy N=125 (n=66 trans 
females, n=59 trans males) 
BUT 
 
DSM Trans females= 24 had never 
take CHT, 42 were taking 
CHT. Trans males=33 had 
never taken CHT and 26 were 
on CHT. All pre-SRS. 
CHT can alleviate body uneasiness 
without surgery in trans females  
 
Fleming et al. 1982 USA  N=44 (n=22 postsurgical 
trans males, n=22 controls)   
BCS  None Nine had not had hysterectomy, 
8 had hysterectomy but not 
phalloplasty, and 5 had 
phalloplasty 
SRS > bodily satisfaction 
Khoosal et al 2009 England N=40 (compared to 
Garners normative data) 
EDI ICD Had undergone sexual 
reassignment surgery  
SRS> body satisfaction 
Kraemer et al. 2008 Switzerland  N=45 (n= 23 pre-operative, 
n= 22 post-operative) 
Body Image Measure (FBeK)  DSM  23 pre-SRS, 22 post-SRS 
 
SRS > body satisfaction  
Kozee et al. 
 
2012 USA Study 2: N=342  Transgender Congruence Scale  None Information not collected Transgender congruence <body 
dissatisfaction  
Lai et al. 2010 China 
 
N=5010 (gender dysphoria 
n= 225, cisgender n= 4785) 
Adult self-report Inventory-4   DSM Information not reported Body dysmorphic disorder was 
associated with gender dysphoria in 
female (35.2%) and males (40.8%)  
Lindgren & Pauly 1975 USA N=32 (n=16 trans males, 
n=16 trans female) 
BIS 
 
None Some participants were tested 
during the assessment period 
and others after the start of 
hormone treatment (exact 
numbers are not given). One 
participant had undergone SRS  
Sexual reassignment > body 
satisfaction 
 
Marone et al.  1998 Italy N=30 (n=15 trans females, 
n=15 trans males) 
Sensory Integration Body 
Imagery Test  
None None had SRS Trans females are most dissatisfied 
with their whole body  
Trans males are most dissatisfied 
with their chest 
Pauly & Lindgren  1976 USA N=131 (n=66 gender 
dysphoria, n=65 controls) 
BIS  None  30 assessment, 27 post-CHT, 9 
SRS 
SRS > body image satisfaction 
Silverstein & 
Carpman  
1990 USA N=188  
 
Disordered eating was 
measured by questions found 
by Silverstein et al. (1988) 
Draw-A-Person test  
None  Not reported Participants who reported a 
conflicted gender identity were also 
more likely to report eating disorder 
behaviours  
Smith et al.  2005 Netherlands N=162 (n=104 trans 
females, n=58 trans males) 
BIS 
Appraisal of Appearance 
Inventory 
DSM 52 participants: breast 
augmentation.  
10 participants:  
phalloplasty  
SRS > body image satisfaction 
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Author(s) Year Country that the 
study was 
conducted in 
Participants Outcome measures (relevant) Classification 
System  
Stage of Transition Main finding(s) 
Steensma et al.  2013 Netherlands N=127 (n=79 boys and 
n=48 girls) 
BIS  DSM 47 of the participants reapplied 
to the gender clinic in 
adolescents, requested medical 
treatment.  
Those who reapplied to the gender 
clinic in adolescence reported more 
body dissatisfaction in comparison 
to those who did not reapply 
Vocks et al. 2009 Germany, Austria 
and Switzerland 
N=356 (n= 88 trans 
females, n= 43 trans males, 
n=72 eating disorders,  n= 
163 controls) 
Eating Disorder Examination 
Questionnaire  
EDI-2  
Body Checking Questionnaire 
Drive for Muscularity Scale 
None 57% of trans females on CHT 
and 18% had SRS 
61% of trans males on CHT 
and 33% had SRS 
Trans participants > body 
dissatisfaction and eating disorder 
behaviour and attitudes in 
comparison to controls but these 
levels were not as high as the eating 
disorder patients 
Wiseman & 
Moradi 
2010 USA N=231 (2% transgender 
and 97% as cisgender) 
Objectified body consciousness 
scale  
EAT-26  
None Information not reported Eating problems and body image 
concerns rarely experienced 
Witcomb et al.  2015 UK  N=600 (n=200 
transsexuals, n=200 eating 
disorder patients and 
n=200 controls) 
EDI-2  
The Hamburg Body Drawing 
Scale  
ICD  Trans were at the assessment 
stage  
Trans individuals do not have 
clinically significant eating 
disorders, but they may exhibit > 
eating disorder symptomology 
compared to controls 
Wolfradt & 
Neumann  
2001 Germany N=90 (n=30 trans females, 
n=60 controls) 
The Body-Image Questionnaire   None SRS and voice operation   SRS > body image satisfaction.  
Note: EAT (Eating Attitudes Test), EDI (Eating Disorder Inventory), BUT (Body Uneasiness Test), BCS (Body Cathexis Sclae), BIS (Body 
Image Scale), SRS (sexual-reassignment surgery), GnRHa (gonadotrophin-releasing hormone agonists), CHT (cross-sex hormone therapy), 
DSM (Diagnostic Statistical Manual), ICD (Internationally Classification of Diseases).  
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3.4.1. Study characteristics  
The oldest paper was published in 1975 (Lindgren & Pauly, 1975) and the newest papers 
were published in 2015 (Becker et al., 2016; Colizzi, Costa, & Todarello, 2015; Witcomb et 
al., 2015). Out of the 26 papers which met the criteria for inclusion in this review, 18 
explored the prevalence of body image in a trans population (Bandini et al., 2013; Becker et 
al., 2016; Bozkurt et al., 2006; Colizzi et al., 2015; de Vries et al., 2011, 2014; Fisher et al., 
2013, 2014; Fleming, MacGowan, Robinson, Spitz, & Salt, 1982; Kozee, Tylka, & 
Bauerband, 2012; Kraemer, Delsignore, Schnyder, & Hepp, 2008; Lai, Chiu, Gadow, Gau, & 
Hwu, 2010; Lindgren & Pauly, 1975; Marone, Lacoella, Cecchini, & Ravenna, 1998; Pauly 
& Lindgren, 1976; Smith, Van Goozen, Kuiper, & Cohen-Kettenis, 2005; Steensma, 
McGuire, Kreukels, Beekman, & Cohen-Kettenis, 2013; Wolfradt & Neumann, 2001). Three 
studies explored disordered eating in trans individuals (Ålgars et al., 2012; Khoosal, 
Langham, Palmer, Terry, & Minajagi, 2009; Silverstein, Carpman, Perlick, & Perdue, 1990). 
Five papers related to both disordered eating and body image and explored the prevalence of 
these constructs (Ålgars et al., 2010; Cella, Iannaccone, & Cotrufo, 2013; Vocks, Stahn, 
Loenser, & Legenbauer, 2009; Wiseman & Moradi, 2010; Witcomb et al., 2015). It is 
important to note that the studies included within the review that examined eating disorder 
psychopathology did not explore clinically significant eating disorders because diagnostic 
tools were not employed. 
 
In relation to the methodology of these studies, the majority were cross-sectional. This type 
of research design is limiting because cause and effect cannot be determined. A longitudinal 
research design can be employed to determine cause and effect and five studies included in 
this review employed this type of design (de Vries et al., 2011, 2014; Khoosal et al., 2009; 
Smith et al., 2005; Steensma et al., 2013). Only one study employed an experimental research 
design (Marone et al., 1998). Of the 26 studies, only eight had a control group (Bandini et al., 
2013; Becker et al., 2016; Bozkurt et al., 2006; Fleming et al., 1982; Pauly & Lindgren, 1976; 
Vocks et al., 2009; Witcomb et al., 2015; Wolfradt & Neumann, 2001). For four of these 
studies, their control group included participants from the general population (i.e., they did 
not have a diagnosis of Gender Dysphoria) (Becker et al., 2016; Fleming et al., 1982; Pauly 
& Lindgren, 1976; Wolfradt & Neumann, 2001). Three studies compared data from a trans 
population to a cisgender population and to an eating disorder control group (Bandini et al., 
2013; Vocks et al., 2009; Witcomb et al., 2015) and one study compared to a homosexual 
and cisgender control group (Bozkurt et al., 2006). Fourteen studies obtained an official 
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DSM or ICD diagnosis relating to gender identity issues which was determined by a clinician 
or a self-report measure (Bandini et al., 2013; Becker et al., 2016; Bozkurt et al., 2006; 
Colizzi et al., 2015; de Vries et al., 2011, 2014 Fisher et al., 2013, 2014; Khoosal et al., 2009; 
Kraemer et al., 2008; Lai et al., 2010; Smith et al., 2005; Steensma et al., 2013; Witcomb et 
al., 2015). In relation to sample size of trans participants, 12 studies had 100 or more trans 
participants, seven studies had 50-100 trans participants, and nine studies had fewer than 50 
trans participants.   
 
3.4.2. Body dissatisfaction in trans people  
3.4.2.1. Body dissatisfaction in trans people: Measures used  
Ten different measures were used by studies considered in this review to assess body image. 
Some papers employed more than one measure to assess their outcomes. 
 
Body Image Scale (BIS) (Lindgren & Pauly, 1975): This was the most frequently employed 
body image measure which was used in six of the studies within this review (de Vries et al., 
2014, 2011; Lindgren & Pauly, 1975; Pauly & Lindgren, 1976; Smith et al., 2005; Steensma 
et al., 2013). The BIS was developed specifically for assessing body image in trans people. It 
lists 30 body parts and the individual has to rate on a five-point satisfaction scale each body 
part and whether they may want this feature to be altered through medical or surgical 
treatment. The higher the score, the more body dissatisfaction reported. 
 
Body Uneasiness Test (BUT) (Cuzzolaro, Vetrone, Marano, & Garfinkel, 2006): This was 
employed by five studies in this review (Bandini et al., 2013; Cella et al., 2013; Colizzi et al., 
2015; Fisher et al., 2013, 2014). The measure has two parts: part A which measures weight 
phobia, body image concerns, avoidance, compulsive self-monitoring, detachment and 
depersonalisation; and part B which assesses worries about specific body parts (e.g., ‘I would 
do anything to change some parts of my body’). A high score indicates a higher level of body 
uneasiness. The BUT was developed and evaluated with an eating disorder population.  
 
Body Cathexis Scale (Secord & Jourard, 1953): This measure was employed by two studies 
reported on within this review (Bozkurt et al., 2006; Fleming et al., 1982) and was developed 
with a US college population. It assesses the strength and direction of feeling which the 
individual has about each part or function of their body and also includes 55 items that 
represent the various conceptual aspects of the self. Participants are asked to choose one of 
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five responses (e.g., 1 = ‘Have strong feelings and wish change could somehow be made’, 5 
= ‘Consider myself fortunate’). A higher score indicates that an individual is more satisfied 
with their body. 
 
Body Checking Questionnaire (Reas, Whisenhunt, Netemeyer, & Williamson, 2002): This 
tool was employed by Vocks et al. (2009). It has three subscales: checking related to overall 
appearance, checking of specific body parts, and idiosyncratic checking rituals. A higher 
score indicates more intense body dissatisfaction. It was developed with an eating disorder 
population and US college women.  
 
Body Image Measure (FBek) (Strauβ & Richter-Appelt, 1996): This was employed by 
Kraemer et al. (2008) and is recommended for use with psychiatric and psychosomatic 
disorders and for assessing body image concepts under sexological considerations. It is a 
multidimensional body self-relation questionnaire and has three subscales; insecurity/concern 
(e.g., ‘My body does whatever it wants’), attractiveness/self-confidence (e.g., ‘I am satisfied 
with my body weight and body height’), and accentuation of body appearance (e.g., ‘My 
appearance is important to me’). A high score indicates more body image concerns. 
 
Objectified Body Consciousness scale (OBC) (McKinley & Hyde, 1996): This was employed 
by Wiseman and Moradi (2010) and has three subscales; body surveillance, body shame and 
appearance control beliefs. A high score on the OBC would indicate a more negative body 
experience. It was developed and validated with a non-clinical, female population.  
 
Drive for Muscularity Scale (McCreary & Sasse, 2000): This measures attitudes and 
behaviour regarding one’s looks and muscularity (e.g., ‘I think that my arms are not muscular 
enough’) was employed by Vocks et al. (2009). Higher scores indicate a greater drive for 
muscularity. It was developed and validated with the general population.  
 
Body Image Questionnaire (BIQ) (Clement & Löwe, 1996): This measure was employed by 
Wolfradt and Neumann (2001) and assesses ‘the dynamic body image’ (e.g., ‘I feel very fit’) 
and ‘rejected body image’ (e.g., ‘My body often annoys me’). It was developed for 
psychosomatic patients and a higher score is related to a more negative body image.  
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Hamburg Body Drawing Scale (Appelt & Strauss, 1988): This was employed by Becker et al. 
(2016) and Witcomb et al. (2015). This tool is a pictorial measure that assesses 33 different 
body parts in relation to body (dis)satisfaction and has recently been validated with a trans 
population (Becker et al., 2016). In Becker et al.’s version, a higher score indicates a low 
level of body dissatisfaction.  
 
Transgender Congruence Scale (Kozee et al., 2012): This was developed and employed by 
Kozee et al. (2012). The measure has two subscales; ‘Gender Identity Acceptance’ and 
‘Appearance Congruence’ (e.g., the degree to which a trans person perceives their external 
appearance to represented their gender identity). A higher score indicates a higher level of 
transgender congruence. It was developed and empirically tested with a trans population.  
   
3.4.2.2. Body dissatisfaction in trans people: Review of the studies 
Eighteen studies identified in this review addressed gender dysphoria and body image 
without looking into disordered eating (see Table 3.3.). The findings appear to suggest that 
lower transgender congruence between external presentation and internal self is related to 
lower levels of body satisfaction (Kozee et al., 2012). This low level of body satisfaction is 
not thought to be found within cisgender populations. As an example, Steensma et al. (2013) 
recruited trans individuals who met all or some of the criteria for Gender Identity Disorder 
(GID; DSM-IV) during childhood and followed them up in adolescence. They found that 
those who reapplied to the gender clinic in adolescence (n=47) reported more body 
dissatisfaction in comparison to those who did not reapply (n=80) (it was presumed that their 
gender dysphoria had desisted). These findings suggest that body image is related to gender 
dysphoria although it must be considered that not all participants met all the DSM-IV criteria. 
Body dissatisfaction may be experienced in relation to specific body parts. Marone et al. 
(1998) found a gender difference in relation to eye gaze for specific body parts. Both trans 
males and females gazed at their feet for the shortest amount of time, indicating that they 
perceived less dissatisfaction regarding this body part. Trans females gazed longest at their 
whole body whereas trans males gazed longest at their chest, therefore suggesting that these 
body parts caused the most dissatisfaction. In comparison to trans males, trans females gazed 
at their genitals longer, suggesting they were more dissatisfied with these body parts than 
trans males. In support of these findings, trans females have been found to dislike more body 
parts than trans men (Fisher et al., 2013). Recently, Becker et al. (2016) also found trans 
males to perceive body dissatisfaction regarding all female body parts, not just sex-specific 
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body parts. In contrast, trans females reported being extremely dissatisfied with sex-specific 
body parts (e.g., body hair, genitals). They concluded that whilst sexual reassignment (i.e., 
hormones and/or sex reassignment surgery; SRS) may increase body satisfaction for a trans 
person, enhancing body image should also take a more holistic stance, paying more attention 
to the psychological component of body image. In contrast to these findings, Bozkurt et al. 
(2006) found that although there was some difference in body satisfaction with some parts of 
the body, overall body satisfaction did not significantly differ in trans females (n=52), when 
compared to homosexual people (n=36) and aged matched heterosexual cisgender people 
(n=72). They concluded that trans people experience similar levels of body dissatisfaction in 
comparison to homosexual and cisgender people.  
The successfulness of gender dysphoria treatment in relieving body dissatisfaction suggests 
that body image plays a central role in gender dysphoria (Fleming et al., 1982; Kraemer et al., 
2008; Lindgren & Pauly, 1975; Pauly & Lindgren, 1976; Smith et al., 2005; Wolfradt & 
Neumann, 2001). Lindgren and Pauly (1975) and Pauly and Lindgren (1976), who were the 
first to explore the effectiveness of gender dysphoria treatment, found that after sexual 
reassignment treatment (i.e., hormones and/or SRS), body dissatisfaction levels reduced in 
both trans females and males.  
To determine at what stage of treatment trans individuals become more or less satisfied with 
their bodies, de Vries et al. (2011) assessed trans people (n=70) at two different time points; 
once shortly after their first visit to the gender identity clinic (T0; mean age=13.65 years) and 
once shortly before starting CHT (T1; mean age=16.64 years). They found that between T0 
and T1 (mean age=14.75 years), participants started puberty suppression (Gonadotrophin-
releasing hormone agonists; GnRHa). GnRHa did not significantly reduce levels of body 
dissatisfaction between T0 and T1. Interestingly, between T0 and T1, natal females (trans 
males) became more dissatisfied with their secondary and neutral sexual characteristics 
compared to males (trans females). The authors concluded that body dissatisfaction only 
suppresses once trans individuals undergo CHT. However, it must be noted that the 
participants in this study were adolescents, a demographic for whom body dissatisfaction is 
more prevalent in comparison to other age groups (e.g., Tiggemann, 2004) although body 
dissatisfaction exists in women of all ages (Runfola et al., 2013). de Vries et al. (2014) 
followed up this study with 55 trans individuals (from the original dataset) and with an 
additional time point, one year after SRS (T2). Body image concerns continued to remit after 
SRS for both primary and secondary sex characteristics. There was no significant difference 
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for neutral body characteristics between T0 and T2. In combination, de Vries et al.'s (2011, 
2014) studies suggest that body dissatisfaction only starts to remit after sexual reassignment, 
which appears to be in relation to sex-specific body parts. However, Fisher et al. (2014) 
suggested that it is not always necessary for trans people to undergo invasive treatment (i.e., 
SRS) to feel satisfied with their bodies. They found that when trans females received a 
cumulative dose of CHT, body uneasiness was relieved. 
 
To put body dissatisfaction into context at different stages of treatment, Bandini et al. (2013) 
compared body image scores from 100 trans people with a DSM-IV GID diagnosis (50 
without SRS and 50 with SRS), 88 eating disorder patients, and 107 controls. They found that 
in comparison to controls, trans individuals without SRS had higher levels of body 
uneasiness, similar to those with eating disorders. Additionally, trans individuals who had 
SRS reported body uneasiness levels that were not as low as controls, but they were lower 
than the trans people who had not had SRS and lower than the eating disorder participants’ 
levels. This study’s findings support the view that SRS relieves body uneasiness.  
 
Gender dysphoria has been reported to co-occur with other disorders that affect body image. 
Lai et al. (2010) recruited 5010 first year university students, 225 of whom self-reported GID, 
and found that body dysmorphic disorder (a condition included within DSM-5 that causes a 
person to have a distorted perception of their body and consequently feel anxious about their 
appearance) co-occurred with GID in trans males (40.8%) and females (35.2%). Levels of 
body dysmorphic disorder in participants that did not report GID were 15.2% and 20.2% in 
cisgender males and cisgender females, respectively. Colizzi et al. (2015) explored the 
comorbidity of dissociative disorder in trans patients. Dissociative disorder is a DSM-5 
condition that alters a person's sense of reality. People with this condition may feel their body 
is unreal and they may have different identities, and therefore it is thought to be similar to 
gender dysphoria (Colizzi et al., 2015). Colizzi and colleagues found that trans patients with a 
dissociative disorder also reported higher levels of body uneasiness in comparison to trans 
patients who did not report a dissociative disorder. As a result of these findings the authors 
questioned whether body uneasiness is a genuine symptom of gender dysphoria or an 
expression of pathological dissociative experiences. Dissociation may also be a result of 
gender dysphoria, in the sense that trans people may be unable to connect with their bodies.  
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The body image and gender dysphoria findings, when taken together, appear to indicate that 
there is an association between body dissatisfaction and gender dysphoria. Body image 
concerns appear to be core to the distress that trans individuals experience prior to gender 
dysphoria treatment, given the evidence which suggests that treatment appears to alleviate at 
least some of the unhappiness trans individuals experience in relation to their bodies.  
 
3.4.3. Disordered eating in trans people 
3.4.3.1. Disordered eating in trans people: Measures used 
Three different disordered eating measures were employed by studies considered in this 
review.  
 
Eating Disorder Inventory version 1, 2 and 3 (EDI-1-2-3) (Garner, Olmstead, & Polivy, 1983;  
Garner, 1991; Garner, 2004): This was the most frequently used measure, which was used 
four times by studies considered within this review (Ålgars et al., 2012; Cella et al., 2013; 
Khoosal et al., 2009; Witcomb et al., 2015). This measure was developed for an eating 
disorder population and explores symptoms and psychological characteristics commonly 
related to eating disorders. The first three subscales (drive for thinness, bulimia and body 
dissatisfaction) relate to features of eating disorders. High scores indicate more disordered 
eating.  
 
Eating Attitude Test (EAT-26) (Garner, Olmsted, Bohr & Garfinkel, 1982): This tool was 
employed twice by studies considered in this review (Ålgars et al., 2010; Wiseman & Moradi, 
2010). It assesses the cognitive, attitudinal and behavioural dimensions of eating behaviour. It 
has three subscales: dieting; bulimia and food preoccupation; and, oral control. High scores 
indicate more disordered eating. 
 
Eating Disorder Examination Questionnaire (EDE-Q) (Fairburn & Cooper, 1993): This was 
employed once by Vocks et al. (2009). It assesses eating behaviour and weight concerns (e.g., 
‘Over the past 4 weeks, have you wanted your stomach to be empty?’) and has four subscales: 
restraint, eating, shape and weight concern. Higher scores indicate higher levels of eating 
disorder psychopathology.  
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3.4.3.2. Disordered eating in trans people: Review of studies 
It has been suggested that individuals diagnosed with Gender Dysphoria are also at risk of 
disordered eating (e.g., Ålgars et al., 2010). Within this review, three studies explored the 
relationship between disordered eating and gender dysphoria (see Table 3.3.). Silverstein et al. 
(1990) recruited 188 women at a university in the US. They found that women who reported 
a gender identity conflict were more likely to also report purging or frequent binging in 
comparison to the women in the study who did not report a conflicted gender identity. 
However, this study did not establish whether participants who reported a gender identity 
conflict had an ICD or DSM related diagnosis. Ålgars et al. (2012) also set out to explore 
disordered eating by measuring eating behaviour and cognitions in a trans population. They 
found that the majority of trans individuals reported current or past disordered eating in an 
attempt to suppress features of their biological gender or to accentuate features of their 
gender identity, although the trans participants did not report clinical levels of disordered 
eating on the EDI-3. These findings suggest that the participants were dissatisfied with their 
bodies as they were not congruent with their gender identity and so were engaging in 
disordered eating behaviours, potentially as a way to address this. A limitation of this study 
was the small sample size (N=20) and self-identification of being trans. 
 
Khoosal et al. (2009) explored how features of eating disorder behaviour may change over 
the course of physical treatments in a sample of trans females (N=40) with an official ICD-10 
diagnosis. They found that six months after SRS, trans females reported lower levels of 
eating psychopathology and body image dissatisfaction in comparison to people with an 
eating disorder and to the general population. 
 
3.4.4. Body dissatisfaction and disordered eating in trans people 
3.4.4.1. Body dissatisfaction and disordered eating in trans people: Review of the studies  
So far, the literature appears to suggest that body dissatisfaction plays a key role in the 
development of disordered eating (Ålgars et al., 2012; Khoosal et al., 2009; Silverstein et al., 
1990). Within this review, five papers were identified which explored disordered eating as 
well as body image in trans people (see Table 3.3.). Three of these studies found that the 
trans participants had higher levels of body dissatisfaction and disordered eating (e.g., 
bulimic behaviour) in comparison to cisgender populations (Ålgars et al., 2010; Vocks et al., 
2009) and heterosexual and homosexual men and women (Cella et al., 2013). In contrast, 
Wiseman and Moradi (2010) explored body image and disordered eating in a sexual minority 
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population and found eating problems and body image concerns were rarely experienced. 
However, only 2% of this sample identified themselves as trans and therefore these findings 
are unlikely to be representative of the trans population. Strengthening these findings, 
Witcomb et al. (2015) found levels of disordered eating and body dissatisfaction to be higher 
in trans (n=200) than cisgender people (n=200), suggesting trans may exhibit higher levels of 
disordered eating than controls. However, eating disorder patients (n=200) had significantly 
higher levels of disordered eating and body dissatisfaction in comparison to trans people. 
 
The studies presented in this section appear to suggest that trans individuals do not have 
clinically significant eating disorders but may display disordered eating and body 
dissatisfaction, although empirical research into potential explanations as to why trans people 
may engage in disordered eating is sparse.  
 
3.5. Discussion 
The aim of this review was to critically and systematically review the available literature 
examining body dissatisfaction or disordered eating in a trans population, and also the 
literature pertaining to how body dissatisfaction and disordered eating are related in trans 
people. Overall this review found that body dissatisfaction is core to the distress of trans 
people which may put some people at risk for disordered eating.  
Body dissatisfaction appears to be core to the distress trans people experience prior to gender 
dysphoria treatment. This is likely to be a result of the incongruence between biological 
assigned sex and gender identity (e.g., Ålgars et al., 2012). In addition, trans women may 
internalise the commonly emphasised message in Western culture that thin is beautiful. Thin-
ideal internalisation is defined by the extent to which a person engages in behaviours 
designed to produce an approximation of these ideals (Thompson & Stice, 2001). 
Additionally, trans women have reported striving for thinness to appear more feminine 
(Ålgars et al., 2012), which may suggest that trans women are vulnerable to these cultural 
messages. In cisgender populations, thin-ideal internalisation is thought to directly foster 
body dissatisfaction as this ideal is virtually unattainable for most females (e.g., 
Fitzsimmons-Craft, 2011; Thompson & Stice, 2001). Achieving this ideal may be even more 
unrealistic for trans females as some bodily features cannot be altered medically or physically 
(i.e., broad shoulders). The male equivalent to drive for thinness is the drive for muscularity 
(McCreary & Sasse, 2000). In a cisgender population, appearance comparisons and 
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internalisations are associated with muscularity-orientated body dissatisfaction and risky 
body change behaviour (Karazsia & Crowther, 2010). This is evidenced by Goodwin, 
Haycraft and Meyer (2014) who found that peer and family messages to become more 
muscular predicted compulsive exercise in teenage boys. In light of the review’s findings and 
previous literature, clinicians working with trans people must be mindful that body 
dissatisfaction may be driven by gender dysphoria and also by culturally emphasised gender-
specific ideals (which are probably unattainable) in order to achieve a more feminine or 
masculine body shape, depending on their gender identity.  
This review also found that gender dysphoria treatment is capable of increasing body 
satisfaction (e.g., de Vries et al., 2014). This increase in body satisfaction is thought to be a 
result of sex-specific body parts becoming more congruent with gender identity (e.g., de 
Vries et al., 2014). However, interestingly, Becker et al. (2016) found trans males were 
dissatisfied with all female body parts (not just sex-specific) and therefore concluded that 
body image concerns in trans people should not be reduced to sex-specific body parts. This 
finding can be explained by the fact that not all body parts associated with natal females (e.g., 
curvaceous hips) and natal males (e.g., large hands) can be modified through body changing 
behaviours (i.e., surgery or exercise). In light of the review’s findings and previous literature, 
it seems appropriate for clinicians to continue to monitor body dissatisfaction and utilise 
gender dysphoria treatments. At the same time, clinicians working with trans people should 
take a more holistic stance on body image. Rather than only focusing on improving 
satisfaction with sex-specific body parts through medical intervention, the psychological and 
social aspects of body image should be addressed (i.e., challenging negative thought 
processes about the body, positive re-framing of aspects that cannot be changed and 
challenging perceived negative reactions from society). For example, Cognitive Behavioural 
Therapy programmes targeted at US college women have been found to increase affective 
body image and decrease maladaptive body image cognitions (Butters & Cash, 1987). At the 
same time, future research would benefit from taking a more holistic approach when 
measuring body image, instead of focusing on satisfaction with sex-specific body parts.  
This review found that trans people engage in disordered eating (e.g., Khoosal et al., 2009). 
Only one study by Ålgars et al. (2012) explored why trans people may engage in this 
behaviour and found that trans people are motivated to engage in disordered eating to 
suppress features of their natal gender and accentuate features of their gender identity; thus 
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they are motivated by their body dissatisfaction. This is a finding that has been replicated 
within cisgender populations; Stice and Shaw (2002) suggested that body dissatisfaction is 
the main contributor towards the onset and maintenance of an eating disorder. Within 
cisgender populations there are thought to be several moderating factors that influence the 
relationship between body dissatisfaction and eating disorders. McLean, Paxton and Wetheim 
(2010), for example, found that women were more likely to suffer from an eating disorder if 
they had a higher body mass index, if they placed high importance on their appearance, and if 
they had lower cognitive reappraisal and self-care scores. More recently, Machado, 
Gonçalves, Martins, Hoek and Machado (2014) found perfectionism and a family history of 
an eating disorder to be prevalent in individuals who develop Anorexia Nervosa. Fortunately, 
the evidence from this current review suggests that disordered eating in trans people does not 
appear to be clinically significant (e.g., Witcomb et al., 2015). Perhaps in a trans population, 
body dissatisfaction does not manifest into an eating disorder since trans people are 
dissatisfied with aspects of their body (i.e., hands) that cannot be modified through diet 
restriction (Witcomb et al., 2015). It may also be that as body dissatisfaction improves with 
CHT and SRS (e.g., de Vries et al., 2014), disordered eating decreases, given that body 
dissatisfaction is thought to manifest disordered eating (Ålgars et al., 2012). In relation to 
clinical implications, clinicians working with trans people should be aware that disordered 
eating may be present. If this is the case, clinicians should work with the trans person to 
ascertain why the individual may be engaging in this disordered behaviour. This will help 
inform clinical choices regarding how best to address this disordered behaviour. Clinicians 
working in other areas should also be mindful that patients, both those identifying as trans 
and those yet to explore their gender identity, may present with disordered eating as a 
consequence of their gender dysphoria. In addition to this, more empirical research needs to 
explore why trans people may be at risk for disordered eating as there is currently only one 
study by Ålgars et al. (2012) that has explored potential explanations. Researchers should 
also explore body (dis)satisfaction with regard to body parts that cannot be modified through 
medical intervention (i.e., hands or feet). This in turn would enable a better understanding of 
body image in trans people which would inform clinical practice. 
Despite these important findings, the review was limited by the methodological quality of 
studies considered within it. With regard to body dissatisfaction, numerous different 
measures were used to assess this construct. Even though interesting and varied findings have 
been produced from such studies, the lack of consistency means it is hard to make cross-
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study comparisons. The content of the measures employed to explore body image, disordered 
eating and gender dysphoria was also varied and sometimes limited. For instance, BIS (the 
most commonly employed body image measure) only taps into the cognitive dimension of 
body image and fails to recognise the attitudinal, perceptual, or behavioural dimensions. 
Therefore, this measure is unlikely to provide a comprehensive understanding of body image. 
The field would benefit from consolidating the most useful components of existing measures 
to develop a comprehensive and validated measure that taps all dimensions of body image. 
While cross-sectional research has identified an association between gender dysphoria, body 
image (e.g., Kozee et al., 2012) and disordered eating (e.g., Ålgars et al., 2010), there is a 
lack of longitudinal research within the field. This is problematic as how body dissatisfaction 
and disordered eating change over time (i.e., during the treatment programme) is poorly 
understood. Studies also typically employed a small sample of trans people who did not 
always have a clinical diagnosis of Gender Dysphoria in accordance with the ICD or DSM. 
This prevents the generalisability of such findings to those who have an official diagnosis. In 
addition to the research areas’ methodological limitations, the current systematic review also 
has some limitations which should be considered. This review only considered papers as 
being eligible for inclusion if they were written in English, Spanish or Dutch and therefore 
papers that may have been relevant but were written in other languages were not reviewed. 
This review also excluded studies that explored body image and/or disordered eating in 
intersex people and therefore the findings of this review cannot be generalised to this 
population.  
3.5.1. Conclusion 
This systematic review has highlighted how body dissatisfaction is core to the distress of 
trans people which may put some people at risk for disordered eating. To enhance our 
understanding of body image and disordered eating in trans people, more methodologically 
robust research needs to be conducted (e.g., larger sample sizes, longitudinal designs). As a 
consequence, it is hoped that a more advanced empirical knowledgebase will be established, 
which in turn will inform clinical practice.  
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Chapter 4 
Gaps within the literature 
4.1. Introduction  
Chapters 1 to 3 have highlighted that, due to experiencing gender incongruence and the 
distress associated with this, transgender people are particularly vulnerable to body 
dissatisfaction, eating disorder psychopathology, and poor mental health; all of which might 
be alleviated by physical activity and/or sport engagement. However, chapters 2 and 3 
identified several gaps and limitations within the current physical activity and body image 
literature. The aim of chapter 4 is to highlight and discuss the gaps within: (i) the transgender 
physical activity and sport literature determined in chapter 2; and, (ii) the transgender body 
dissatisfaction and eating disorder literature identified in chapter 3. Chapter 4 will then 
outline how the studies reported on in the thesis intend to address the research gaps identified 
in chapters 2 and 3 by presenting the aims of the empirical chapters within this thesis. By 
addressing the gaps in the literature through the empirical studies within this thesis, it is 
hoped that a better understanding of physical (in)activity, experiences of body 
(dis)satisfaction and mental health within the transgender population will be obtained. 
 
4.2. Physical activity and sport  
Poor mental health and body dissatisfaction impose great challenges for the transgender 
population which need to be addressed (e.g., Dhejne, Van Vlerken, Heylens, & Arcelus, 2016; 
Witcomb et al., 2015). Based on the findings of research conducted with the cisgender 
population, physical activity and/or sport engagement may potentially be able to alleviate 
poor mental health and body dissatisfaction experienced by transgender people (e.g., Carter, 
Morres, Meade, & Callaghan, 2016; Cox, Ullrich-French, Howe, & Cole, 2017; Herring, 
Jacob, Suvey, & O’Conner, 2011; Kruger, Lee, Ainsworth, & Macera, 2008; Lantz, Hardy, & 
Ainsworth, 1997; McMahon et al., 2017; Rebar et al., 2016). However, chapter 2, which 
systematically reviewed the literature pertaining to physical activity and sport in the 
transgender population, concluded that despite a lack of literature it appears that the majority 
of transgender people have a negative experience when being (or attempting to be) physically 
active or participating in sport. This conclusion was based mainly on qualitative studies that 
were concerned with participation in competitive sport at an elite level. There is even less 
research that has considered transgender people’s experiences of participating in physical 
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activity and/or recreational sport for leisure or fitness. This is surprising as it would be 
expected that transgender people would be more likely to engage in physical activity and/or 
recreational sport rather than competitive sport at an elite level. In addition to this, none of 
the studies within the systematic review concerned with physical activity and recreational 
sport had considered the role of medically transitioning. Medically transitioning has been 
associated with an increase in mental well-being and a decrease in body dissatisfaction (i.e., 
increase in body satisfaction; e.g., Costa & Colizzi, 2016; Fisher et al., 2014; Gorin-Lazard et 
al., 2013; Heylens, Verroken, De Cock, T’Sjoen, & De Cuypere, 2014). Better mental well-
being and lower body dissatisfaction (i.e., greater body satisfaction) have been associated 
with greater physical activity and/or sport engagement within the cisgender population (e.g., 
Carter et al., 2016; Cox et al., 2017; Kruger et al., 2008; McMahon et al., 2017). Therefore, 
given that there is limited research which has explored the experiences of treatment seeking 
and medically transitioning transgender people in physical activity and recreational sport, 
further exploratory qualitative research is needed. Such research will facilitate our 
understanding of the specific experiences of this population and, if necessary, start to reveal 
how physical activity and recreational sport can be made more accessible. This will help to 
determine whether physical activity and/or recreational sport (engaged in for leisure or fitness) 
would be a feasible mechanism to alleviate mental health problems and body dissatisfaction 
in transgender people.  
 
Although qualitative research will be useful in obtaining an understanding of physical activity 
and recreational sport experiences within the transgender population, such findings cannot be 
generalised. In contrast, the findings from quantitative research conducted with larger, 
representative samples can be more widely generalised. The systematic review in chapter 2 
identified that there is currently a lack of quantitative research that has considered the amount 
of, and factors associated with, physical activity and recreational sport participation within 
the transgender population. It is important that quantitative research in this area is increased 
so that the findings can be used to inform the development of interventions and initiatives 
which aim to increase the accessibility of physical activity and/or recreational sport within 
the transgender population. Such interventions may have important benefits in relation to 
mental health and body dissatisfaction.  
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4.3. Body dissatisfaction and disordered eating 
Alleviating body dissatisfaction within the transgender population is paramount as the 
systematic review in chapter 3 concluded that body dissatisfaction appears to make this 
population vulnerable to disordered eating (Ålgars, Alanko, Santtila, & Sandnabba, 2012), 
although it was noted that only one study to date has explicitly studied the association 
between body dissatisfaction and eating disorder psychopathology. In addition to this, 
research conducted with the cisgender population has found disordered eating to be 
influenced by multiple factors and, consequently, to be highly complex (e.g., Mazzeo & 
Bulik, 2009). No research to date has explored whether factors, other than body 
dissatisfaction, are capable of explaining eating disorder psychopathology within the 
transgender population. This is significant as many factors that have been found to be 
associated with eating disorder psychopathology within the cisgender population are pertinent 
among transgender people. For instance, poor mental health (i.e., symptoms of anxiety and 
depression) has been associated with eating disorder psychopathology in cisgender people 
(e.g., Brechan & Kvalem, 2015; DeBoer & Smits, 2013). Due to their minority identity, 
transgender people are thought to be particularly vulnerable to poor mental health (e.g., 
Dhejne et al., 2016; Hendricks & Testa, 2012; Meyer, 2003). Understanding risk factors 
associated with eating disorder psychopathology within the transgender population will allow 
for specific prevention and alleviation strategies to be established. Therefore it is apparent 
from the systematic review of the literature presented in chapter 3 that there is a need for 
more research that explores why transgender people are vulnerable to disordered eating.  
 
The systematic review in chapter 3 also highlighted how research has shown that gender 
affirming medical interventions are capable of alleviating body dissatisfaction (i.e., 
increasing body satisfaction; Kraemer, Delsignore, Schnyder, & Hepp, 2008; Smith, Van 
Goozen, Kuiper, & Cohen-Kettenis, 2005). As body dissatisfaction has been associated with 
eating disorder psychopathology within the transgender population (Ålgars et al., 2012), it 
would be expected that gender affirming medical interventions are also capable of alleviating 
eating disorder symptoms. Only one study within the systematic review in chapter 3 
considered the role of gender affirming medical interventions on eating disorder symptoms, 
finding these symptoms to be alleviated following gender affirming surgery (Khoosal, 
Langham, Palmer, Terry, & Minajagi, 2009). However, this study only considered the role of 
gender affirming surgery and not the isolated role of cross-sex hormones. Khoosal et al.’s 
(2009) study was also limited by the fact that only a small sample (N=40) of transgender 
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females were recruited. Due to these limitations, conclusions about the role of gender 
affirming medical interventions on eating disorder symptoms cannot be made. In light of this, 
more research is needed in a large sample of treatment seeking transgender males and 
females. Such research is important because, if an association between gender affirming 
interventions and eating disorder symptoms is found, it may suggest that eating disorder 
symptoms are secondary to gender incongruence.  
 
Research has suggested that transgender people may experience dissatisfaction with all of 
their body and not just parts of the body that are associated with their gender assigned at birth 
(e.g., Becker et al., 2016). Additionally, research has found some transgender people to 
continue to report high levels of body dissatisfaction after gender affirming medical 
interventions (van de Grift et al., 2017a). In light of the findings from previous literature, it 
would seem that interventions (other than gender affirming medical interventions) which are 
capable of alleviating body dissatisfaction are necessary. One potential intervention that may 
be able to alleviate body dissatisfaction in the transgender population is physical activity 
and/or sport engagement. However, the systematic review in chapter 2 revealed that there is 
very little known about the amount of physical activity and sport transgender people engage 
in or about the factors that are associated with being physically active. Therefore it is 
unknown whether physical activity and sport engagement would be an acceptable and 
effective intervention to transgender people. Preventing this knowledge from being obtained 
is also the lack of available tools that can assess important intervention outcomes, such as 
mental health and body dissatisfaction, within the transgender population. 
  
4.4. Measurement issues in transgender health   
To determine whether interventions that are aimed at improving mental health and body 
dissatisfaction within the transgender population have been effective, reliable measurement 
of these constructs is imperative. The systematic review in chapter 3 identified a lack of 
consistency in the tools used to assess body dissatisfaction within the transgender population. 
Measurement consistency is important in order to allow comparisons to be made easily across 
studies. The review also highlighted that tools which are used to assess body dissatisfaction 
within the transgender population tend to have been developed and validated with the 
cisgender population (e.g., the Body-Cathexis Scale; Secord & Jourard, 1953), or with 
populations known to experience high levels of body dissatisfaction, such as people with an 
eating disorder (e.g., Eating Disorder Inventory-2; Garner, 1991). While these measures have 
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undoubtedly been useful in starting to explore body dissatisfaction and eating 
psychopathology in transgender individuals, the systematic review in chapter 3 demonstrated 
how body dissatisfaction experienced by transgender people differs in many aspects from 
body dissatisfaction experienced by the cisgender population and by people with an eating 
disorder. For instance, weight and shape concerns are core to a diagnosis of anorexia and 
bulimia nervosa within the International Classification of Diseases (ICD-10; World Health 
Organization (WHO), 1992) and the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5; American Psychiatric Association (APA), 2013). In contrast, transgender people 
report primarily experiencing dissatisfaction with body parts that are a reminder of the gender 
they were assigned at birth (e.g., genitals; van de Grift et al., 2016a; 2016b). Transgender 
people are thought to engage in disordered eating to suppress body features associated with 
their gender assigned at birth and accentuate body features associated with their gender 
identity (Ålgars et al., 2012). In light of this, self-report measures employed within this group 
should assess body dissatisfaction in relation to gender incongruence (i.e., ‘I am dissatisfied 
with my body as it does not align with my gender identity’). This will allow for measurement 
of body dissatisfaction within the transgender population to be more accurate and meaningful. 
This issue is not isolated to the measurement of body dissatisfaction. Currently, mental health 
measures employed with the transgender population do not assess mental health in relation to 
gender incongruence and gender distress (dysphoria) (i.e., ‘I feel low in mood because the 
gender I was assigned at birth and my gender identity do not match’) (Dhejne et al., 2016).  
This is problematic as the full nature of this population’s experiences of mental health 
problems cannot be established which is likely to affect the conclusions drawn from research 
and, consequently, the successfulness of interventions which aim to alleviate mental health in 
this population. In response to this, there is a need for the development of a measure that has 
been designed with the transgender population in mind and is capable of assessing mental 
health and body dissatisfaction in relation to gender incongruence and gender distress. Such a 
measure will be beneficial for clinical purposes and will also extend past research by 
enhancing the accuracy and reliability of data collected on mental health and body 
dissatisfaction from the transgender population. 
  
4.5. Empirical aims of the thesis 
The overarching aim of this thesis was to further the current understanding around physical 
(in)activity, experiences of body (dis)satisfaction and mental health within the transgender 
population. In light of the gaps identified in chapters 2 and 3, the empirical research 
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presented in this thesis was concerned with exploring whether transgender people engage in 
physical activity and/or sport as well as the role that gender affirming medical interventions, 
mental health and body (dis)satisfaction play in being active. The research comprising this 
thesis also aimed to explore the role of mental health and body dissatisfaction in eating 
disorder psychopathology with the purpose of understanding why this population is 
vulnerable to eating disorder symptoms. Additionally, the research within this thesis was 
concerned with exploring the role of cross-sex hormones on eating disorder symptoms within 
the transgender population. Due to the issues surrounding measurement of mental health and 
body dissatisfaction, increasing the reliability of self-report measurement of these constructs 
within the transgender population was a further aim of the research presented in this thesis. 
The thesis has seven specific aims which are listed below, along with the relevant chapter 
number and corresponding empirical study. The main research questions and different areas 
of investigation to be explored in the thesis are displayed in Figure 4.1.  
  
1. To qualitatively understand the experiences that treatment seeking transgender people 
have when engaging (or attempting to engage) in physical activity and/or recreational 
sport for leisure and fitness (chapter 6; study 1). 
2. To establish the amount of physical activity that treatment seeking transgender people 
engage in (chapter 7; study 2).  
3. To establish the role of cross-sex hormones on physical activity levels in treatment 
seeking transgender people (chapter 7; study 2).  
4. To quantitatively identify factors that are associated with physical activity in 
treatment seeking transgender people (chapter 7; study 2). 
5. To establish why transgender people are vulnerable to disordered eating by exploring 
which factors are associated with eating disorder symptoms in treatment seeking 
transgender people (chapter 8; study 3). 
6. To better understand the alleviating effects that cross-sex hormones might have on 
eating disorder symptoms in treatment seeking transgender people (chapter 8; study 3). 
7. To develop and validate a new transgender health outcome measure that is capable of 
assessing gender distress, gender congruence, associated mental well-being, and life 
satisfaction for use in research and clinical settings (chapter 9; study 4). 
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The seven research aims were addressed by conducting four empirical studies, as summarised 
below. 
 
1. Study 1: A qualitative study to explore the experiences that treatment seeking 
transgender people have when engaging (or attempting to engage) in physical activity 
and/or recreational sport for leisure and fitness. 
2. Study 2: A quantitative study to explore the levels, factors associated with, and role of 
cross-sex hormones on physical activity engagement among treatment seeking 
transgender people.  
3. Study 3: A quantitative study to explore why treatment seeking transgender people are 
vulnerable to disordered eating as well as the that role cross-sex hormones might have 
on eating disorder symptoms.  
4. Study 4: A study to develop and validate a new transgender health outcomes measure.  
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Gender Incongruence 
& Distress
The amount of 
physical activity and 
sport (study 2)
Factors associated 
with physical activity 
and sport (studies 1 & 
2)
The role of gender 
confirming medical 
interventions in 
physical activity 
(studies 1 & 2) 
The  role of cross-sex 
hormones in eating 
disorder 
psychopathology 
(study 3) 
Body dissatisfaction 
Poor mental health 
Eating disorder psychopathology
Benefits of physical activity and 
sport
Are physical activity & 
sport engaged in by 
transgender people? 
Why are transgender 
people vulnerable to 
eating disorder 
psychopathology? 
Poor specificity
Can the specificity of 
self-report measures be 
increased? 
Self-report measurement 
Main research 
questions Factors to explore
Explore factors 
associated with  
eating disorder 
psychopathology 
(study 3)
To develop a new 
measure (study 4)
To validate a new 
measure (study 4)
 
Figure 4.1. Main research questions and factors to be explored within the thesis  
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Chapter 5  
General methodology 
5.1. Introduction 
The aim of this chapter is to introduce the methodology employed within this thesis. The 
research design chosen for this thesis will be outlined, followed by a description of the 
participants involved and procedures conducted for the studies that comprise this thesis. This 
will be followed by details of the measures used within this thesis and an overview of the 
data analysis strategy employed. The specific methodology used within each study is 
discussed in detail within the method section of each chapter. 
 
5.2. Research design 
In this thesis, a critical realist perspective was adopted which has been described as 
transcending the polarised perspectives of positivism and relativism (Bhaskar, 1989). A 
critical realist believes that the research design should be dictated by the research questions 
(McEvoy & Richards, 2006). Therefore, based on the research aims of the thesis (see section 
4.5.) an exploratory sequential mixed method research design (i.e., exploratory qualitative 
research followed by quantitative research) was deemed the most appropriate. Triangulating 
qualitative and quantitative research can provide complementary perspectives on a 
phenomenon (McEvoy & Richards, 2006). Given the paucity of research in this area (see 
chapters 2 and 3), a cross-sectional approach was chosen to enable initial inroads to be made 
in exploring physical activity, body (dis)satisfaction and mental health in transgender 
individuals. The cross-sectional research studies (chapters 6 to 9) highlight novel findings 
and suggest that longitudinal research is warranted with the transgender population, 
especially over the course of gender affirming medical interventions, to build on these 
findings.  
 
5.3. Participants  
Both transgender and cisgender participants were recruited for studies within this thesis to 
address the research questions stated within each chapter.  
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5.3.1. Transgender participants 
For all of the empirical chapters in this thesis (chapters 6 to 9), people who self-identified as 
transgender were asked to take part in the research. In light of the issues surrounding 
diagnoses discussed in section 1.4., transgender participants were not required to have a 
formal diagnosis to take part in the studies within this thesis. However, for all of the studies 
in this thesis, a large proportion of the participants were recruited from a transgender health 
service within the United Kingdom (UK; Nottingham Centre for Transgender Health) and 
therefore it is acknowledged that the majority of transgender participants that contributed 
towards the research did have an official diagnosis (Transsexualism as per ICD-10 or Gender 
Dysphoria as DSM-5) to allow them to access the treatments offered at the transgender health 
service (see section 1.4.). It is also acknowledged that transgender participants recruited from 
the Nottingham Centre for Transgender Health might have taken part in more than one study 
reported on in this thesis, but it is not possible to identify specific instances given that 
individuals took part anonymously in all studies apart from study 1 (chapter 6).  
 
To be eligible to participate in the empirical studies (chapters 6 to 9) that comprise this thesis, 
transgender people were required to be aged 17 years or over (when recruited from a 
transgender health service (as adult transgender health services in the UK receive referrals 
from people aged 17 and above)) and aged 18 years and over when recruited from the 
community (e.g., lesbian, gay, bisexual and transgender (LGBT) organisations).  
 
5.3.2. Cisgender participants  
Cisgender participants were recruited for studies 2 and 4 (chapters 7 and 9, respectively). To 
be eligible to participate, cisgender participants were required to not identify as transgender 
or to experience incongruence between the gender they were assigned at birth and gender 
identity. Cisgender participants were also required to be age 18 years or over.  
 
5.3.3. All participants  
For both the transgender and cisgender groups, participants were not excluded based on their 
reported levels of physical activity, body (dis)satisfaction and mental health. Participants 
were also not excluded based on any socio-demographic variables, such as age, gender, race, 
ethnicity or religion.  
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5.4. Recruitment of participants  
The recruitment method for each study is discussed in turn, below. 
 
5.4.1. Chapter 6: Study - A qualitative study to explore the barriers and facilitator of physical 
activity/sport in the transgender population  
Only transgender participants were invited to take part in study 1. For this study all 
participants who had undergone assessment and been accepted onto the treatment programme 
at the Nottingham Centre for Transgender Health were invited to take part (see section 1.5.). 
Clinicians working within the centre were asked to identify patients from their case load who 
would be suitable to take part in the research (i.e., they were not deemed as vulnerable or 
fragile by their clinician and were fluent in English). Suitable patients were informed about 
the study by their clinician who explained during a routine appointment that there was a 
research project taking place at the service that was interested in exploring the experiences 
that transgender people have regarding physical activity and sport. It was made clear to the 
patient that they were under no obligation to participate in the research and that their decision 
would have no impact on the treatment or services that they received. If the patient wanted to 
find out more about the study, then a meeting with the primary researcher (PhD candidate) 
was arranged at the centre.  
 
5.4.2. Chapter 7: Study 2 – Determining the levels and predictors of physical activity in the 
transgender population 
Both transgender and cisgender participants were invited to take part in this study.  
 
5.4.2.1. Transgender participants 
For this study, all participants that were accepted for assessment by the Nottingham Centre 
for Transgender Health and were awaiting initial assessment at the service were invited to 
take part in the research. When patients at this service were sent an appointment letter for 
their first assessment in the post, they also received an invitation to take part in the study. It 
was made clear to all participants that participation was voluntary and they did not have to 
take part in the research project if they did not wish. It was also made clear that if they did 
take part, their care at the service would not be affected. This study was part of a larger 
longitudinal study aiming to investigate the clinical correlates and outcomes for people 
treated at the Nottingham Centre for Transgender Health. A questionnaire on physical 
activity was included into the questionnaire pack for the sole purpose of this study and 
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therefore the data extracted from the Nottingham Centre for Transgender Health’s database 
for this study were all collected within the timeline of this PhD research. 
 
5.4.2.2. Cisgender participants 
This sample was invited to take part in the research by sharing an online link to the 
questionnaire (developed through Bristol Online Survey) using snowball sampling. This 
involved sharing the link with members of the community through social media sites such as 
Facebook and Twitter and via email. People who took part in the research were asked to pass 
information about the study onto anyone else who may be interested in taking part in the 
research. 
 
5.4.3. Chapter 8: Study 3 – The role of cross-sex hormones on eating disorder symptoms in 
the transgender population 
Only transgender participants were invited to take part in this study. As in study 2, 
transgender participants were invited to participate in the research while waiting for their 
initial assessment at the Nottingham Centre for Transgender Health. When the patients’ first 
appointment was sent out to them in the post, information regarding the study was included. 
All patients were invited to take part but it was clearly explained to them that they did not 
have to. If they decided to take part in the research it was made clear that this would not 
affect the care they received at the service. As in study 2, this study was part of a longitudinal 
study taking place at the Nottingham Centre for Transgender Health. Collection of data for 
this study began in 2012 and therefore some of the data used within this study were historical 
(i.e., were collected before the research for this PhD thesis commenced).  
 
5.4.4. Chapter 9: Study 4 – Development and validation of a new transgender health outcome 
measure  
Both transgender and cisgender participants were invited to take part in study 4.  
 
5.4.4.1. Transgender participants 
Participants for this study were invited from the Nottingham Centre for Transgender Health. 
Patients who were being assessed or were already in the treatment programme at the centre 
were invited to take part. Clinicians working at the centre were asked to identify potential 
participants from their case load (i.e., those who were not perceived to be vulnerable or 
fragile by their clinician and had a good understanding of written English). Once appropriate 
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patients had been identified, the clinician involved in their care provided written information 
about the study in an envelope. The questionnaire pack for this study was also included 
within the same envelope and patients were asked to complete the questionnaires if they were 
happy to take part. The research team’s contact details were included within the envelope and 
information on how the patient could seek independent advice about taking part in the study 
was also included within the pack.  
 
Transgender participants were also invited from the community through LGBT support 
organisations and charities. Gatekeepers at these organisations and charities who agreed to 
facilitate recruitment were asked to share a brief outline of the research project on their 
websites, mailing lists and/or newsletters (whichever worked best for them). They were 
provided with an electronic flyer (see Appendix A) and a summary (see Appendix B0F1) that 
described the study and could be used to advertise the study through the suggested mediums. 
Snowball sampling was also used. Charities, organisations and people who took part in the 
study were asked to pass on the study information to other potentially interested parties (i.e., 
other relevant charities or transgender people).   
 
5.4.4.2. Cisgender participants 
Cisgender people were invited to take part in the research through the community via 
snowball sampling. This involved sharing details of the research study with people through 
social networking sites (e.g., Facebook and Twitter) and email. In addition to this, people 
who took part in the research were asked to pass information about the study onto anyone 
else who may be interested in taking part in the research. Flyers advertising the study (see 
Appendix A) were also placed on noticeboards at Loughborough University.  
 
5.5. Procedures 
5.5.1. Chapter 6: Study 1 - A qualitative study to explore the barriers and facilitators of 
physical activity/sport in the transgender population 
Patients who were interested in finding out more about study 1 were given an information 
sheet by the PhD candidate which they could read in their own time (see Appendix C). It was 
                                            
 
1 Within this summary the scale is named the ‘Nottingham Gender and Body Dysphoria Scale’. Within chapter 9 
this scale is named the ‘Gender Congruence and Life Satisfaction Scale’. The name of the scale was changed in 
chapter 9 after the validation process as it was felt to better represent the contents of the scale.  
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verbally explained to the participant that if they agreed to participate, they would be required 
to take part in a semi-structured interview. The patient was given 24 hours to decide whether 
or not they would like to take part in the study and after this time the PhD candidate 
telephoned the patient to determine the outcome of their decision. If the patient decided they 
would like to take part in the study, then a date and time for the interview was arranged 
during this telephone conversation. It was explained on the telephone that these interviews 
would last approximately 30 to 60 minutes and would be audio recorded with the 
participant’s permission. This time frame was determined from a pilot interview that was 
conducted prior to the main data collection phase. The pilot interview was conducted between 
the PhD candidate (interviewer) and another member of the research team (interviewee) to 
ensure an appropriate breath of topics were covered in the interview and that it was an 
appropriate length (i.e., not too long). The PhD candidate conducted all of the semi-structured 
interviews with the participants. The interviews were offered either face-to-face at the 
Nottingham Centre for Transgender Health or over the telephone, whichever the participant 
preferred. When the interview was conducted over the telephone, informed consent was 
provided through an online survey prior to the interview (see Appendix D). When the 
interview was being conducted face-to-face, participants provided written informed consent 
prior to interview (see Appendix E). The rationale for offering participants the choice of 
method of interview was for pragmatic reasons. Patients travel from all over England and 
Wales to access the Nottingham Centre for Transgender Health and usually only access this 
service once every three months. Despite travel expenses being offered to all participants, for 
some it would be impractical and inconvenient to travel to the centre for the interview alone 
if the interview could not be scheduled on the same date as the patient’s routine appointment. 
 
5.5.2. Chapter 7: Study 2 - Determining the levels and predictors of physical activity in the 
transgender population 
For this study, both transgender and cisgender people were invited to complete self-report 
measures.  
 
5.5.2.1. Transgender participants  
This study was part of a larger longitudinal study aiming to investigate the outcomes of 
people treated at the Nottingham Centre for Transgender Health and the clinical correlates. 
Before the first appointment at the centre, all patients were sent a questionnaire pack in the 
post and invited to take part. After reading the information sheet (see Appendix F) and 
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providing informed consent (see Appendix G), participants were asked to return the 
completed paper questionnaire pack to the Nottingham Centre for Transgender Health using 
the prepaid envelope provided. Alternatively, patients could bring their completed 
questionnaires to their first appointment at the Nottingham Centre for Transgender Health. 
The completion of these questionnaire packs took approximately 20 to 30 minutes. 
 
5.5.2.2. Cisgender participants  
The study was explained using an information sheet (see Appendix H) and informed consent 
was obtained prior to participants taking part (see Appendix I). Participants were invited to 
complete a short online survey (which took approximately 10 minutes) which only asked 
about their physical activity engagement. 
 
5.5.3. Chapter 8: Study 3 - The role of cross-sex hormones on eating disorder symptoms in 
the transgender population 
The procedures for study 3 are the same as those for the transgender participants in study 2 
(see section 5.5.2.1.).  
 
5.5.4. Chapter 9: Study 4 - Development and validation of a new transgender health outcome 
measure 
5.5.4.1. Transgender participants 
Patients who were interested in taking part in this study were given an envelope by their 
clinician which included the information sheet (see Appendix J1F2) and questionnaires. 
Participants were asked to return the completed questionnaire either in the prepaid envelope 
provided or by bringing the questionnaire to their next appointment at the Nottingham Centre 
for Transgender Health. A pilot study determined that completion of the questionnaire pack 
took approximately 20 minutes. 
 
Alternatively, patients from the transgender health service were directed to an online version 
of the questionnaire pack which had been set-up on Bristol Online Survey. This included the 
                                            
 
2 Within this information sheet the scale is named the ‘Nottingham Gender and Body Dysphoria Scale’. Within 
chapter 9 this scale is named the ‘Gender Congruence and Life Satisfaction Scale’. The name of the scale was 
changed in chapter 9 after the validation process as it was felt to better represent the content of the scale. 
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information sheet (see Appendix K2F3), consent form (see Appendix L) and questionnaires. The 
same procedure was followed with transgender people who were invited from the community 
(i.e., via transgender support organisations). The questionnaires that community participants 
were invited to complete were the same as those administered to the transgender people 
recruited from the Nottingham Centre for Transgender Health. Participants completed these 
questions in their own time and submitted their responses online. 
 
5.5.4.2. Cisgender participants 
Participants were directed to the online questionnaire pack which had been compiled for this 
study (on Bristol Online Survey). They were invited to complete the survey in their own time 
and submit their responses online. The questionnaire pack was the same as that administered 
to the transgender participants except that this group were not asked to provide information 
about gender transition. These questions were filtered out in the online questionnaire when 
the participant indicated (by checking a box) that their gender assigned at birth and gender 
identity were the same.  
 
5.6. Ethical considerations 
When participants were recruited from the Nottingham Centre for Transgender Health 
(chapters 6 to 9; studies 1 to 4, respectively), ethical approval was sought and granted from 
the relevant NHS ethics committee and from the Research and Development Department of 
the Nottinghamshire Healthcare NHS Foundation Trust (see Appendix M). For the 
recruitment of transgender people from the community (LGBT charities and organisations) 
and of cisgender people (chapters 7 and 9; studies 2 and 4, respectively), ethical approval was 
obtained from Loughborough University’s ethical advisory committee (see Appendix M).  
 
Following ethical approval, participants in each study were provided with an information 
sheet. After reading this, participants were given the opportunity to ask questions about the 
research. The PhD candidate’s contact details were always provided as well as the contact 
details of the supervisors. When participants were recruited from the Nottingham Centre for 
Transgender Health, they were offered the opportunity to obtain independent advice about 
                                            
 
3 Within this information sheet the scale is named the ‘Nottingham Gender and Body Dysphoria Scale’. Within 
chapter 9 this scale is named the ‘Gender Congruence and Life Satisfaction Scale’. The name of the scale was 
changed in chapter 9 after the validation process as it was felt to better represent the content of the scale. 
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taking part in the research from the Patient Advice Liaison Service (PALS) available within 
the NHS. Informed consent was obtained from all participants prior to them taking part in any 
research reported on in this thesis. When research was conducted face-to-face, or when paper 
questionnaires were completed, written informed consent was obtained. When research was 
conducted online, participants were asked to tick a box that indicated their consent to take 
part. Participants could not proceed with the survey unless this box had been checked. For 
study 4, when participants were recruited from the Nottingham Centre for Transgender 
Health, returning their completed questionnaire was evidence of informed consent. This 
procedure was recommended and approved by the NHS ethics committee and by the 
Research and Development Department of the Nottinghamshire Healthcare NHS Foundation 
Trust.  
 
Taking part in the research reported on in this thesis was completely voluntary and no 
incentives were offered. Participants were made aware of their right to withdraw at any stage 
without giving reason. If participants were required to withdraw their responses before data 
analysis had begun, a date for this cut-off was always specified on information sheets. 
Transgender people who were recruited from the Nottingham Centre for Transgender Health 
were made aware that withdrawing from the study would not affect the care or treatment they 
received at the service. No participants requested that their data be withdrawn in any of the 
studies that comprise this thesis.  
 
The information sheets for all studies stated that all data collected from participants would be 
confidential and anonymous. On completion of the study, participants were debriefed (either 
verbally or on paper/online) and directed to appropriate support organisation if necessary 
(e.g., Mind, Samaritans). Paper documentation (e.g., questionnaire packs, consent forms) was 
stored in a locked cabinet at the Nottingham Centre for Transgender Health for chapters 6 to 
9 (studies 1 to 4). Data were then entered into a password protected computer at the 
Nottingham Centre for Transgender Health and transferred using an encrypted memory stick 
to Loughborough University for data analysis. Data collected online for chapters 7 and 9 
(studies 2 and 4) were stored on a password protected computer at Loughborough University.  
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5.7. Measures 
5.7.1. Interviews  
As identified in chapter 2 (see section 2.5.1.), limited research has explored the experiences 
of transgender people regarding physical activity and recreational sport, and therefore a 
qualitative approach was deemed appropriate for study 1 (chapter 6). Individual semi-
structured interviews were conducted with participants, which were guided by questions and 
prompts. This is in accordance with the critical realist approach which values interviews as a 
data collection tool (Smith & Elger, 2014). The questions and prompts were not prescriptive 
and did not follow a chronological order, although a question that was suitable to begin the 
interview was identified. A semi-structured interview schedule was seen as necessary to 
ensure that the interview maintained focus and relevance (e.g., Fossey, Harvey, McDermott, 
& Davidson, 2002), whilst allowing participants to shape the interview through discussion of 
their individual experiences. The interview schedule was developed after consulting the 
relevant academic literature and academic clinicians working within the area of transgender 
health (see Appendix N). 
 
5.7.2. Questionnaires 
5.7.2.1. Socio-demographic information 
In all empirical chapters that comprise this thesis (including the qualitative chapter; study 1), 
participants were asked to report information about their age, gender assigned at birth, and 
gender identity (if relevant). Transgender participants were also asked to provide information 
about their social gender role and medical transition (e.g., hormone blockers, cross-sex 
hormone treatment, chest surgery (mastectomy and chest reconstructive surgery or breast 
augmentation), genital surgery). The information sought from participants about their social 
gender role and medical transition differed depending on the research question(s) of the 
particular study. See Appendix O for the socio-demographic questionnaires used in the 
empirical chapters that comprise this thesis.  
 
5.7.2.2. Selection process for self-report questionnaire measures 
Measures were selected in accordance with several criteria. First and foremost, it was vital 
that the measure was capable of appropriately assessing the construct in question. This was 
determined by exploring the face validity of the measure and also whether or not the measure 
was psychometrically sound and had undergone validity testing. Where possible, measures 
that had been validated with the transgender population, or had previously been used with the 
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transgender population and shown to have good reliability, were given priority. Considering 
participants in chapters 7 to 9 (studies 2 to 4) were asked to complete several different 
measures at one time, the length of the measure (i.e., the number of questions included) was 
also important. Respondent burden has been found to be great when participants are asked to 
complete numerous measures (e.g., Rolstad, Adler, & Ryden, 2011; Turner et al., 2007) 
which can adversely affect the quality of data collected (e.g., Diehr, Chen, Patrick, Feng, & 
Yasui, 2005; Snyder et al., 2007). Therefore, measures were selected which were valid, 
assessed the construct(s) of interest, had been used with transgender samples previously 
(wherever possible), and were not overly long. Copies of the measures used within the thesis 
and their scoring instructions are presented within the appendix (see Appendix P to X). 
Psychometric properties of the measures when used with the samples recruited for the 
research reported on in this thesis are presented in the relevant chapter (chapters 7 to 9). 
 
Transgender Congruence Scale (TCS; Kozee, Tylka, & Bauerband, 2012): This self-report 
measure asks participants the degree to which they feel their gender identity is congruent with 
the gender they were assigned at birth (see Appendix P). It was designed specifically for use 
with the transgender population. There are 12 items in total and two subscales, one that 
assesses ‘appearance congruence’ (9-items; e.g., ‘My outwards appearance represents my 
gender identity’) and another that assesses ‘gender identity acceptance’ (3-items; e.g., ‘I have 
accepted my gender identity’). Participants are asked to rate their responses on a 5-point 
Likert scale from 1 = ‘strongly disagree’ to 5 = ‘strongly agree’. Three items are reverse 
scored (where 1 = 5, 2 = 4, 3 = 3, 4 = 2, 5 = 1). A global score can also be calculated by 
calculating the mean score for all 12 items. A higher mean score indicates a higher level of 
transgender congruence. The measure has been validated with the transgender population and 
has demonstrated excellent reliability (Cronbach’s α=.92; Kozee, Tylka, & Bauerband, 2012).  
 
Experience of Transphobia Scale (Clements-Nolle, Marx, & Katz, 2006; Nuttbrock et al., 
2010): There is currently a lack of validated, self-report measures that assess transphobia (the 
experience of discrimination and prejudice on the basis of gender identity). In light of this, an 
item assessing verbal transphobia (‘Have you ever been verbally abused or harassed due to 
your gender identity or presentation?’) and an item assessing physical transphobia (‘Have you 
ever been physically abused or beaten due to your gender identity or presentation?’) were 
adapted from previous studies that have measured transphobia (Clements-Nolle et al., 2006; 
Nuttbrock et al., 2010; see Appendix Q). Participants were asked to rate, on a 4-point Likert 
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scale (from 0 = ‘never’ to 3 = ‘several times’), the frequency that they have experienced such 
behaviour. Responses from these two questions were analysed separately. A higher score 
indicates a more frequent experience of transphobia.  
 
Hamburg Body Drawing Scale (HBDS; Becker et al., 2016): This self-report measure 
assesses (dis)satisfaction with different parts of the body. The measure was originally 
developed for use with individuals with different forms of psychoendocrinological disorders 
(Appelt & Strauss, 1988). It has since been adapted to include items specific to people 
assigned male and female at birth, it has gender-specific subscales, and it has been validated 
with the transgender population (Becker et al., 2016; see Appendix R). The measure assesses 
27 body features that are gender neutral with respect to gender assigned at birth (e.g., arms, 
thighs). There are an additional five items that are specifically relevant to people assigned 
male at birth (e.g., Adam’s apple) and an additional six items that are specifically relevant to 
people assigned female at birth (e.g., breasts).  Therefore the version concerned with people 
assigned male at birth includes 32 items in total and the version concerned with people 
assigned female at birth includes 33 items in total. When evaluation does not need to be 
specific in relation to gender, an item that assesses overall satisfaction with the body 
(‘Satisfaction with your overall appearance’) can be used. This was the only item used in this 
thesis. Participants are asked to rate their responses on a 5-point Likert scale (1 = ‘very 
dissatisfied’ to 5 = ‘very satisfied’). A high score indicates a low level of body dissatisfaction 
(i.e., body satisfaction). The measure was chosen as it has been validated among transgender 
people and been previously shown to be reliable (e.g., Cronbach’s α=.62-.91; Becker et al., 
2016; Davey, Arcelus, Meyer, & Bouman, 2016).  
 
Eating Disorder Inventory-2 (EDI-2; Garner, 1991): This self-report measure assesses 
behaviours and psychological traits associated with eating disorder psychopathology (see 
Appendix S). In total, the EDI-2 comprises 11 subscales. Three of these subscales, drive for 
thinness, bulimia and body dissatisfaction, specifically assess eating-related symptoms (e.g., 
‘I feel satisfied with the shape of my body’). The remaining eight subscales (ineffectiveness, 
perfectionism, interpersonal distrust, interoceptive awareness, maturity fears, asceticism, 
impulse regulation, and social insecurity) are associated with eating-related psychological 
disturbance (e.g., ‘I have extremely high goals’). These 11 subscales comprise 91 questions, 
however in this thesis only items related to the drive for thinness (n=7), bulimia (n=7), body 
dissatisfaction (n=9), perfectionism (n=6) and interpersonal distrust (n=7) subscales were 
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employed and therefore participants were asked to complete 36 items in total. Participants are 
asked to rate their responses on a 6-point Likert scale (3 = ‘always’, 2 = ‘usually’, 1 = ‘often’, 
0 = ‘sometimes’, 0 = ‘rarely’, 0 = ‘never’), responses are summed and a higher score 
indicates a high levels of eating psychopathology. Eleven items are reverse scored (where 3 = 
0, 2 = 0, 1 = 0, 0 = 1, 0 = 2, 0 = 3). While the EDI-2 is not a diagnostic tool, it has been 
extensively employed within the academic literature and clinical practice. It has been found 
to have good reliability among people with diagnosed eating disorders and the general 
population (e.g., Nevonen, Clinton, & Norring, 2006). The EDI-2 was employed within this 
thesis as it has previously been used with the transgender population and is capable of 
distinguishing between people with diagnosed eating disorders, transgender people and 
cisgender controls with no diagnosed eating disorder (see Khoosal, Langham, Palmer, Terry, 
& Minajagi, 2009; Witcomb et al., 2015).  
 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983): This self-report 
measure is widely used within different aspects of research to assess symptoms of anxiety 
and depression (see Appendix T). The measure comprises 14 items in total, seven which 
assess specifically anxiety (e.g., ‘I feel tense or wound up’; HADS-A) and seven which 
assess depression (e.g., ‘I have lost interest in my appearance’; HADS-D). A total score (sum) 
is calculated for each subscale. Participants are asked to rate their responses on a 4-point 
Likert Scale from 0 = ‘not at all’ to 3 = ‘most of the time’. Six items are reverse scored 
(where 3 = 0, 2 = 1, 1 = 2, 0 = 3). For each subscale, scores between 0-7 are considered 
‘normal’, scores between 8-10 are considered ‘borderline clinical’, and scores of 11 and 
above are considered ‘clinically relevant’ (Snaith, 2003). However, the HADS is not a 
diagnostic tool. The highest score possible for each subscale is 21. The HADS has been 
shown to be a reliable measure within the general population and other specific populations 
(e.g., psychiatry, primary care; Bjelland, Dahl, Haug, & Neckelmann, 2002). Although the 
measure was developed with the cisgender population, there is currently no measure that 
assesses anxiety and depression that has been developed and validated with transgender 
people and so the HADS was used to assess these constructs within this thesis. The HADS 
has previously been used successfully with the transgender population (e.g., Bouman et al., 
2016b; Hepp, Kraemer, Schnyder, Miller, & Delsignore, 2005). 
 
Rosenberg Self-Esteem Scale (Rosenberg, 1965): This is a 10-item self-report measure that 
assesses participants’ feelings in relation to self-esteem using both positively and negatively 
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framed questions (see Appendix U). An example item is: ‘At times, I think I am no good at 
all’. Participants are asked to rate their responses on a 4-point Likert scale from 3 = ‘strongly 
agree’ to 0 = ‘strongly disagree’. Five items are reverse scored (where 3 = 0, 2 = 1, 1 = 2, 0 = 
3). Scores from the 10 individual items are summed to calculate the global score. The highest 
possible score is 30, which indicates very high self-esteem. This measure was chosen to 
assess self-esteem in this thesis given its brevity and because it has been shown to have 
reliability within the general population (e.g., Robins, Hendin, & Trzensniewski, 2001) and 
within specific populations, such as transgender people (Cronbach’s α=.92; Davey et al., 
2016).   
 
World Health Organisation Quality of Life-BREF (WHOQOL-BREF) (Harper, 1998): The 
WHOQOL-BREF is a cross-culturally comparable quality of life measure (see Appendix V). 
This measure assesses quality of life with 26 items across four subscales: psychological (n=6; 
e.g., ‘How much do you enjoy life?’), physical (n=7; e.g., ‘Are you well able to get around?’), 
relationships (n=3; e.g., ‘How satisfied are you with your sex life?’), and environment (n=8; 
e.g., ‘How satisfied are you with your access to health services?’). There is also an item that 
assesses overall quality of life and another which assesses overall health. In this thesis, only 
the psychological and relationships subscales were used as well as the item that assesses 
overall quality of life. Participants are asked to rate their responses on a 5-point Likert scale 
(anchored from 1 to 5). Although the anchor remains the same throughout, the wording of the 
response scale differs for some questions (e.g., ‘very dissatisfied’ to ‘very satisfied’; ‘never’ 
to ‘always’; ‘very poor’ to ‘very good’). The four individual subscale scores are each 
generated by calculating the mean and multiplying this by four. The rationale for multiplying 
the mean score by four is to make the scores from the WHOQOL-BREF comparable to the 
WHOQOL-100 (Harper, 1998), which is the longer, original questionnaire. Three items are 
reverse scored (where 1 = 5, 2 = 4, 3 = 3, 4 = 2, 5 = 1). A higher score indicates a higher 
quality of life. The WHOQOL-BREF has been found to have good reliability (e.g., 
psychological subscale Cronbach’s α=.81, relationship subscale Cronbach’s α=.68) and 
validity in the general population and in clinical populations (e.g., rehabilitation, primary care, 
mental health) across 23 countries (Skevington, Lofty, & O’Connell, 2004), hence it was felt 
to be an appropriate measure to assess quality of life within the thesis.  
 
Rapid Assessment of Physical Activity (Topolski et al., 2006): This self-report measure was 
chosen as it quickly assesses physical activity engagement over the past week (see Appendix 
Chapter 5: General methodology 
95 
 
W). The measure assesses the frequency and type of physical activity (e.g., ‘I do 30 minutes 
or more a day of moderate physical activities, 5 or more days a week’). The measure has nine 
statements in total, seven that relate to aerobic physical activity (items 1 to 7) and two items 
that relate to strength and flexibility physical activity (items 8 and 9). To determine levels of 
physical activity, participants are asked to indicate the degree to which the nine statements 
relate to them by ticking ‘Yes’ or ‘No’. There are no other response options available. The 
two subscales are scored separately. Total scores are calculated by choosing the highest item 
with an affirmative response and scoring accordingly. For example, if question three was the 
highest question which the participant scored ‘Yes’ to on the aerobic physical activity 
subscale, then they would be given a score of three. High levels of physical activity 
engagement are indicated by a higher score, and scores under six on the aerobic physical 
activity subscale are considered to indicate a suboptimal level of physical activity. The 
strength and flexibility subscale was not used within this thesis. This measure has good 
reliability with the general population as it has been found to have better specificity, 
sensitivity and predictive power than other self-report measures used to assess physical 
activity (Topolski et al., 2006).  
 
Internet Gaming Disorder Scale-Short Form (IGDS9-SF; Pontes & Griffiths, 2015): This 
measure was developed in accordance with the nine criteria that define internet gaming 
disorder within the DSM-5 (APA, 2013). However, the IGDS9-SF is not a diagnostic tool. 
The IGDS9-SF aims to efficiently assess the severity of internet gaming disorder and any 
associated negative effects that it may have on a person’s life (e.g., ‘Do you systematically 
fail when trying to control or cease your gaming activity?’; see Appendix X). The IGDS9-SF 
assesses online and offline gaming activities over the past 12 months using just nine items. 
Participants are asked to rate their responses on a 5-point Likert scale (1 = ‘never’ to 5 = 
‘very often’). No items are reversed scored. The global score is calculated by summing scores 
from the nine individual items and therefore scores can range from 9-45. A higher score 
indicates a higher level of problematic internet gaming behaviour. It is suggested by its 
developers that people who score 36 and above should be classified as ‘problematic gamers’. 
The measure has been found to be psychometrically sound and to have good reliability 
(Cronbach’s α=.87; Pontes & Griffiths, 2015). The measure has also been used within the 
transgender population and has been found to be reliable (Cronbach’s α=.92; Arcelus et al., 
2016).  
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5.7.3. Summary of questionnaire measures used within this thesis 
Table 5.1., below, outlines which questionnaire measures were used in each of the 
quantitative studies reported on in the thesis (studies 2 to 4; chapters 7 to 9).  
 
Table 5.1. Questionnaire measures used within each quantitative study (studies 2 to 4) 
Questionnaire measures Study 2 Study 3 Study 4 
Transgender Congruence Scale    
Experience of Transphobia     
Hamburg Body Drawing Scale    
Eating Disorder Inventory     
Hospital Anxiety and Depression Scale    
Rosenberg Self-Esteem Scale    
World Health Organisation Quality of Life-BREF     
Rapid Assessment of Physical Activity     
Internet Gaming Disorder Scale-Short Form     
 
5.8. General data analysis strategy 
5.8.1. Qualitative data analysis 
5.8.1.1. Thematic analysis 
To analyse the semi-structured interview data, thematic analysis was chosen as it provides a 
rich thematic description of the entire data set, which in turn highlights the most prominent 
and important themes (Braun & Clarke, 2006; Braun, Clarke, & Weate, 2016). Thematic 
analysis has consistently been used in qualitative psychological research due to its theoretical 
independence (Braun & Clarke, 2006; Braun et al., 2016). Thematic analysis is also valuable 
in research with participants whose perceptions on the topic have not been listened to before, 
such as in study 1 (chapter 6) (Braun & Clarke, 2006; Braun et al., 2016). Inductive thematic 
analysis was conducted, whereby themes were driven by the data as opposed to being 
theoretically driven by predefined themes. However, it is acknowledged that the researcher’s 
epistemological position will likely have affected and shaped the data analysis process to 
some degree, even when researchers attempt to distance themselves from the interview data 
(Braun & Clarke, 2006; Braun et al., 2016). This is in accordance with the critical realist 
approach that aims to develop deeper explanation and understanding of a particular 
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phenomenon whilst acknowledging that reality cannot be fully understood as our perceptions 
are shaped by theory and research interests (McEvoy & Richards, 2006). 
 
All audio data were transcribed verbatim by the PhD candidate. To perform the thematic 
analysis, the steps outlined by Braun and Clarke (2006) and by Braun et al. (2016) were 
followed. To facilitate the analysis process, NVivo software was employed. NVivo is a 
qualitative software package that allows researchers to efficiently code data and identify 
connections. It is especially useful with large datasets, such as in the current study. First, the 
PhD candidate gained in-depth familiarisation with the data by reading and re-reading the 
interview transcripts, whilst making notes on potential codes. Next, codes were sought within 
each data transcript and noted down the left margin of the transcripts. In the right-hand 
margin, a description of how the interviewee discussed the topic was noted. Once all the 
interview transcripts had been coded, a second coder was asked to code a proportion of the 
transcripts (see section 5.8.1.2. for more details on this process). Codes from the first and 
second coder were then brought together to formulate themes and subthemes. These themes 
were critically reviewed by the whole research team to ensure they accurately represented the 
participants’ discussions and provided a sound narrative. Extracts to support each of the 
themes and subthemes were then identified; again, these themes and subthemes were 
consistently reviewed by the whole research team and were agreed upon before being 
finalised.  
 
5.8.1.2. Ensuring validity 
To ensure the findings from the qualitative study were valid and to increase trustworthiness, 
an independent researcher was sought to second code 20% of the transcripts (n=2). A 
discussion about the codes, and themes, was then held between the first (PhD candidate) and 
second coder. This process was undertaken to determine whether the coders were in 
agreement about the codes assigned to particular passages of text. On the whole, the first and 
second coders were in agreement. However, in a few instances, the second coder offered 
insight into how some passages of text could be assigned to more than one code. This 
feedback was incorporated into the themes and subthemes to ensure comprehensive analysis. 
In addition to this, critical discussions with the other members of the research team were held 
during the analysis process. These discussions allowed the PhD candidate to challenge 
interpretations and offered insight into how interpretations could be developed further. 
During these discussions, critical reflection on the development of themes and subthemes was 
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also encouraged. This process allowed the themes (and subthemes) to be refined in relation to 
both their content and labels.  
 
5.8.2. Quantitative data analysis 
5.8.2.1. Preliminary data analysis 
Quantitative data analysis was conducted using IBM SPSS (Statistical Package for the Social 
Sciences) version 23 (IBM, 2015). Prior to the main analysis, preliminary checks were 
conducted to assess whether or not the datasets met parametric assumptions. To do this, the 
distributions of the datasets in each study were explored using histograms and by conducting 
a Kolmogorov-Smirnov normality test. Kolmogorov-Smirnov is suitable to use in samples 
greater than 50, however, the data were also interpreted in conjunction with histograms as the 
Kolmogorov-Smirnov test can be significant in large samples, even when scores are only 
slightly different from the normal distribution (Field, 2009).  
 
In all quantitative chapters (studies 2 to 4), the data were shown to be non-normally 
distributed. Therefore, non-parametric tests were conducted when such an alternative was 
available (e.g., Mann-Whitney U test, Spearman’s Rho correlation). When a non-parametric 
equivalent test was not available, the data were transformed using log transformations and 
square-root transformations (as the data showed a positive skew; Field, 2009). In all cases, 
these transformations did not correct the distribution of the data to normal and therefore the 
relevant parametric test was conducted with the untransformed data.  
 
Missing data were dealt with using the pairwise method as this is a more conservative method 
than the listwise exclusion method. The only exception to this was when Mann-Whitney U 
tests were conducted and missing data were excluded using the test-by-test method (i.e., a 
case is only removed when data are missing for the dependent variable). 
 
5.8.2.2. Descriptive and inferential statistics 
Prior to any hypothesis testing, descriptive statistics for each dataset were generated (e.g., 
mean age of participants, frequencies of gender identities) to allow the subsequent analysis to 
be interpreted accordingly.  
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5.8.2.3. Tests of association, regression and mediation analyses 
In all three quantitative chapters (studies 2 to 4), one-tailed Spearman’s Rho correlations 
were conducted (as the data were non-normally distributed) to explore relationships between 
variables within the dataset. To control for Type 1 error, Bonferroni corrections were used in 
all correlational analysis (α = .05 ÷ number of comparisons). The correlational analyses also 
helped assess the assumption for multicollinearity by ensuring variables were not too highly 
correlated (e.g., above r = .90; Pallant, 2010). This assumption was never violated. In studies 
2 and 3, all variables which significantly correlated with the outcome variable (either physical 
activity or eating disorder psychopathology) were entered into subsequent multiple linear 
regression models to determine whether these significantly correlated variables were capable 
of predicting the outcome in question (physical activity or eating disorder psychopathology). 
Only variables that significantly correlated with the outcome were entered into the multiple 
linear regression models to increase the robustness of these models. When categorical 
variables (e.g., gender) were being explored as potential predictor variables, dummy variables 
were created. In study 3, the multiple linear regression analysis was followed up with 
mediation analysis using the PROCESS software (Hayes, 2013). To conduct the mediation 
analysis, the bias-corrected bootstrap confidence interval approach was employed as this 
method has been found to have more power and better control for Type 1 errors in 
comparison to the causal steps method, popularised by Baron and Kenny (1986), and normal 
theory approaches of mediation (e.g., the Sobel test; Fritz & MacKinnon, 2007; Hayes, 2009; 
MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002). In contrast, the bootstrap 
confidence interval approach has been found to have very high power and is best for 
controlling for Type 1 errors (MacKinnon et al., 2002). 
 
5.8.2.4. Tests of difference 
Studies 2, 3 and 4 also employed Mann-Whitney U tests to explore differences in mean 
scores between groups of interest within the data sets (e.g., differences in physical activity 
behaviour based on cross-sex hormone use). Mann-Whitney U tests were conducted as the 
data were non-normally distributed. In all cases the Monte Carlo method was used as the 
sample size was large and in these circumstances this method is seen to be more accurate 
(Field, 2009). Study 3 also employed an ANCOVA to explore differences in eating disorder 
psychopathology mean scores between two groups (people who had and had not taken cross-
sex hormones) whilst controlling for variables that had been shown to affect eating disorder 
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psychopathology. These analyses were not followed up with post-hoc tests as no significant 
differences were found between the two groups. 
 
5.8.2.5. Factor analysis (principal component analysis) 
In study 4, principal component analysis was conducted to explore the factor structure of a 
newly developed scale. It was expected that the items on the developed scale would be 
related and so therefore oblique (direct oblimin criterion) rotation was employed.  
 
5.8.2.6. Power analysis 
Prior to participant recruitment commencing, power calculations were conducted for each 
study using guidelines provided by Cohen (1992). This calculation estimated the number of 
participants required for the study to be adequately powered to detect a medium effect size 
with power at 0.8 (p=.05); see Table 5.2. For study 4, a minimum of 300 participants was 
sought which is considered adequate for principal component analysis (Comrey & Lee, 1992; 
see Table 5.2.). 
 
Table 5.2. Summary of the main method of analysis used within each study, the number of 
people needed for power in the main analysis, and the number of people actually recruited 
 Main method of analysis used 
in the study 
Number of 
people needed 
for main analysis 
Number of 
people recruited 
for main analysis 
Study 1 Thematic analysis NA 14 
Study 2 Multiple linear regression 91 360 
Study 3 Multiple linear regression 97 563 
Study 4 Principal component analysis 300 789 
Note: NA (not applicable); in study 2, 674 transgender and cisgender people were recruited in 
total but only the transgender participants were used in the main analysis (n=360) 
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Chapter 6 (study 1) 
Barriers and facilitators of physical activity and sport participation among 
young transgender adults who are medically transitioning 
 
This chapter has been published in the International Journal of Transgenderism as:   
Jones, B. A., Arcelus, J., Bouman, W. P., & Haycraft, E. (2017). Barriers and facilitators of 
physical activity and sport participation among young transgender adults who are medically 
transitioning. International Journal of Transgenderism, 18(2), 227-238. 
36Thttp://www.tandfonline.com/doi/abs/10.1080/15532739.2017.129358136T 
 
The content of chapter 6 (study 1) is largely the same as the published paper, however some 
small changes have been made to the formatting and presentation to ensure it is consistent 
with the rest of the chapters that comprise this thesis.  
 
Statement of authorship 
Research conception and design: BJ, JA & EH. 
Data collection: BJ. 
Data analysis and interpretation: BJ, JA & EH. 
Drafting of article: BJ. 
Article editing and revisions: BJ, JA, WB & EH. 
 
The findings from chapter 6 (study 1) have also been presented at the following academic 
conferences:  
Jones, B. A., Arcelus, J., Bouman, W. P., & Haycraft, E. (2017). Physical activity and sport 
in the transgender population. National Centre for Sport and Exercise Medicine (NCSEM) 
Conference. Loughborough, UK: 16th September. Oral presentation.  
 
Jones, B. A., Arcelus, J., Bouman, W. P., & Haycraft, E. (2017). Understanding the physical 
activity disparity between transgender and cisgender people. International Society of Critical 
Health Psychology’s (ISCHP) 10th Biennial Conference. Loughborough, UK: 9th-12th July. 
Oral presentation.  
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Jones, B. A., Arcelus, J., Bouman, W. P., & Haycraft, E. (2017). Sport and physical activity 
participation among young transgender adults: The facilitators and barriers. European 
Professional Association for Transgender Health (EPATH) Biennial Conference. Belgrade, 
Serbia: 6th-8th April. Poster presentation.  
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that young transgender adults experience when engaging in physical activity and sport. 
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Oral presentation.  
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6.1. Abstract 
Transgender people (those who feel incongruence between the gender they were assigned at 
birth and their gender identity) engage in lower levels of physical activity compared to 
cisgender people (non-transgender). Several factors have been shown to affect physical 
activity engagement in the cisgender population however; the physical activity experiences of 
young transgender adults have not been explored. It was therefore the aim of the current 
study to understand what factors are associated with physical activity and sport engagement 
in young transgender adults who are medically transitioning. Semi-structured interviews were 
conducted with 14 young transgender adults (18-36 years) who had initiated their medical 
transition at a transgender health service in the United Kingdom. The data were analysed 
using thematic analysis. Two main themes were identified: (1) barriers and (2) facilitators to 
physical activity and sport. Overall, the young transgender adults were insufficiently active 
due to inadequate changing facilities, body dissatisfaction, fears surrounding ‘passing’ and 
not being accepted by others. At the same time, participants were motivated to engage in 
physical activity to increase their body satisfaction and gender congruence. However, 
participants felt there were a lack of safe and comfortable spaces to engage in physical 
activity and sport. In conclusion, young transgender adults who are medically transitioning 
experience several barriers to physical activity and sport, despite being motivated to be 
physically active. Initiatives to facilitate young transgender adults to be able to put their 
motivations into practice (i.e., to be more physically active) are needed. 
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6.2. Introduction 
Physical activity can be defined as any activity engaged in (e.g., while working, playing, 
carrying out household chores, travelling, and recreational pursuits) that involves muscular-
skeletal movement and energy expenditure and is vital for promoting physical and mental 
well-being (Lee et al., 2012; World Health Organisation (WHO), 2016). Across the world in 
2010, 23% of adults (aged 18+) were not active enough, which is concerning considering that 
physical inactivity is the fourth leading risk factor for non-communicable diseases (e.g., 
cancer, diabetes, cardiovascular disease) (WHO, 2016). In 2008, non-communicable diseases 
accounted for approximately 5.3 million deaths around the world (Lee et al., 2012). It is 
therefore important to promote physical activity engagement, especially among groups that 
may be vulnerable to inactivity, such as transgender people (Jones et al., 2016a; see chapter 
7). 
 
‘Transgender’ is an umbrella term used to describe people who experience incongruence 
between the gender they were assigned at birth and their gender identity. Transgender males 
are people who were assigned female at birth but who later identify as male. Transgender 
females are people who were assigned male at birth but later identify as female. Cisgender 
people (non-transgender) do not experience incongruence between their assigned gender and 
gender identity. Some transgender people may choose to change their social gender role, but 
not necessarily undergo gender confirming medical treatments (e.g., cross-sex hormones, 
gender confirming surgery) (Beek, Kreukels, Cohen-Kettenis, & Steensma, 2015; Coleman et 
al., 2012; Wylie et al., 2014), but many do. Cross-sex hormone treatment (oestrogen or 
testosterone) induce the development of secondary sex characteristics, which align with 
experienced gender (e.g., breast growth for transgender females, increase in muscle mass and 
lowering of voice for transgender males). In addition, some transgender people will choose to 
undergo irreversible gender confirming surgeries to create a male or female chest and 
genitals.  
 
People who attend transgender health services have reported (at the time of first contact with 
the service) high levels of mental health problems (specifically anxiety, depression and self-
harm) in comparison to cisgender people (Arcelus, Claes, Witcomb, Marshall, & Bouman, 
2016; Bouman, Davey, Meyer, Witcomb & Arcelus, 2016a; Bouman et al., 2017a; Davey, 
Arcelus, Meyer, & Bouman, 2016; Dhejne, Van Vlerken, Heylens, & Arcelus, 2016; Millet, 
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Longworth, & Arcelus, 2017). Although mental health difficulties do not prevent a 
transgender person accessing transgender healthcare, it may be necessary in some 
circumstances to manage these difficulties prior to gender confirming medical treatment 
(Coleman et al., 2012; Wylie et al., 2014).  
 
Within cisgender populations, physical activity and sport have been found to alleviate 
symptoms of depression and anxiety (e.g., De Moor, Beem, Stubbe, Boomsma, & De Geus, 
2006; Maltby & Day, 2001). In view of this, the National Health Service (NHS) in the United 
Kingdom (UK) recommends engaging in physical activity three times a week (at least 45 
minutes each day) to alleviate mild to moderate depression (National Institute for Health and 
Care Excellence (NICE), 2016). Social support has also been found to be a product of 
physical activity and sport participation within the cisgender population (e.g., Armstrong & 
Oomen-Early, 2009). Based on these findings, engaging in frequent physical activity and/or 
sport may be particularly beneficial in relation to the mental well-being of transgender 
individuals. Furthermore, physical activity and sport participation can also contribute towards 
reaching the appropriate weight necessary to undergo some gender confirming surgeries. 
Kohl and Cook (2013) emphasise the importance of promoting physical activity to young 
people and providing them with ongoing opportunities to be active, as health-related 
behaviours (e.g., physical (in)activity) have been shown to track from childhood into 
adulthood.  
 
Research that has explored levels of physical activity in transgender people has found that 
aerobic, strength and flexibility physical activity levels are low in comparison to cisgender 
people, when age and gender are controlled for (Jones et al., 2016a; see chapter 7). A recent 
systematic review concluded that transgender people on the whole have a negative experience 
when engaging in physical activity and competitive sport due to specific barriers relating to 
gender identity (e.g., changing facilities), transphobic behaviour (i.e., discrimination and 
violence relating to gender identity), lack of awareness about the needs of transgender people 
in physical activity and sport environments, and discriminatory policies for transgender 
people in competitive sport (see chapter 2; Jones, Arcelus, Bouman, & Haycraft, 2017a). 
However, this systematic review found that most studies were concerned with elite 
competitive sport, highlighting the dearth of research concerning recreational sport and 
physical activity that is engaged in for leisure and fitness. Such research is important 
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considering that most people who attend transgender health services will not be involved in 
elite competitive sport. Additionally, the studies reviewed did not consider the stage of 
transition of their participants (e.g., social transition, medical transition) and the implications 
this may have on physical activity levels.  
 
A recent qualitative study has demonstrated how the stage of transition is significant when 
understanding physical activity and sport engagement in transgender people. Elling-
Machartzki (2015) found that, post–transition, transgender people felt less ashamed of their 
bodies and therefore more comfortable when engaging in physical activity and sport than 
they did before transition. However, the mean age of the participants in Elling-Machartzki’s 
(2015) study was quite high (40.5 years, range 27-51) which may have affected the amount of 
physical activity participants engaged in as levels of physical activity have been found to 
decrease with age (e.g., British Heart Foundation, 2015). Therefore, when investigating 
physical activity among a specific population, age would be an important variable to 
consider. To date, no research has explored the experiences of young transgender adults 
(defined as people aged 18-39 years) in relation to engaging in physical activity and sport.  
 
With the intention of addressing the limitations of previous literature, the current study was 
interested in understanding what factors are associated with physical activity and recreational 
sport engagement in young transgender adults who are medically transitioning. To adequately 
address the research aim, participants were purposefully recruited from a transgender health 
service in the UK once gender confirming medical treatment had been initiated. Given the 
lack of research with young transgender adults undergoing medical transition regarding their 
physical activity and sport participation, an inductive qualitative approach was seen as 
appropriate. One of the main advantages of this methodology is the rich and in-depth 
understanding of participant experience that it provides.  
 
6.3. Method 
6.3.1. Participants and recruitment 
Participants were recruited through a national transgender health service within the UK. This 
service is part of the NHS and offers assessment and treatment for transgender people who 
wish to transition. During a routine appointment at the service, young adult patients who had 
begun treatment were invited to take part in the research. The study was approved by an NHS 
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ethics committee and also received University ethical approval from the first author’s 
institution (see Appendix M). 
 
In total, 14 participants were recruited into the study from the transgender health service; nine 
transgender males and five transgender females. The gender difference seen is solely a 
reflection of people who agreed to participate in the study. The participants were recruited 
over eight months during 2015/2016. The mean age of participants was 22.71 years (range 
18-36). The sample size of this study is in line with recommendations for thematic analysis 
(e.g., Guest, Bunce, & Johnson, 2006). Table 6.1. provides the demographic information of 
all participants in the study. Twelve out of the 14 participants currently engaged in physical 
activity or sport.  
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Table 6.1. Socio-demographic characteristics of participants included within the study 
Participant Age (years) Gender identity Stage of 
transition 
Length of time 
on CHT when 
interviewed 
Currently engaging 
in physical activity 
and/or sport?  
Type of physical activity 
or sport currently 
engaged in 
01 18  Male CHT 1 month Yes Football, muscle 
strengthening exercises 
02 18  Male CHT 4 months Yes Tennis, muscle strengthening 
exercises 
03 33 Male CHT 4 months Yes Muscle strengthening 
exercises, cardio exercises 
04 18  Male CHT 4 months  Yes Muscle strengthening 
exercises, cardio exercises 
05 18  Male CHT 11 months  Yes Muscle strengthening 
exercises, cardio exercises  
06 25  Male CHT 7 months Yes Muscle strengthening 
exercises, cardio exercises 
07 18  Female CHT 
 
6 months No  NA 
08 18  Male CHT 4 months Yes  Muscle strengthening 
exercises, cardio exercises 
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Participant Age (years) Gender identity Stage of 
transition 
Length of time 
on CHT when 
interviewed 
Currently engaging 
in physical activity 
and/or sport?  
Type of physical activity  
or sport currently 
engaged in 
09 23  Male CHT and double 
mastectomy 
9 months No  NA 
10 18  Female CHT and blockers 2 years  Yes  Cardio 
11 29  Female CHT 
 
6 months Yes Squash, swimming  
12 18  Female CHT 6 months Yes  Muscle strengthening 
exercises 
13 36  Female CHT and blockers 1 year  Yes  Cardio exercises 
14 28  Male CHT and double 
mastectomy  
3 years  Yes Rugby, muscle strengthening 
exercises 
Note: NA (not applicable), CHT (cross-sex hormone treatment)
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6.3.2. Interviews 
Semi-structured interviews were conducted with all the participants in this study. The 
majority of interviews were conducted face-to-face at the transgender health service (n=11). 
For participants that could not travel to the NHS premises outside their scheduled 
appointment time, a telephone interview was conducted instead (n=3). All interviews were 
audio recorded, transcribed verbatim and lasted an average of 24 minutes (range 15 to 37 
minutes).  
 
To guide the interviews, a semi-structured interview schedule was developed by consulting 
the relevant academic literature as well as clinicians working with transgender individuals. 
The interview schedule included questions pertaining to transgender people’s experiences of 
physical activity and sport prior to, and across their transition.  
 
6.3.3. Data analysis 
Thematic analysis was employed to analyse the interviews and the guidelines outlined by 
Braun and Clarke (2006) were followed. Thematic analysis provides a rich thematic 
description of the entire data set, which in turn highlights the most prominent and important 
themes (Braun & Clarke, 2006). Five steps were followed. First, the first author read the 
interview transcripts whilst making notes on potential codes. Codes were then noted down the 
left margin, with a description of how the interviewee discussed the topic in the right hand 
margin. At this stage, an independent coder second coded approximately 20% (n=2) of the 
transcripts. Codes from both the first and second coder were then brought together to develop 
themes and subthemes, and relevant extracts to support these were identified. Themes and 
subthemes were then reviewed and refined by all the authors, creating a narrative and names 
for each theme/subtheme.  
 
6.4. Results 
Thematic analysis revealed two overarching themes: 1) barriers to engaging in physical 
activity and sport; 2) facilitators of physical activity and sport engagement. Within each of 
these overarching themes, two core themes were identified: i) internal (or personal) 
barriers/facilitators; ii) external (or environmental) barriers/facilitators. Within each theme, 
several subthemes were identified. See Table 6.2. for a summary of the themes and 
subthemes.  
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Table 6.2. Core themes, themes and subthemes identified from the thematic analysis 
Core themes Themes Subthemes 
1. Barriers to physical 
activity and sport 
1.1. Internal barriers 1.1.1. Gender incongruence 
1.1.2. Body dissatisfaction  
1.1.3. Anxiety about others 
reactions  
1.2. External or 
environmental barriers 
1.2.1. Changing facilitates  
1.2.2. Sport-related clothing 
1.2.3. Team sports 
2. Facilitators of physical 
activity and sport 
2.1. Internal facilitators 2.1.1. Body satisfaction as a 
motivator  
2.1.2. The accentuation of 
body changes as a motivator  
2.1.3. Gender confirming 
surgery as a motivator  
2.2.External or environmental 
facilitators 
2.2.1. Trans only environments 
 
1) Barriers to physical activity and sport 
This theme highlights the various barriers that participants experienced when engaging in (or 
attempting to engage in) physical activity and sport. Participants discussed their experiences 
in relation to both internal or personal barriers (e.g., body dissatisfaction) and external or 
environmental barriers (e.g., changing facilities).  
 
1.1. Internal and personal barriers 
Three main subthemes grouped under ‘internal and personal barriers’ were described by the 
interviewees. Although each subtheme is described separately, it is noted that one almost 
certainly has an effect on the other and complete separation of these factors is not possible.  
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1.1.1. Gender incongruence: For the majority of participants (n=10), the stage of transition 
and their gender incongruence were related to their physical inactivity. Some people who 
were previously physically active stopped such activity when socially transitioning:  
 
“I stopped going [to the gym] when I socially transitioned” (Participant 09, 
transgender male) 
 
“I was in a football team before everything [social transition] and I also did martial 
arts for five years” (Participant 08, transgender male) 
 
Others who were hoping to enjoy the physical activity they used to enjoy, such as swimming 
(an activity where the body is highly visible), described no longer engaging in such activities 
as they had not yet seen the desired body changes expected from medical treatment (cross-sex 
hormones). The lack of body changes, and hence perceived lack of gender congruence, was 
mentioned by several participants as a reason why they had become physically inactive since 
they medically transitioned. The degree to which participants perceived they ‘passed’ as their 
gender identity (due to a lack of perceived gender congruence) was related to confidence 
levels: 
 
“I haven’t been on hormones for that long so the breast growth hasn't developed 
properly. It is sort of just lacking confidence in that sort of respect and how I come 
across which is stopping me” (Participant 12, transgender female) 
 
The gender incongruence that participants discussed appeared to be exacerbated in situations 
when the binary gender system was prominent. Changing rooms were mentioned numerous 
times by all interview participants and interlinked with several different themes and 
subthemes in this study, which magnifies the magnitude of this barrier. In the context of this 
subtheme, the participants perceived that their gender incongruence and an inability to ‘pass’ 
as their gender identity affected their use of changing rooms as they feared other users would 
judge them: 
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“I feel uncomfortable; I feel like people are looking at me going ‘why are they going 
into the male changing rooms’” (Participant 06, transgender male)  
 
1.1.2. Body dissatisfaction: All participants discussed how the severe body dissatisfaction 
they experienced (i.e., negative evaluation about one’s appearance), defined by many 
participants as body dysphoria, was a barrier to engaging in physical activity and sport:  
 
“When you feel so dysphoric with your body you can’t manage to go and do sports or 
go and do the gym and things like that” (Participant 09, transgender male) 
 
“I haven’t been swimming but that is more of a confidence thing with body issues” 
(Participant 13, transgender female) 
 
Engaging in physical activity appeared to heighten awareness of specific body parts that 
participants felt were not congruent with their gender identity when running or jumping, for 
example. For two participants, certain sportswear acted as a reminder of this incongruence 
due to the way it interacted with the body when being active:  
 
 “When you are running when the wind is blowing, your clothes sort of stick to you and 
that makes me feel quite dysphoric” (Participant 04, transgender male) 
 
The discomfort that participants felt in relation to their bodies also prevented them using 
changing facilities in public leisure centres, gyms and sports clubs. This was evidently 
perceived as a highly distressing environment by participants:  
 
 “I would have to be comfortable in my body [to use changing facilities] and I don't 
think that right now that is something I could do. I can’t even think about it. It would be 
too much right now” (Participant 07, transgender female) 
 
1.1.3. Anxiety about others’ reactions: The majority (n=8) of the participants discussed how 
they were concerned about others negatively evaluating their gender expression. The example 
quotation below illustrates how this anxiety was significant enough, for the majority of 
participants, to prevent them from engaging in physical activity and sport in public spaces: 
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“That fear of what other people think. Like you’ve always got that thing in your mind 
as if someone would just be like ‘hold on, that's a girl’. That’s why I don't like going to 
the gym” (Participant 08, transgender male) 
 
Some (n=5) participants also discussed avoiding changing facilities during their social and 
medical transition as they anticipated or experienced overt transphobia (i.e., discrimination, 
abuse and stigma on the basis of gender identity):  
 
“I don’t wanna be getting changed and y’know a cis guy comes in, he spots physical 
breasts and y’know beats me up” (Participant 03, transgender male) 
 
“I actually have been into a changing room since I have changed to female and it didn't 
go very well. Someone complained to the head office at the reception and then they 
came in and told me that I wasn't allowed to be in there so that sort of put a downer on 
that and I haven’t ever really done it since” (Participant 10, transgender female) 
 
However, the actual experience of verbalised negative evaluation or transphobia from others 
was rare. The majority of discussions held by participants (n=13) indicated that this internal 
fear derived from beliefs of non-acceptance from others, perhaps due to previous negative 
experiences: 
 
“[When I go to the gym] I feel like people are looking at me erm with knowledge that I 
am trans and I know that is impossible so I just ignore it just push it to the back of my 
mind” (Participant 06, transgender male) 
 
“Nobody really ever said anything to me but it was just as you know there are a lot of 
big guys in the gym, and I mean like massive guys, so when somebody that they 
perceive to be a girl is in the gym like doing the same like in the same weight room as 
they are they kind of look at you a bit funny” (Participant 09, transgender male) 
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1.2. External or environmental barriers  
Three subthemes were grouped under the core theme of ‘external or environmental barriers’. 
Once again, the separation between themes and subthemes is artificial as one will likely be 
affected by another. Most of the external barriers mentioned were linked to the fear of being 
abused, judged negatively, treated differently or laughed at. These fears appeared to be more 
prevalent when the participants felt vulnerable, such as in changing rooms. 
 
1.2.1. Changing and showering facilities: All participants in this study discussed how 
changing facilities in leisure centres or sports clubs were one of the biggest barriers to their 
participation in physical activity and sport. From the participants’ discussions it was evident 
that the infrastructure of these facilities was the primary issue. When environments such as 
changing rooms are divided by the binary gender, people have to choose whether to enter one 
gendered facility or the other. All participants found changing facilities that were designed 
around the binary gender system uncomfortable:  
 
“General like awkwardness around things that are categorised into male and female 
and it is like where do you fit sometimes cos for all intents and purposes now that I 
have had my top surgery I fit perfectly into a male changing room but in any situation 
where I might have to take off my trousers for something then it is quite obvious I don't 
have a penis” (Participant 09, transgender male) 
 
Participants were also concerned about others seeing their incongruent chest or genitals when 
changing or showering. This concern arose due to the openness and lack of privacy of such 
facilities, which was evidently uncomfortable:  
 
“To have cubicle changing rooms, that would be ideal. It would just cut away all that 
rubbish as far as having to deal with open changing rooms and I think it'’s intimidating 
anyway” (Participant 03, transgender male) 
 
“I use the private one [changing facility] just because I don't feel very comfortable 
changing out of my swim clothes in the women’s room because when they see me like 
that it is going to be a bit weird” (Participant 11, transgender female)  
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1.2.2. Sport-related clothing: Most participants (n=11) discussed how sport-related clothing, 
stereotypically worn by males and females, was uncomfortable to wear when in public and 
engaging in physical activity or sport. The discussions held by participants suggested that this 
was due to the revealing nature of some clothing: 
 
“Well I would wear it [sports-related clothing] if I was on my own but I don’t like my 
body and the shape. I wouldn’t want to go and expose myself when exercising with 
other people” (Participant 07, transgender female) 
 
“I am thinking along the lines of if I was wearing yoga pants and things like that and 
they were quite tight. So yes that would be an issue for me and that is probably why like 
whenever I go cycling I don't wear specific like cycling shorts I just wear like ordinary 
baggy shorts” (Participant 13, transgender female) 
 
This was especially an issue in relation to swimwear which is highly revealing and can be an 
indication of one’s gender (e.g., swimming shorts are worn by men and a costume by women):  
 
“I have to think what sort of swimwear will I use because obviously there is going to be 
some bulging in the area and then that might trigger like nasty responses” (Participant 
11, transgender female) 
 
Several participants (n=9) felt they could address this issue by wearing concealing sportswear 
(e.g., baggy t-shirts), however, to achieve this they had to compromise by deviating from 
clothing that is traditionally or stereotypically worn when engaging in that specific physical 
activity:  
 
 “I would wear like surf shorts that are a little like less revealing and a bit of a longer 
swimming top” (Participant 11, transgender female) 
 
However, two participants clearly felt uncomfortable about having to adapt traditional and 
stereotypical sportswear as they felt it drew unwanted attention towards them: 
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“Every time I have gone [to the gym] I have never felt comfortable because you see all 
the lads wearing sort of really revealing tops like vests and things like that and I am 
having to wear a full covered top and it gets you get all hot and sweaty. You get people 
looking at you” (Participant 01, transgender male) 
 
“The swimming pool is kind of a bit uncomfortable because I have to wear a t-shirt and 
it looks a bit weird” (Participant 04, transgender male) 
 
Several participants (especially transgender males) also felt it was impossible prior to gender 
confirming surgery to both engage in physical activity or sport and conceal their breasts and 
genitals at the same time. All the transgender males within this study explained that to be 
physically comfortable during physical activity (e.g., unrestricted breathing), they could not 
wear a binder3F1 but to maintain a clear gender presentation and feel comfortable in public, 
they had to wear their binder: 
 
“I can’t really run around because I have my binder on all the time [and] I get very, 
very uncomfortable and I can’t breathe. Pretty much that is the main reason why I 
don’t do sport that involves seeing other people” (Participant 02, transgender male) 
 
“I will probably run a lot more because it is quite awkward running because obviously 
you can’t bind because it compresses your chest. But it is quite uncomfortable to have 
to not bind and you have to try and find somewhere to run where people are not going 
to see you” (Participant 04, transgender male) 
 
What was significant here is how participants were more likely to engage in physical activity 
within the comfort of their homes as opposed to public spaces (e.g., gyms). Participants 
discussed how they did not feel it was necessary to maintain a clear gender expression or 
wear traditional sportswear when at home:  
 
                                            
 
1 A binder is an item of clothing worn under a t-shirt or shirt by some transgender males (or non-binary people) 
before chest surgery (mastectomy). The binder minimises the chest area to give the appearance of a male chest.  
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“If I am doing training in my room I can I usually just do it in my lounge wear so I 
don’t have to worry about it. It’s a lot more comfortable [not wearing a binder]” 
(Participant 02, transgender male) 
 
1.2.3. Team sports: Half of the participants (n=7) spoke about how they were part of a sports 
team (e.g., football) or sports club (e.g., taekwondo) prior to socially transitioning (i.e., in 
their gender assigned at birth). However, at their current stage of medical transition, being 
involved in team sport was rare as participants felt that there was not a team that aligned with 
their gender identity or a gendered team they would comfortably fit into:  
 
“I don't really fit into a bracket where I could play for a team anymore so I tend not to 
bother” (Participant 08, transgender male) 
 
“It is quite hard to be part of a sport team because obviously like with the transition 
and everything I would have had to change sport teams and that's quite difficult” 
(Participant 04, transgender male) 
 
Transgender men in this study also compared their size and strength levels to cisgender males 
and therefore felt it was difficult or dangerous to play against cisgender males. They 
understandably felt playing on a female team was out of the question:  
 
“It is too aggressive for me to play on the male football team I’d end up getting like. 
Basically I have a fear of getting like broken and female football obviously I can’t do 
that anymore” (Participant 08, transgender male) 
 
The concern about their lack of strength appeared to be related to their low levels of 
testosterone before transition or during early medical transition:  
 
“When I was on low levels of T [testosterone] and I was still kind of in a transitional 
state with it, it was difficult going to a man’s rugby team. I started playing when I was 
quite weedy and small in comparison to these big old you know 28 year old blokes who 
are big and muscly” (Participant 14, transgender male) 
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2) Facilitators of physical activity and sport 
This theme was divided into two core themes (internal and external/environmental 
facilitators), as per the previous theme, each of which had further subthemes (see Table 6.2.).  
 
2.1. Internal facilitators 
In the general population, people are motivated to engage in physical activity and/or sport for 
health reasons, to change their appearance, and/or enjoyment (e.g., Salmon, Owen, Crawford, 
Bauman, & Sallis, 2003; Williams & Cash, 2001). For the young transgender adults 
interviewed in this study, this was not different. However, specific motivating factors related 
to their transgender identity and transitional process, were mentioned which will be discussed 
in the following sections. As with the previous theme, subthemes are discussed separately, 
but are evidently interconnected.   
 
2.1.1. Body satisfaction as motivator to be physically active: Despite describing extreme 
distress in relation to their bodies, most participants (n=9) were motivated to use physical 
activity to increase body satisfaction and confidence: 
 
 “The dysphoria is a motivator to change it [the body]. It’s not necessarily particularly 
comfortable but it is a motivator to change it [the body] into something that’s more 
desirable” (Participant 03, transgender male) 
 
“I suppose being more comfortable with my own body. I think that is probably the main 
motivation” (Participant 04, transgender male) 
 
The two participants that had undergone chest reconstructive surgery felt they engaged in 
more physical activity, or were more likely to engage in physical activity, where the body 
was more visible (e.g., swimming) as they felt more comfortable with it:  
 
“We stayed in a hotel and had a bit of a swim and a dip and that is the first time I have 
been topless since the chest surgery” (Participant 14, transgender male) 
 
When the other twelve participants were asked about their future physical activity and sport 
participation following gender confirming surgery, they hypothesised that they would be 
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more likely to engage in physical activity and sport in public and mainstream spaces due to 
an increase in body satisfaction:  
 
“I’m not a member of the gym or anything but once, you know, once the top surgery’s 
out of the way I will feel more confident using gym facilities. That’s the only thing 
that’s stopping me” (Participant 03, transgender male) 
 
“I think that will be a real life changer [gender confirming surgery] because I will no 
longer be held back by situations like “oh what if that gym doesn't have cubicle 
showers” and “what if that changing room for swimming is all open”. Like it won’t be 
an issue anymore because nobody would see the difference so I think that will definitely 
help” (Participant 09, transgender male) 
 
2.1.2. The accentuation of body changes as a motivator to be physically active: It was evident 
that most of the female and male participants interviewed (n=11) were striving to meet body 
ideals emphasized in Westernised culture (i.e., women are curvaceous but thin and men are a 
V-shape and muscular). All but one of the transgender males in this study engaged in weight 
training (see Table 6.1.). Building muscle for a young transgender man will likely improve 
their self-esteem and self-perception as their appearance becomes more congruous with what 
they perceive a stereotypical male physique to be:  
 
“At the moment I am seeing a big progress. I am happy with like my arms they are 
starting to get bigger and I am starting to look more masculine. My shoulders are 
broader” (Participant 08, transgender male) 
 
Several transgender males (n=8) discussed how it was easier to achieve their masculine body 
ideal once cross-sex hormones had commenced. It was evident that they were motivated to 
increase their gender congruence (which affects their ability to ‘pass’ as their gender identity) 
by combining physical activity and the masculinising effects of testosterone:  
 
“Like muscle like on the shoulders and arms and stuff erm it helps you pass better if 
you have got more muscles” (Participant 04, transgender male) 
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“I think that when you have got more muscle and you feel more defined and more toned 
you feel better and it is more socially acceptable as well so people tend to accept you 
more how you want them to” (Participant 09, transgender male) 
 
One transgender female in this study spoke about the positive effects that the combination of 
cross-sex hormone treatment and physical activity had on the body:  
 
“I am now happier with how my workout mixes in with my medication. I have noticed 
changes happening to certain parts of my body which makes me more comfortable with 
it” (Participant 12, transgender female) 
 
There were noticeable gender differences in the appearance that transgender males and 
transgender female were aiming to accentuate. Whilst transgender males were striving for 
muscularity, one transgender female spoke about how she was attempting to achieve “a 
toning and slimming” effect which she felt was more achievable once cross-sex hormones 
had been initiated.  
 
2.1.3. Gender confirming surgery as a motivator: There were a few participants (n=4) in this 
study that discussed surgery as a motivator for engaging in physical activity. Participants 
recognised the importance of being in good physical health, and achieving a specific weight 
prior to gender confirming surgeries:   
 
“I am motivated to go running just to keep healthy for future things like surgery” 
(Participant 10, transgender female) 
 
“Yeah I guess that’s another one as well-being as fit and as healthy as I can for 
surgery as well” (Participant 03, transgender male) 
 
Transgender males, before chest surgery, were especially aware of the benefits weight 
training would have in relation to surgical outcomes: 
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“I did a push-up app on my phone to try and get my shoulders and my chest just a bit 
muscly for surgery. It is better for your results if you do get a bit built before 
[surgery]” (Participant 09, transgender male) 
 
2.2. External facilitators or environmental facilitators 
Finally, participants discussed physical activity and sport environments that felt more 
welcoming and accessible to them, and hence facilitated engagement in physical activity or 
sport.  
 
2.2.1. Trans only environments: Several participants (n=6) discussed the facilitating effect 
‘safe spaces’ had on physical activity engagement. These ‘safe spaces’ were usually 
characterised by only including other transgender people and therefore participants perceived 
they would feel more comfortable, especially during their medical transition. Much of the 
discussion held by participants was hypothetical as these ‘safe spaces’ were not freely 
available. Several participants spoke about this in relation to ‘trans specific’ swimming 
groups:  
 
“I think that would be a great idea because I’ve got friends that are trans as well that 
like swimming but won’t go. So I think it would be something nice to go to a swimming 
pool with other people that are just like us. No one judges you” (Participant 08, 
transgender male) 
 
“Like if it is made for transgender people [swimming group] then there is nothing to 
worry about is there?” (Participant 10, transgender female) 
 
While the majority of participants felt that ‘trans specific’ spaces would encourage physical 
activity at their current stage of transition, some (n=2) felt these spaces did not promote 
transgender inclusion in mainstream physical activity and sport:  
 
“I know there are trans specific sort of swim sessions and I would not feel comfortable. 
I just rather integrate in and y’know not making it about a trans thing y’know. I’m just 
another guy going to the gym or going to the pool - do you know what I mean?” 
(Participant 03, transgender male) 
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6.5. Discussion 
This study aimed to understand the factors which are associated with recreational physical 
activity and sport engagement among young transgender people who are undergoing medical 
transition. Overall, young transgender adults are insufficiently active due to inadequate 
changing facilities, body dissatisfaction, fears surrounding ‘passing’ and not being accepted. 
At the same time, participants appeared to be motivated to engage in physical activity to 
increase their body satisfaction and gender congruence. Despite this motivation, participants 
felt there was a lack of ‘safe’ public environments (e.g., gyms) in which to engage in physical 
activity and sport. 
 
One of the most significant findings of this study was the challenge that changing facilities 
imposed for the young transgender adults; a finding that supports previous research with 
older transgender adults (e.g., Hargie, Mitchell, & Somerville, 2015). The binary 
infrastructure of changing rooms and the lack of privacy was core to this challenge. Leisure 
centres and sport clubs should consider non-binary changing rooms, with private changing 
and showering cubicles. This would help transgender people access public physical activity 
and sport environments. However, the challenges that changing facilities imposed appeared 
to be much more deep-seated than this as body dissatisfaction, fears about passing, and the 
fear of transphobia interlinked with this barrier. 
 
Despite all the participants being on cross-sex hormones which have been found to increase 
body satisfaction (e.g., Becker et al., 2016; Fisher et al., 2014), body dissatisfaction was still 
a significant barrier to physical activity and sport participation in the current study which has 
previously been found with older transgender people (mean age 40.5 years, range 27-51; 
Elling-Machartzki, 2015). The young transgender adults in the current study discussed how 
their bodies had not yet started to change or changed a significant amount in accordance with 
their gender identity and, hence, dissatisfaction was still problematic in relation to physical 
activity and sport. In contrast to previous research (Elling-Machartzki, 2015), the current 
study established an understanding as to why the body is a barrier. Participants explained 
how their awareness of incongruent body parts became heightened during physical activity, 
sometimes due to the sports clothing worn as it acted as a reminder of these body parts 
because of the way it interacted with the body. In addition, sports clothing for some sports 
can be clearly gendered (e.g., swimming costumes are worn by women and trunks by men) 
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and revealing. Due to the high levels of dissatisfaction that participants in this study 
experienced with their bodies, they found such revealing clothing to be a barrier to their 
participation in physical activity and sport. In light of this, sports clothing brands should 
consider developing gender neutral and less revealing sportswear. This would be especially 
beneficial for sports such as swimming, gymnastics, athletics and cycling. Additionally, for 
the young transgender men in this study, concealing their chest and engaging in physical 
activity or sport in a safe and comfortable way was impossible. The development of effective 
(e.g., conceals chest) but more comfortable (e.g., less restrictive) and water-friendly chest 
binders would be a much welcomed product for this population. 
 
The fear of being mis-gendered (i.e., not passing as the gender they identify with) was also 
core in explaining physical activity and sport disengagement in the current study. Concerns 
surrounding a lack of gender congruence were sometimes so significant that participants 
feared physical abuse from others. Previous research has found transgender people to avoid 
physical activity and sport due to transphobia (Hargie et al., 2015; Muchicko, Lepp, & 
Barkley 2014). However, in the current study it was found that for the majority of 
participant’s negative evaluation from others and transphobia was anticipated as opposed to 
experienced. It may therefore be beneficial to develop interventions that challenge these 
negative thought processes, with the aim of encouraging physical activity and sport in public 
spaces (e.g., gyms, swimming pools, exercise classes). An intervention that is based on 
Cognitive Behavioural Therapy and hence challenges negative thought process (e.g., you are 
not being judged, no one is going to hurt you) may be particularly beneficial in this context.  
 
However, for the young transgender adults in this study, there was evidently the desire and 
motivation to engage in physical activity and/or sport to increase gender congruence and 
body satisfaction. Engagement in physical activity in the current study was common, with 12 
out the 14 participants currently reporting to be active. This may be due to the fact that 
participants who were currently physically active felt motivated to take part in a study about 
physical activity and sport. This finding may also be explained by the participants’ age as 
young people have been found to be more physically active then older people (e.g., British 
Heart Foundation, 2015). However, it is important to emphasise that physical activity was 
very rarely done in public spaces (e.g., gyms) as participants preferred to engage in physical 
activity within the comfort of their own homes. Participation in team based sport was also 
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uncommon in those who took part in this study, which was also previously found by Hargie 
et al. (2015). The young transgender adults in our study commented on the difficulties of 
aligning with a gendered team (e.g., male or female) during their medical transition, a finding 
previously supported (Caudwell, 2012). However, in our study, transgender males were 
particularly concerned about the danger of playing with and against cisgender males as they 
felt their size and strength was not yet comparable. This is an important finding that needs to 
be addressed by sport organisations who need to make a conscious effort to increase sport 
participation and competition among the transgender population, especially given the 
psychosocial benefits team sport can have (e.g., Armstrong & Oomen-Early, 2009). The 
development of mixed gendered teams that remove the pressure of being a certain size and 
strength would be beneficial. When the size of competitors is a concern, the Canadian Centre 
for Ethics in Sport (2016) suggests developing size categories, such as in wrestling. A few 
participants in this study pointed out that it may be unhelpful to create an abundance of ‘trans 
only’ sports club as this may further promote the exclusion of transgender people in 
mainstream sport. Instead, it may be more useful to increase awareness and acceptance of 
gender diversity within the public domain. This could be achieved through public campaigns 
that increase awareness of transgender people. 
 
The findings from the current study suggest that socially and medically transitioning is core 
to physical activity and sport disengagement and that, once medical transition is complete, 
the barriers (and facilitators) are likely to change. Comments made by participants in this 
study suggest that physical activity and sport engagement will increase after transition. Future 
research now needs to explore whether there are any differences in physical activity levels 
between transgender people who have undergone a transition and cisgender people, and if a 
difference is found, why.  
 
This study is the first to explore the experiences of physical activity and sport in a young 
sample of treatment seeking transgender adults. Being specific in relation to the age and stage 
of transition of our participants will allow for specific interventions and initiatives (that 
promote physical activity) to be developed. However, there are some limitations to be taken 
into consideration. Three of the interviews were conducted via telephone and whilst the 
interviewer felt this method was as effective as the face-to-face interviews, telephone 
interviews have been criticised as important social cues cannot be responded to which can 
Chapter 6 (study 1): Experiences of physical activity and sport 
 
126 
 
affect the rapport between interviewer and interviewee (e.g., Cook, 2012; Novick, 2008). 
This may have consequently affected the depth of data that was collected from these 
interviews. Another limitation of the study was the fact that the number of male (n=9) and 
female (n=5) participants was not equal and, while not expected, gender differences were 
found especially in relation to males (e.g., the issue with binders, building muscle). Future 
research may therefore want to consider recruiting a larger transgender female population 
(assigned male at birth) to further explore these gender differences.   
 
6.5.1. Conclusion 
There are a range of positive and negative factors that affect physical activity and recreational 
sport engagement among young transgender adults who are medically transitioning. Internal 
(e.g., body dissatisfaction) and external (e.g., sport-related clothing) barriers prevent this 
population from engaging in physical activity and sport. Despite this, young transgender 
adults are motivated by body dissatisfaction and perceived gender incongruence to be 
physically active. However, due to the uncomfortable and unwelcoming environment that is 
sometimes experienced or anticipated in public physical activity and sport spaces (e.g., 
leisure centres), young transgender adults find it difficult to be physically active. Awareness 
of transgender people needs to be increased through public campaigns, and leisure centres 
and sports clubs need to consider ways in which they can make their spaces more accessible 
and welcoming for people with a variety of different gender identities (e.g., gender neutral 
changing facilities and showers). 
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Chapter 7 (study 2) 
In the previous chapter (chapter 6, study 1) it was established that young treatment seeking 
transgender people experience a range of internal and external barriers when engaging (or 
attempting to engage) in recreational physical activity and/or sport. Consequently it was 
hypothesised that these barriers would negatively affect the amount of physical activity that 
treatment seeking transgender people engage in. Therefore the aim of chapter 7 (study 2) was 
to explore this hypothesis by determining the amount of physical activity that treatment 
seeking transgender people engage in when compared to cisgender people (whilst controlling 
for age and gender). Building on the findings from the qualitative study presented in chapter 
6, it was also the aim of study 2 to explore factors which statistically predict physical activity 
participation in the treatment seeking transgender population, given that quantitative findings 
have greater generalisability in comparison to qualitative findings.  
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The levels and predictors of physical activity engagement within the 
treatment seeking transgender population: A matched control study 
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7.1. Abstract  
Physical activity has been found to alleviate mental health problems and could be beneficial 
for at-risk populations, such as transgender people. This study had three aims. First, to 
explore the amount of physical activity that treatment seeking transgender people engage in, 
and to compare this to matched cisgender people. Second, to determine whether there was a 
difference in physical activity depending on cross-sex hormone use. Third, to determine 
factors which predict physical activity among treatment seeking transgender people. 
Transgender (n=360) and cisgender people (n=314) were recruited from the UK. Participants 
were asked to complete questionnaires about physical activity, symptoms of anxiety and 
depression, self-esteem, body satisfaction and transphobia. Transgender people engaged in 
less physical activity than cisgender people. Transgender people who were on cross-sex 
hormones engaged in more physical activity than transgender people who were not. In 
transgender people on cross-sex hormones, high body satisfaction was the best statistical 
predictor of physical activity while high self-esteem was the best statistical predictor in 
people who were not. In conclusion, transgender people are less active than cisgender people. 
Cross-sex hormone treatment appears to be able to indirectly increase physical activity within 
this population, which may be beneficial for mental well-being.  
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7.2. Introduction 
Physical activity is defined as any activity (e.g., while working, playing, carrying out 
household chores and recreational pursuits) that involves muscular-skeletal movement and 
energy expenditure (World Health Organization (WHO), 2016). In 2010, 23% of adults 
around the world were not active enough (WHO, 2016), highlighting that inactivity represents 
a global public health problem. Globally, engaging in insufficient physical activity is the 
fourth leading risk factor for non-communicable diseases (e.g., cancer, diabetes, 
cardiovascular disease) (WHO, 2016), which accounted for approximately 5.3 million deaths 
globally in 2008 (Lee et al., 2012). Physical activity has also been found to alleviate mental 
health problems, particularly depression and anxiety (Carter, Morres, Meade, & Callaghan, 
2016; Herring, Jacob, Suveg, & O’Connor, 2011; McMahon et al., 2017; National Institute 
for Health and Care Excellence (NICE), 2016; Rebar et al., 2016). In light of this, physical 
activity may be beneficial for populations that are vulnerable to mental health problems.  
 
One of these vulnerable populations is transgender people who experience incongruence 
between their sex assigned at birth and their gender identity. Transgender women are those 
assigned male at birth but who identify as female. Transgender men are those assigned 
female at birth but who identify as male. Some people may identify outside the binary gender 
system (e.g., gender neutral, non-gender, gender queer) or be more fluid in their gender 
identity (i.e., a person whose gender identity varies over time) (Arcelus & Bouman, 2017a). 
Cisgender people do not experience such gender incongruence (Arcelus & Bouman, 2017a). 
The majority of transgender people will choose to socially transition (i.e., present as their 
gender identity at work, with friends and family) and many will choose to undergo a medical 
transition. This may include cross-sex hormone treatment (oestrogen for transgender 
females/non-binary and testosterone for transgender males/non-binary), mastectomy 
(transgender males/non-binary), breast augmentation (transgender females/non-binary), and 
surgery to create male or female genitalia depending on gender identity. However, it is 
important to point out that not every transgender person will wish to undergo a medical 
transition and that some individuals may only wish to undergo a partial medical transition 
(i.e., cross-sex hormones and no surgery; Beek, Kreukels, Cohen-Kettenis, & Steensma, 
2015).  
 
Mental health problems such as depression, anxiety, and self-harm have been found to be 
particularly prevalent in transgender people (Arcelus, Claes, Witcomb, Marshall, & Bouman, 
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2016; Bouman, Davey, Meyer, Witcomb, & Arcelus, 2016a; Bouman et al., 2016b; Bouman 
et al., 2017a; Claes et al., 2015; Dhejne, Van Vlerken, Heylens, & Arcelus, 2016; Marshall, 
Claes, Bouman, Witcomb, & Arcelus, 2016; Millet, Longworth, & Arcelus, 2017; Warren, 
Smalley, & Barefoot, 2016) and therefore physical activity may be a useful coping 
mechanism. In addition to this, engaging in frequent physical activity may help transgender 
people reach a suitable Body Mass Index required for gender affirming surgery (if this is 
what the person wishes). Although research is inconclusive, it has shown cross-sex hormone 
treatment may put transgender females at risk of cardiovascular disease and may make 
transgender males more susceptible to risk factors associated with cardiovascular disease 
(Unger, 2016). For this reason, frequent physical activity engagement is essential to maintain 
heart health. Transgender males have also discussed being motivated to increase muscle mass 
on the upper torso through engaging in frequent weight training to enhance surgical outcomes 
after mastectomy (see chapter 6; Jones, Arcelus, Bouman, & Haycraft, 2017b). However, 
there is a lack of research that has explored levels of physical activity among transgender 
people and therefore it is unknown as to whether engaging in physical activity would be 
feasible among this population. 
 
A systematic review concluded that the majority of transgender people have a negative 
experience when engaging in physical activity (see chapter 2; Jones, Arcelus, Bouman, & 
Haycraft, 2017a). This is supported by a recent qualitative study (see chapter 6; Jones et al., 
2017b) which found that a range of external factors, such as changing rooms, sport-related 
clothing and discrimination, stigmatisation and prejudice on the basis of gender identity 
(transphobia), all discouraged transgender people from engaging in physical activity. Gender 
incongruence and body dissatisfaction were also identified as barriers to physical activity 
engagement (see chapter 6; Jones et al., 2017b). Based on this knowledge, it is likely that 
levels of physical activity are low among the transgender population and therefore research 
should focus on identifying ways to increase activity levels in these individuals in light of the 
known mental health benefits (e.g., Carter et al., 2016).  
 
The only quantitative study to explore the amount of physical activity transgender people 
engage in supports this suggestion, as transgender people were found to engage in less 
physical activity then cisgender people (Muchicko, Lepp, & Barkley, 2014). This study 
recruited 47 cisgender people and compared them with 33 (non-matched) transgender people. 
Although the study is of interest, the lack of matching between the two groups for age and 
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gender (variables known to affect levels of physical activity; British Heart Foundation (BHF), 
2015; WHO, 2016) limits the impact of its findings. In addition, there was a lack of 
information regarding the transgender participants’ stage of medical transition (i.e., whether 
they were on cross-sex hormone treatment). Research has shown that cross-sex hormone 
treatment, which helps the person’s body to align with their gender identity (either by the 
development of breasts for transgender females or by an increase in muscle mass and 
lowering of voice for transgender males), increases mental well-being in the transgender 
population (e.g., Bouman et al., 2016b; Costa & Colizzi, 2016; Heylens, Verroken, De Cock, 
T’Sjoen, & De Cuypere, 2014; Fisher et al., 2014; Gorin-Lazard et al., 2013). This 
information is of significance when exploring physical activity within the transgender 
population as cisgender people with better mental health have been found to engage in more 
physical activity compared to people with poorer mental health (e.g., Kruger, Lee, Ainsworth, 
& Macera, 2008; McMahon et al., 2017; Noordstar, van der Net, Jak, Helders, & Jongmans 
2016).  
 
Although the studies discussed above have suggested that levels of physical activity are low 
among transgender people and have identified potential barriers to engaging in physical 
activity, they are limited by their qualitative nature, which means that findings cannot be 
generalised and interventions cannot be developed (see chapter 6; Jones et al., 2017b), or by 
the small number of participants, lack of matching and lack of information about stage of 
transition (Muchicko et al., 2014). Quantitatively understanding whether there is a physical 
activity inequality between cisgender and transgender people, as well as understanding 
factors that are associated with physical activity in the transgender population, is essential in 
order that specific initiatives to increase physical activity can be developed for this 
population.  
 
Taking into consideration the limitations of previous studies, this study has three main aims. 
First, to explore the amount of physical activity that treatment seeking transgender people 
engage in, and to compare this to cisgender people matched for age and gender. Second, in 
light of the positive psychological benefits that cross-sex hormones can have on mental well-
being in the transgender population (e.g., Costa & Colizzi, 2016) this study also aims to 
determine whether there is a difference in physical activity levels between people who are 
and are not on cross-sex hormone treatment as well as to determine whether levels of 
physical activity in people who are on cross-sex hormone treatment are comparable to 
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cisgender people, when age and gender are controlled for. Finally, this study aims to 
determine factors which predict physical activity participation in transgender individuals. 
This will be explored for the whole group of transgender participants and also for people who 
are and are not on cross-sex hormone treatment, separately. Factors which have previously 
been found to predict physical activity in the cisgender population will be explored as 
potential statistical predictors, such as younger age and male gender (BHF, 2015; WHO, 
2016) low anxiety and depression levels (Carter et al., 2016; McMahon et al., 2017), high 
body satisfaction (Kruger et al., 2008; Lantz, Hardy, & Ainsworth, 1997) and high self-
esteem (Joseph, Royse, Benitez, & Pekmezi, 2014; Noordstar et al., 2016; Sonstroem & 
Morgan, 1989). Transphobia has been found to be a predisposing factor to high levels of 
anxiety, depression and low self-esteem (Hendricks & Testa, 2012; Meyer, 2003) and has 
been identified as a barrier to physical activity in the transgender population (see chapter 6; 
Jones et al., 2017b). Hence, transphobia will also be explored as a potential statistical 
predictor of physical activity.  
 
First, it was hypothesised that treatment seeking transgender people would engage in less 
physical activity than cisgender people. Second, it was hypothesised that levels of physical 
activity would be greater in the group that were on cross-sex hormone treatment (compared to 
those who were not) and that this would be comparable to cisgender people’s physical 
activity levels. Finally, it was hypothesised that younger age, male gender identity, lower 
levels of anxiety, lower levels of depression, high body satisfaction, high self-esteem, and 
fewer experiences of transphobia would predict greater physical activity engagement.  
 
7.3. Method 
7.3.1. Participants and recruitment 
Transgender participants aged 17 or over were recruited from a national transgender health 
service in the United Kingdom (UK) during a 12 month period in 2015/2016. Participants 
were recruited at the assessment stage. None of the participants had received gender 
affirming medical interventions from the service, but some were taking cross-sex hormones 
and blockers (medication used to inhibit puberty) prescribed from NHS providers (as their 
care was transferred from the child and adolescent service to the adult service), private 
providers or was self-prescribed via the internet.  
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The cisgender participants were recruited from the community over four months in 2016 
using a snowball sampling technique. Cisgender participants were required to not experience 
incongruence between the sex they were assigned at birth and their gender identity. All 
cisgender participants were age 18 or over.   
 
The study was approved by an NHS research ethics committee and by the Research and 
Development Department of the Nottinghamshire Healthcare NHS Foundation Trust (see 
Appendix M). Ethical approval for recruitment of the cisgender participants was granted from 
the first author’s university research ethics committee (see Appendix M).  
 
7.3.2. Procedure 
After informed consent had been obtained from participants, the transgender sample was 
invited to complete the self-report questionnaires listed below. The completion of these 
questionnaires took approximately 20 to 30 minutes. Cisgender participants were invited to 
take part in a short survey (approximately 10 minutes) which only asked about their physical 
activity engagement. 
 
7.3.3. Measures 
Socio-demographic information: Information was collected about participants’ age, sex 
assigned at birth, and gender identity. For the transgender participants, information about 
whether they were taking cross-sex hormones was also collected.  
 
Rapid Assessment of Physical Activity (Topolski et al., 2006): This measure has nine 
statements that rapidly assess the frequency of engagement in physical activity (e.g., I do 30 
minutes or more a day of moderate physical activities, 5 or more days a week). Participants 
are asked to indicate whether the statement relates to them or not by ticking ‘Yes’ or ‘No’. 
There are no other response options. The scale has two subscales: 1) aerobic physical activity 
(7 items); and 2) strength and flexibility physical activity (2 items). In the current study, only 
the aerobic physical activity subscale was used. Total scores are calculated by choosing the 
highest item (1 to 7) with an affirmative response and scoring this accordingly. For example, 
if question 3 was the highest question that the participant responded ‘yes’ to, then they would 
be given a score of 3. High levels of physical activity engagement are indicated by a higher 
score. Scores under 6 are considered a suboptimal level of physical activity. Reliability 
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analysis was not conducted for the current sample due to the ‘yes’, ‘no’ response style but 
this measure has been shown to have good reliability previously (Topolski et al., 2006). 
 
Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983): This measure has 14 
items; seven assess anxiety and seven assess depression. Scores for each subscale (anxiety 
and depression) are calculated by summing the scores for each individual item. For each 
subscale, scores between 0-7 are considered ‘normal’, scores between 8-10 are considered 
‘borderline clinical’, and scores of 11 and above are considered ‘clinically relevant’ (Snaith, 
2003). The highest score possible is 21 for each subscale. The measure has previously been 
found to have good reliability (Bjelland, Dahl, Haug, & Neckelmann, 2002). In the current 
study, both the anxiety (α=.86) and depression (α=.75) subscales had good reliability. 
 
Hamburg Body Drawing Scale (HBDS) (Becker et al., 2016): This measure was originally 
developed for use with individuals with different forms of psychoendocrinological disorder 
(Appelt & Strauß, 1988) and has since been adapted and validated with transgender people 
(Becker et al., 2016). In total, satisfaction with 33 body parts is assessed. To assess a 
individuals’ overall satisfaction with their body, just one individual item is used (‘Satisfaction 
with your overall appearance’). In the current study, only the item that assesses overall 
appearance satisfaction was used. A 5-point Likert scale ranging from 1 (very dissatisfied) to 
5 (very satisfied) is used and therefore a high score indicates a high level of body satisfaction. 
Reliability analysis was not conducted for the current sample as only one item of the HBDS 
was used but the scale has previously been found to have good reliability (Becker et al., 
2016).  
 
Rosenberg Self-Esteem Scale (Rosenberg, 1965): This is a 10-item self-report measure that 
assesses self-esteem. Responses are scored on a 4-point Likert scale (strongly agree (3) to 
strongly disagree (0)). The global score is calculated by summing the scores from the 
individual items. A high score indicates a higher self-esteem (highest possible score is 30). 
The measure has previously been shown to have good reliability (α=.88-.90) (Robins, Hendin, 
& Trzeniewski, 2001). In the current sample, the measure had excellent reliability (α=.91).  
 
Experience of Transphobia Scale (Clements-Nolle, Marx, & Katz, 2006; Nuttbrock et al., 
2010): An item assessing verbal transphobia (‘Have you ever been verbally abused or 
harassed due to your gender identity or presentation?’) and an item assessing physical 
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transphobia (‘Have you ever been physically abused or beaten due to your gender identity or 
presentation?’) were adapted from previous studies that measured transphobia (Clements-
Nolle et al., 2006; Nuttbrock et al., 2010). Participants were asked to rate, on a 4-point Likert 
scale (from ‘never’ to ‘several times’), the frequency that they have experienced such 
behaviour. A higher score indicates a more frequent experience of verbal and/or physical 
transphobia.  
 
7.3.4. Data analysis 
Data were analysed using SPSS 23 (IBM, 2015). The data were not normally distributed and 
therefore non-parametric tests were conducted, where possible (Field, 2009). To address the 
first aim, each transgender individual was matched by age and experienced gender identity 
with a cisgender participant and a Mann-Whitney U test was conducted to explore differences 
in physical activity between these two groups. For the second aim, a Mann-Whitney U test 
was conducted between people who had and had not taken cross-sex hormones to determine 
whether there was a difference in physical activity. Each transgender individual who had 
taken cross-sex hormones was then matched, by age and gender identity, with a cisgender 
participant and a Mann-Whitney U test was conducted between these two groups to explore 
differences in physical activity. For all Mann-Whitney U analyses, an effect size was 
calculated (z2 ÷ N-1). For the final aim, one-tailed Spearman’s Rho correlations were 
conducted between physical activity and the potential statistical predictor variables (age, 
gender identity, anxiety, depression, overall body satisfaction, self-esteem and transphobia) 
for the whole group and also for those who were and were not on cross-sex hormone 
treatment, separately. Spearman’s Rho correlations were conducted in relation to the 
participants’ gender identity in accordance with recommendations made by Auer et al. (2013). 
As gender identity had more than two categories (e.g., neither male or female), six dummy 
variables were created to allow this variable to be entered into the Spearman’s Rho 
correlation analysis. Given the large number of Spearman’s Rho correlations being run (i.e., 
26), a Bonferroni correction was applied to correct for multiple comparisons. An adjusted p-
value of .002 was therefore used to indicate significance in the correlations (i.e., .05 [standard 
p-value] ÷ 26 [number of correlations] = .002 [adjusted p-value]). Only variables that 
significantly correlated with physical activity were entered into the subsequent analysis to 
increase its robustness. To determine which variable(s) was the best statistical predictor of 
physical activity, stepwise multiple linear regression analysis was conducted. The level of 
significance used was p<.05.  
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7.4. Results 
During the data collection period, 383 people were accepted for assessment at the transgender 
health service. Of this sample, 360 participants (94%) provided informed consent to 
participate in the study. Three hundred and fourteen cisgender participants were recruited 
from the community and all provided informed consent.  
 
7.4.1. Aim 1: Comparing levels of physical activity between transgender and cisgender 
people  
From the pool of transgender (n=360) and cisgender (n=314) participants, 137 transgender 
and 137 cisgender participants were matched by age and gender identity. From the 
transgender sample, people with non-binary gender identities were removed from the 
matching process (n=30, 8.33%). A further 14 people (3.89%) were removed as they had not 
yet decided on their gender identity and a further three people (.83%) were excluded as they 
did not provide any information about their gender identity. The socio-demographic 
characteristics of the matched transgender (n=137) and cisgender (n=137) participants are 
displayed in Table 7.1. According to Topolski et al. (2006) both the transgender (mean=4.24) 
and cisgender (mean=5.12) participants engaged in insufficient levels of physical activity. 
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Table 7.1. Socio-demographic information for the cisgender and transgender samples who 
are matched for age and gender identity 
 Cisgender 
(n=137) (%) 
Transgender 
(n=137) (%) 
Mean age (SD) 30.15 (11.87) 30.15 (11.87) 
Sex assigned at birth   
Male 42 (30.7) 95 (69.3) 
Female  95 (69.3) 42 (30.7) 
Gender identity    
Male 42 (30.7) 42 (30.7) 
Female 95 (69.3) 95 (69.3) 
Cross-sex hormone treatment prior to assessment    
Yes NA 53 (38.7) 
No NA 82 (59.9) 
No response NA 2 (1.5) 
Note: NA (not applicable)   
 
Cisgender participants engaged in significantly more physical activity (mean=5.12, SD=1.80, 
median=6.00, IQR=3.00) in comparison to those in the transgender group (mean=4.24, 
SD=2.05, median=4.00, IQR=3.00; U=7108.00, z=-3.53, effect size=.05, p=.001). To further 
explore any differences in physical activity between transgender and cisgender participants, 
participants were split in relation to their gender identity. This analysis showed that cisgender 
males (n=42, mean=5.40, SD=1.79, median=6.00, IQR=3.00) engaged in significantly more 
physical activity in comparison to transgender males (n=42, mean=4.17, SD=2.05, 
median=4.00, IQR=4.00; U=583.50, z=-2.73, effect size=.05, p=.004). Cisgender females 
(n=95, mean=5.00, SD=1.80, median=5.00, IQR=3.00) also engaged in significantly more 
physical activity than transgender females (n=95, mean=4.27, SD=2.07, median=4.00, 
IQR=3.00; U=3614.50, z=-2.41, effect size=.04, p=.007). The participants were then split in 
relation to the gender they were assigned at birth. Two comparisons were conducted: 
cisgender males (n=42) vs. transgender females (assigned male at birth; n=95, mean=4.34, 
SD=2.06, median=4.00, IQR=3.00; U=1412.00, z=-2.77, effect size=.06, p=.002), and 
cisgender females (n=95) vs. transgender males (assigned female at birth; n=42, mean=4.02, 
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SD=2.05, median=4.00, IQR=4.00; U=1451.50, z=-2.58, effect size=.05, p=.005). Both tests 
supported what was found when the analysis was conducted in relation to gender identity.  
 
7.4.2. Aim 2: Comparing physical activity levels of people who were on cross-sex hormone 
treatment and those who were not 
It was found that the transgender patients who were on cross-sex hormone treatment (n=102) 
engaged in significantly more physical activity (mean=4.65, SD=1.92, median=4.00, 
IQR=3.00) compared to the patients who were not (n=241; mean=4.07, SD=1.82, 
median=4.00, IQR=3.00; U=10027.00, z=-2.74, effect size=.02, p=.003).  
 
To determine whether the level of physical activity engaged in by transgender people who 
were on cross-sex hormones was comparable to the cisgender population, these two groups 
were matched by age and gender identity. People were excluded if they had not provided 
information about their gender identity (n=3; 2.94%), or if they had a non-binary gender 
identity (n=8; 7.84%). Therefore, 91 transgender people were matched with 91 cisgender 
people. In these samples, 52 identified as female and 39 as male. The mean age was 31.84 
(SD=13.55). 
 
Cisgender people (mean=5.33, SD=1.92, median=6.00, IQR=3.00) were found to engage in 
significantly more physical activity than transgender people who were on cross-sex hormones 
(mean=4.73, SD=1.97, median=5.00, IQR=4.00; U=3356.50, z=-2.27, effect size=.03, 
p=.010). When people with a female gender identity were explored, there was no significant 
difference in physical activity levels between transgender females on cross-sex hormone 
treatment (mean=4.79, SD=2.01, median=5.00, IQR=4.00) and cisgender females 
(mean=5.33, SD=1.92, median=6.00, IQR=3.00; U=1133.00, z=-1.47, effect size=.02, 
p=.065). When people with a male gender identity were explored, cisgender males 
(mean=5.33, SD=1.94, median=6.00, IQR=3.00) engaged in significantly more physical 
activity than transgender males on cross-sex hormones (mean=4.64, SD=1.93, median=4.00, 
IQR=3.00; U=593.00, z=-1.73, effect size=.04, p=.041).  
 
7.4.3. Aim 3: Statistical predictors of physical activity in transgender people 
To satisfy the third aim, only transgender people were included (n=360). The socio-
demographic variables of the transgender sample, presented for the whole sample, and 
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separately for people who were on cross-sex hormone treatment (n=102) and those who are 
not (n=241), are displayed in Table 7.2.  
 
Table 7.2. Socio-demographic characteristics of the whole sample of transgender participants, 
participants on cross-sex hormone treatment and those not on cross-sex hormone treatment 
 Whole 
sample 
(n=360) 
No CHT group 
(n=241) 
CHT group 
(n=102) 
 Sample size (%) 
Sex assigned at birth    
Female 151 (41.9) 98 (40.7) 44( 43.1) 
Male 209 (58.1) 143 (59.3) 58 (56.9) 
Gender identity     
Female 166 (46.1) 107 (44.4) 52 (51.0) 
Male 131 (36.4) 84 (34.9) 39 (38.2) 
Partly male and female 14 (3.9) 9 (3.7) 4 (3.9) 
Neither male or female 17 (4.7) 13 (5.4) 3 (2.9) 
Unsure 18 (5.0) 18 (7.5) 0 (0.0) 
Other 8 (2.3) 7 (2.9) 1 (1.0) 
Missing 6 (1.7) 3 (1.2) 3 (2.9) 
CHT    
Yes  102 (28.3)   
No  241 (66.9)   
No response 17 (4.7)   
CHT and blocker in combination   35 (34.3) 
CHT only   67 (65.7) 
Blockers only (no CHT)   7 (2.9)  
Note: CHT (cross-sex hormone treatment) 
 
7.4.3.1. Statistical predictors of physical activity for the whole sample of transgender 
participants 
To examine the significant correlates of physical activity in the whole sample (n=360), one-
tailed Spearman’s Rho correlations were conducted (see Table 7.3.). Age, depression, body 
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satisfaction, and self-esteem were all found to be significantly correlated with physical 
activity. Therefore, the four significantly correlated variables were entered into a stepwise 
regression to explore the best statistical predictor(s) of physical activity. Overall the model 
was significant (F(2,300)=12.34, p=.001) and explained 7.6% (R2=.076) of the total variance 
of physical activity. Self-esteem (β=.20, p=.001) and body satisfaction (β=.12, p=.049) were 
the best statistical predictors of physical activity, both of which had a positive relationship 
with the outcome variable. 
 
Table 7.3. One-tailed Spearman’s Rho correlations between physical activity and the study 
variables, presented for the whole sample and separately for those who were and were not on 
cross-sex hormone treatment prior to assessment 
 Whole group 
(n=360) 
No cross-sex 
hormone 
treatment 
group (n=241) 
Cross-sex hormone 
treatment group 
(n=102)  
 Physical activity Physical activity Physical activity 
Age .18*** .20*** .07 
Male gender identity† .03 .03 -.00 
Female gender identity† .05 .02 .09 
Partly male and female 
gender identity†  
-.10 -.09 -.09 
Neither male or female 
gender identity†  
-.04 .01 -.11 
Not sure of gender identity†  -.04 -.02 NA 
Other gender identity†  -.02 -.03 .06 
Verbal transphobia .04 .08 -.08 
Physical transphobia .06 .08 -.02 
Self-esteem .27*** .23*** .29*** 
Anxiety  -.12 -.07 -.14 
Depression -.22*** -.21*** -.15 
Body satisfaction .21*** .11 .38*** 
Note: † (dummy coded variables); NA (not applicable) 
*p<.05, **p<.01, ***p<.001 (corrected for multiple comparisons) 
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7.4.3.2. Statistical predictors of physical activity in people who were and were not on 
cross-sex hormones 
The socio-demographics of people who were and were not on cross-sex hormone treatment 
are presented in Table 7.2. Mann-Whitney U tests were also conducted to explore differences 
between these two groups on the study’s variables (see Table 7.4.). People who were on 
cross-sex hormones were significantly older, reported higher levels of self-esteem and body 
satisfaction, and experienced less anxiety and depression in comparison to participants who 
were not on cross-sex hormones (see Table 7.4.). There were no significant differences 
between the groups in relation to experiences of verbal and physical transphobia.  
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Table 7.4. Descriptive statistics and tests of difference between transgender people who were and were not on cross-sex hormone treatment for 
all predictor variables 
 No cross-sex hormone 
treatment group (n=241) 
Cross-sex hormone treatment 
group (n=102) 
Mann-Whitney U 
Mean (SD) Median (IQR) Mean (SD) Median (IQR) U z Effect size p 
Age 26.91 (12.15) 22.00 (10.00) 32.81 (14.91) 29.00 (24.30) 9291.00 -3.58 .04 .001 
Verbal transphobia 1.51 (1.16) 2.00 (2.00) 1.58 (1.14) 2.00 (2.30) 11729.50 -.51 .01 .310 
Physical transphobia 0.34 (0.78) 0.00 (0.00) 0.38 (0.87) 0.00 (0.00) 12053.00 -.68 .01 .460 
Self-esteem 14.39 (5.92) 14.00 (9.00) 18.19 (6.39) 18.00 (25.00) 7332.50 -4.71 .06 .001 
Anxiety  10.20 (3.42) 9.00 (7.00) 9.09 (3.68) 7.00 (7.00) 9646.00 -2.84 .02 .001 
Depression 5.90 (3.26) 7.00 (5.50) 4.71 (3.29) 5.00 (6.00) 9264.00 -3.23 .03 .022 
Body satisfaction 1.86 (0.70) 2.00 (1.00) 2.17 (0.86) 2.00 (1.00) 7656.50 -3.00 .03 .001 
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In the group that was not on cross-sex hormones, age, depression and self-esteem were found 
to be significantly correlated with physical activity (see Table 7.3.) and these variables were 
therefore entered into a stepwise regression. Overall, the model was significant and explained 
4.8% of the variance in physical activity engagement (see Table 7.5.). The only variable to 
have a significant relationship with physical activity engagement was self-esteem which was 
positively related (see Table 7.5.).  
 
Table 7.5. Stepwise regression models reporting the unstandardized beta, standard error of 
beta, and the standardised beta (β) coefficients for (i) those who were not and (ii) those who 
were on cross-sex hormone treatment prior to assessment 
*p<.05, **p<.01, ***p<.001 
 
In the group that was on cross-sex hormones, body satisfaction and self-esteem were found to 
be significantly correlated with physical activity (see Table 7.3.) and were therefore entered 
into a stepwise regression. Overall, the model was significant and explained 12.4% of the 
total variance in physical activity (see Table 7.5.). The only variable that significantly 
predicted physical activity engagement was body satisfaction, which was positively related 
(see Table 7.5.).  
 
7.5. Discussion 
This study found that, overall, treatment seeking transgender people engaged in less physical 
activity compared to cisgender people. Cross-sex hormone treatment was found to have an 
important role in physical activity as transgender people who were taking cross-sex hormones 
engaged in significantly more physical activity compared to transgender people who did not; 
also, the best statistical predictors of physical activity in these two groups differed. While 
 F R2 beta SE beta β 
(i) No cross-sex hormone treatment group 
(n=241) 
11.32** .048    
Self-esteem .07 .02 .22*** 
 
(ii) Cross-sex hormone treatment group 
(n=102) 
 
11.16*** 
 
.124 
   
Body satisfaction  .79 .24 .35*** 
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greater body satisfaction (i.e., feeling less dissatisfied with one’s body) was found to be the 
best predictor of physical activity in transgender people who were taking cross-sex hormones, 
greater self-esteem was found to be the best statistical predictor in participants who were not 
taking cross-sex hormones. Transgender males (who were taking cross-sex hormones) 
engaged in less physical activity than cisgender males, however this study did not find a 
significant difference between transgender females who were on cross-sex hormone treatment 
and cisgender females. This highlights the importance of increasing the accessibility of cross-
sex hormone treatment. Currently, people have to wait a significant amount of time before 
they are seen at transgender health services (Bouman & Richards, 2013; Kanamori & 
Cornelius, 2016; Kattari, Walls, Whitfield, & Langenderfer-Magruder, 2015) but our findings 
suggest that this delay could be adversely impacting their physical activity engagement, 
which could contribute to poorer mental well-being. 
 
Both the transgender and cisgender people in the current study reported engaging in 
insufficient levels of physical activity (Topolski et al., 2006). However, it was found that, 
overall, treatment seeking transgender people were significantly less active in comparison to 
cisgender people who were matched on age and gender identity. This finding supports 
previous research (Muchicko et al., 2014) and, given the known mental and physical health 
benefits of physical activity (Carter et al., 2016; Herring et al., 2011; Lee et al., 2012; 
McMahon et al., 2017; Rebar et al., 2016; WHO, 2016) highlights the need to improve 
support for physical activity engagement of treatment seeking transgender people. Efforts 
should focus on factors that have been shown to predict physical activity within the 
transgender population.  
 
Based on the amount of barriers that transgender people experience when engaging in 
physical activity and sport (see chapters 2 and 6; Jones et al., 2017a; 2017b), it is 
understandable that greater self-esteem was found to be the best statistical predictor of 
physical activity in this current study (for the whole group and for participants who had not 
taken cross-sex hormones). Although the mechanisms contributing to self-esteem levels are 
likely to differ in transgender and cisgender people, self-esteem has also been shown to affect 
physical activity engagement within the cisgender population (Joseph et al., 2014; Noordstar 
et al., 2016; Sonstroem & Morgan, 1989). Consequently, self-esteem interventions developed 
for the general population (e.g., behaviour change interventions that focus on self-esteem) 
may be useful in increasing physical activity within the transgender population (Fennel, 1996; 
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Staring et al., 2016). Furthermore, gender affirming medical treatment (e.g., cross-sex 
hormone treatment and gender affirming surgery) has been found to increase self-esteem in 
transgender people (e.g., Gorin-Lazard et al., 2013; Murad et al., 2010) and hence also 
appears to be crucial in indirectly increasing physical activity levels in transgender people 
who are treatment seeking. 
 
This study found that once cross-sex hormone treatment had commenced, self-esteem was no 
longer the best statistical predictor of physical activity. In addition, transgender people who 
were taking cross-sex hormones engaged in significantly more physical activity than 
participants who were not. This finding further supports the notion that cross-sex hormone 
treatment is crucial in indirectly increasing physical activity engagement (in transgender 
people who are treatment seeking). Participants who were taking cross-sex hormones had 
greater self-esteem levels, were less anxious and less depressed, and had a higher body 
satisfaction (i.e., were less dissatisfied with their bodies). These are all psychological factors 
that have been positively associated with physical activity in the cisgender population 
(Kruger et al., 2008; McMahon et al., 2017; Noordstar et al., 2016) and therefore may explain 
why this group was more active in the current study compared to the group of people who 
was not taking cross-sex hormones.  
 
In transgender people who were taking cross-sex hormones, a higher level of body 
satisfaction was found to be the best statistical predictor of physical activity. This finding is 
consistent with research that has found body satisfaction to increase once cross-sex hormone 
treatment has started (Fisher et al., 2014; van de Grift et al., 2017a) as well as research with 
cisgender people that has found that people who have higher levels of body satisfaction 
engage in more physical activity (Kruger et al., 2008; Lantz et al., 1997). Interestingly, this 
study found that levels of physical activity in transgender females on cross-sex hormones did 
not differ to levels in cisgender females. Cross-sex hormones appear to alleviate the physical 
activity inequality seen between cisgender and transgender females. Therefore, body 
satisfaction interventions aimed at cisgender women in an effort to increase their physical 
activity levels may also be applicable among transgender females on cross-sex hormone 
treatment, although the feasibility of this would need to be tested.  
 
In comparison to transgender males on cross-sex hormone treatment, cisgender males were 
found to engage in significantly more physical activity. This difference might be explained by 
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the findings from a recent qualitative study where transgender males who were taking cross-
sex hormones discussed how wearing a chest binder4F1 during physical activity was extremely 
uncomfortable (see chapter 6; Jones et al., 2017b). In addition, body satisfaction in 
transgender males has been found to significantly increase following chest reconstructive 
surgery (van de Grift et al., 2016c). In light of the current study’s findings and previous 
research, chest reconstructive surgery should be offered in a timely manner in accordance 
with the recommended Standards of Care, if this is what the person wishes (Coleman et al., 
2012; Wylie et al., 2015). This may help to indirectly increase physical activity levels among 
transgender males (i.e., by increasing their levels of body satisfaction).  
 
This is the first large scale study to compare physical activity levels of treatment seeking 
transgender people with a matched sample of cisgender people, and to quantitatively explore 
a range of factors which might predict physical activity. There are, however, some limitations. 
Transphobia was not significantly associated with physical activity, which was surprising 
given that 79% of survey respondents felt that transphobia was a barrier to participating in 
sport (Smith, Cuthbertson, & Gale, 2012). This lack of association in our study may be 
explained by the fact that some transgender people anticipate, as opposed to experience, 
transphobia (see chapter 6; Hargie, Mitchell, & Somerville, 2017; Jones et al., 2017b) and the 
measure in the current study only asked about the experience of transphobia. In addition, the 
percentage of physical activity explained by the regression models was low. This was despite 
age and depression being significantly correlated with physical activity. Future research 
should consider exploring why these factors were significantly associated with physical 
activity, but did not statistically predict the behaviour. In the current study, the physical 
activity measure used lacked specificity in relation to the type of physical activity engaged in. 
In this area of research, understanding the type of physical activity engaged in may highlight 
important nuances in relation to being active based on gender identity (i.e., to achieve a 
masculine or feminine body shape). Future research may also wish to extend the current 
study by exploring physical activity levels of non-binary people and determining how and 
why these may differ to transgender people who identify as female or male.  
 
                                            
 
1A chest binder is a garment of clothing worn by some transgender men to minimise breast tissue and increase 
the appearance of a male chest. 
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The findings of this research lead to several recommendations which could be useful for 
health professionals who are working with transgender individuals to implement in an effort 
to support physical activity engagement in this group. These include a need to develop or 
implement interventions to increase self-esteem and body satisfaction (and, in turn, physical 
activity). In addition to this, it is recommended that gender affirming medical interventions 
are offered in a timely manner, especially cross-sex hormone treatment and mastectomy, so 
as to facilitate transgender individuals’ engagement in physical activity.  
 
7.5.1. Conclusion 
In conclusion, there is an inequality in physical activity engagement between treatment 
seeking transgender people (especially those not on cross-sex hormones) and cisgender 
people. Cross-sex hormone treatment appears to be crucial in indirectly increasing physical 
activity engagement within the transgender population. Therefore the accessibility of cross-
sex hormone treatment for transgender individuals needs to be increased. 
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Chapter 8 (study 3) 
Chapters 6 and 7 (studies 1 and 2, respectively) found body (dis)satisfaction to have an 
instrumental role in physical activity and sport (dis)engagement in transgender people. 
Research presented in chapter 3 also suggested that body dissatisfaction has a key role in the 
eating disorder symptoms experienced by many transgender people. The aim of chapter 8 
(study 3) was therefore to explore the role that body (dis)satisfaction (alongside other factors) 
plays in eating disorder psychopathology in the treatment seeking transgender population.  
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Risk factors for eating disorder psychopathology within the treatment 
seeking transgender population: The role of cross-sex hormone treatment 
 
This chapter has been published in the European Eating Disorders Review (impact factor: 
3.39) as:  
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factors for eating disorder psychopathology within the treatment seeking transgender 
population: The role of cross-sex hormone treatment. Advance online publication. doi: 
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8.1. Abstract 
Many transgender people experience high levels of body dissatisfaction, which is one of 
numerous factors known to increase vulnerability to eating disorder symptoms in the 
cisgender (non-trans) population. Cross-sex hormones can alleviate body dissatisfaction so 
might also alleviate eating disorder symptoms. This study aimed to explore risk factors for 
eating disorder symptoms in transgender people and the role of cross-sex hormones. 
Individuals assessed at a national transgender health service were invited to take part in this 
study (N=563). Transgender people not on cross-sex hormones reported higher levels of 
eating disorder psychopathology than people who were. High body dissatisfaction, 
perfectionism, anxiety symptoms and low self-esteem were risk factors for eating 
psychopathology but, after controlling for these, significant differences in eating 
psychopathology between people who were and were not on cross-sex hormones 
disappeared. Cross-sex hormones may indirectly alleviate eating disorder psychopathology. 
Given the high prevalence of transgender identities, clinicians at eating disorder services 
should assess for gender identity issues. 
 
Chapter 8 (study 3): Eating disorder psychopathology 
153 
 
8.2. Introduction 
Eating disorder psychopathology, which includes restrictive eating, binge eating and 
compensatory behaviours (e.g., self-induced vomiting, misuse of diet pills and laxatives), has 
been found to be more prevalent among adolescent girls and young adult women compared to 
men (e.g., Duncan, Ziobrowski, & Nicol, 2017; Fairburn & Harrison, 2003). Body 
dissatisfaction (i.e., the negative evaluation of one’s appearance; which is also more prevalent 
among adolescents and young people), has consistently been associated with eating disorder 
psychopathology in both females and males (e.g., Keel, Fulkerson, & Leon, 1997; Stice & 
Shaw, 2002; Wang, Lydecker, & Grilo, 2017). Body dissatisfaction is influenced by Western 
society’s view of beauty (e.g., Fitzsimmons-Craft, 2011). As a consequence, women who are 
dissatisfied with their bodies often strive to obtain a thin body, while men are more likely to 
strive to obtain a muscular physique (e.g., Grogan, 2016; McCreary & Sasse, 2000). There 
are certain populations that have been found to be at increased risk of high levels of body 
dissatisfaction, such as the lesbian, gay, bisexual and transgender (LGBT) community (e.g., 
Calzo, Blashill, Brown, & Argenal, 2017; McClain & Peebles, 2016; Morgan & Arcelus, 
2009). Within this group, transgender people are particularly vulnerable to body 
dissatisfaction due to the distress and incongruence they experience with their gender and 
body, yet this population is severely under researched in relation to eating disorder 
psychopathology (see chapter 3; Jones, Haycraft, Murjan, & Arcelus, 2016b; Witcomb et al., 
2015).   
 
Transgender people experience incongruence between their gender assigned at birth 
(determined from their sex characteristics (i.e., genitals)) and the gender they identify with. 
Transgender men are assigned female at birth but identify as male, while transgender women 
are assigned male at birth but identify as female (Arcelus & Bouman, 2017a; Bouman et al., 
2017b). Cisgender people (non-transgender) do not experience such incongruence. Prior to 
undergoing gender affirming medical interventions (e.g., cross-sex hormone treatment 
(CHT), gender affirming surgery), many treatment seeking transgender people are 
dissatisfied with their body shape and/or weight, which may put them at risk of developing an 
eating disorder (Witcomb et al., 2015). It has been hypothesised that it is the body 
dissatisfaction (a common feature of eating disorder psychopathology), linked to the wish to 
achieve a masculine or feminine body ideal, which influences the development of eating 
disorder psychopathology, specifically drive for thinness and bulimia, among transgender 
people (Ålgars, Alanko, Santtila, & Sandnabba, 2012; Bouman & Arcelus, 2016; Khoosal, 
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Langham, Palmer, Terry, & Minajagi, 2009). In addition, it has also been hypothesised that 
the wish to stop menstruation and puberty, as well as not wanting to develop a feminine body 
shape (such as the development of breasts), can also play a role in the development of an 
eating disorder in transgender males (Bouman & Arcelus, 2016). This may explain why 
disordered eating has been found to be prevalent in transgender adolescents (Watson, Veale, 
& Saewyc, 2017). For example, Diemer, Grant, Munn-Chernoff, Patterson and Duncan 
(2015) found that transgender adolescents more frequently self-reported an eating disorder 
diagnosis in the past year (15.84%), and presented with eating disorder symptoms such as the 
use of diet pills (13.50%), self-induced vomiting and laxative abuse (15.61%), compared to 
cisgender adolescents.  
 
As well as presenting to transgender health services with symptoms of an eating disorder, 
transgender people may initially present to eating disorder services. Case studies have 
reported on individuals who first present with eating disorder symptoms (e.g., food 
restriction, vomiting and body image distortion) without disclosing their transgender identity 
which, through exploration, has later been expressed as a desire to achieve a masculine or 
feminine body (different to the body associated with their gender assigned at birth) and, 
hence, identified as secondary to their gender identity  (e.g., Couturier, Pindiprolu, Findlay, 
& Johnson, 2015; Winston, Acharya, Chaudhuri, & Fellowes, 2004). These findings are 
concerning considering that gender incongruence is not routinely assessed within eating 
disorder services given that the prevalence of transgender people is considered to be low. 
However, recently the prevalence of transgender people has increased and there has been a 
significant increase in demand for transgender health services across Europe and North 
America (Aitken et al., 2015; Arcelus et al., 2015; de Vries, Kreukels, T’Sjoen, Ålgars, & 
Mattila, 2015; House of Commons, 2016; Jones et al., 2017c). Therefore, gender 
incongruence may need to be considered by clinicians working at eating disorder services.  
 
Within the cisgender population, several factors (such as body dissatisfaction (e.g., Keel et 
al., 1997; Stice & Shaw, 2002), high levels of perfectionism (e.g., Egan, Wade, & Shafran, 
2011; Tchanturia, Larsson, & Adamson, 2016), the existence of interpersonal problems (e.g., 
Arcelus, Haslam, Farrow, & Meyer, 2013), low self-esteem (Dakanalis et al., 2016), and 
symptoms of anxiety and depression (e.g., Brechan & Kvalem, 2015; DeBoer & Smits, 2013; 
Fairburn, Cooper, & Shafran, 2003; Harrison, Sullivan, Tchanturia, & Treasure, 2009; Puccio 
et al., 2017)) have been identified as being associated with eating disorder psychopathology 
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and found to increase the risk of developing an eating disorder. Body dissatisfaction has 
consistently been found to be associated with eating disorder psychopathology (e.g., Keel et 
al., 1997; Stice & Shaw, 2002). Dissatisfaction with one’s body has been described as a core 
feature, but not sufficient to completely explain the development of eating disorders (Polivy 
& Herman, 2002). The relationship between eating disorder psychopathology and body 
dissatisfaction has been found to be complex as cognitive-behavioural and emotion regulation 
theories of eating disorders have suggested that negative emotions, such as anxiety and 
depression, as well as self-esteem, mediate the relationship between body dissatisfaction and 
eating disorder psychopathology (e.g., Brechan & Kvalem, 2015; DeBoer & Smits, 2013; 
Fairburn et al., 2003; Harrison et al., 2009). Anxiety symptomatology has also been found to 
partially mediate the association between self-orientated perfectionism (a trait often 
associated with eating disorders; Egan et al., 2011) and eating disorder psychopathology 
(Egan et al., 2013), which suggests that anxiety plays a role in eating disorder development. 
Furthermore, interpersonal difficulties have also been linked to behaviours associated with 
eating disorders within the cisgender population (e.g., Arcelus et al., 2013).  
 
Factors associated with, and found to mediate, eating disorder psychopathology in the 
cisgender population may be particularly pertinent among transgender people. This is 
because research has consistently shown treatment seeking transgender people to report high 
levels of mental health problems, such as anxiety and depression (e.g., Arcelus, Claes, 
Witcomb, Marshall, & Bouman, 2016; Bouman, Davey, Meyer, Witcomb, & Arcelus, 2016a; 
Bouman et al., 2017a; Dhejne, Van Vlerken, Heylens, & Arcelus, 2016; Millet, Longworth, 
& Arcelus, 2017), perfectionism (Khoosal et al., 2009), and interpersonal problems (Davey, 
Bouman, Meyer, & Arcelus, 2015) in comparison to cisgender people. Therefore these 
factors may be important when exploring risk factors for eating disorder psychopathology 
within the transgender population.  
 
Once a medical transition has been initiated (e.g., CHT and gender affirming surgery), body 
dissatisfaction has been found to significantly improve in transgender adults (e.g., de Vries, 
Steensma, Doreleijers, & Cohen-Kettenis, 2011, de Vries et al., 2014; Fisher et al., 2014; van 
de Grift et al., 2016c, 2017a) and, therefore, these interventions may reduce the risk of 
developing an eating disorder or help to alleviate eating disorder symptoms. Although 
research is limited (one study to date), eating disorder symptoms have been found to reduce 
after gender affirming surgery (Khoosal et al., 2009). However, this study only considered 
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the role of surgery and not CHT. The study is also limited by the small sample size (N=40) 
and only recruiting transgender women. In light of this, the current study was concerned with 
exploring the role of CHT only and recruiting a larger sample comprising both transgender 
men and women. In addition to this, this study was concerned with exploring risk factors in 
transgender people yet to undergo a medical transition as this vulnerable population may first 
present to eating disorder services (without disclosing their transgender identity). As the 
cisgender literature suggests that eating disorders are complex and multifactorial this is also 
likely to be the case within the transgender population. Variables that can mediate between 
identified risk factors and eating disorder psychopathology will be explored. These analyses 
within the transgender population are important to determine through which mechanisms 
gender affirming medical interventions (e.g., CHT) are capable of alleviating eating disorder 
symptoms. Taking into consideration some of the limitations of previous research, the study 
had three specific aims: 
 
1. To examine the role of CHT in eating disorder symptoms by determining whether 
there is a difference in eating disorder psychopathology (drive for thinness and 
bulimia) between a large sample of transgender people who are or who are not on 
CHT. 
2. To explore risk factors (age, assigned gender, body dissatisfaction, perfectionism, 
interpersonal problems, self-esteem, anxiety, and depression) associated with eating 
disorder psychopathology in transgender people who are not on CHT. 
3. To explore factors that mediate the relationship between identified risk factors and 
eating disorder psychopathology (drive for thinness and bulimia) in transgender 
people who are not on CHT. 
 
Based on previous research it was first hypothesised that transgender people on CHT would 
have lower levels of eating disorder psychopathology compared to participants who are not 
on cross-sex hormones (e.g., Fisher et al., 2014; Khoosal et al., 2009). Second, it was 
hypothesised that younger age, identifying as female (because transgender people adopt and 
perform the social gender role (i.e., behaviours, attributes) associated with their experienced 
gender identity), higher levels of body dissatisfaction, anxiety, depression, perfectionism, 
interpersonal problems and lower levels of self-esteem would be risk factors for eating 
disorder psychopathology in transgender people who are not on CHT. Third, based on the 
centrality of body dissatisfaction to both gender incongruence (see chapter 3; Jones et al., 
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2016b) and eating disorders (e.g., Stice & Shaw, 2002), it was hypothesised that if a 
significant relationship was found between body dissatisfaction and eating disorder 
psychopathology (addressed in aim 2), then the other identified risk factors would mediate 
this relationship in people who are not on CHT.  
 
8.3. Method 
8.3.1. Participants and recruitment  
All patients offered an assessment at a national transgender health service in the United 
Kingdom (UK) between 2012 and 2015 were invited to take part in the study. This 
transgender health service offers assessment and gender affirming medical interventions to 
adults aged 17 and over who are considering, or wish to, medically transition.  
 
8.3.2. Procedure  
At initial assessment, participants were invited to complete socio-demographic questions and 
a range of self-report measures. This was part of a larger study for which ethical approval 
was obtained from the National Health Service (NHS) ethics committee and from the 
Research and Development Department from the Nottinghamshire Healthcare NHS 
Foundation Trust in accordance with Health Research Authority guidance (HRA, 2013; see 
Appendix M). 
 
8.3.3. Measures  
Socio-demographic information: Participants were asked to provide information about their 
age, gender assigned at birth, and stage of medical transition before assessment (e.g., whether 
or not they were on CHT). They were then invited to complete the following selection of self-
report measures. 
 
Eating Disorder Inventory-2 (EDI-2; Garner, 1991): This questionnaire is commonly used to 
assess behaviours and psychological traits associated with eating disorder psychopathology. 
It has 11 subscales; three which assess eating-related symptoms (drive for thinness, bulimia, 
and body dissatisfaction) and eight which are associated with eating-related psychological 
features common in eating disorders (ineffectiveness, perfectionism, interpersonal distrust, 
interoceptive awareness, maturity fears, asceticism, impulse regulation, and social 
insecurity). In the current study, the drive for thinness and bulimia subscales were used to 
measure eating disorder psychopathology. The body dissatisfaction, perfectionism and 
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interpersonal distrust subscales were also used. Responses are rated on a 6-point Likert scale 
anchored from ‘never’ to ‘always’ and a higher score indicates a higher level of eating 
disorder psychopathology. All the subscales have previously been found to have good 
reliability among patients with an eating disorder and the general population (e.g., Nevonen, 
Clinton, & Norring, 2006). In the current study, the Cronbach’s alpha values were as follows: 
drive for thinness (α=.85), bulimia (α=.83), body dissatisfaction (α=.85), perfectionism 
(α=.70) and interpersonal distrust (α=.80), showing that all had good reliability.  
 
Rosenberg Self-Esteem Scale (RSE; Rosenberg, 1965): This is a 10-item self-report measure 
that assesses self-esteem using a 4-point Likert scale (‘strongly agree’ = 3 to ‘strongly 
disagree’ = 0). It produces a global score, which is calculated by summing the scores from 
the individual items. A high score indicates a higher self-esteem (highest possible score is 
30). The measure has been validated and has excellent reliability (α=.88-.90; Robins, Hendin, 
& Trzesniewski, 2001). In the current study, the reliability was also excellent (α=.92).  
 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983): This measure has 
14 items in total, seven which relate to anxiety (HADS-A) and seven which relate to 
depression (HADS-D). The HADS-A and HADS-D subscale scores are calculated by 
summing scores from the individual items. Participants are asked to rate their responses on a 
4-point Likert Scale (‘not at all’ = 1 to ‘most of the time’ = 3). For each subscale, scores 
between 0-7 are considered normal, scores between 8-10 are considered borderline clinical, 
and scores of 11 and above are considered clinically relevant (Snaith, 2003). The highest 
score possible is 21 for each subscale. The measure has good reliability in somatic, 
psychiatric and primary care patients as well as in the general population (Bjelland, Dahl, 
Haug, & Neckelmann, 2002). In the current study, both the anxiety (α=.84) and depression 
(α=.77) subscales had good reliability.  
 
8.3.4. Data analysis  
Data were analysed using SPSS 23 (IBM, 2015). The data were not normally distributed and 
therefore non-parametric tests were used when possible. Missing data were excluded using 
the pairwise method apart from in the Mann-Whitney U analysis where the test-by-test 
method was employed. Before the main analysis, descriptive analysis was conducted. For the 
first aim, a Mann-Whitney U test was conducted to determine whether there was a difference 
in eating disorder psychopathology between people who had taken CHT and those who had 
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not. For the second aim, preliminary one-tailed Spearman Rho correlations were conducted 
between the dependent variables (drive for thinness and bulimia) and independent variables 
(age, gender assigned at birth, anxiety, depression, self-esteem, body dissatisfaction, 
interpersonal distrust and perfectionism). As categorical variables cannot be entered into 
correlational analysis, a dummy variable was created for gender assigned at birth. The 
function of the Spearman’s Rho correlations was to determine which variables significantly 
correlated with the dependent variables and, consequently, to include only these variables in 
subsequent regression analysis to increase its robustness. Multicollinearity was not a cause 
for concern as no variable correlated at r ≥ .90 with the outcome variables (Pallant, 2010). As 
multiple comparisons were conducted, Bonferroni corrections were used for the correlation 
analysis (.05 ÷ 16 = .003). To determine which variables were able to explain the most 
variance in eating disorder psychopathology (drive for thinness and bulimia) in people who 
were yet to take CHT, stepwise multiple linear regression analysis was conducted. Once the 
risk factors had been established an ANCOVA was conducted to determine whether there 
was a significant difference in eating disorder symptoms between people who were and were 
not on CHT after controlling for the risk factors identified in the multiple linear regression 
analysis. For the third aim, mediation analysis was conducted to better understand the 
mechanisms that underlie the relationship between the independent variable (hypothesised to 
be body dissatisfaction) and eating disorder psychopathology (drive for thinness and 
bulimia). Mediation analysis was conducted using the PROCESS macro in SPSS (Hayes, 
2013). Model 4, which uses the bias-corrected bootstrap confidence interval method, was 
employed. The level of significance used for all the analysis was p<.05.  
 
8.4. Results  
In total, 586 patients were invited for assessment during the study period and 563 (96%) 
agreed to participate. The mean age of participants was 29.49 years (SD = 13.67), slightly 
more participants were assigned male at birth (n=352, 62.5%), and the majority were not on 
CHT prior to assessment at the transgender health service (n=416, 73.9%; see Table 8.1.). 
While all participants were recruited at the point of assessment, some people had initiated 
CHT prior to assessment at this service (n=139, 24.7%). Some participants may have initiated 
this intervention as their care was transferred from the child and adolescent gender identity 
development service and others might have obtained CHT through private health providers or 
via the Internet (Mepham, Bouman, Arcelus, Hayter, & Wylie, 2014). Table 8.1. also 
presents descriptive statistics separately for people who were and were not on CHT.  
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Table 8.1. Socio-demographic characteristics for the whole sample, for participants who 
have taken CHT, and for participants who have not taken CHT  
 Total sample 
(N=563) 
CHT (excluding 
blockers only†) 
(n=139) 
No CHT 
(n=416) 
 Sample size (%) 
Mean (SD) age 29.49 (13.67) 35.37 (16.02) 27.46 (12.15) 
Gender assigned at birth    
Female 211 (37.5) 44 (31.7) 166 (39.9) 
Male 352 (62.5) 95 (68.3) 250 (60.1) 
Cross-sex hormones    
Yes (excluding blockers 
only) 
139 (24.7)   
No 416 (73.9)   
No response 8 (1.4)   
Blockers only (no CHT)   17 (4.1) 
Note: CHT (cross-sex hormone treatment); † (People who had only taken blockers (and not 
CHT) were excluded from the cross-sex hormones group as in contrast to CHT, hormone 
blockers do not affect secondary sex characteristics. Based on this, these people were 
included within the no cross-sex hormone group) 
 
8.4.1. Aim 1: Differences in eating disorder psychopathology between people who were on 
CHT and those who were not 
A Mann-Whitney U test was conducted to determine whether participants who were (n=139) 
and were not (n=416) on CHT differed in levels of drive for thinness and bulimia. The 
analysis demonstrated that transgender people who were not on CHT reported significantly 
higher levels of drive for thinness and bulimia compared to participants who were on CHT 
(see Table 8.2.).  
 
Mann-Whitney U tests also showed that people who were not on CHT were significantly 
younger, had higher levels of body dissatisfaction and interpersonal distrust, more symptoms 
of anxiety and depression, and lower levels of self-esteem than participants who were on 
CHT (see Table 8.2.). There was no significant difference in levels of perfectionism between 
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the two groups. A Pearson Chi-Squared test was conducted to explore differences in gender 
assigned at birth based on CHT use and this test was not significant (χ2 (1) =3.01, p=.083) 
suggesting that gender assigned at birth is independent of CHT use.  
 
Table 8.2. Means, standard deviations (SD) and Mann Whitney U tests of difference between 
people who have taken CHT and those who have not for all study variables 
 No CHT 
(n=416) 
CHT 
(n=139) 
 Mann-Whitney U 
Mean (SD) Mean (SD) U Z Effect 
size 
p 
Age 27.46 (12.15) 35.37 (16.02) 20126.50 -5.38 .23 .001 
Drive for thinness  3.87 (4.95) 2.82 (4.07) 25207.50 -2.14 .09 .019 
Bulimia 1.87 (3.54) 0.96 (2.32) 24178.00 -2.99 .13 .002 
Body 
dissatisfaction  
12.13 (6.96) 9.62 (6.83) 22368.00 -3.86 .16 .001 
Interpersonal 
distrust 
5.66 (4.60) 3.56 (3.86) 20609.50 -4.72 .36 .001 
Anxiety 8.27 (4.31) 6.45 (4.00) 21021.50 -4.39 .19 .001 
Depression 7.22 (3.88) 5.18 (3.48) 19270.50 -5.37 .23 .001 
Self-esteem  14.74 (6.52) 19.01 (6.49) 17849.00 -6.31 .27 .001 
Perfectionism  5.10 (4.19) 4.88 (3.86) 27975.50 -.28 .01 .410 
Note: CHT (cross-sex hormone treatment) 
 
8.4.2. Aim 2: Risk factors of eating disorder psychopathology in people who were not on 
CHT 
Drive for thinness: Body dissatisfaction, high levels of perfectionism, the experience of 
interpersonal distrust, symptoms of anxiety and depression and low self-esteem were all 
significantly correlated with drive for thinness in people who were not on CHT (n=416; see 
Table 8.3.) and were therefore entered into the subsequent stepwise regression analysis. 
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Table 8.3. One-tailed Spearman’s Rho correlations between drive for thinness, bulimia and 
the study variables for people who have not taken CHT (n=416) 
 Drive for thinness Bulimia 
Age .01 -.12 
Male gender assigned at birth† -.05 -.07 
Female gender assigned at birth† .05 .07 
Body dissatisfaction   .48*** .31*** 
Perfectionism .24*** .26*** 
Interpersonal distrust .27*** .30*** 
Anxiety .35*** .36*** 
Depression .30*** .28*** 
Self-esteem -.37*** -.48*** 
Note: CHT (cross-sex hormone treatment); † entered as dummy variables  
*p<.05, **p<.01, ***p<.001 (corrected for multiple comparisons) 
 
Overall, the stepwise regression model was significant and the significant variables explained 
30% of the total variance of drive for thinness (see Table 8.4.). Higher levels of body 
dissatisfaction made the largest contribution to the variance followed by high levels of 
perfectionism and anxiety symptoms (see Table 8.4.). The average VIF (Variance Inflation 
Factor) for this model was 1.10 and the average tolerance was .91. The average VIF was not 
greater than 10 (Myers, 1990) and the average tolerance was not below .10 (Menard, 1995), 
which indicates that the assumptions of multicollinearity for this model were met and hence 
the variables were not too highly correlated.  
 
Bulimia: Body dissatisfaction, high levels of perfectionism, the experience of interpersonal 
distrust, symptoms of anxiety and depression, and low self-esteem were all significantly 
correlated with bulimia in people who were not on CHT (n=416; see Table 8.3.). These six 
variables were therefore entered into a subsequent stepwise regression model. Overall, this 
model was significant and explained 25% of the total variance in bulimia (see Table 8.4.). 
Low self-esteem made the largest contribution to the variance, followed by high levels of 
perfectionism, body dissatisfaction and symptoms of anxiety (see Table 8.4.). The average 
VIF for this model was 1.38 and the average tolerance was .75 indicating that there is no 
multicollinearity within the model (Menard, 1995; Myers, 1990). 
Chapter 8 (study 3): Eating disorder psychopathology 
163 
 
Table 8.4. Stepwise regression models showing the significant risk factors of (i) drive for 
thinness and (ii) bulimia for people who have not taken CHT (n=416) 
 F R2 beta SE beta β 
Drive for thinness 57.32*** .30    
Body dissatisfaction   .31 .03 .43*** 
Perfectionism   .18 .05 .16*** 
Anxiety   .18 .05 .16*** 
Bulimia 32.86*** .25    
Self-esteem   -.13 .03 -.24*** 
Perfectionism   .15 .04 .18*** 
Body dissatisfaction    .08 .02 .16*** 
Anxiety   .12 .05 .14** 
Note: CHT (cross-sex hormone treatment) 
*p<.05, **p<.01, ***p<.001 
 
After determining the risk factors for eating disorder psychopathology in people yet to 
commence cross-sex hormones (n=416), an ANCOVA was conducted to determine whether 
there was a significant difference in eating disorder psychopathology between people who 
were (n=139) and were not (n=416) on CHT, after controlling for the identified risk factors. 
It was found that there was no longer a significant difference in drive for thinness between 
people who were and were not on CHT when body dissatisfaction, perfectionism and 
symptoms of anxiety were controlled for (F(1, 538) = .35, p=.885).  It was also found that 
there was no longer a significant difference in levels of bulimia between people who were 
and were not on cross-sex hormones after self-esteem, perfectionism, body dissatisfaction 
and symptoms of anxiety were controlled for (F(1, 529) =.03, p=.868). 
 
8.4.3. Aim 3: Exploring the mediators of the relationship between risk factors and eating 
disorder psychopathology in people who were not on CHT  
In addressing aim 2, it was found that high levels of body dissatisfaction were a risk factor 
for both drive for thinness and bulimia. Due to the centrality of body dissatisfaction in both 
gender incongruence (see chapter 3; Jones et al., 2016b, van de Grift et al., 2016c, 2017a) and 
eating disorders (e.g., Stice & Shaw, 2002), mediators of the relationship between body 
dissatisfaction and eating disorder psychopathology were explored for people who had not 
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yet commenced CHT (n=416). The remaining risk factors identified in aim 2 were explored 
as mediators (perfectionism, symptoms of anxiety and self-esteem). Mediation occurs when 
the bootstrapped lower and upper confidence intervals do not include zero.  
 
Perfectionism (model 1) and symptoms of anxiety (model 2) were explored separately as 
mediators of the relationship between body dissatisfaction and drive for thinness. Self-esteem 
(model 3), perfectionism (model 4) and anxiety (model 5) were explored separately as 
mediators of the relationship between body dissatisfaction and bulimia. Figure 8.1. 
demonstrates the five different models analysed through the direct and indirect effects. As 
can be seen by the unstandardized beta model coefficients (a, b, c) in Table 8.5., X (the 
independent variable; body dissatisfaction) always significantly predicted M (the mediator) 
depicted by pathway (a), and M always significantly predicted Y (the outcome variable; 
drives for thinness or bulimia) depicted by pathway (b), in all five models analysed. The 
direct effect (X-Y; depicted by pathway c) was also significant in all models (see Table 8.5.). 
For the indirect effect, a bias-corrected bootstrap confidence interval based on 5000 bootstrap 
sample was explored. As the bootstrapped lower and upper confidence intervals did not 
include zero it can be concluded that perfectionism (model 1) and symptoms of anxiety 
(model 2) each significantly mediated the relationship between body dissatisfaction and drive 
for thinness. This indicates that the relationship between body dissatisfaction and drive for 
thinness can be explained by the presence of perfectionism and anxiety symptoms. In 
addition, self-esteem (model 3), perfectionism (model 4) and symptoms of anxiety (model 5) 
each mediated the relationship between body dissatisfaction and bulimia (see Table 8.5.). 
This indicates that the relationship between body dissatisfaction and bulimia can be explained 
by the low self-esteem, perfectionism and anxiety symptoms. 
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Predictor variable (X): 
Body dissatisfaction
Outcome variables (Y):
Drive for thinness 
OR
Bulimia 
Mediator variables (M):
Perfectionism
OR
Self-esteem
OR 
Anxiety 
a b
c
Direct effect
Indirect effect
 
Figure 8.1. Mediation analyses for perfectionism and anxiety as mediators between body 
dissatisfaction and drive for thinness and, for self-esteem, perfectionism and anxiety as 
mediators between body dissatisfaction and bulimia 
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Table 8.5. Perfectionism, self-esteem and anxiety as potential mediators of the relationship between body dissatisfaction and eating disorder 
psychopathology (drive for thinness and bulimia) in people who have not taken CHT (n=416) 
 Regression model unstandardized beta coefficients for paths a, b, c and ab and bootstrapped lower and upper 
confidence intervals 
Outcome variable  Mediator in model a (beta) (X-M) b (beta) (M-Y) c (beta) (X-
Y; direct 
effect) 
ab (beta) 
(indirect 
effect) 
Bootstrap 
lower CI 
Bootstrap 
upper CI 
Drive for thinness        
 Model 1: Perfectionism  .09** .23*** .33*** .02 .01 .04 
 Model 2: Anxiety .15*** .23*** .31*** .03 .02 .06 
Bulimia        
 Model 3: Self-esteem -.39*** -.19*** .10** .07 .05 .10 
 Model 4: Perfectionism .09*** .29*** .14*** .02 .01 .04 
 Model 5: Anxiety .15*** .25*** .12*** .04 .02 .06 
Note: X-body dissatisfaction, M-mediator variable (perfectionism, self-esteem and anxiety), Y-outcome variable (drive for thinness or bulimia).  
CHT (cross-sex hormone treatment) 
*p<.05, **p<.01, ***p<.001 
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8.5. Discussion 
This study aimed to understand the risk factors for eating disorder psychopathology within 
the transgender population, as well as the role of CHT in eating disorder psychopathology. 
The current study found that transgender people who were on CHT had significantly lower 
levels of eating disorder symptoms than transgender people who were not. When comparing 
this finding to previous literature, people within the current study who were on CHT 
presented with similar levels of eating disorder psychopathology compared to the general 
population (Witcomb et al., 2015). In contrast, transgender people in the current study who 
were not on CHT presented with higher levels of eating psychopathology than is found within 
the general population (Witcomb et al., 2015). When the current study’s finding and previous 
research are considered together, it suggests that CHT may be able to alleviate eating disorder 
psychopathology, which is in keeping with previous research (Fisher et al., 2014; Khoosal et 
al., 2009) and case studies (Couturier et al., 2015; Winston et al., 2004) that have supported 
the notion that eating disorder psychopathology in transgender people is secondary to gender 
incongruence.  
 
This study is novel in that it aimed to understand why CHT might alleviate eating disorder 
symptoms by exploring risk factors in transgender people yet to undergo a medical transition. 
The current study found that high levels of body dissatisfaction, perfectionism, symptoms of 
anxiety, and low self-esteem were all risk factors for eating disorder psychopathology as 
reported in the cisgender literature (e.g., Brechan & Kvalem, 2013; Dakanalis et al., 2016; 
Egan et al., 2011; Fairburn et al., 2003; Keel et al., 1997; Puccio et al., 2017; Tchanturia et 
al., 2016). Once the identified risk factors for eating disorder psychopathology were 
controlled for, there was no longer a significant difference in eating disorder symptoms 
between people who were and were not on CHT. This finding suggests that CHT alleviates 
eating disorder symptoms as it reduces levels of body dissatisfaction, perfectionism, 
symptoms of anxiety and increases self-esteem.  
 
Within the cisgender literature, body dissatisfaction has been described as a core feature of -
though not sufficient to adequately explain - eating disorder symptoms (Polivy & Herman, 
2002) and, consequently, other factors have been found to mediate the relationship between 
body dissatisfaction and eating disorder psychopathology (e.g., Brechan & Kvalem, 2015; 
DeBoer & Smits, 2013; Fairburn et al., 2003; Harrison et al., 2009). This also appears to be 
the case within the transgender population as the current study found high levels of 
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perfectionism and symptoms of anxiety to mediate the relationship between body 
dissatisfaction and drive for thinness. Additionally, low self-esteem, high levels of 
perfectionism and symptoms of anxiety were found to mediate the relationship between body 
dissatisfaction and bulimia in transgender individuals. These findings help to clarify the 
mechanisms through which CHT might be able to alleviate eating disorder symptoms. They 
suggest that CHT primarily alleviates high body dissatisfaction, which in turn reduces levels 
of perfectionism and symptoms of anxiety, and increases self-esteem. In combination, these 
factors then appear to alleviate eating disorder symptoms. This is the first study with 
transgender people that has been able to indicate how cross-sex hormones alleviate eating 
disorder symptoms, although this finding needs to be replicated with longitudinal research.  
 
Clinicians working in eating disorder services should routinely assess gender identity issues 
as this is where transgender people may first present due to experiencing high levels of body 
dissatisfaction and eating disorder symptoms that are secondary to gender incongruence. 
Such patients should be referred to transgender health services as this study has shown the 
positive role that CHT plays in eating disorder symptoms. CHT is likely to be more effective 
than interventions offered at eating disorder services in these circumstances (Ewan, 
Middleman, & Feldmann, 2014). 
 
When patients are referred to transgender health services with symptoms of an eating 
disorder, clinicians might be reluctant to accept such patients onto the treatment programme 
until these issues are resolved. The findings of the current study indicate that for patients 
presenting with high levels of eating disorder symptoms (that are secondary to gender 
identity issues), timely initiation of CHT may reduce these symptoms, as well as gender 
incongruence. Given the existence of barriers to accessing transgender healthcare (Bouman & 
Richards, 2013; Jones et al., 2017c; Kanamori & Cornelius-White, 2016; Scheim, Zong, 
Giblon, & Bauer, 2017), it is imperative that access to these services is increased to minimise 
the risk of eating disorder psychopathology. In addition, although gender affirming medical 
interventions alleviate body dissatisfaction (a core feature of eating disorder 
psychopathology) for many people, patients who report very high body dissatisfaction before 
gender affirming medical interventions have been found to continue to do so after gender 
affirming medical interventions (van de Grift et al., 2017a). Clinicians at transgender health 
services must consider that these patients (who continue to report high body dissatisfaction 
after gender affirming interventions) may be vulnerable to eating disorder psychopathology.  
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Within the current study, neither age or gender (assigned at birth) were found to be risk 
factors for eating disorder psychopathology within treatment seeking transgender people who 
were yet to commence CHT. This contrasts with research within the cisgender population 
which has found adolescents and young adult females to be at greater risk than males and 
older people (e.g., Fairburn & Harrison, 2003; Zeiler et al., 2016) and was despite the current 
study finding that people who were yet to commence CHT were significantly younger (and 
reported more eating disorder symptoms) than people who had initiated CHT. Previous 
research with transgender people has found transgender men (assigned female at birth) to 
report very high levels of body dissatisfaction (a common feature of eating disorder 
psychopathology) that were comparable to cisgender men with an eating disorder (Witcomb 
et al., 2015). This finding was not replicated when transgender women were compared to 
cisgender women with an eating disorder (Witcomb et al., 2015). Therefore, although gender 
may not be a risk factor for eating disorder symptoms within the transgender population, 
clinicians at both eating disorder and transgender health services should be mindful that 
people assigned female at birth may report a higher prevalence of eating disorder symptoms 
than people assigned male at birth.  
 
For the first time, the current study has identified multiple risk factors for eating disorder 
psychopathology within a large sample of treatment seeking transgender people. In addition 
to this, the alleviating role that CHT plays in eating disorder symptoms has been recognised. 
This is in contrast to previous research, which has found levels of eating disorder symptoms 
in the transgender population to be higher than in the general population without 
understanding why (Witcomb et al., 2015). However, the following limitations should be 
considered. First, this study is cross-sectional and therefore causality cannot be determined. 
Risk factors need to be explored with further longitudinal research. Second, the group sizes 
within the comparative analysis were different which might have impacted on the findings. 
Finally, analysis was conducted in relation to gender assigned at birth. The majority of 
transgender people will transition within the binary gender system (i.e., man or woman) but 
there are increasing numbers of transgender people who identify outside the binary gender 
system (i.e., gender neutral, non-gender, bigender) or are fluid with their gender identity 
(Arcelus & Bouman, 2017a). Therefore, future research should be concerned with 
transgender people who identify as a woman, a man, and outside the binary gender system.  
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8.5.1. Conclusion  
In conclusion, transgender people who were not on CHT reported more eating disorder 
symptoms than transgender people who were on CHT. The findings suggest that CHT may be 
able to alleviate eating disorder symptoms primarily through positively impacting on body 
dissatisfaction (i.e., increasing body satisfaction) which, in turn, reduces levels of 
perfectionism and symptoms of anxiety and increases self-esteem. Clinicians working at 
eating disorder services should incorporate the assessment of gender identity issues within 
their clinical practice and refer patients with such issues to transgender health services so that 
they can be evaluated for CHT.  
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Chapter 9 (study 4) 
Previous literature and the findings from the research presented in this thesis so far have 
established that treatment seeking transgender people are vulnerable to poor mental health 
and body dissatisfaction in comparison to cisgender people, especially when a medical 
transition has not yet been initiated. However, this knowledge has been established through 
the use of self-report measures that have not been developed or validated with the transgender 
population and therefore such measures lack specificity. In light of this, the aim of chapter 9 
(study 4) was to develop and validate a new transgender health outcome measure with the 
transgender population.  
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The Gender Congruence and Life Satisfaction Scale (GCLS): Development 
and validation of a scale to measure outcomes from transgender health 
services 
 
This chapter is under review with the Archives of Sexual Behavior (impact factor: 2.72) as: 
Jones, B. A., Bouman, W. P., Haycraft, E. & Arcelus, J. (2017). The Gender Congruence and 
Life Satisfaction Scale (GCLS): Development and validation of a scale to measure outcomes 
from transgender health services.  
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9.1. Abstract 
It is vital that the treatment offered at transgender health services can be evaluated to ensure a 
high quality of care. However, there are currently no tools that are capable of assessing 
improvements in patients’ experiences of gender distress, gender incongruence, associated 
mental well-being, and general life satisfaction, simultaneously. This study therefore aimed to 
develop and validate such a tool. The Gender Congruence and Life Satisfaction Scale 
(GCLS) was developed through reviewing the literature, conducting interviews with 
transgender people, and holding discussions with experts working in transgender healthcare. 
An initial pool of items was developed and feedback on these was obtained. A total of 789 
participants (451 transgender (171 transgender females, 147 transgender males, 133 non-
binary individuals), and 338 cisgender (254 females, 84 males)) were recruited from the UK 
to test the factor structure and validity of the GCLS. Exploratory factor analysis retained 38 
items which formed seven subscales (psychological functioning; genitalia; social gender role 
recognition; physical and emotional intimacy; chest; other secondary sex characteristics; and, 
life satisfaction). These seven subscales were found to have good internal consistency and 
convergent validity. The GCLS was also found to be capable of discriminating between 
groups (e.g., people who have and have not undergone gender affirming medical 
interventions). Transgender and cisgender subscale norms are provided for the GCLS. It can 
therefore be concluded that the GCLS is a suitable tool to use with the transgender population 
to measure health-related outcomes for both clinical and research purposes.  
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9.2. Introduction 
Transgender people are those who experience a discrepancy between the gender they were 
assigned at birth and their gender identity. Transgender males are people who were assigned 
female at birth, on the basis of their sexual characteristics, but identify as male. Transgender 
females are people who were assigned male at birth, on the basis of their sexual 
characteristics, but identity as female. Some transgender people may also identify between or 
outside the binary gender spectrum. These people may choose to identify as gender neutral 
(feeling that one is neither male nor female), non-gender (having no gender in relation to 
presentation), or gender queer (identifying and presenting in a way that is outside the gender 
dichotomy of male and female) (Arcelus & Bouman 2017; Richards et al., 2016). Some 
people may also be more fluid with their gender identity whereby they do not have a fixed 
gender and it can therefore vary over time. Cisgender people do not experience such 
discrepancy (Arcelus & Bouman, 2017a; Bouman et al., 2017b). Many transgender people 
experience high levels of distress due to the discrepancy between their birth-assigned gender 
and gender identity (e.g., Beek, Kreukels, Cohen-Kettenis, & Steensma, 2015). To alleviate 
this distress, many transgender people will approach transgender health services in order to 
access gender affirming medical interventions to help them transition to the gender they 
identify with. Health professionals working at transgender health services may start their 
patients on cross-sex hormone treatment to induce either masculinisation (with testosterone) 
or feminisation (with oestrogen and often with testosterone-blocking medication), depending 
on the patient’s gender identity (Coleman et al., 2012; Wylie et al., 2014). After living as 
their experienced gender, transgender people, if they wish to do so, can be referred for gender 
affirming surgery (Coleman et al., 2012; Wylie et al., 2014).  
 
Transgender health services throughout Europe and North America have seen a substantial 
increase in the number of referrals in recent years. This has put a strain on these services, 
especially in relation to waiting times for assessment and treatment (Aitken et al., 2015; de 
Vries, Kreukels, T’Sjoen, Ålgars, & Mattila, 2015). In the United Kingdom (UK) patients can 
expect to wait more than one year before their first appointment at a transgender health 
service (Bouman & Richards, 2013; UK Trans Info, 2016). In light of this, evaluating the 
care and treatment received at these services is important. This will allow for the quality of 
care to be improved and will also facilitate the identification of service and personal factors 
associated with positive and negative outcomes (e.g., Dawson, Doll, Fitzpatrick, Jenkinson, 
& Carr, 2010). If factors associated with positive and negative outcomes of transgender 
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health services can be identified, patient-centred services can be created which provide extra 
support for patients who are vulnerable to poorer outcomes. Identification of these factors 
may also help to make the treatment process timely and more efficient for patients who are 
deemed not to be vulnerable. Patient-centred services are crucial in improving patient 
outcomes (e.g., Lauver et al., 2002). In addition, within nationalised social healthcare systems 
which are present in most European countries, access to care, including transgender 
healthcare, is free at the point of access for all citizens. However, these healthcare systems 
have limited resources and, at some point, rationing decisions may have to be made. Tools 
that predict which interventions are associated with good outcomes are vital to assist with 
making decisions regarding the allocation of healthcare resources and to explore how to 
improve overall patient outcomes. 
 
In the literature, there are few studies that have explored patient treatment outcomes after 
gender affirming interventions, such as cross-sex hormones and gender affirming genital 
surgery. On the whole, these studies have demonstrated that mental health and quality of life 
improve following gender affirming medical interventions (Davis & Meier 2014; De 
Cuypere, Elaut, Heylens, & Monstrey, 2006; Fisher et al., 2014; Gorin-Lazard et al., 2012; 
Heylens, Verroken, De Cock, T’Sjoen, & De Cuypere, 2014; Jones, Haycraft, Murjan, & 
Arcelus, 2016b; Lindqvist et al., 2016; Murad et al., 2010; Ruppin & Pfäfflin 2015; van de 
Grift et al., 2016c). The main focus of outcome evaluations at transgender health services has 
often been based around mental health symptoms (e.g., anxiety, depression) (e.g., Heylens et 
al., 2014; Murad et al., 2010). While mental health is evidently an important aspect to include 
within any outcome assessment of gender affirming medical interventions, given the high 
prevalence of mental health problems transgender people often experience before gender 
affirming medical interventions (Dhejne, Van Vlerken, Heylens, & Arcelus, 2016), it should 
not be the sole focus. Researchers have argued that improvements in mental health should not 
be the only focus of transgender health service evaluations, as mental health interventions are 
generally not provided by transgender health services (Arcelus & Bouman, 2015; Dhejne et 
al., 2016). Patient outcomes will also be biased by levels of mental health problems 
experienced before treatment. Moreover, the treatment pathways for transgender people 
consist of multidisciplinary treatment options, which further complicates the evaluation of 
these interventions.  
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One of the most important outcomes that should be measured after gender affirming medical 
interventions is a change in the distress and unhappiness a person experiences with their 
experienced gender and body as a result of their gender identity being at odds with their 
assigned gender (i.e., gender incongruence). Measurement of this outcome is often neglected 
due to the lack of available measures that have been developed with the transgender 
population and are capable of assessing a change in distress and unhappiness a person 
experiences with their gender and body. The few measures that are available to assess gender 
distress (such as the Utrecht Gender Dysphoria Scale; Cohen-Kettenis & van Goozen, 1997) 
and body dissatisfaction (such as the Hamburg Body Drawing Scale; Becker et al., 2016), 
although useful, are limited. These measures have been developed with the binary gender 
system in mind (i.e., male or female) which is problematic in light of an increasing number of 
people identifying as non-binary or outside the gender binary (Beek et al, 2015; Richards et 
al., 2016); also, participants are asked to complete different versions depending on the gender 
they were assigned at birth. Measures developed to assess treatment outcomes within the 
transgender population therefore need to ensure they encapsulate people with non-binary 
gender identities and be gender neutral (i.e., applicable to all genders). A gender neutral 
measure also allows clinicians to assess outcomes using the same tool throughout the medical 
transition.  
 
In addition, for outcome evaluations to be meaningful, the measures employed must have 
been developed for, and validated with, the population in question (Dawson et al., 2010). 
Currently, mental health and quality of life measures that are used to assess patient outcomes 
at transgender health services have often been developed for use with other specific (and 
dissimilar) populations (e.g., Eating Disorder Inventory-2; Garner, 1991) or the general 
population (e.g., Hospital Anxiety and Depression Scale; Zigmond & Snaith, 1983). 
Therefore, these measures are unlikely to be specific enough (i.e., unlikely to ask about 
mental health problems in relation to gender distress) to be used with the transgender 
population for meaningful evaluations. Due to the lack of a suitable, validated mental health 
and quality of life measure, transgender health services usually invite patients to complete a 
series of measures that assess different constructs relating to mental health and quality of life 
to ensure evaluations are comprehensive. Research has found respondent burden to be great 
when patients are asked to complete multiple questionnaires, especially when these 
questionnaires assess similar constructs (Rolstad, Adler, & Ryden, 2011; Turner et al., 2007). 
Respondent burden can affect the quality of data gathered and may reduce response rates 
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(Diehr, Chen, Patrick, Feng, & Yasui, 2005; Snyder et al., 2007). In light of this, treatment 
evaluations collected at transgender health services are likely to be of a poor quality as they 
might have been affected by respondent burden.  
 
9.2.1. Aims 
The objective of this study was to develop a self-report tool that was capable of assessing 
gender distress, gender congruence, associated mental well-being, and life satisfaction. Such 
a tool is imperative to ensure evaluations are mapped onto the most important aims of gender 
affirming medical treatment and to allow meaningful and efficient evaluations to take place at 
transgender health services. The tool that was developed in the current study has been named 
the Gender Congruence and Life Satisfaction Scale (GCLS). Details of the development of 
the GCLS will be provided in the method. Once the tool had been developed, the first aim of 
this study was to explore the factor structure of the GCLS. The second aim was to explore the 
convergent and discriminant validity of the GCLS (types of construct validity). The final aim 
was to determine whether the GCLS can distinguish between subgroups (i.e., transgender and 
cisgender people) and be sensitive to changes in gender distress, gender incongruence, 
associated mental well-being, and life satisfaction throughout the treatment process (known-
groups validity; a further type of construct validity). The final aim therefore also provides an 
opportunity to pilot the GCLS with transgender people and provide subscale norms.  
 
9.3. Method 
9.3.1. Participants and recruitment 
Two different groups of participants were involved in this study: transgender people and 
cisgender (non-trans) people.  
 
Part of the study sample comprised transgender people who were invited from a national 
transgender health service within the UK. This is a National Health Service (NHS) funded 
centre, which offers assessment and treatment to transgender people who are pursuing, or are 
considering, medical transition. The centre is one of the largest in Europe and receives around 
1000 referrals a year from England and Wales. This service accepts referrals from people 
aged 17 and over. Clinicians at the service informed participants of the existence of the study 
and provided them with the information sheet and details about how to participate.  
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Some transgender people and all of the cisgender participants were recruited through the 
community via snowball sampling. All transgender and cisgender people recruited through 
the community were required to be aged 18 or over. This was achieved by sharing an online 
link to the study with transgender support organisations (for transgender people only), via 
social media websites, and by email. The content of this advertisement was the same for 
transgender and cisgender people recruited through the community. Participants that took part 
in the online survey were then asked to pass the link on to others in their network.  
 
Recruitment took place over four months during 2016. A total of 458 transgender participants 
were invited. However from this sample, seven people were removed as they either had 
provided no information about their gender assigned at birth and gender identity (n=3) or had 
not indicated whether or not their gender assigned at birth and gender identity were the same 
(n=4). The final sample consisted of 451 transgender people. In addition, a total of 375 
cisgender participants were invited. Of these participants, 37 were removed as they reported a 
gender identity that was different from the gender they were assigned at birth. The final 
cisgender sample therefore consisted of 338 participants. The final sample size therefore 
included 789 participants (338 identified as cisgender (42.8%) and 451 as transgender 
(57.2%)). 
 
9.3.2. Procedure 
After participants had read through the information sheet and decided whether or not they 
would like to take part, they were invited to complete the first iteration of the newly 
developed tool (GCLS). Participants recruited from the transgender health service were either 
asked to complete a paper questionnaire pack in their own time and return this to the service 
in a prepaid envelope, or complete the online survey. Community participants were asked to 
complete the survey online. No paper alternative was offered. Informed consent was obtained 
from all participants prior to taking part in the study. 
 
The study was approved by an NHS research ethics committee and by the Research and 
Development Department of Nottinghamshire Healthcare NHS Foundation Trust 
(16/EM/0183) in line with Health Research Authority guidance (HRA, 2013), as well as 
Loughborough University Research Ethics Committee (see Appendix M).  
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9.3.3. Development of the Gender Congruence and Life Satisfaction Scale 
Several processes were undertaken to complete the development of the GCLS. First, 
systematic reviews of the available literature on treatment outcomes, including body 
dissatisfaction (see chapter 3; Jones et al., 2016b) and mental health were conducted (see 
Dhejne et al., 2016). This was followed by a review of existing body dissatisfaction measures 
that are currently used to assess patient outcomes at transgender health services (Jones et al., 
2016b). Next, in-depth interviews with 14 transgender people attending a national 
transgender health service in the UK were undertaken as part of a larger study (see chapter 6; 
Jones, Arcelus, Bouman, & Haycraft, 2017b). These interviews highlighted how distress and 
dissatisfaction with gender, associated mental well-being, and life satisfaction improved over 
the treatment process. The study provided valuable information regarding the most important 
objectives of transgender health services from the patients’ point of view. Following this, 
several discussions took place with clinicians from different transgender health services in the 
UK, Sweden and Belgium. All of the outlined processes and studies mentioned above 
informed the first draft of the GCLS. The items within this first draft were developed as a 
result of the authors reviewing other self-report measures relating to gender incongruence, 
gender distress, mental well-being (including body dissatisfaction), and life satisfaction used 
with the transgender and cisgender population. This promoted a discussion among the 
research team about some of the limitations of these measures (e.g., not transgender specific, 
developed within the binary gender system). Some of the limitations were identified through 
earlier phases of development (i.e., the review of existing measure used to assess body 
dissatisfaction). The team then worked together to develop a list of items whilst taking into 
consideration some of the limitations identified in the previous phase. To be a valid item it 
had to: 1) be related to gender incongruence, gender distress, mental well-being or life 
satisfaction; 2) assess this construct in relation to gender incongruence and/or gender distress 
(i.e., I have felt extremely distressed when looking at my genitals); 3) be gender neutral. This 
process resulted in 85 items being developed.  
 
The first draft of the GCLS was then discussed with the Nottingham Centre for Transgender 
Health Patient and Public Involvement (PPI) group. This PPI group consisted of 21 people 
who were attending, or had attended, the service and agreed to provide feedback for research 
projects taking place at the service. This consultation resulted in a revised draft of the GCLS. 
The authors also worked in consultation with transgender people in the community who were 
recruited through charities and support organisations for transgender and LGBT people 
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within the UK. This included asking people to comment on the tool and the items that 
comprised it. Feedback was collected which allowed the development of the next draft of the 
scale, which was shared with several clinicians and academics in the field, including clinical 
academics from outside the UK (Sweden and Belgium). Following feedback, several drafts 
were developed which were discussed with the above groups until a tool that satisfied 
everyone was created.  This process resulted in a tool with 42 items initially being created. 
 
9.3.4. Measures 
Socio-demographic questions: Information about participants’ age, their gender assigned at 
birth and gender identity was collected. Participants were invited to provide information (if 
applicable) about their gender transition, including the amount of time they spend living in 
their experienced gender in their daily lives (less than 50%, more than 50%, or 100% of the 
time). They were also asked whether they were using cross-sex hormones and/or blockers (if 
relevant) and whether they had undergone any gender affirming surgery (‘Yes’ or ‘No’ 
response style). On the online survey, these questions were only visible to individuals who 
indicated incongruence between their birth and experienced gender (i.e., these questions were 
not visible to cisgender participants). 
 
Gender Congruence and Life Satisfaction Scale (GCLS; Jones, Bouman, Haycraft, & Arcelus, 
2017): This 38-item scale aims to assess change and measure improvements in gender 
(in)congruence, related mental well-being, and life satisfaction throughout the process of 
undergoing gender affirming medical interventions. The scale is independent of gender 
assigned at birth and was developed to be relevant to people who identify as male, female, as 
well as those who identify outside the binary gender system (e.g., non-binary). The GCLS 
asks respondents to think about how they have felt over the last 6 months and to rate their 
responses on a 5-point Likert scale (always=1; never=5).. In the final (38 item) version of the 
scale, 11 items were reverse coded (i.e., never = 1; always = 5). A higher score indicates a 
greater gender congruence, greater gender-related well-being, and greater life satisfaction. 
In contrast, a lower score indicates lower gender congruence, poorer gender-related well-
being, and poorer general life satisfaction. 
 
Hamburg Body Drawing Scale (HBDS; Becker et al., 2016): This scale was originally 
developed by Appelt and Strauss (1988) for use with individuals with different forms of 
psychoendocrinological disorders and assesses satisfaction with 33 different body parts. 
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Becker et al. (2016) recently validated the scale with the transgender population and adapted 
it to include male and female specific subscales (Becker et al., 2016). There is also an item 
that assesses overall satisfaction with appearance. This was the only item used in the current 
study and the reason for including it was to assess the convergent validity of the GCLS (i.e., 
to determine whether two measures that theoretically should be related, are related). The male 
and female subscales were not used within the current study as they are not appropriate to use 
with non-binary transgender people. Participants are asked to rate their responses on a 5-point 
Likert scale (1 = very dissatisfied; 5 = very satisfied) and therefore a higher score indicates a 
higher level of body satisfaction. Becker et al. (2016) found the HBDS subscales to have 
good reliability in a transgender population (α=.62-.91). As it is not possible to conduct 
reliability analysis with just one item, this was not calculated in the current study.  
 
Transgender Congruence Scale (TCS; Kozee, Tylka, & Baurband, 2012): This measure has 
12 questions, of which nine correspond with ‘appearance congruence’ (e.g., ‘I do not feel that 
my appearance reflects my gender identity’; ‘I am generally comfortable with how others 
perceive my gender identity when they look at me’) and three relating to ‘gender identity 
acceptance’ (e.g., ‘I am not proud of my gender identity’). Mean scores are calculated for 
each subscale. A global score can also be calculated by finding the mean of all responses. In 
the current study, only the 9-item appearance congruence subscale was used to assess 
convergent validity. Responses are rated on a 5-point scale from 1 = strongly disagree to 5 = 
strongly agree. A higher score indicates a higher level of transgender congruence. This 
measure has been found to have good reliability (α=.93; Kozee et al., 2012) and in the current 
sample, the appearance congruence subscale had excellent reliability (α=.96).  
 
World Health Organisation Quality of Life-BREF (WHOQOL-BREF; Harper, 1998): The 
WHOQOL-BREF has 26 items which measures four domains: psychological, physical, 
relationships, and environment. There are also two items which are assessed separately that 
ask about overall quality of life and overall health. In the current study the psychological and 
relationships subscales were used as well as the item that assessed overall quality of life, so 
as to assess convergent validity. The questions are rated on a 5-point Likert scale (1 = very 
dissatisfied; 5 = very satisfied) and a higher score indicates a higher quality of life. The 
subscale scores are calculated using the mean and then multiplied by four. This is to make the 
scores from the WHOQOL-BREF comparable to the WHOQOL-100 (Harper, 1998), which 
is the longer original questionnaire. The WHOQOL-BREF has been found to have good to 
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excellent reliability and validity in the general population and in clinical populations (e.g., 
rehabilitation, primary care, mental health) across 23 countries (Skevington, Lofty, & 
O’Connell, 2004). In this study, the psychological (α=.89) and relationships (α=.76) 
subscales had very good reliability.  
 
Internet Gaming Disorder Scale-Short Form (IGDS; Pontes & Griffiths, 2015): This measure 
is a brief 9-item questionnaire that assesses internet gaming behaviour (e.g., ‘Do you 
systematically fail when trying to control or cease your gaming activity?’). Participants are 
asked to rate their responses on a 5-point Likert scale (1 = never; 5 = very often). Scores 
range from 9-45 and are calculated by summing all responses. A higher score indicates more 
problematic gaming behaviour. The measure has good reliability (α=.87) (Pontes & Griffiths, 
2015) and in this study had excellent reliability (α=.92). This measure was included within 
the current study to assess discriminant validity (i.e., to determine whether two measures are 
not related, as would theoretically be expected).  
 
9.3.5. Data analysis 
For the first aim of the study, principal component analysis was conducted with data from the 
transgender participants only to determine the factor structure of GCLS. For factor analysis, 
Comrey and Lee (1992) suggested that 300 participants is a good sample size and therefore 
the number of transgender participants (n=451) is considered adequate. For the second aim, 
convergent and discriminant validity testing was conducted. To assess convergent and 
discriminant validity, one-tailed Spearman’s Rho correlations (as the data were non-normally 
distributed) were conducted between the GCLS and the WHOQOL, HBDS, TCS and IGDS 
with the transgender participants only (n=451). As multiple comparisons were conducted, 
Bonferroni corrections were used (p.05 ÷ 13 = p.004). For the final aim, known-groups 
validity testing (another form of construct validity) was conducted. This analysis determines 
whether known-groups within the dataset, in this circumstance transgender people at different 
stages of their transition (i.e., cross-sex hormones vs. no cross-sex hormones) and cisgender 
people score in a theoretically expected way on the GCLS (e.g., transgender people score 
lower than cisgender people indicating a poorer outcome). Norm values were also generated 
for the GCLS subscales, global scale and clusters explored among the different groups. One-
tailed Mann-Whitney U tests were conducted for this aim as the data were non-normally 
distributed. The significance level was set at p<.05. 
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9.4. Results 
Descriptive statistics relating to the gender identities of the transgender people are displayed 
in Table 9.1. The mean age of all transgender participants was 36.94 (SD=15.46) and ranged 
from 17 to 77 years. Of the 451 transgender people, 189 (41.9%) had not undergone any 
gender affirming medical intervention, 145 (32.2%) had taken cross-sex hormone treatment 
only, 22 (4.9%) had taken cross-sex hormones and undergone mastectomy only, 92 (20.4%) 
had taken cross-sex hormone treatment and undergone genital surgery (+/- mastectomy) and 
3 (.7) had undergone genital surgery but were not taking cross-sex hormone treatment. The 
gender identities of these groups are displayed in Table 9.1. In the cisgender sample, 84 
(24.9%) were male and 254 female (75.1%). The mean age of the cisgender sample was 
36.52 (SD=12.23) and ranged from 19 to 70 years.  
 
Table 9.1. Gender identities of the transgender sample by stage of medical transition  
 Transgender 
female 
Transgender 
male 
Non-binary 
Whole transgender sample (n=451) (%) 171 (37.9) 147 (32.6) 133 (29.5) 
No GAMI group (n=189) (%) 45 (23.8) 46 (24.4) 98 (51.8) 
CHT only (n=145) (%) 78 (53.8) 50 (34.5) 17 (11.7) 
CHT and mastectomy only (n=22) (%) 0 17 (77.4) 5 (22.6) 
CHT and genital surgery (+/- mastectomy) 
(n=92) (%) 
47 (51.1) 33 (35.8) 12 (13.1) 
Genital surgery but no CHT (n=3) (%) 1 (33.3) 1 (33.3) 1 (33.3) 
Note: CHT (cross-sex hormone treatment; GAMI (gender affirming medical interventions) 
 
9.4.1. Aim 1: Factor structure of GCLS 
9.4.1.1. Preliminary analyses 
To explore the factor structure of the GCLS, principal component analysis was conducted. It 
was expected that the items on the GCLS would be related and so therefore oblique (direct 
oblimin criterion) rotation was employed. As preliminary analysis, multicollinearity and 
singularity were assessed. The determinant was above .00001 and therefore multicollinearity 
and singularity were not a cause for concern. Bartlett’s Test of Sphericity was also significant 
(p<.001) suggesting that correlations between variables were significantly different from zero 
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and therefore it was concluded that variables were adequately related to find clusters within 
the dataset.  
 
9.4.1.2. Exploratory factor analysis and item elimination 
Analysis to determine the number of factors to retain was conducted. Kaiser (1960) suggested 
that factors with an eigenvalue greater than one should be retained. Kaiser’s criteria is seen to 
be accurate when the sample size exceeds 250 (current sample n=451) and the average 
communality is equal or greater than .6 (.67 in the current study; Field, 2009). Seven factors 
with an eigenvalue greater than one were identified which explained 67.30% of the total 
variance. In contrast, the scree plot suggested five factors should be extracted (Cattell, 1966). 
Courtney and Gordon (2013) recommended that other statistical techniques (other than the 
eigenvalue and scree plot) should also be used to establish the number of factors to extract. 
Additional analysis was therefore conducted and Ruscio and Roche’s (2012) comparative 
data technique suggested seven factors should be retained, as did Velicer’s (1976) minimum 
average partial (MAP) test. Courtney and Gordon (2013) found Ruscio and Roche’s (2012) 
comparative data technique to have 87.14% accuracy and Velicer’s (1976) MAP test to have 
59.60% accuracy in determining the number of factors to retain. Based on these analyses, 
seven factors were explored.  
 
Item retention and elimination were subsequently considered in accordance with several 
criteria. Stevens (2002) suggested that for a sample size greater than 300 (current sample 
n=451), item loadings should be greater than .30 to be retained within a factor. All item 
loadings in the current study were above .30 and therefore all 42 items were retained at this 
stage. Next, the interpretability of items was explored by an expert panel working in the area 
of transgender health (n=8) and any items which were not found to theoretically or 
conceptually fit within the factor they had been placed were excluded. Based on this review, 
items 21, 27, 28 and 30 were excluded. When items cross-loaded simultaneously onto two (or 
more) factors with a difference of less than .10, the face validity of the item was considered. 
This applied to items 10, 19, 26 and 41. Items 10 (-.39), 26 (.42) and 41 (-.39) and were felt 
to conceptually fit better within the factors that they loaded highest with and therefore were 
retained within these factors. It was felt that item 19 did not conceptually fit within factor 1 
(the factor which the item loaded the highest, .41), however it also loaded highly onto factor 
3 (.38) and was felt to conceptually fit better within this factor (in comparison to factor 1). 
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Therefore item 19 was retained within factor 3. In total, four items were removed which 
resulted in the revised version of the GCLS comprising 38 items. 
 
9.4.1.3. Analysis of the remaining 38 items  
The remaining 38 items were then subjected to a second principle components analysis with 
oblique (direct oblimin criterion) rotation. Seven factors had an eigenvalue greater than one, 
which explained a large proportion of the overall variance (68.01%; see Table 9.2.). All item 
loadings were greater than .30 and all items conceptually and theoretically fitted within the 
factor that they had been placed. The only exception to this rule was item 19, which loaded 
highly onto factor 1 and factor 3 and was moved from factor 1 to 3 as it was felt to better 
conceptually fit within factor 3. Therefore 38 items were retained to comprise the final 
version of the GCLS.  
 
The first factor (10 items) included items that related to psychological functioning associated 
with gender (in)congruence and was labelled ‘psychological functioning’. The second factor 
(6 items) included questions that pertained to distress and incongruence relating to the 
genitals and therefore was named ‘genitalia’. The third factor (4 items) included questions 
that asked about the degree to which participants were satisfied with how others perceived 
their gender role and therefore these items were categorised as ‘social gender role 
recognition’. The fourth factor (4 items) asked participants about satisfaction with their 
physical and emotional relationships and therefore was named ‘physical and emotional 
intimacy’. The fifth factor (4 items) was labelled ‘chest’ as it included questions that asked 
about distress and incongruence with the chest. The sixth factor (3 items) included questions 
that were related to distress and incongruence experienced in relation to non-genital 
secondary sex characteristics (e.g., hair, voice) and therefore these questions were categorised 
as ‘other secondary sex characteristics’. The seventh factor (7 items) included questions that 
assessed general life satisfaction (not related to gender incongruence) and therefore was 
labelled ‘life satisfaction’. From reviewing these subscales, they appear to conceptually 
cluster into two overarching themes; one that directly assesses the degree of gender 
congruence (factors 2, 3, 5 and 6) and another that assesses gender-related mental well-being 
and general life satisfaction (factors 1, 4 and 7). The clusters can be used by calculating the 
mean scores for the involved items.  
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9.4.1.4. Internal consistency 
Internal consistency for each of the GCLS subscales and the global score (comprising all 38 
items) was calculated. All seven subscales were found to have good (>.7) internal consistency 
(Nunnally, 1978; see Table 9.2.) and the internal consistency for the global score was 
excellent (α=.95). 
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Table 9.2. Factor loadings, eigenvalues and percentage of variance each factor explains for the final 38 items of the GCLS (n=451) 
Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 
Factor 1-psychological functioning         
(2) I have not gone to school/college/work .79 .02 .01 .01 -.04 -.05 .09 
(6) I have been unable to leave the house .75 -.01 -.02 .02 .07 -.10 -.04 
(1) I have avoided social situations and/or social interactions .59 -.03 .02 .17 .13 -.15 -.05 
(4) I have suffered from anxiety .58 -.11 .16 .02 .12 -.04 -.14 
(13) I have thought about hurting myself or taking my own life .56 -.21 .04 -.01 .05 .01 -.26 
(11) I have not engaged in leisure activities .51 -.05 -.07 .19 .29 .00 -.15 
(8) I have thought about cutting or hurting my chest, genitals and/or surrounding areas .49 -.35 .06 -.07 .11 .07 -.08 
(9) I have felt that life is meaningless .47 -.17 .03 .12 .07 .01 -.37 
(12) I have suffered from low mood .46 -.12 .16 .08 .18 -.01 -.27 
(7) I have found it difficult to make friends .45 .03 -.02 .23 .02 -.14 -.32 
Factor 2-genitalia         
(29) I have felt that genital surgery will address the unhappiness I experience in relation to 
my gender 
.06 
-.83 -.10 .18 -.04 -.06 .16 
(22) I have felt unhappy about my genitalia since they do not match my gender identity -.04 -.82 .06 .07 .12 -.10 .03 
(33) I have felt extremely distressed when looking at my genitals .05 -.81 .03 .08 .16 -.03 .03 
(14) I have felt distressed when touching my genitals as they do not match my gender 
identity 
.11 
-.78 .09 .07 .12 -.01 .10 
(31) I have been unable to have a fulfilling life because of the distress relating to my 
genitalia 
.08 
-.69 .06 .20 .12 -.02 -.06 
(26) I have felt that my genitals do match with my gender identity# .18 .42 .10 .27 .06 .29 .34 
Factor 3-social gender role recognition         
(23) I have felt comfortable with how other people perceive my gender based on my 
physical appearance# 
-.11 
-.04 .82 -.03 .10 .07 -.04 
(16) I have felt comfortable with how others have perceived my gender# -.02 -.03 .79 -.01 .02 .06 -.04 
(20) I have felt satisfied with the pronouns that others use when talking about me# .02 .05 .79 .01 -.09 -.20 .08 
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Item  Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 
(19) I have found it distressing that others do not address me according to my gender 
identity† 
.41 .04 .39 -.09 .18 -.33 .21 
Factor 4-physical and emotional intimacy         
(37) I have felt satisfied with my sex life# -.19 -.25 .14 .76 -.02 -.08 .03 
(36) I have felt satisfied with my emotional relationship(s)# -.05 -.02 .03 .75 .00 -.06 -.26 
(5) I have not been able to be physically intimate with other people .15 -.26 -.08 .70 .07 -.01 .11 
(3) I have not been able to have emotional relationships with other people .32 -.01 -.07 .63 .08 -.07 -.06 
Factor 5-chest        
(34) I have felt satisfied with my chest# -.16 .08 .02 .05 .94 -.08 -.01 
(18) I have felt like my chest does not match my gender identity -.12 .01 .07 -.03 .92 -.11 .03 
(32) I have felt extremely distressed when looking at my chest .10 -.19 .01 -.06 .81 -.01 -.01 
(15) I have felt so distressed about my chest that I have not been able to have a fulfilling 
life 
.22 -.14 -.05 -.07 .76 .08 -.01 
Factor 6-other secondary sex characteristics         
(17) I have felt that my body hair conflicts with my gender identity, either because I have it 
and do not like it or because I would like to have it   
.01 -.03 .02 .09 .07 -.80 -.03 
(25) I have felt that my facial hair conflicts with my gender identity, either because I have it 
and do not like it or because I would like to have it 
.04 -.12 -.01 .01 .12 -.78 -.02 
(24) I have felt that my voice has affected the way other people have perceived my gender 
identity which has been distressing for me 
.28 -.01 .16 .06 .14 -.53 .19 
Factor 7-life satisfaction         
(39) I have not felt satisfied with my friends .11 .15 -.04 .07 .10 -.03 -.65 
(40) I have felt satisfied with the support I have received from other significant people# -.04 .20 .15 .31 .01 -.22 -.48 
(42) I have felt satisfied with life in general# .07 -.09 .30 .16 .09 .04 -.48 
(38) I have felt satisfied in my leisure activities and hobbies# .14 -.03 .14 .22 .21 .08 -.45 
(35) I have felt satisfied at school/college/work# .21 -.05 .24 .13 -.05 -.01 -.39 
(41) I have not felt satisfied with my health .30 .01 .14 -.12 .03 .05 -.39 
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Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 
(10) I have not enjoyed life .38 -.18 .15 .19 .08 .02 -.39 
Items removed for conceptual reasons        
(21) I have felt depressed when looking in the mirror as the body I have does not match my 
gender identity) 
.10 -.37 .06 -.01 .03 .54 -.11 
(27) I have felt that the way my body looks naked does not represent my gender identity -.06 -.46 .07 .05 .07 .50 -.03 
(28) I have felt distressed about my gender as my body does not match my gender identity .11 -.49 .10 -.03 .12 .40 -.01 
(30) I have felt that I do not need sex hormones to make me feel happy about my gender .10 -.26 -.43 .20 .26 .04 .05 
Eigenvalue 14.83 3.35 2.30 1.84 1.24 1.21 1.07 
Variance explained (%) 39.03 8.82 6.04 4.85 3.25 3.20 2.82 
Cronbach’s alpha  .93 .79 .77 .85 .92 .81 .83 
Notes: GCLS (Gender Congruence and Life Satisfaction Scale); # indicates reverse scored items (n=11); † item 19 was retained within factor 3 
(rather than factor 1) for conceptual reasons. 
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9.4.2. Aim 2: Convergent and discriminant validity  
In order to test the construct validity of the GCLS (i.e., the degree to which the GCLS 
measures what it claims to), Spearman’s Rho correlations were conducted between the GCLS 
and the WHOQOL, HBDS, TCS and IGDS with the transgender participants only (n=451). 
Construct validity comprises convergent and discriminant validity. For the GCLS to show 
convergent validity (i.e., to determine whether two measures that theoretically should be 
related, are related), it would be expected to have a moderate to high correlation with the 
WHOQOL, HBDS and TCS (Evans, 1996). As might be expected, the GCLS physical and 
emotional intimacy subscale had a strong significant association with the WHOQOL 
relationships subscale, as did the GCLS psychological subscale and the WHOQOL 
psychological subscale. Additionally, the GCLS chest, GCLS genitalia and GCLS other 
secondary sex characteristics subscales had a moderate to strong association with the HBDS 
overall satisfaction scale. The GCLS social gender role recognition, GCLS other secondary 
sex characteristics, GCLS chest and GCLS genitalia subscales also all had a moderate to 
strong significant association with the TCS appearance congruence subscale. The strongest 
significant association was found between the GCLS life satisfaction and the WHOQOL 
overall quality of life subscale. These results confirm the convergent validity of the GCLS 
(see Table 9.3.).  
 
Next, correlations were run to determine discriminant validity; that is, to test whether the 
GCLS and IGDS are unrelated (i.e., a weak correlation) as would theoretically be expected. 
Table 9.4. shows that the GCLS subscales and the IGDS are unrelated as the two measures 
are weakly associated with one another (e.g., below r=.39; Evans, 1996). This suggests that 
the GCLS has discriminant validity. It is likely that some of these correlations will have 
reached statistical significance due to the large sample size of the current study (Field, 2009). 
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Table 9.3. Spearman’s Rho correlation matrix between GCLS, HBDS, TCS and WHOQOL assessing convergent validity (n=451; transgender 
participants only) 
 1 2 3 4 5 6 7 8 9 10 11 12 
1 GCLS: psychological functioning -            
2 GCLS: genitalia   .52*** -           
3 GCLS: social gender role recognition  .51*** .26*** -          
4 GCLS: physical and emotional 
intimacy  
.60*** .50*** .30*** -         
5 GCLS: chest .61*** .55*** .49*** .41*** -        
6 GCLS: other secondary sex 
characteristics 
.50*** .48*** .48*** .42*** .54*** -       
7 GCLS: life satisfaction  .76*** .34*** .52*** .56*** .47*** .40*** -      
8 GCLS: global  .90*** .70*** .63*** .70*** .78*** .69*** .80*** -     
9 TCS: appearance congruence  .46*** .43*** .63*** .36*** .56*** .50*** .51*** .62*** -    
10 HBDS: overall satisfaction .58*** .42*** .46*** .44*** .56*** .54*** .56*** .67*** .62*** -   
11 WHOQOL: overall  .62*** .27*** .42*** .46*** .41*** .35*** .74*** .62*** .45*** .51*** -  
12 WHOQOL: psychological  .66*** .41*** .44*** .51*** .51*** .41*** .74*** .71*** .54*** .63*** .73*** - 
13 WHOQOL: relationships .44*** .34*** .23*** .73*** .27*** .34*** .58*** .54*** .32*** .39*** .52*** .53*** 
Note: GCLS (Gender Congruence and Life Satisfaction Scale); TCS (Transgender Congruence Scale); WHOQOL-BREF (WHO Quality of Life-
BREF); HBDS (Hamburg Body Drawing Scale);  
*p <.05, **p <.01, ***p <.001 (corrected for multiple comparisons)
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Table 9.4. One-tailed Spearman’s Rho correlations between the GCLS and the IGDS to 
assess discriminant validity (n=451; transgender participants only) 
GCLS subscales IGDS 
Psychological functioning -.27*** 
Genitalia   -.10** 
Social gender role recognition  -.19*** 
Physical and emotional intimacy  -.16*** 
Chest -.14*** 
Other secondary sex characteristics  -.08 
Life satisfaction  -.28*** 
Global  -.24*** 
Note: GCLS (Gender Congruence and Life Satisfaction Scale); IGDS (Internet Gaming 
Disorder Scale) 
*p <.05, **p <.01, ***p <.001 
 
9.4.3. Aim 3: Known-groups’ validity  
To determine whether the GCLS is capable of distinguishing between subgroups (e.g., 
cisgender people and transgender people who have had no gender affirming medical 
intervention) and to determine whether groups score in a theoretically expected way (e.g., 
people who have undergone gender affirming medical treatments will be expected to score 
higher than people who have not undergone gender affirming medical treatments on all 
subscales of the GCLS) known-groups validity (a further type of construct validity) was 
conducted using Mann-Whitney U tests (Hattie & Cooksey, 1984). Known-groups testing has 
previously been used to assess the construct validity of self-report measures (e.g., Alvarenga, 
Scagliusi, & Philippi, 2010). In the current study, some of these analyses were conducted 
between known-groups within the transgender sample, and some between transgender and 
cisgender participants. These analyses are not exhaustive but provide subscale and cluster 
norms for the different groups explored.  
 
Initially, responses on the GCLS for transgender participants who had not undergone any 
gender affirming medical treatment (n=189) and cisgender people (n=338) were compared. It 
was found that the cisgender participants scored significantly higher (indicating a more 
positive outcome) on all GCLS subscales and the global scale than transgender people who 
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had not undergone any gender affirming medical interventions (see Table 9.5.). Responses 
between the two groups were also compared on the GCLS clusters previously identified. It 
was found that cisgender people scored significantly higher (indicative of a more positive 
outcome) than transgender people who were yet to undergo gender affirming medical 
interventions on the gender congruence cluster and the gender-related mental well-being and 
life satisfaction cluster (see Table 9.5.). All effect sizes for the comparative analysis were 
large (Field, 2009).  
 
Table 9.5. Mean, standard deviation and Mann-Whitney U test scores for transgender people 
who have undergone no GAMI (n=189) vs. cisgender people (n=338) on the GCLS 
 No GAMI 
group 
Cisgender 
group 
Mann-Whitney U 
Mean(SD) Mean(SD) U z Effect 
size 
p 
Psychological functioning 3.36 (1.01) 4.84 (.41) 3830.50 -17.96 .78 .001 
Genitalia   3.22 (1.04) 4.54 (.33) 7063.50 -15.56 .68 .001 
Social gender role 
recognition  
2.73 (.83) 4.03 (1.07) 11650.00 -12.21 .53 .001 
Physical and emotional 
intimacy  
2.98 (1.07) 4.26 (.61) 10492.00 -12.85 .56 .001 
Chest 2.57 (1.17) 4.60 (.50) 3835.00 -16.99 .74 .001 
Other secondary sex 
characteristics  
2.55 (1.25) 4.79 (.47) 3811.00 -18.03 .79 .001 
Life satisfaction  3.06 (.77) 3.90 (.61) 12609.50 -11.55 .50 .001 
Global GCLS 3.03 (.78) 4.45 (.31) 2398.50 -17.62 .77 .001 
Cluster 1: gender 
congruence  
2.83 (.84) 4.48 (.37) 2228.00 -17.74 .77 .001 
Cluster 2: gender-related 
mental well-being and 
life satisfaction  
3.18 (.84) 4.41 (.40) 5850.50 -15.57 .68 .001 
Note: GCLS (Gender Congruence and Life Satisfaction Scale); GAMI (gender affirming 
medical intervention) 
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Next, a Mann-Whitney U test was conducted to compare responses on the GCLS between 
transgender males who had not undergone any gender affirming medical intervention (n=46) 
and transgender males who had taken cross-sex hormone treatment and undergone 
mastectomy (but not genital surgery; n=17). Within the UK (which is where these data were 
collected) mastectomy is funded by the NHS. However, breast augmentation is not, hence 
these analyses were only conducted in relation to transgender males. The analyses 
demonstrated that transgender males who had taken cross-sex hormones and undergone a 
mastectomy scored significantly higher (more positive outcome) on the psychological 
functioning, social gender role recognition, chest, other secondary sex characteristics, and life 
satisfaction subscales of the GCLS as well as the global scale, than transgender males who 
had not undergone any gender affirming medial intervention (see Table 9.6.). No significant 
differences were found between the two groups on the genitalia and physical and emotional 
intimacy subscales of the GCLS. The two groups were also compared on the GCLS clusters 
and it was found that transgender males who had taken cross-sex hormones and undergone a 
mastectomy scored significantly higher (more positive outcome) on the gender congruence 
cluster and the gender-related mental well-being and life satisfaction cluster than transgender 
males who had not undergone any gender affirming medical interventions (see Table 9.6.). 
Effect sizes for the comparative analysis were large (social gender role recognition; chest; 
other secondary sex characteristics; global scale; and cluster one), medium (psychological 
functioning; cluster two) and small (genitalia; physical and emotional intimacy; life 
satisfaction) (Field, 2009). 
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Table 9.6. Mean, standard deviation and Mann-Whitney U test scores for transgender males 
who have undergone no GAMI (n=46) vs. transgender males who are taking CHT and have 
undergone mastectomy (n=17) on the GCLS 
 Transgender 
males: no 
GAMI 
Transgender 
males: CHT 
and 
mastectomy 
Mann-Whitney U 
Mean (SD) Mean(SD) U z Effect 
size 
p 
Psychological 
functioning 
2.82 (.79) 3.64 (.70) 180.00 -3.27 .41 .001 
Genitalia   2.49 (.93) 2.79 (.95) 306.50 -1.31 .17 .098 
Social gender role 
recognition  
2.63 (.76) 3.76 (1.01) 110.00 -4.37 .55 .001 
Physical and emotional 
intimacy  
2.64 (1.04) 3.08 (1.02) 301.00 -1.40 .18 .083 
Chest 1.54 (.66) 4.24 (1.14) 35.50 -5.58 .70 .001 
Other secondary sex 
characteristics  
1.91 (.91) 3.63 (1.29) 83.00 -4.80 .60 .001 
Life satisfaction  2.90 (.64) 3.39 (.71) 245.00 -2.27 .29 .001 
Global GCLS 2.54 (.57) 3.48 (.60) 95.50 -4.58 .58 .001 
Cluster 1: gender 
congruence 
2.20 (.55) 3.51 (.76) 66.00 -5.04 .63 .001 
Cluster 2: gender-related 
mental well-being and 
life satisfaction  
2.81 (.68) 3.45 (.66) 210.50 -2.80 .35 .002 
Note: GCLS (Gender Congruence and Life Satisfaction Scale); CHT (cross-sex hormone 
treatment); GAMI (gender affirming medical intervention) 
 
Finally, a Mann-Whitney U test was conducted between responses on the GCLS for 
transgender participants who were yet to undergo any gender affirming medical intervention 
(n=189) and people who had taken cross-sex hormone treatment and undergone genital 
surgery (+/- mastectomy; n=92).  People who had taken cross-sex hormone treatment and 
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undergone genital surgery (+/- mastectomy) scored significantly higher (more positive 
outcome) on all GCLS subscales and the global scale compared to people who had not 
undergone any gender affirming medical interventions (see Table 9.7.). The groups were also 
compared on the two clusters and it was found that transgender people who had taken cross-
sex hormone treatment and undergone genital surgery (+/- mastectomy) scored significantly 
higher (more positive outcome) on the gender congruence cluster and the gender-related 
mental well-being and life satisfaction cluster than people who had not undergone any gender 
affirming medical intervention (see Table 9.7.). Effect sizes for the comparative analysis 
were large (social gender role recognition; chest; cluster one), medium (psychological 
functioning; other secondary sex characteristics; life satisfaction; global scale; cluster two) 
and small (genitalia; physical and emotional intimacy) (Field, 2009). 
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Table 9.7. Mean, standard deviation and Mann-Whitney U test scores for transgender people 
who have not undergone any GAMI (n=189) vs. transgender people who have taken CHT 
and undergone genital surgery (+/- mastectomy; n=92) on the GCLS  
 No GAMI 
group  
CHT and 
genital 
surgery (+/-
mastectomy) 
Mann-Whitney U 
Mean (SD) Mean (SD) U z Effect 
size 
p 
Psychological 
functioning 
3.36 (1.01) 4.15 (.72) 4687.50 -6.27 .37 .001 
Genitalia   3.22 (1.04) 3.81 (.92) 5858.00 -4.33 .26 .001 
Social gender role 
recognition  
2.73 (.83) 3.93 (.73) 2523.50 -9.68 .58 .001 
Physical and 
emotional 
intimacy  
2.98 (1.07) 3.36 (1.14) 6923.50 -2.65 .16 .001 
Chest 2.57 (1.17) 4.27 (.89) 2174.50 -10.15 .61 .001 
Other secondary sex 
characteristics  
2.55 (1.25) 3.65 (1.10) 4484.00 -6.61 .39 .001 
Life satisfaction  3.06 (.77) 3.72 (.72) 4537.00 -6.51 .39 .001 
Global GCLS 3.03 (.78) 3.88 (.60) 3461.50 -8.19 .49 .001 
Cluster 1: gender 
congruence 
2.83 (.84) 3.92 (.61) 2761.00 -9.28 .55 .001 
Cluster 2: gender-
related mental 
well-being and life 
satisfaction  
3.18 (.84) 3.86 (.70) 4755.00 -6.16 .37 .001 
Note: GCLS (Gender Congruence and Life Satisfaction Scale); CHT (cross-sex hormone 
treatment); GAMI (gender affirming medical intervention) 
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9.4.4. Summary of analysis  
Factor analysis on items of the GCLS supported a 7-factor solution with 38 items retained in 
total. The seven subscales are: psychological functioning; genitalia; social gender role 
recognition; physical and emotional intimacy; chest; other secondary sex characteristics; and 
life satisfaction. The subscales can be categorised into two clusters; 1) gender congruence 
(genitalia, chest, other secondary sex characteristics and social gender role recognition), and 
2) gender-related mental well-being and general life satisfaction (physical and emotional 
intimacy, psychological functioning and life satisfaction). A higher score indicates a greater 
gender congruence, greater gender-related well-being, and greater life satisfaction. The 
GCLS subscales and the global scale have undergone vigorous testing and have demonstrated 
good reliability and validity. Subscale, global scale and cluster norms for transgender people 
at different stages of medical transition, as well as cisgender people have been generated. The 
known-groups’ analysis also demonstrated that the measure is capable of discriminating 
between groups of interest (e.g., people who have and have not undergone gender affirming 
medical interventions) and highlights how gender incongruence, gender-related mental well-
being and general life satisfaction improve over the course of the medical transition. It can 
therefore be concluded that the GCLS is a suitable tool to use with the transgender population 
to measure gender congruence and life satisfaction, and - in particular - improvements in 
these that are likely to occur during the treatment process. 
 
9.5. Discussion 
The main aim of this study was to develop and evaluate a new transgender health outcome 
measure: the Gender Congruence and Life Satisfaction Scale (GCLS) which is capable of 
measuring changes in gender congruence and life satisfaction over the course of gender 
affirming medical interventions. The GCLS is the first transgender health outcome measure 
that can simultaneously assess gender congruence, gender distress, associated mental well-
being and general life satisfaction, and can do so independently of gender assigned at birth 
and gender identity. This study confirmed that the GCLS is a valid and reliable measure to 
use with the transgender population and is capable of producing high quality outcome data 
for clinical and research purposes.  
 
Having a brief, self-report questionnaire that is capable of assessing transgender health 
outcomes is important in order to measure the quality of care that is offered at transgender 
health services (Dawson et al., 2010), to enable transgender patients to be followed-up over 
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time (both before and after gender affirming medical interventions), and to determine what 
transgender healthcare needs people require. The latter may help with financial planning and 
future workforce and service development in the field of transgender healthcare.  
 
The GCLS was developed in collaboration with the transgender population and healthcare 
professionals working in the field of transgender health. This has ensured that the GCLS is a 
meaningful and relevant measure for people attending transgender health services. Factor 
analysis suggested the retention of 38 items, which comprise seven subscales (psychological 
functioning, genitalia, social gender role recognition, physical and emotional intimacy, chest, 
other secondary sex characteristics, and life satisfaction) that are clustered into two themes: 
1) gender congruence, 2) gender-related mental well-being and general life satisfaction. The 
two clusters have clinical relevance and applicability as some transgender people may or may 
not experience mental health problems in association with the distress and unhappiness they 
experience with their gender (e.g., Dhejne et al., 2016). The existence of two separate clusters 
therefore allows these factors to be considered separately. In addition, the outcome of 
transgender health services can be divided into short term and long term outcomes. Short-
term outcomes refer to changes in the symptomatology that the individual presents to the 
service with (i.e., gender incongruence and gender dysphoria) and may be achieved in a 
relatively short time (e.g., chest incongruence decreases following mastectomy). Long-term 
outcomes relate to improvements in life satisfaction, quality of life and psychological well-
being. Long-term outcomes may take significantly longer to achieve. This two-cluster based 
tool (GCLS) allows for the measurement of short term and long term outcomes to be assessed 
separately. Being able to review the scores on these two clusters will allow clinicians and 
healthcare professionals to deliver a patient-centred service. The delivery of patient-centred 
interventions is crucial to improve patient outcomes (e.g., Lauver et al., 2002). The mean 
scores given for each subscale, the global score and cluster of the GCLS for transgender 
people at different stages of medical transition within the current study can be used as norms. 
Subscale and cluster norms have also been provided for cisgender people; a sample who may 
provide a useful reference point for both future clinical and research purposes.  
 
It is expected that the GCLS will not only be a useful clinical tool but will also aid research in 
the field of transgender health. As part of the validation process, the GCLS has already 
demonstrated that it can distinguish between subgroups of transgender individuals who are at 
different stages of medical transition, which makes it a suitable research tool. The current 
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study found that transgender people who had not undergone any gender affirming medical 
interventions reported worse outcomes on all GCLS subscales, the global scale and two 
clusters than both cisgender people and transgender people who had taken cross-sex hormone 
treatment and undergone genital surgery (+/- mastectomy). These findings support previous 
research that has shown patients to report less distress with their gender, lower levels of body 
dissatisfaction, better mental well-being, and greater life satisfaction after they had undergone 
gender affirming surgery (De Cuypere et al., 2005; De Cuypere et al., 2006; Lindqvist et al., 
2016; Ruppin & Pfäfflin, 2015; van de Grift, Elaut, Cerwenka, Cohen-Kettenis, & Kreukels, 
2017b). 
 
This study also found that transgender males who had not undergone any gender affirming 
medical intervention reported worse outcomes on the chest, other secondary sex 
characteristics, social gender role recognition, psychological functioning, and life satisfaction 
subscales of the GCLS, as well as the global scale and the two clusters, than transgender 
males who had taken cross-sex hormone treatment and undergone mastectomy. There was no 
significant difference between the two groups on the genitalia and physical and emotional 
intimacy subscales of the GCLS. This finding supports previous research which has found 
dissatisfaction and distress with the genitalia to be increasingly prevalent after mastectomy in 
treatment-seeking transgender men (van de Grift et al., 2016c). Research with cisgender 
populations has found body dissatisfaction (Woertman & van den Brink, 2012), as well as 
specific genital dissatisfaction (Schick, Calabrese, Rima, & Zucker, 2010), to affect sexual 
satisfaction and therefore the high levels of dissatisfaction and distress experienced in relation 
to the genitalia in transgender men in the current study (before genital surgery) is likely to 
impact on their physical relationships.   
 
The analysis we conducted with known-groups demonstrates the sensitivity of the GCLS and 
its ability to distinguish between outcomes at different stages of medical transition (i.e., chest 
distress dissipates after mastectomy). Having a validated tool that is capable of having this 
level of sensitivity will be extremely useful in advancing research in transgender health. For 
instance, when the length of time a person has been on cross-sex hormone treatment is 
known, longitudinal research may be able to identify a time frame in which long term 
outcomes, such as psychological functioning and life satisfaction, improve. Establishing this 
in different subgroups (e.g., non-binary people) is also important. The GCLS has been 
developed independent of gender assigned at birth and gender identity and therefore would be 
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an appropriate measure to use with non-binary transgender people. Research with this 
population is in its infancy, but suggests poorer mental health than binary transgender people 
(Rimes, Goodship, Ussher, Baker, & West, 2017; Warren, Smalley, & Barefoot, 2016). Some 
of the subscales from the GCLS can also be used to advance knowledge concerning factors 
that predict good outcomes in transgender people, for example, factors that predict life 
satisfaction. Establishing factors that predict a good outcome among non-binary transgender 
people is also essential as the factors are likely to differ to what is seen among transgender 
people who identify within the binary gender system.  
 
The GCLS is the first transgender health outcome measure to be developed and validated 
with the transgender population and is capable of assessing important treatment outcomes. 
However, there are some limitations. First, the GCLS is only validated in an English speaking 
adult population. Future research should focus on validating the GCLS in other languages and 
other age groups (e.g., children and adolescents). Second, although gender incongruence, 
related mental well-being, and life satisfaction were all found to improve over the course of 
gender affirming medical interventions in the current study, it must be considered that these 
conclusions are based on cross-sectional data. In addition to this, data were not collected in 
relation to whether or not participants were accessing transgender health services (i.e., were 
treatment seeking) or the length of time on cross-sex hormone treatment. To further explore 
the short and long term outcomes of gender affirming medical interventions, longitudinal 
research that uses the GCLS in treatment seeking transgender people needs to be conducted. 
As this study provided no statistical evidence to support the two clusters (which represent 
short and long term outcomes), future longitudinal research employing the GCLS should 
determine (statistically) whether distinct patterns of change are present to support these 
clusters. The gender of the cisgender participants within this study was also skewed (i.e., the 
majority were female). Future research should look to employ the GCLS with a larger sample 
of cisgender males to compare scores with transgender males. Contrary to expectations, some 
subscales of the GCLS significantly correlated with the IGDS. This is likely to be due to the 
large sample size in the current study (Field, 2009) however, this finding may warrant further 
research into gaming behaviour of transgender people.  
 
9.5.1. Conclusion  
In conclusion, the findings from this study suggest that the GCLS is a suitable and robust 
measure to assess treatment outcomes in relation to gender congruence, related mental well-
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being, and life satisfaction within the transgender population in both a clinical and research 
capacity. Having a measure that is capable of assessing these outcomes will allow for the 
quality of gender affirming medical interventions to be improved within transgender health 
services, and thus will improve the quality of life of transgender people and their families.  
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Chapter 10 
General discussion 
10.1. Introduction 
In this closing chapter, the initial aims of the thesis and the gaps identified by the systematic 
reviews (chapters 2 and 3) will be recapped. The empirical aims of this thesis will then be 
restated followed by a summary of the findings from these chapters (chapters 6 to 9). The 
implications that the findings of the research within this thesis have in relation to 
understanding physical (in)activity, body (dis)satisfaction and mental health within the 
transgender population will then be considered. This will be followed by a discussion of the 
implications, strengths, limitations and future directions for research. The chapter will close 
with a conclusion of the findings from this research reported on in this thesis.  
 
10.2. Recap of the aims of the thesis 
10.2.1. Initial aims and gaps within the literature 
The overarching aim of this thesis was to further our understanding around physical 
(in)activity, experiences of body (dis)satisfaction and mental health in transgender people. An 
increasing number of transgender people are presenting to transgender health services across 
Europe and North America (Aitken et al., 2015; Arcelus, Bouman, Witcomb, Van De 
Noortgare, Claes, & Fernandez-Aranda, 2015; de Vries, Kreukels, T’Sjoen, Ålgars, & Mattila, 
2015) or self-identifying as transgender without necessarily presenting to transgender health 
services (Kuyper & Wijsen, 2014). As the prevalence of transgender people increases, the 
challenges that this population face regarding physical (in)activity, body dissatisfaction (and 
associated vulnerability to eating disorder psychopathology), and poor mental health will 
undoubtedly become more pronounced within society. This is concerning as research has 
identified that transgender people have difficulties accessing healthcare, whether this be 
related to gender incongruence or general health (Winter et al., 2016). Consequently, there is 
a real need to understand how to improve the well-being of transgender people. A recent 
systematic review on mental health within the transgender population identified that when 
first assessed at a transgender health service, transgender people have poorer mental health 
than cisgender people (Dhejne, Vlerken, Heylens, & Arcelus, 2016). Following gender 
affirming medical interventions, poor mental health was found to dissipate to levels found 
within the cisgender population (Dhejne et al., 2016). However, there had been no systematic 
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reviews that had investigated physical activity and sport or body dissatisfaction and eating 
disorder symptoms. To address this gap, the initial aim of this thesis was to conduct two 
systematic reviews with the goal of synthesising the literature concerned with physical 
activity and sport in the transgender population (chapter 2), and the literature concerned with 
body dissatisfaction and disordered eating within the transgender population (chapter 3).  
 
10.2.2. Summary of the findings from chapter 2 
Chapter 2 concluded that many transgender people have a negative experience when 
engaging (or attempting to engage) in physical activity and sport (Jones, Arcelus, Bouman, & 
Haycraft, 2017a). This is problematic as physical activity and sport engagement within the 
cisgender population has been associated with a decrease in body dissatisfaction (i.e., an 
increase in body satisfaction) and with better mental health (e.g., Carter, Morres, Meade, & 
Callaghan, 2016; Cox, Ullrich-French, Howe, & Cole, 2017; Herring, Jacob, Suvey, & 
O’Conner, 2011; Kruger, Lee, Ainsworth, & Macera, 2008; Lantz, Hardy, & Ainsworth, 
1997; McMahon et al., 2017; Rebar et al., 2016). This might therefore also be the case within 
the transgender population. However, chapter 2 found there to be a lack of qualitative 
research that has explored the experiences that transgender people have in relation to physical 
activity and recreational sport participation or engagement for leisure and fitness (Jones et al., 
2017a). This is a significant omission as the majority of transgender people will not engage in 
sport at an elite level (i.e., they will not be professional athletes) and so these recreational 
sport/activity experiences are particularly worthy of study. In addition, previous research has 
not considered the role of gender affirming medical interventions in physical activity and 
sport engagement. This is important as medically transitioning has been associated with body 
satisfaction and, consequently, better mental health (e.g., Costa & Colizzi, 2016; Fisher et al., 
2014; Gorin-Lazard et al., 2013; Heylens, Verroken, De Cock, T’Sjoen, & De Cuypere, 
2014). Greater body satisfaction and mental well-being within the cisgender population have 
been associated with greater physical activity and sport engagement (e.g., Carter et al., 2016; 
Cox et al., 2017; Kruger et al., 2008; McMahon et al., 2017). The systematic review in 
chapter 2 also identified a lack of quantitative (and therefore more easily generalisable) 
research which has considered the amount of physical activity and sport that transgender 
people engage in, or the predictive factors associated with (in)activity (Jones et al., 2017a). 
There is also a lack of research that has considered the physical activity levels of transgender 
people compared to the cisgender population. This is important in order to determine whether 
there is an inequality in accessing physical activity and sport between transgender and 
Chapter 10: General discussion  
205 
 
   
cisgender people. The gaps identified in chapter 2 informed the empirical research reported 
on in this thesis as such research is likely to be important for the development of initiatives 
that aim to increase physical activity and sport engagement and which might benefit the well-
being of the transgender population. 
 
10.2.3. Summary of the findings from chapter 3 
From the evidence synthesised and presented in chapter 3, it was clear that there is a need to 
alleviate body dissatisfaction experienced by transgender people as body dissatisfaction 
makes this population vulnerable to eating disorder psychopathology (Jones, Haycraft, 
Murjan, & Arcelus, 2016b). Research within the cisgender population has found eating 
disorder psychopathology to be multifactorial (e.g., Polivy & Herman, 2002) yet there was no 
research that had explored whether this is the case within the transgender population. Factors 
such as body dissatisfaction (e.g., Keel, Fulkerson, & Leon, 1997; Stice & Shaw, 2002), high 
levels of perfectionism (e.g., Egan, Wade, & Shafran, 2011; Tchanturia, Larsson, & Adamson, 
2016), the existence of interpersonal problems (e.g., Arcelus, Haslam, Farrow, & Meyer, 
2013), low self-esteem (Dakanalis et al., 2016), and symptoms of anxiety and depression (e.g., 
Brechan & Kvalem, 2015; DeBoer & Smits, 2013; Fairburn, Cooper, & Shafran, 2003; 
Harrison, Sullivan, Tchanturia, & Treasure, 2009; Puccio et al., 2017) have all been 
associated with eating disorder psychopathology within the cisgender population. Many of 
the psychological factors found to be associated with eating disorder psychopathology within 
the cisgender population are also prominent among transgender people and therefore may be 
able to explain eating disorder symptoms within this population. Experiencing body 
dissatisfaction, symptoms of anxiety and depression, high levels of perfectionism and 
experiencing interpersonal problems have all been found to be prominent among transgender 
people (e.g., Davey, Bouman, Meyer, & Arcelus, 2015; Dhejne et al., 2016; Khoosal, 
Langham, Palmer, Terry, & Minajagi, 2009). In addition to this, and unique to the 
transgender population, is the role of gender affirming medical interventions in eating 
disorder symptoms. One study found gender affirming surgery to alleviate eating disorder 
symptoms (Khoosal et al., 2009). However, this study had a very small sample size and was 
only concerned with transgender females (Khoosal et al., 2009). Additionally, chapter 3 
identified that there is currently no research that has explored the potential role of cross-sex 
hormones in eating disorder symptoms. Cross-sex hormones have been found to alleviate 
body dissatisfaction (i.e., improve body satisfaction; e.g., Fisher et al., 2014). Therefore it 
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was hypothesised that cross-sex hormones may potentially be capable of alleviating eating 
disorder symptoms in the transgender population.  
 
To understand whether gender affirming medical interventions (i.e., cross-sex hormones and 
gender affirming surgery) aimed at improving the well-being of transgender people 
(including body dissatisfaction) have been beneficial, they need to be evaluated. Chapter 3 
identified that there was currently a lack of appropriate tools to complete reliable evaluations 
of gender affirming medical interventions; hence the lack of research that has explored body 
dissatisfaction and eating disorder psychopathology as outcomes. In addition to this, Dhejne 
et al. (2016) identified that there had been a variety of different measures used to assess 
mental well-being and called for the development of a more robust measure that is capable of 
assessing mental well-being in relation to gender incongruence. These identified gaps in the 
literature informed the empirical aims of the thesis. 
 
10.2.4. Empirical aims of the thesis 
Following on from the systematic reviews and gaps highlighted in the literature, seven 
specific empirical aims of this thesis were identified. These were initially presented in section 
4.5. and are outlined again, below.  
 
1. To qualitatively understand the experiences that treatment seeking transgender people 
have when engaging (or attempting to engage) in physical activity and/or recreational 
sport for leisure and fitness (chapter 6; study 1). 
2. To establish the amount of physical activity that treatment seeking transgender people 
engage in (chapter 7; study 2).  
3. To establish the role of cross-sex hormones on physical activity levels in treatment 
seeking transgender people (chapter 7; study 2).  
4. To quantitatively identify factors that are associated with physical activity in 
treatment seeking transgender people (chapter 7; study 2). 
5. To establish why transgender people are vulnerable to disordered eating by exploring 
which factors are associated with eating disorder symptoms in treatment seeking 
transgender people (chapter 8; study 3). 
6. To better understand the alleviating effects that cross-sex hormones might have on 
eating disorder symptoms in treatment seeking transgender people (chapter 8; study 3). 
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7. To develop and validate a new transgender health outcome measure that is capable of 
assessing gender distress, gender congruence, associated mental well-being, and life 
satisfaction for use in research and clinical settings (chapter 9; study 4). 
 
10.3. Summary of the findings from the empirical studies  
A summary of the findings of the research presented in this thesis will be presented below, 
chapter by chapter. Figure 10.1. presents an overview of the main research questions, 
different factors explored, and the key research findings.  
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Gender Incongruence 
& Distress
The amount of 
physical activity and 
sport (study 2)
Factors associated 
with physical activity 
and sport (studies 1 & 
2)
The role of gender 
confirming medical 
interventions in 
physical activity 
(studies 1 & 2) 
The  role of cross-sex 
hormones in eating 
disorder 
psychopathology 
(study 3) 
Body dissatisfaction 
Poor mental health 
Eating disorder psychopathology
 Body dissatisfaction, 
perfectionism, self-esteem and 
anxiety are all risk factors for 
eating disorder 
psychopathology
Taking cross-sex hormones 
alleviates factors associated with 
eating disorder psychopathology 
Taking cross-sex hormones 
reduces eating disorder 
psychopathology 
Taking cross-sex hormones 
increases physical activity 
Variety of external and 
internal barriers experienced
Motivated to be physically 
active
Levels are low in comparison 
to cisgender people 
Benefits of physical activity and 
sport
Are physical activity & 
sport engaged in by 
transgender people? 
Why are transgender 
people vulnerable to 
eating disorder 
psychopathology? 
GCLS is a reliable and valid 
self-report measure to use in a 
clinical and research capacity
Poor specificity
Can the specificity of 
self-report measures be 
increased? 
Self-report measurement 
Main research 
questions Factors investigated Findings
Explore factors 
associated with  
eating disorder 
psychopathology 
(study 3)
To develop a new 
measure (study 4)
To validate a new 
measure (study 4)  
Figure 10.1. Main research questions, factors investigated, and findings of the thesis  
GCLS: Gender Congruence and Life Satisfaction Scale 
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10.3.1. Chapter 6 (study 1): Barriers and facilitators of physical activity and sport 
participation among young transgender adults who are medically transitioning 
There is a dearth of qualitative research that has considered the experiences that treatment 
seeking transgender people have when engaging in physical activity and recreational sport 
(see sections 1.7.5.2. and 10.2.2.). Therefore, study 1 aimed to explore the experiences that 
young treatment seeking transgender adults have when engaging in physical activity and 
recreational sport. This study was concerned with exploring the experiences of young 
treatment seeking transgender people because research with the cisgender population has 
shown older people to engage in less physical activity and sport compared to younger people 
(e.g., British Heart Foundation, 2015).  
 
Overall, the findings of study 1 support and extend previous research that has found 
transgender people to have a negative experience when engaging in physical activity and 
sport (e.g., Hargie, Mitchell, & Somerville, 2017; Jones et al., 2017a; see chapter 2). The 
young people in this study reported both internal (e.g., body dissatisfaction) and external (e.g., 
changing facilities) barriers to physical activity and recreational sport. Despite all the young 
people in this study being on cross-sex hormones (which initiate the development of 
secondary sex characteristics), experiencing body dissatisfaction was still described as a 
barrier to physical activity and sport, as was previously found in an older sample of 
transgender people (Elling-Machartzki, 2015). The findings of study 1 built on previous 
research as the young people explained that although the cross-sex hormones had started to 
change their bodies in a positive way (i.e., bring their bodies in line with their gender 
identity), these changes were not significant enough for body dissatisfaction to be alleviated 
to a level which they felt allowed them to engage in physical activity and sport in a 
comfortable way. In addition to this, and in support of previous research (Hargie et al., 2017; 
Muchiock et al., 2014), transphobia was found to be a barrier to physical activity and sport 
engagement. However, study 1 extended previous findings as it found that for the majority of 
participants, transphobia was anticipated as opposed to experienced.  
The young people in this study also reported factors which they felt could facilitate physical 
activity and sport engagement. This is the first time that positive determinants of physical 
activity and/or sport within the transgender population have been reported in-depth within the 
literature. The majority of the participants in study 1 were physically active, although they 
reported rarely engaging in physical activity or sport in public spaces (e.g., gyms, leisure 
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centres). It was evident from this study that the young people were motivated to engage in 
physical activity and sport. They were motivated to change their bodily appearance and 
increase perceived gender congruence, to enhance surgical outcomes of gender affirming 
surgery (transgender males only), and to ensure they were in good physical health to undergo 
these major surgeries. However, due to the barriers they experienced, participants could not 
always act on this motivation, especially when attempting to engage in physical activity 
and/or sport in a public space.  
In summary, the findings of this study suggest that young transgender people have difficulties 
accessing physical activity and recreational sport. The young transgender adults in study 1 
were motivated to be active; however, they reported experiencing numerous barriers which 
prevent many of this population from engaging in physical activity and/or recreational sport. 
In many cases, this means that access to physical activity or sport, and the positive health 
benefits that it could bring, is prevented by the existence of these barriers. Many of these 
barriers appeared to be directly or indirectly related to body (dis)satisfaction. Some of these 
barriers also appeared to be related to the uncomfortable and unwelcoming environment that 
is sometimes experienced in physical activity and/or recreational sport spaces by this 
population. As a consequence of these barriers, it was hypothesised that the amount of 
physical activity that the transgender population engages in would be low in comparison to 
the cisgender population. 
 
10.3.2. Chapter 7 (study 2): The levels and predictors of physical activity engagement within 
the treatment seeking transgender population: A matched control study 
Study 2 was interested in exploring the hypothesis that physical activity engagement would 
be low in transgender people in comparison to cisgender people in order to determine 
whether there is inequality in physical activity and sport engagement between these two 
groups. It is essential that physical activity is accessible to transgender people so that they can 
benefit from the potential benefits in terms of alleviating mental health and body 
dissatisfaction which may be particularly relevant for this vulnerable population (e.g., Carter 
et al., 2016; Cox et al., 2017; Herring et al., 2011; Kruger et al., 2008; Lantz et al., 1997; 
McMahon et al., 2016; Rebar et al., 2016). In order to build on and complement the findings 
from study 1, study 2 was concerned with quantitatively exploring factors that might be 
associated with physical (in)activity. Adopting a quantitative approach facilitates 
generalisation of the findings (which is not possible with qualitative research) which can be 
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used to inform the development of specific interventions and initiatives to increase physical 
activity within the transgender population.  
 
Study 2 found that transgender people engaged in significantly less physical activity than 
cisgender people after controlling for age and gender identity. This relationship was then 
broken down by exploring differences in physical activity depending on cross-sex hormone 
use and gender identity. It was found that transgender people who had not taken cross-sex 
hormone treatment engaged in significantly less physical activity than people who had taken 
cross-sex hormones. When transgender females who had taken cross-sex hormones were 
compared to cisgender females, no significant difference was found between their physical 
activity levels, even after controlling for age. For transgender females, body dissatisfaction 
may have been alleviated to a level sufficient to enable these individuals to engage in 
physical activity comfortably, as supported by the findings from study 1 (see chapter 6; Jones, 
Arcelus, Bouman, & Haycraft, 2017b). However, transgender males on cross-sex hormones 
were found to engage in significantly less physical activity than cisgender males, after 
controlling for age. This finding may be explained by the fact that many treatment seeking 
transgender men choose to wear a chest binder5F1 before mastectomy and chest reconstructive 
surgery. Wearing a chest binder has been described as a significant barrier to physical activity 
and sport engagement due to the discomfort of wearing the garment (see chapter 6; Jones et 
al., 2017b). After mastectomy and chest reconstructive surgery, dissatisfaction with the chest 
has been found to significantly diminish among transgender men (van de Grift et al., 2016c) 
and so not having to wear a binder is likely to have a positive effect on physical activity 
engagement.  
In the participants who were yet to take cross-sex hormones, high self-esteem was found to 
be the best statistical predictor of physical activity, which supports research within the 
cisgender population (e.g., Joseph, Royse, Benitez, & Pekmezi, 2014; Noordstar, van der Net, 
Jak, Helders, & Jongmans, 2016; Sonstroem & Morgan, 1989). In people who were taking 
cross-sex hormones, greater body satisfaction was found to be the best statistical predictor of 
physical activity engagement, which is also consistent with findings from the cisgender 
population (e.g., Cox et al., 2017; Goodwin, Haycraft, & Meyer, 2016; Kruger et al., 2008; 
                                            
 
1 A chest binder is a garment of clothing worn by some transgender men to minimise breast tissue and increase 
the appearance of a male chest. 
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Lantz et al., 1997; Marquez & McAuely, 2001; Williams & Cash, 2001). In addition to this, 
people who had taken cross-sex hormones in study 2 (compared to participants that had not) 
reported higher self-esteem, fewer symptoms of anxiety and depression, and higher body 
satisfaction; all of which are factors that have been positively associated with physical 
activity engagement within the cisgender population (e.g., Kruger et al., 2008; McMahon et 
al., 2017). This finding suggests that cross-sex hormones are capable of increasing physical 
activity in treatment seeking transgender people indirectly through increasing mental well-
being, self-esteem and decreasing body dissatisfaction (i.e., increasing body satisfaction).   
In conclusion, the findings from study 2 provide important information about factors that can 
statistically predict physical activity engagement in treatment seeking transgender people 
who have and have not taken cross-sex hormones. Cross-sex hormone treatment appears to be 
crucial in indirectly alleviating the inequality in physical activity participation that is seen 
between treatment seeking transgender people and cisgender people, especially in treatment 
seeking transgender females. Mastectomy and chest reconstructive surgery may also play a 
positive role in physical activity engagement among transgender males. This study has 
further demonstrated how body (dis)satisfaction plays a key role in the amount of, and factors 
associated with, physical activity engagement in treatment seeking transgender people. Body 
dissatisfaction has also been found to be central to other mental health problems that can 
affect the well-being of transgender people, such as eating disorder psychopathology.  
 
10.3.3. Chapter 8 (study 3): Risk factors for eating disorder psychopathology within the 
treatment seeking transgender population: The role of cross-sex hormone treatment 
Study 3 was concerned with understanding other ways in which body dissatisfaction might 
make transgender people vulnerable. The systematic review presented in chapter 3 concluded 
that body dissatisfaction might make transgender people vulnerable to eating disorder 
psychopathology (e.g., Ålgars, Alanko, Santtila, & Sandnabba, 2012; Bouman & Arcelus, 
2016; Jones et al., 2016b; Khoosal et al., 2009). However, what was evident from this review 
was that no research had explored other factors associated with eating disorder symptoms. 
This is important as eating disorder symptoms are likely to be multifactorial in transgender 
people (see sections 3.5., 4.3. and 10.2.3.). The review also highlighted the lack of research 
exploring the role of cross-sex hormones (see sections 4.3. and 10.2.3.). Cross-sex hormone 
treatment has been found to alleviate body dissatisfaction (e.g., de Vries, Steensma, 
Doreleijers, & Cohen-Kettenis, 2011; de Vries et al., 2014; Fisher et al., 2014; van de Grift et 
Chapter 10: General discussion 
 
213 
 
al., 2017a) and is therefore also likely to alleviate eating disorder symptoms. In light of these 
gaps, study 3 aimed to determine factors associated with eating disorder symptoms in a large 
sample of transgender people and to explore the potential role of cross-sex hormone 
treatment on these symptoms.  
 
Study 3 found that treatment seeking transgender people who were yet to initiate cross-sex 
hormone treatment had higher levels of eating disorder psychopathology compared to 
treatment seeking transgender people who had initiated cross-sex hormone treatment. When 
the levels of eating disorder symptoms of the transgender people in study 3 who had taken 
cross-sex hormones were compared to levels previously found within the cisgender 
population (Witcomb et al., 2015), no significant difference was found. In contrast, 
transgender people who had not taken cross-sex hormones reported much higher levels of 
eating disorder psychopathology than had previously been found within the cisgender 
population (Witcomb et al., 2015). When taken together, these findings suggest that cross-sex 
hormone treatment may be capable of alleviating eating disorder symptoms in treatment 
seeking transgender people. 
 
Study 3 built on previous research by attempting to establish why and how cross-sex 
hormones are able to alleviate eating disorder symptoms. This study found that high levels of 
body dissatisfaction, perfectionism, symptoms of anxiety, and low self-esteem were all risk 
factors for eating disorder psychopathology in treatment seeking transgender people who 
were yet to initiate a medical transition. In addition to this, there was no longer a significant 
difference in eating disorder psychopathology between people who had and had not taken 
cross-sex hormones after the identified risk factors were controlled for. Therefore, it was 
concluded that cross-sex hormones are potentially capable of alleviating eating disorder 
symptoms by reducing levels of body dissatisfaction, high perfectionism, and symptoms of 
anxiety, and by increasing self-esteem. This study further highlighted the potential 
mechanisms through which this was possible. Mediation analysis suggested that cross-sex 
hormones primarily alleviate body dissatisfaction which in turn reduces high levels of 
perfectionism and symptoms of anxiety and increases self-esteem. 
 
In conclusion, treatment seeking transgender people who are yet to initiate a medical 
transition report more eating disorder symptoms than transgender people who have initiated a 
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medical transition. The findings of this study suggest that cross-sex hormones may 
potentially be able to alleviate eating disorder symptoms in the treatment seeking transgender 
population by reducing some of the identified risk factors.  
 
10.3.4. Chapter 9 (study 4): The Gender Congruence and Life Satisfaction Scale (GCLS): 
Development and validation of a scale to measure outcomes from transgender health services 
The previous three studies (studies 1, 2 and 3) emphasised the importance of increasing 
transgender people’s well-being. The findings of the research in this thesis suggest that this 
may be possible through gender affirming medical interventions. To determine the 
effectiveness of these interventions, treatment outcomes need to be evaluated. This can be 
achieved through self-report measures; however, the majority of self-report measures used 
with this population have several limitations (see sections 1.7.5.1., 3.5., 4.4. and 10.2.3.). 
Self-report measures used with transgender people to assess intervention outcomes, which 
may include the measurement of body (dis)satisfaction and mental well-being, have been 
developed and validated with the cisgender population (e.g., Hospital Anxiety and 
Depression Scale; Zigmond & Snaith, 1983), or with other specific populations, such as 
people with eating disorders (e.g., Eating Disorder Inventory-2; Garner, 1991). This is 
problematic as these measures are unlikely to be specific enough to be used with the 
transgender population (i.e., because they do not assess body dissatisfaction and mental 
health in relation to gender identity issues). This therefore means that evaluations of body 
(dis)satisfaction and mental well-being are susceptible to unreliability. Given the importance 
of reliably assessing these constructs from both a research and clinical point of view, study 4 
aimed to develop a measure that is capable of assessing treatment outcomes. Prior to the 
development of this tool, the most important intervention outcomes were identified. These 
were gender incongruence, gender distress, mental well-being (including body 
(dis)satisfaction), and life satisfaction. This measure was developed with members of the 
transgender population and experts working within the area of transgender healthcare in the 
United Kingdom (UK), Sweden and Belgium. It was named the Gender Congruence and Life 
Satisfaction Scale (GCLS). After developing the GCLS, study 4 aimed to validate the 
measure. 
 
Assessment of the factor structure of the GCLS revealed seven subscales (genitalia, chest, 
other secondary sex characteristics, social gender role recognition, physical and emotional 
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intimacy, psychological functioning, and life satisfaction). The first four subscales were 
categorised into the gender congruence cluster and the latter three subscales were categorised 
into the gender-related mental well-being and general life satisfaction cluster. These clusters 
were developed to facilitate clinicians’ assessments of important short term and long term 
outcomes from gender affirming medical interventions. In the short term, clinicians aim to 
alleviate gender incongruence and distress. In the long term, clinicians will be looking for 
improvements in psychological well-being and life satisfaction.  
 
Study 4 also demonstrated that the GCLS is a valid and reliable measure to use with the 
transgender population. As part of these analyses, the GCLS was found to be capable of 
distinguishing between known-groups at different stages of social gender role and medical 
transition. For instance, transgender people who had not undergone any gender affirming 
medical interventions reported poorer outcomes on all the GCLS subscales compared to 
cisgender people as well as transgender people who had taken cross-sex hormone treatment 
and undergone genital surgery (+/- mastectomy and chest reconstructive surgery). This 
finding is consistent with research that has reported on the positive effects of gender 
affirming medical interventions on gender incongruence, body dissatisfaction, mental well-
being and life satisfaction (De Cuypere et al., 2005; De Cuypere, Elaut, Heylens, & Monstrey, 
2006; Lindqvist et al., 2017; Ruppin & Pfäfflin, 2015; van de Grift et al., 2017a), but builds 
on past research by providing a transgender-specific tool through which to measure these 
changes. This demonstrates that the GCLS is a suitable tool to use within a research capacity.  
 
In conclusion, study 4 developed and validated a new self-report measure (the GCLS) 
capable of assessing short and long term outcomes in transgender people at different stages of 
transition. The GCLS is likely to have clinical and research implications which will be 
discussed in sections 10.5.3. and 10.7.2., respectively.  
 
10.4. Contribution of findings to understanding physical (in)activity, body 
(dis)satisfaction and mental health in transgender people 
This thesis presents research which furthers our understanding of physical (in)activity, 
experiences of body (dis)satisfaction and mental health in the transgender people and has 
made significant advances to extend knowledge. However, what is apparent is that body 
(dis)satisfaction is core to explaining many of the findings of this thesis. This is not surprising 
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as body dissatisfaction has been described as core to the distress and unhappiness that 
transgender people experience (see chapter 3; Jones et al., 2016b; Witcomb et al., 2015).  
 
10.4.1. Body image 
Body image is the mental representation that people create of their physical selves. This 
mental representation can be affected by different external (e.g., the media) and internal (e.g., 
self-esteem) factors. People may experience satisfaction with their body image, however, it is 
increasingly common for people to experience dissatisfaction with their body and/or the 
image that a person has about their body and this is referred to as body dissatisfaction (Levine, 
Smolak, Moodey, Shurman, & Hessen, 2006). Body ideal internalisation (i.e., an individual’s 
acceptance of societal beliefs, attitudes and standards of body image) is thought to be a major 
risk factor for body dissatisfaction within the cisgender population (e.g., Fitzsimmons-Craft, 
2011; Grogan, 2016; Thompson & Stice, 2001). These body ideals are most commonly 
emphasised through sociocultural messages within the media, from friends and family (Grabe, 
Ward, & Hyde, 2008; Leit, Gray, & Pope, 2002; Stice & Shaw, 2002; Yamamiya, Cash, 
Melnyk, Posavac, & Posavac, 2005). Standards of beauty have changed over time but 
feminine body ideals in the twenty-first century place emphasis on being thin with good 
muscle tone (i.e., looking firm) and large breasts (Grogan, 2016). Masculine body ideals in 
the twenty-first century emphasise being muscular and thin, sometimes defined as the V-body 
shape (Grogan, 2016; McCreary & Sasse, 2000). Body ideals for most women and men are 
unattainable (e.g., Fitzsimmons-Craft, 2011; Thompson & Stice, 2001).  
 
10.4.2. Body dissatisfaction in transgender people 
Transgender people also experience dissatisfaction with their bodies because their body 
image and body ideal (e.g., a body of a women or man) do not match (see chapter 3; Jones et 
al., 2016b; Kozee, Tylka, & Bauerband, 2012) even following gender affirming medical 
treatment. Much of the research in this area has focused on sex-specific characteristics which 
chapter 3 concluded transgender people are often highly dissatisfied with (Becker et al., 2016; 
Jones et al., 2016b). Following gender affirming medical interventions (if this is what a 
person wishes), dissatisfaction with sex-specific body parts has been found to alleviate (i.e., 
body satisfaction increases; e.g., Bandini et al., 2013; de Vries et al., 2011, 2014; Fisher et al., 
2014; van de Grift et al., 2017a). As gender affirming medical interventions are capable of 
alleviating body dissatisfaction within the transgender population, it has been suggested that 
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body dissatisfaction is at least partly driven by gender incongruence (e.g., Kozee et al., 2012). 
This is supported by a study which found that prior to gender affirming medical interventions, 
gender incongruence was positively associated with genital dissatisfaction (i.e., the higher the 
level of gender incongruence, the higher genital dissatisfaction; van de Grift et al., 2017a). 
However, the same study also found that overall body dissatisfaction and gender 
incongruence were not significantly associated prior to gender affirming medical 
interventions (van de Grift et al., 2017a). Such research suggests that not all body 
dissatisfaction experienced by transgender people is associated with gender incongruence. As 
with cisgender people, transgender people may also be dissatisfied with their weight and 
shape (Witcomb et al., 2015). In support of this, chapter 3 found evidence of transgender 
women striving for thinness (through diet restriction) so as to appear more feminine (Ålgars 
et al., 2012; Jones et al., 2016b). Additionally, the transgender males in chapter 6 (study 1) 
reported engaging in weight training to gain more muscle on their upper torso (Jones et al., 
2017b). When taken together, the findings of this thesis and previous research suggest that 
while transgender people experience body dissatisfaction with sex-specific characteristics, 
transgender people are also susceptible to body ideals emphasised in Western society through 
sociocultural messages.  
 
10.4.3. Body dissatisfaction and mental health in transgender people 
Within the cisgender population, research has found poor body image to impact several 
aspects of a person’s life. Body dissatisfaction has been found to be a predictive factor for 
depression and low self-esteem (Paxton, Neumark-Sztainer, Hannan, & Eisenberg, 2006; 
Stice, Hayward, Cameron, Killen, & Taylor, 2000). One study unpacked these findings and 
found body dissatisfaction to lower self-esteem which in turn increases symptoms of anxiety 
and depression (Duchesne et al., 2017). Experiencing mental health problems can be 
stigmatising as can having a minority identity, such as being transgender (Hendricks & Testa, 
2012; Meyer, 2003). Therefore, some transgender people have been described as being 
vulnerable to a double stigma (Mizock, 2012). Stigmatisation has also been associated with 
social isolation and a fear of entering close relationships (Hatzenbuhler, Phelan, & Link, 
2013). The development of and effects of having poor body image for transgender people are 
therefore complex and widespread.  
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10.4.4. Body dissatisfaction, physical activity and sport participation 
Body dissatisfaction has also been associated with social physique anxiety within the 
cisgender population (Lantz et al., 1997). Social physique anxiety is defined as the anxiety 
experienced by individuals who perceive that their physique (i.e., the shape and size of their 
body) will be negatively evaluated by others, affecting the way they see their body 
themselves (Hart, Leary, & Rejeski, 1989). Social physique anxiety has been found to be 
negatively associated with physical activity motivation (e.g., Hausenblas & Fallen, 2002; 
Kruger et al., 2008; Tiggemann & Williamson, 2000) and participation (e.g., Lantz et al., 
1997). This may explain why study 1 (chapter 6) found body dissatisfaction to be one of the 
biggest barriers faced by young transgender adults when attempting to engage in physical 
activity and sport (Jones et al., 2017b). Additionally, study 2 (chapter 7) found physical 
activity engagement to be low among treatment seeking transgender people (who often 
experience very high levels of body dissatisfaction) when compared to cisgender people 
(Jones, Haycraft, Bouman, & Arcelus, 2018). In combination, findings from this thesis 
findings and from previous research are concerning given the evidence which suggests that 
engaging in frequent physical activity and sport is likely to have a number of physical and 
mental health benefits for the transgender population.  
 
10.4.5. Body dissatisfaction and eating disorder symptoms in transgender people 
Body dissatisfaction has been found to make transgender people vulnerable to eating disorder 
symptoms (see chapter 3; Ålgars et al., 2012; Bouman & Arcelus, 2016; Jones et al., 2016b; 
Khoosal et al., 2009). Study 3 (chapter 8) found the relationship between eating disorder 
psychopathology and body dissatisfaction to be complex. Self-esteem, anxiety and 
perfectionism were each found to significantly mediate the relationship between body 
dissatisfaction and drive for thinness, as well as the relationship between body dissatisfaction 
and bulimia, in people who had not taken cross-sex hormones. These findings support 
cognitive-behavioural and emotion regulation theories of eating disorders and previous 
research that has described the mediating role of symptoms of anxiety and self-esteem (e.g., 
Brechan & Kvalem, 2015; DeBoer & Smits, 2013; Fairburn et al., 2003; Harrison et al., 
2009). Low self-esteem and high levels of anxiety within the transgender population are 
thought to be connected, and at least partly caused by the discrimination, stigmatisation and 
prejudice (transphobia) that (some) transgender people experience (Hendricks & Testa, 2012; 
Meyer, 2003). Interestingly, experiencing stigmatisation (due to minority gender identity) has 
Chapter 10: General discussion 
 
219 
 
been linked to higher levels of disordered eating among transgender youth (Watson, Veale, & 
Saewyc, 2017). Experiencing transphobia is likely to cause a negative emotional state which 
some transgender people may find difficult to regulate and so, consequently, coping 
mechanisms are sought. These mechanisms may be healthy, such as physical activity and/or 
sport engagement. However, the findings reported in this thesis indicate that transgender 
people have difficultly accessing physical activity and/or sport (see chapter 6; Jones et al., 
2017b). Therefore, transgender people may be susceptible to adopting unhealthy coping 
mechanisms. When considered in light of previous research with the cisgender population, 
the findings of study 3 suggest that transgender people may binge, self-induce vomiting 
and/or restrict their food to regulate negative emotions.  
 
Within study 3, high levels of perfectionism also predicted both drive for thinness and 
bulimia, which supports cisgender research (e.g., Egan et al., 2011; Tchanturia et al., 2016). 
Slade (1982) proposed that high levels of perfectionism, when coupled with dissatisfaction 
with life and self (i.e., low self-esteem), leaves people wanting complete control in their life. 
Gaining complete control in many aspects of life is often unattainable and therefore 
controlling body shape, weight and food intake can become the focus (Slade, 1982). This 
explanation may be particularly pertinent among treatment seeking transgender people who 
are yet to take cross-sex hormones as they may especially feel a lack of control over their 
medical transition. Currently, long waiting times for assessment and treatment are 
experienced in transgender health services across the UK and Europe (Bouman & Richards, 
2013; Kanamori & Cornelius-White, 2016). In this sense, self-reported perfectionism within 
the transgender population may be a proxy for feeling a lack of control which is likely to be 
caused by temporary uncertainty surrounding their medical transition. Therefore, in this 
context, it is possible that perfectionism appears to be a state (i.e., striving for things to be 
perfect in response to feeling a lack of control during medical transition) as opposed to being 
a stable personality trait. Therefore, treatment seeking transgender people who are yet to take 
cross-sex hormones may seek to gain control through temporarily engaging in disordered 
eating behaviours. 
 
Research presented within this thesis has also supported that cross-sex hormones may be able 
to alleviate eating disorder symptoms within the treatment seeking transgender population 
(see chapter 8; study 3). Previous research has also found undergoing gender affirming 
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surgery in transgender females to alleviate eating disorder psychopathology (Khoosal et al., 
2009). When these findings and previous research are considered in combination, they may 
suggest that eating disorder symptoms experienced by the treatment seeking transgender 
population are secondary to gender incongruence (i.e., that eating disorder symptoms are 
caused by gender incongruence) due to the positive effects of gender affirming medical 
interventions.  
 
10.4.6. Evaluating the impact of gender affirming medical interventions on body 
dissatisfaction  
Due to the widespread impact that body dissatisfaction appears to have for the transgender 
population, it is imperative to evaluate the gender affirming medical interventions offered at 
transgender health services which aim to increase gender-related body satisfaction. The 
majority of the research within this area has been concerned with mental health outcomes, 
such as anxiety and depression (e.g., Davis & Meier 2014; De Cuypere et al., 2006; Gorin-
Lazard et al., 2012; 2013; Heylens et al., 2014; Lindqvist et al., 2016; Murad et al., 2010; 
Ruppin & Pfäfflin 2015). This is evidently an important outcome to assess as transgender 
people often report poor mental well-being (e.g., Dhejne et al., 2016). However, the primary 
aim of interventions offered at transgender health services is to alleviate gender incongruence 
(and associated body dissatisfaction). This outcome is frequently neglected. The majority of 
research that has been concerned with assessing outcomes from interventions offered at 
transgender health services also has methodological limitations. For instance, the majority of 
research is cross-sectional and therefore true cause and effect cannot be determined. To date 
there has been little research that has explored the longitudinal outcomes of gender affirming 
medical interventions offered to transgender people. This research is important in order to 
reliably determine the effects of gender affirming medical interventions. There is also very 
limited research that has explored factors which are associated with positive and negative 
outcomes. Therefore patients who are vulnerable to a poorer outcome cannot be identified nor 
can preventative support be provided. Identifying interventions that are associated with 
positive outcomes is important for the allocation of healthcare resources. Conducting 
longitudinal outcome research has been hampered by the lack of an appropriate tool to do so 
(see study 4; chapter 9). Section 10.7.2. will consider specific ways in which the tool 
developed within this thesis (the Gender Congruence and Life Satisfaction Scale; GCLS) may 
be able address these gaps within the literature and ultimately improve transgender healthcare.  
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10.5. Implications of this thesis  
The research presented within this thesis has highlighted several notable practical 
implications. These relate to a need to improve transgender people’s access to, and 
engagement in, physical activity and sport. Additionally there is a need to alleviate body 
dissatisfaction as well as a need to improve access to, and treatment offered by, transgender 
health services. 
 
10.5.1. Facilitating physical activity and sport participation within the transgender 
population  
Physical activity and sport engagement is likely to have a number of benefits for mental 
health and body dissatisfaction within the transgender population (e.g., Carter et al., 2016; 
Herring et al., 2011; McMahon et al., 2016; Rebar et al., 2016). However, the research in this 
thesis (see chapter 6; Jones et al., 2017b) found that many treatment seeking transgender 
people avoid participating in physical activity or recreational sport. The following two 
sections make specific recommendations which may facilitate increased physical activity in 
the transgender population.    
 
10.5.1.1. Recommendations for physical activity and sport organisations  
Study 1 (chapter 6) identified that some young transgender people are avoidant of physical 
activity and sport due to a fear of transphobia (Jones et al., 2017b). Anticipating transphobia 
and consequently avoiding intolerant environments may be seen as a useful coping 
mechanism by many transgender people. However, avoiding physical activity and sport is 
problematic for this population due to the known health benefits. There are activity groups 
and sporting clubs that are open to transgender people only and these might be more 
acceptable for some transgender people. However, the research within this thesis identified 
that there is a lack of these groups available for transgender people (see chapter 6; Jones et al., 
2017b). Therefore sports organisations, leisure centres and gyms should work to increase the 
number of transgender only physical activity and sport groups/sessions. For some transgender 
people, these groups will not be acceptable as they may be seen to promote transgender 
exclusion from mainstream physical activity and sport (see chapter 6; Jones et al., 2017b). 
Consequently, it is important that physical activity spaces and sports clubs are made to be 
inclusive of transgender people. One potential way to do this is to introduce more mixed-
gendered sports teams that reduce the pressure of being a certain size or strength, especially 
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when sport is being engaged in at a recreational level. This will better support transgender 
people at varying stages of social and medical transition to be able to participate in team sport 
without having to align themselves with a male or female team. Mixed gendered sports teams 
will also help non-binary and gender neutral transgender people to be able to access sport. If 
sports organisations are concerned about transgender people having an athletic advantage 
they could consider developing gender neutral (i.e., not divided by the binary gender system) 
size categories. Any sports organisation wanting to exclude transgender people from their 
sport will have difficulty justifying their decision given the findings of empirical research. 
There is currently no consistent or direct physiological research that has found transgender 
people to have an unfair athletic advantage (see chapter 2; Jones et al., 2017a). After 
considering the limited physiological evidence, chapter 2 concluded that it is only 
transgender females who are potentially seen to have an athletic advantage due to androgenic 
hormones (i.e., testosterone) (Jones et al., 2017a). However, it is still debated within the 
literature as to whether or not androgenic hormones are a useful marker of athletic advantage 
(Karkazis, Jordan-Young, Davis, & Camporesi, 2012).  
 
While awareness of gender diversity has increased significantly over the past few years, more 
still needs to be done. The findings from this thesis suggest that increasing awareness of the 
barriers that transgender people face when engaging (or attempting to engage) in physical 
activity and sport will increase the accessibility of mainstream physical activity and sport for 
this population. Awareness training should be made available and delivered to people 
concerned with the implementation of physical activity and sport, such as sports team 
managers and staff working at leisure centres and gyms. People working within these arenas 
need to ensure that changing facilities are inclusive for this population. Study 1 (chapter 6) 
identified how changing facilitates were one of the biggest barriers to transgender people 
attempting to be active which is concerning considering that changing facilities are 
instrumental to physical activity and sport engagement (Jones et al., 2017b). In light of this, it 
is recommended that more gender neutral (i.e., not divided by the binary gender system) 
changing facilities are introduced into leisure centres, gyms, swimming baths and sports clubs. 
Within these facilitates, separate and private cubicles should be available. However, it is 
acknowledged that in some countries, the implementation of gender neutral changing 
facilities will be a challenge. For instance, Donald Trump has recently revoked guidance in 
the USA to allow transgender school students to use the gendered toilet which matches their 
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gender identity (BBC News, 2017) so it is acknowledged that, unfortunately, this 
recommendation will not be straightforward to roll-out globally.  
 
10.5.1.2. Recommendations regarding sport-related clothing 
Study 1 (chapter 6) also found that the clothing that people wear to engage in physical 
activity and sport can be problematic for transgender people (Jones et al., 2017b). Such 
clothing is often very revealing and an indication of one’s gender. Therefore sports clothing 
brands should consider developing more gender neutral and less revealing sports clothing, 
especially for activities such as swimming, gymnastics, athletics and cycling where clothing 
is often highly revealing. For recreational engagement in physical activity and sport, the 
performance-enhancing benefits of certain clothes would be less important to the transgender 
population, meaning that making some sport clothing less revealing should not significant 
impact the majority of transgender sport participants. Some transgender people also have 
concerns about effectively concealing their chest and/or genitals in sports clothing, especially 
transgender males (see chapter 6; Jones et al., 2017b). The transgender males in study 1 
spoke at length in relation to the issues they had (before mastectomy and chest reconstructive 
surgery) with binding their chest and engaging in physical activity and sport in a safe and 
comfortable way (Jones et al., 2017b). In response to this, sports clothing brands should 
consider developing a chest binder that is effective (i.e., conceals the chest) but also 
comfortable (i.e., is not restricting).  
 
10.5.2. Recommendations to alleviate body dissatisfaction and eating disorder symptoms 
In section 10.4., it was evident that there is a need to alleviate experiences of body 
dissatisfaction within the transgender population due to the widespread implications that this 
can have on a person’s life. Study 3 (chapter 8) also identified how body dissatisfaction may 
make some treatment seeking transgender people vulnerable to eating disorder symptoms. In 
support of previous research, study 4 (chapter 9) demonstrated that cross-sex hormones and 
gender affirming surgery are associated with a decrease in body dissatisfaction (i.e., increase 
in body satisfaction) (e.g., e.g., Bandini et al., 2013; de Vries et al., 2011, 2014; Fisher et al., 
2014; van de Grift et al., 2017a). Study 4 found that gender affirming medical interventions 
directly increase satisfaction with parts of the body that are responsive to the concerned 
intervention. For example, transgender males who had undergone mastectomy and chest 
reconstructive surgery reported significantly more satisfaction with their chest compared to 
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transgender males who hadn’t undergone this intervention (see section 9.4.3.). Research has 
also found this increase in body satisfaction to be reported in relation to body parts that are 
unresponsive to gender affirming medical interventions (van de Grift et al., 2017a). However, 
van de Grift et al. (2017a) found that overall body dissatisfaction before gender affirming 
medical interventions is associated with higher overall body dissatisfaction after gender 
affirming medical interventions. As overall body dissatisfaction is not thought to be 
associated with levels of gender incongruence (van de Grift et al., 2017a), transgender people 
who continue to report body dissatisfaction after gender affirming interventions may benefit 
from holistic body image interventions.  
 
Although transgender people experience a variety of different barriers to physical activity and 
sport (see chapters 2 and 6; Jones et al., 2017a; 2017b), the young transgender people in 
study 1 (chapter 6) discussed how they felt they would be able to be more active following 
their medical transition due to an increase in gender congruence (Jones et al., 2017b). In light 
of this, physical activity and sport engagement may be an effective intervention for 
transgender people who continue to report high levels of body dissatisfaction after a medical 
transition. Research with the cisgender population has found physical activity and sport 
engagement to have positive effects on body image (e.g., Cox et al., 2017; Goodwin et al., 
2016; Kruger et al., 2008; Lantz et al., 1997; Marquez & McAuely, 2001; Williams & Cash, 
2001). A meta-analysis found that physical activity interventions are most effective (i.e., they 
reduce body dissatisfaction the greatest) when physical activity is engaged in more frequently 
and is the sole component of the intervention (i.e., a healthy diet isn’t also incorporated) 
(Campbell & Hausenblas, 2009). Interestingly, the duration, intensity, mode or length of 
physical activity was not associated with the successfulness of the intervention (Campbell & 
Hausenblas, 2009). With this in mind, physical activity can be seen as a flexible (in relate to 
duration, intensity, mode and length) intervention to alleviate body dissatisfaction. In 
comparison to other interventions that may be offered to alleviate body dissatisfaction, 
physical activity may be seen as cost-effective. Physical activity can be engaged in at home 
or in public spaces. Having an intervention that is cost-effective is of great importance given 
the immense financial pressure that the UK’s National Health Service (NHS) is currently 
under (National Health Service England, 2017). Such interventions will also be beneficial for 
transgender people who have to pay for their own healthcare, such as in the USA. 
Recommending physical activity and sport engagement to alleviate body dissatisfaction 
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within the transgender population (especially among those who have undergone a medical 
transition) may also be an acceptable intervention as the young transgender adults in study 1 
(chapter 6) explained that they were motivated to engage in physical activity and sport to 
change their bodily appearance (Jones et al., 2017b).  
 
The findings reported in this thesis have supported the notion that transgender people may be 
susceptible to body ideals emphasised within Western society (e.g., Grabe et al., 2008; Leit et 
al., 2002; Stice & Shaw, 2002; Yamamiya et al., 2005). Achieving these body ideals may be 
even more unrealistic among the transgender population, when compared to the cisgender 
population especially when a medical transition is initiated after puberty has finished. 
Testosterone therapy will increase muscle mass in a male pattern and decrease body fat, 
especially around the hips and buttocks (Meyer et al., 1986). However, the size and shape of 
the pelvis (which gives a feminine hourglass shape) cannot be altered through medical or 
physical (i.e., weight training) intervention. Oestrogen therapy will reduce muscle mass in a 
male pattern and increase body fat by an average of 3.8 kg mainly around the hips and 
buttocks (Elbers et al., 2003). However, there is no medical or physical intervention that can 
change the shape of the pelvis (to give a feminine hourglass shape) or decrease broad 
shoulders (although oestrogen therapy will reduce muscle around the shoulders). 
Interventions used with cisgender people that aim to alleviate susceptibility to the 
internalisation of body ideals may therefore be particularly beneficial with the transgender 
population. Research has found that media literacy interventions, which aim to increase the 
ability to critically analyse and evaluate media content, have been shown to be favourable in 
relation to decreasing body dissatisfaction and the internalisation of body ideals (Coughlin & 
Kalodner, 2006; McLean, Paxton, & Wertheim, 2016; Yamamiya et al., 2005). For instance, 
a study with college women found that the group that received media literacy training 
reported greater body satisfaction and lower internalisation of the thin-ideal than the group 
that received no intervention (Coughlin & Kalodner, 2006). Within this study, the media 
literacy intervention included two sessions which aimed to educate the college women about 
body image and techniques that the media use to create ‘body ideals’. The women were also 
taught cognitive strategies to challenge the messages they are exposed to in the media 
(Coughlin & Kalodner, 2006). In light of the effectiveness of media literacy interventions 
within the cisgender population, these interventions may be beneficial to transgender people 
who are susceptible to sociocultural messages of beauty.  
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As suggested previously, body dissatisfaction may be a risk factor for eating disorder 
symptoms in treatment seeking transgender people although for most people these symptoms 
do not appear to typically manifest into a clinical eating disorder (see chapter 8). The 
sustained body dissatisfaction experienced by some transgender people following gender 
affirming medical interventions (van de Grift et al., 2017a) may continue to put some people 
at risk for eating disorder symptoms. The research within this thesis suggested that treatment 
seeking transgender people may use disordered eating behaviour to regulate their emotions 
(see chapter 8 and section 10.4.5.). Therefore, clinicians working with transgender people 
need to support the individual to identify functional strategies to manage emotions. 
Additionally, clinicians may need to work with individuals to address particularly difficult 
negative emotions. In light of this, Dialectical Behaviour Therapy (DBT), which is based on 
Cognitive Behavioural Therapy but also looks to change unhelpful behaviours, may be useful 
among transgender people who are using disordered eating behaviours to regulate their 
emotions. Within the cisgender population, a low-intensity DBT intervention (which included 
a self-help manual and support phone calls) has been shown to reduce eating disorder 
psychopathology and increase quality of life compared to a wait-list group (Masson, von 
Ranson, Wallace, & Safer, 2013). Low-intensity interventions are likely to be cost-effective 
which is imperative in light of the NHS’s financial situation (National Health Service 
England, 2017).  
 
10.5.3. Implications for transgender health services  
One of the most significant implications of the findings from this thesis is the need to 
increase transgender individuals’ access to gender affirming medical interventions. The 
studies within this thesis suggested that gender affirming medical interventions that are 
offered at transgender health services may be capable of increasing physical activity (studies 
1 and 2), and alleviating body dissatisfaction (studies 2, 3 and 4) (and associated eating 
disorder psychopathology; study 3), mental well-being (studies 2, 3 and 4) and gender 
incongruence and distress (study 4). One key way that accessibility to transgender health 
services can be achieved is by decreasing waiting times. Currently, transgender people in the 
UK have to wait approximately 12-24 months before they are seen at a NHS transgender 
health service (Bouman & Richards, 2013; UK Trans Info, 2016). However, although 
reducing waiting times would greatly improve the lives of transgender people it is 
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acknowledged that reducing waiting times in NHS transgender health services would require 
additional staffing, resources and funding.  
 
Long waiting times for assessment at transgender health services prolongs the amount of time 
that transgender people are inactive or insufficiently active (see chapters 6 and 7; Jones et al., 
2017b; 2018). This is important as being physically active is likely to have a number of 
health benefits for the transgender population. The findings reported on in this thesis also 
suggest that long waiting times at transgender health services may leave some transgender 
people feeling out of control in relation to their medical transition (see chapter 8 and section 
10.4.5.). To gain a sense of control, some transgender people may engage in disordered 
eating behaviours (see chapter 8 and section 10.4.5.). Making the initial assessment process 
more efficient at transgender health services is therefore evidently important and may 
facilitate increased accessibility to gender affirming medical interventions and reduce waiting 
times. At the Nottingham Centre for Transgender Health (from which most of the data for 
this thesis were collected), the assessment process spans over three appointments with two 
separate clinicians (see section 1.5.4.). Research that has investigated this service found that 
60% of patients were recommended for gender affirming medical interventions after the 
assessment process (Jones et al., 2017c). In comparison to patients who were not 
recommended for gender affirming medical interventions, people who were recommended 
for interventions had socially transitioned prior to assessment, did not smoke (cessation of 
smoking is recommended prior to gender affirming medical interventions), were taking cross-
sex hormones prior to assessment, were older, and had been assigned male at birth (Jones et 
al., 2017c). This is the first study that has been able to identify factors that are associated with 
being recommended for gender affirming medical interventions and may be able to be used to 
identify people who would benefit from a shorter assessment. In addition to this, a high level 
of agreement was found between both assessors within this study (Jones et al., 2017c). This 
raises the question as to whether two assessors are required. Having one assessor would 
reduce the length of the assessment process and consequently increase accessibility to gender 
affirming medical interventions. Although it is acknowledged that this recommendation 
cannot be generalised to transgender health services outside the UK due to differences in 
assessment processes, it may pose questions to these transgender health services about how 
they can also increase accessibility to transgender health services in the context of their health 
systems.  
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Additionally, it is important that the care and treatment offered at transgender health services 
is appropriately and meaningfully evaluated. This will help to improve the quality and 
timeliness of care and will allow service and personal factors associated with a positive and 
negative outcome to be identified (e.g., Dawson, Doll, Fitzpatrick, Jenkinson, & Carr, 2010). 
Identification of factors associated with a positive outcome is important for decisions 
regarding the allocation of healthcare resources. Prior to the development of the Gender 
Congruence and Life Satisfaction Scale (GCLS; see study 4, chapter 9), self-report measures 
used to assess important treatment outcomes had not been developed or validated with the 
transgender population. This has had implications in relation to specificity of measurement 
and the conclusions drawn. Clinicians working with transgender people and implementing 
self-report outcome measures into their practice need to consider the reliability of these 
assessments. As part of the research that comprises this thesis, the GCLS was developed and 
validated with the transgender population. This measure is multifactorial in that it assesses 
gender distress, gender congruence, related mental well-being and life satisfaction. It is 
therefore recommended that this measure is employed within clinical practice to assess 
treatment outcomes.  
 
10.6. Strengths and limitations of the thesis 
10.6.1. Strengths 
The initial aims of the thesis were to conduct systematic reviews relating to physical activity 
and sport (chapter 2) and to body dissatisfaction and disordered eating in the transgender 
population (chapter 3). These systematic reviews have significantly added to the literature by 
synthesising two disparate and important fields of research. Additionally, both systematic 
reviews in this thesis were conducted in accordance with the PRISMA statement (Moher, 
Liberati, Tetzlaff, Altman, & PRISMA Group, 2009) and therefore followed evidence-based 
guidelines for reporting systematic reviews. Clarity and consistency in reporting systematic 
reviews is vital as these pieces of evidence can go on to have widespread impact including 
influencing and informing policy and healthcare decision making (Moher et al., 2009). In 
addition to this, the systematic reviews included within this thesis were able to highlight 
important gaps within the current literature and inform some of the empirical chapters of this 
thesis.  
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The systematic review concerned with physical activity and sport in chapter 2 highlighted 
that there was a dearth of research concerned with physical activity and recreational sport 
engaged in for leisure and fitness. Due to the lack of research in this area, the empirical 
chapters of the thesis began with a qualitative study to explore the experiences that this 
population have when being (or attempting to be) active (study 1; chapter 6). Following this 
study, more specific research questions and hypothesis were formulated and a quantitative 
study was conducted (study 2; chapter 7). Triangulation of research methods can strengthen 
findings as it allows researchers to obtain complementary perspectives on one phenomenon 
(McEvoy & Richards, 2006). For instance, in this thesis quantifying the amount of physical 
activity that transgender people engaged in (see study 2; chapter 7) allowed us to understand 
the potential health implications that not being able to access physical activity and sport could 
have for transgender people (see study 1; chapter 6). Additionally, triangulation allows the 
limitations of one design (e.g., qualitative) to be overcome by the other (e.g., quantitative). 
For example, findings from study 1 (chapter 6) cannot be generalised due to their qualitative 
nature however the findings from the quantitative study (chapter 7) can be more widely 
generalised and used to inform the development of interventions. Study 2 (chapter 7) was 
also strengthened by controlling for variables that have consistently been shown to impact 
physical activity engagement within the cisgender population (age and gender). In study 2, 
age and gender were controlled for by rigorously matching participants in the between 
subject groups on these variables. In study 3 (chapter 8), the statistical procedures were 
implemented in order to control for variables that had been shown to impact eating disorder 
psychopathology (i.e., ANCOVA was employed). Controlling for potential confounding 
variables is essential for increasing the internal validity of research findings.  
 
The majority of research that comprised this thesis was conducted with transgender people 
who had been referred to the Nottingham Centre for Transgender Health and were either 
awaiting assessment or had been accepted onto the treatment programme. Treatment seeking 
transgender people may be seen as the most vulnerable to physical inactivity, body 
dissatisfaction and poor mental health in comparison to transgender people who have 
undergone a transition or are not treatment seeking (e.g., Dhejne et al., 2016; Jones et al., 
2017b; Khoosal et al., 2009). Therefore, focusing research on treatment seeking transgender 
people is of great importance for directly improving the lives of this population. Recruiting 
transgender people from transgender health services also allows for the recruitment of 
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homogeneous groups in relation to stage of transition as objective information regarding their 
medical transition can be obtained. In this thesis, this has helped to further our knowledge 
regarding physical activity, body (dis)satisfaction and mental health in transgender people 
and enhanced our understanding of important nuances in people who are at different stages of 
social gender role and medical transition.  
 
Although there are several benefits of having a homogenous sample as discussed above, to 
ensure research is representative heterogeneous samples are also important. In study 4 
(chapter 9), not only were transgender people recruited from the Nottingham Centre for 
Transgender Health but also the community via LGBT support organisations. Consequently, 
transgender people at different stages of social gender role and medical transition who may 
have never been in contact with transgender health services, or were not currently in contact 
with a transgender health service, were recruited and contributed to the development of the 
new health outcomes measure. Therefore the findings of study 4 are applicable to transgender 
people in the community who may not be accessing transgender health services as well as 
those who are.  
 
Both systematic reviews in this thesis identified that the current research concerned with 
physical activity and sport (chapter 2) and with body dissatisfaction and disordered eating in 
the transgender population (chapter 3) had usually been conducted with very small sample 
sizes. Having small sample sizes in quantitative research is problematic as it can impact the 
ability to generalise findings and inflates the probability of a Type 1 error. In response to this, 
the research comprising this thesis recruited larger samples of participants to allow for greater 
power to detect a difference (i.e., to reduce the probability of a Type 1 error; see Table 5.2.).   
 
The findings of the research reported on in this thesis have made important advances in 
important, under-researched areas of transgender health. One of the most notable and 
immediate advances of the research from this thesis is the development and validation of a 
new outcome measure; the Gender Congruence and Life Satisfaction Scale (GCLS). This 
measure will allow for more reliable data to be collected from transgender health services in 
relation to short and long term outcomes. The GCLS has already begun to be implemented in 
transgender health services across Europe and the USA. At the same time, more reliable data 
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within a research capacity can be collected. As use of the GCLS increases, comparisons 
across studies can be made more easily.  
 
10.6.2. Limitations  
Although recruiting participants from transgender health services has several benefits, it is 
acknowledged that not every transgender person will access a transgender health service and 
wish to undergo gender affirming medical interventions (e.g., Beek, Kreukels, Cohen-
Kettenis, & Steensma, 2015). In addition, the assessment process and treatment offered at 
transgender health services differs around the world. Consequently, the findings from data 
collected from the Nottingham Centre for Transgender Health within this thesis cannot be 
generalised beyond treatment seeking transgender adults who are accessing a transgender 
health service within the UK. Within the empirical studies that comprise this thesis, the 
majority of transgender participants identified within the binary gender system (i.e., male or 
female), even though this was not an inclusion criterion for any of the empirical studies. 
There are an increasing number of people who identify outside the binary gender system (e.g., 
non-gender, gender queer, bigender; Beek et al., 2015; Richards, Bouman, Seal, Barker, 
Nieder, & T’Sjoen, 2016) and, consequently, the findings of this thesis cannot be generalised 
to transgender people who identify outside the binary gender system.  
 
The empirical research that comprises this thesis was cross-sectional. While this research 
design has allowed significant inroads to be made in exploring physical (in)activity, body 
(dis)satisfaction and mental health within the transgender population, cause and effect cannot 
be determined. In addition to this, studies 2, 3 and 4 (chapters 7, 8 and 9) within this thesis 
employed self-report measures. Self-report measures are an efficient way to collect large 
amounts of data and can be administered in a paper or online form, which can facilitate 
recruitment. However, as with all questionnaire research, participants may be susceptible to 
over or under reporting. The issue of social desirability may be particularly pertinent for 
transgender people recruited from transgender health services as they may feel that by 
framing themselves in a particular way through the responses they give, it will impact the 
care and treatment they receive. For instance, some people may over report mental health 
problems in an effort to access gender affirming medical interventions in a timely manner 
despite the fact that participants recruited from the Nottingham Centre for Transgender 
Health were explicitly told that their responses would not affect the care and treatment that 
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they received from the service. To minimise social desirability bias, it was made clear to all 
research participants from the outset that their responses would be anonymous and stored 
confidentially.  
 
Within studies 2 and 3 it could have been beneficial to include data on BMI given that BMI 
has been associated with levels of physical activity and eating psychopathology within the 
cisgender population. Future research may wish to consider the inclusion of BMI. 
Additionally, information about cross-sex hormones treatment collected in studies 2 and 3 
was limited by not knowing the dosage or length of time that the patient has been taking the 
hormone. Future research would benefit from obtaining more precise details about cross-sex 
hormone treatment to facilitate a better understanding of the potential impact of this treatment 
on transgender individuals’ health and well-being 
 
10.6.3. Self-reflection 
Within qualitative research it is important to consider the subjectivity of the researcher and 
the ways in which they may have affected how the research was conducted and findings 
interpreted (Sparkes & Smith, 2014). In light of this, acknowledging the PhD candidate’s 
gender identity and how this may have affected the research process is important (Galupo, 
2017). I am a cisgender woman conducting research with the transgender population which 
might have affected the formulation of research questions, the way questions were phrased in 
an interview, and the way in which results are interpreted and framed. In order to minimise 
the impact of this, the qualitative study was reviewed by, and included input from, members 
of the transgender population (as were studies 2, 3 and 4). The qualitative study within this 
thesis was discussed with the Patient and Public Involvement (PPI) group at the Nottingham 
Centre for Transgender Health. This PPI group consists of 21 people who were attending, or 
had attended, the service and agreed to provide feedback for research projects taking place at 
the service. Undertaking this process also allowed the PhD candidate to ensure that the 
research questions were of interest and relevant, and that the research methods and language 
employed were acceptable to the transgender population.  
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10.7. Future research 
10.7.1. Recruitment and samples 
Future research should consider recruiting larger community samples of transgender people 
to further explore physical activity, body (dis)satisfaction and mental health. By working with 
community samples, the experiences of people who are not accessing transgender health 
services, or who do not wish to undergo gender affirming medical interventions, are then 
more likely to be explored. Expanding the recruitment method to the community may also 
mean that more people with a variety of different gender identities are recruited (not just male 
and female). Future research should be concerned with exploring nuances in physical 
(in)activity, body (dis)satisfaction and mental health between transgender people with binary 
and non-binary gender identities, especially as non-binary transgender people are more likely 
to make partial treatment requests (Beek et al., 2015; Richards et al., 2016) and report poorer 
mental health than binary transgender people (Rimes, Goodship, Ussher, Baker, & West, 
2017; Warren, Smalley, & Barefoot, 2016). 
 
10.7.2. Research design and measurement  
Research now also needs to replicate and extend the findings reported on in this thesis using a 
longitudinal design so that temporal relationships can be explored. Such a design would be 
useful in further exploring the role of gender affirming medical interventions (i.e., cross-sex 
hormones and genital affirming surgery) in relation to physical (in)activity, body 
(dis)satisfaction and mental health. When using such a design, it is important that 
measurement is reliable and valid. Future research concerned with physical activity may wish 
to employ objective measures, such as accelerometers, to obtain more reliable outcome data. 
Researchers should also consider employing the Gender Congruence and Life Satisfaction 
Scale (GCLS) that was developed as part of this thesis. This measure is capable of assessing 
the most important outcomes (gender incongruence and distress as well as mental well-being, 
body (dis)satisfaction and life satisfaction) in one tool. It can be used in research to identify 
factors that are associated with a positive or negative outcome. Additionally, it is important to 
follow-up patients not only when they are in the treatment programme, but also after they 
have been discharged from transgender health services. The GCLS has two clusters which 
represent short and long term outcomes that will likely facilitate such research. For example, 
the cluster that represents long term outcomes may facilitate the development of interventions 
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that are capable of alleviating body dissatisfaction after a transgender person has undergone 
gender confirming medical interventions.  
 
10.8. Conclusions  
This research reported on in this thesis aimed to further our understanding around physical 
(in)activity, body (dis)satisfaction and mental health of transgender people. Body 
dissatisfaction is core to explaining many of findings of this thesis. Body dissatisfaction was 
found to be one of the biggest contributing factors to physical (in)activity among transgender 
people. Body dissatisfaction was also found to be related to many of the other barriers to 
engaging in physical activity and sport that transgender people experienced, such as changing 
facilities and sport-related clothing. These barriers need to be addressed by increasing 
awareness of transgender people (i.e., training days, television awareness campaigns), 
increasing the presence of gender neutral changing facilities, developing more gender neutral 
and less revealing sports clothing, developing effective yet comfortable chest binders, having 
a greater presence of transgender only physical activity and sport spaces, and increasing the 
number of mainstream mixed gendered sports teams. Improving access to, and engagement 
with, physical activity and sport is likely to facilitate the alleviation of body dissatisfaction 
and increase mental well-being in this vulnerable group.  
 
The findings from this thesis have shown that people who have taken cross-sex hormones 
engage in more physical activity, report less body dissatisfaction and fewer mental health 
problems in comparison to transgender people who have not taken cross-sex hormones (but 
are seeking intervention). However, this research was cross-sectional. In light of this, 
longitudinal research that aims to explore the temporal relationship between gender affirming 
medical interventions (i.e., cross-sex hormones and genital affirming surgery), physical 
activity, body (dis)satisfaction and mental health is needed. The newly-developed Gender 
Congruence and Life Satisfaction Scale (GCLS) has been confirmed as a suitable, valid and 
reliable tool to evaluate treatment offered at transgender health services. The use of this 
measure in clinical and research settings will help to improve the quality and timeliness of 
care and will allow service and personal factors associated with a positive and negative 
outcome to be identified. Ultimately, further advances in these research areas will continue to 
contribute towards increasing the well-being of the transgender population.  
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Appendix B: Summary explaining the aims of study 4 
 
 
 
Gender, the body and quality of life study 
The aim of this research study is to test how well a newly-developed scale (the 
Nottingham Gender and Body Dysphoria Scale) assesses feelings about gender, the 
body and quality of life. We hope that this scale will be a useful tool to help health 
professionals understand more about the feelings and experiences of transgender 
individuals and to support their treatment and care. To help us with this process we 
are looking for transgender people to complete the survey, as well as cisgender 
people (people who are content with the gender they were assigned at birth).  
If you would like to find out more, or take part in the research then please follow the 
link: https://lboro.onlinesurveys.ac.uk/gender 
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Appendix C: Information sheet for study 1 
 
 
Trans people’s experiences of exercise, physical activity and sport participation  
 
Participant Information Sheet 
 
Study investigator: Bethany Jones  
 
Supervisors: Dr Emma Haycraft, Professor Jon Arcelus and Dr Walter Bouman 
 
What is the purpose of the study? The purpose of this study is to establish the type 
and amount of exercise, sport or physical activity trans people participate in. We want to 
better understand why people may or may not be motivated to engage in physical 
activity, sport or exercise. 
 
Who is doing this research? The primary investigator of this study is Bethany Jones, a 
PhD student at Loughborough University. The study is being supervised by Dr Emma 
Haycraft, a Senior Lecturer at Loughborough University, Professor Jon Arcelus, a 
Consultant Psychiatrist at the Nottingham Centre for Gender Dysphoria and a Professor 
at Loughborough University and Dr Walter Bouman, Lead Clinician and Consultant 
Psychiatrist at the Nottingham Centre for Gender Dysphoria 
 
Who will be taking part in the research? We are looking to recruit approximately 20 
participants who are in the treatment programme at the Nottingham Centre for Gender 
Dysphoria. 
 
What will I be asked to do? You will be asked to take part in a one-to-one, face-to-
face interview at the Nottingham Centre for Gender Dysphoria. You will be reimbursed 
for your travel expenses if you cannot coincide the interview with your appointment. 
During the interview you will be asked questions about your sport, exercise and physical 
activity participation. These interviews will last between 30 minutes to an hour and will 
be audio recorded with your permission and destroyed following transcription. If you are 
unable to travel to the Nottingham Centre for Gender Dysphoria, then a telephone 
interview can be arranged. During the interview you do not have to answer any 
questions you do not wish to and have the right to stop the interview at any time point. 
The interviewer will also stop the interview should you become unduly distressed.  
 
Once I take part, can I change my mind? Yes.  After you have read this information 
and asked any questions you may have we will ask you to complete an informed consent 
form.  However if at any time, before, during or after the interview you wish to withdraw 
from the study, please just contact the main investigator and provide your unique 
identifier code.  You can withdraw at any time, for any reason, and you will not be asked 
to explain your reasons for withdrawing. However, once the results of the study are 
aggregated (expected to be by December 2015) it will not be possible to withdraw your 
individual data from the research. Withdrawing from the study will not affect your care at 
the Nottingham Centre for Gender Dysphoria in any way. 
 
What personal information will be required from me? During the interview you will 
be asked about how much you participate in exercise, physical activity or sport. We will 
also ask questions about what motivates or puts you off engaging in exercise, physical 
activity or sport. 
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Are there any risks in participating? There are no anticipated risks. However, if you 
feel distressed or upset during or after the study then please raise these issues with the 
researcher, your clinician, or contact your local GP, The Samaritans or MIND for support. 
 
Will me taking part in this study be kept confidential? NHS and Loughborough 
University ethical approval for this study has been granted. Procedures for handling, 
processing, storing and destroying your data meet the requirements of the Data 
Protection Act, 1998. All information which is collected about you during the course of 
the research will be kept strictly confidential. At the start of the interview you will be 
assigned a unique identifier code and all your personal information and interview will be 
stored under this code.  All your data will be stored on a password protected memory 
stick or in a locked filing cabinet. All data will be kept securely for 10 years.  After this 
time your data will be disposed of securely.   
 
What will happen to the results of the study? The findings of the research will 
contribute towards an evidence base about how we can encourage trans people to 
participant in sport, exercise and physical activity in a safe, healthy and enjoyable way. 
The findings of this study will also be shared with the Nottingham Centre for Gender 
Dysphoria. The research will also contribute towards the doctoral thesis of Bethany Jones 
and there is the potential that this research may be published.  Extracts from the 
interviews will be used in the final report and in any publications, and so, to protect your 
anonymity all names will be changed. You can request a summary of the findings upon 
completion of the overall study.  
 
I have some more questions, who should I contact? If you have any questions 
please do not hesitate to contact the study investigator, Bethany Jones (Email: 
B.Jones@lboro.ac.uk Phone: 0115 8760160) or her supervisors, Dr Emma Haycraft 
(Email: E.Haycraft@lboro.ac.uk, Phone: 01509 228160), Professor Jon Arcelus (Email: 
j.arcelus@lboro.ac.uk Phone: 0115 8760160) or Dr Walter Bouman (Email: 
walter.bouman@nottshc.nhs.uk Phone: 0115  8760160)  
If you would like independent advice about taking part in research, you may wish to 
contact Patient Advice Liaison Service (PALS): Phone: 0800 015 3367, Email: 
PALS@nottshc.nhs.uk, Website: www.pals.nhs.uk (for general information only) 
Further support If you feel that you require further support then please discuss your 
issues with your clinician, GP or contact: 
 
The Samaritans Email: jo@samaritans.org Telephone:  08457 90 90 90 Website: 
http://www.samaritans.org/  
 
MIND Email: info@mind.org.uk, Telephone: 0300 123 3393, Text: 86463, Website: 
http://www.mind.org.uk/ 
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Sport, exercise and physical activity 
Appendix D: Online consent form for study 1 
 
 
 
 
 
 
 
 
 
Thank you for agreeing to take part in this study. As you will know from reading the information 
sheet, the aim of this study is to establish the type and amount of exercise, sport or physical activity 
trans people do. Below is a consent form which you are required to complete before the interview. If 
you have any questions please don’t hesitate to contact Bethany Jones (Email: 
B.Jones@lboro.ac.uk, Telephone: 0115 8760160). 
 
Full name: 
 
Date: 
 
1. The purpose and details of this study have been explained to me. I understand that this study 
is designed to further scientific knowledge and that all procedures have been approved by the 
Loughborough University Ethics Approvals (Human Participants) Sub-Committee and NHS 
ethics committee. 
o Yes 
o No 
  
2. I have read and understood the information sheet and this consent form. 
o Yes 
o No 
 
3. I have had an opportunity to ask questions about my participation. 
o Yes 
o No 
 
4. I understand that I am under no obligation to take part in the study. 
o Yes 
o No 
Sport, exercise and physical activity interview study 
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5. I understand that I have the right to withdraw from this study at any stage for any reason, and 
that I will not be required to explain my reasons for withdrawing. 
o Yes 
o No 
 
6. I agree to the interviews being recorded on the understanding that the recordings will be 
destroyed following transcription 
o Yes 
o No 
 
7. I understand that all the information I provide will be treated in strict confidence and will be 
kept anonymous and confidential to the researchers unless (under the statutory obligations of 
the agencies which the researchers are working with), it is judged that confidentiality will have 
to be breached for the safety of the participant or others. 
o Yes 
o No 
 
8. I agree to participate in this study. 
o Yes 
o No 
Appendix E 
269 
 
Appendix E: Paper consent form for study 1 
 
 
Trans people’s experiences of exercise, physical activity and sport participation 
 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
The purpose and details of this study have been explained to me.  I 
understand that this study is designed to further scientific 
knowledge and that all procedures have been approved by the 
Loughborough University Ethics Approvals (Human Participants) 
Sub-Committee and NHS ethics committee. 
 
 
Yes □ 
 
 
No □ 
I have read and understood the information sheet and this consent 
form. 
Yes □ No □ 
I have had an opportunity to ask questions about my participation. Yes □ No □ 
I understand that I am under no obligation to take part in the 
study. 
Yes □ No □ 
I understand that I have the right to withdraw from this study at 
any stage for any reason, and that I will not be required to explain 
my reasons for withdrawing. 
 
Yes □ 
 
No □ 
I agree to the interviews being recorded on the understanding that the 
recordings will be destroyed following transcription 
Yes □ No □ 
I understand that all the information I provide will be treated in 
strict confidence and will be kept anonymous and confidential to 
the researchers unless (under the statutory obligations of the 
agencies which the researchers are working with), it is judged that 
confidentiality will have to be breached for the safety of the 
participant or others.  
 
 
Yes □ 
 
 
No □ 
I agree to participate in this study. Yes □ No □ 
 
Your name……………………………………………….  
 
Your Signature…………………………………………. 
 
Investigators Signature……………………………. 
 
Date …………………………
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Appendix F: Information sheet for studies 2 and 3 (transgender participants)  
 
 
                                                    
Participant Information Sheet 
Please retain this information sheet for your own reference 
 
Clinical correlates and outcomes of treatment for trans people 
 
 
Introduction 
 
Please read this information sheet carefully. It is important for you to understand why the 
information is being collected and what it would involve if you agree to take part. If you have any 
questions please contact one of the Nottingham Centre for Transgender Health team members – 
contact details are at the end of this sheet. Please take time to consider whether or not you wish 
to take part. 
 
What is the purpose of this study? 
 
The purpose of this study is to identify what influence treatment has on mental health, self-
esteem, self-harming behaviours, body image, social support and interpersonal functioning of 
people with gender dysphoria. People who have gender dysphoria face a number of difficulties 
unique to their gender identity or gender presentation. These difficulties can be alleviated 
through treatment, including hormone therapy and gender surgery. This study will help clinicians 
better understand the role that treatment pathways plays in people with gender dysphoria. 
 
Why have I been chosen? 
 
All patients attending the Nottingham Centre for Transgender Health will be invited to take part in 
this research project. We need to know how they were before treatment, in order to identify how 
they are after hormones and after surgery (if they wish to have surgery).  
 
You have been invited to take part because you meet the recruitment criteria for the research 
project. You may either have been invited for assessment at the service, you are on hormone 
treatment or you have had surgery. 
 
Although the information from the questionnaires will be used as part of the assessment and 
follow-up process at the Centre, we would like to ask your permission for this information to be 
used as a research study investigating how people with gender dysphoria benefit from treatment.  
 
Who is organising the study? 
 
This research is being organised by Dr Walter Pierre Bouman, Head of Service; Professor Jon 
Arcelus, Consultant Psychiatrist, Dr Gemma Witcomb, Non-clinical psychologist, Christina 
Richards, Senior Specialist Psychology Associate, Dr Meghan Thurston and Bethany Jones from 
the Nottingham Centre for Transgender Health. 
 
Do I have to take part? 
 
Your help in the study is entirely voluntary. If you do not want to take part, you do not have to 
give a reason. If you do take part and later decide to withdraw from the study, you have the right 
to have your data withdrawn and destroyed at any time up until publication (all data is 
anonymous). You do not have to give a reason to withdraw. 
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What do I have to do? 
 
If you have any questions or concerns, please do not hesitate to contact us before proceeding 
(contact details are provided at the end of this sheet). 
 
If you are interested in taking part and have no further questions, you will first need to sign the 
consent form enclosed in this pack. The pack also contains a set of demographic questions and 
several questionnaires related to outcome measures for you to complete. This should take you 
approximately one hour. To return your questionnaire pack, please use the stamped and 
addressed envelope provided or hand it in to your clinician in person. 
 
What are the possible disadvantages of taking part? 
 
These questionnaires should not cause you any discomfort or distress. However, if you do feel 
distressed at any point during the study we would strongly advise you to talk to your clinician. 
Alternatively you may wish to speak to your local GP or The Samaritans (telephone no. 08457 
909090). 
 
If you decide not to take part in the study, your decision will in no way affect your care at the 
Nottingham Centre for Transgender Health. 
 
What are the possible benefits of taking part? 
 
There are no direct benefits of participating in this study but your participation in this study may 
help clinicians understand what the influence is of hormone treatment on quality of life, mental 
health, self-esteem, self-harming behaviours, body image, social support and interpersonal 
functioning of people with gender dysphoria. If you wish to receive a summary of the study’s 
findings on completion of the project, you may request this from the researchers via email. 
 
Will my taking part in this study be kept confidential? 
 
All information given will be kept strictly confidential and will only be accessible to the clinical 
team at the Nottingham Centre for Transgender Health. All questionnaire data entered into the 
research database will be assigned a unique identifier code to achieve anonymity. Completed 
questionnaire packs and consent forms will be separated and stored in your notes in a locked 
filing cabinet at the Centre for Transgender Health. The procedure for handling, processing, 
storage and destruction of your data will be compliant with the Data Protection Act 1998.  
 
What happens if I don’t want to carry on with the study? 
 
You can withdraw from the study at any time without giving a reason for doing so. If you wish to 
withdraw, your data will be discarded from the study and subsequently destroyed. Again this 
decision will not affect your care at the Nottingham Centre for Transgender Health. 
 
What will happen to the results of the research study? 
 
The study’s findings will be shared with the clinical team at the Nottingham Centre for 
Transgender Health and may be published in academic journals and presented at research 
conferences in order to help other clinicians working with people with gender dysphoria. Also a 
summary of the study’s findings will be made available on request to participants on completion 
of the study. 
 
Who has reviewed the study? 
 
This study has been reviewed and was given a favourable ethical opinion for conduct by the 
regional NHS Research and Ethics Committee. 
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What if I have any other questions or concerns? 
 
If you have any questions or concerns about this study, please contact any of us at the 
Nottingham Centre for Transgender Health 
 
Dr Walter P. Bouman or Professor Jon Arcelus 
 
Nottingham Centre for Transgender Health  
3 Oxford Street 
Nottingham 
NG1 5BH 
Telephone: 0115 876 0160 
 
 
If you would like independent advice about taking part in research, you may wish to contact 
Patient Advice Liaison Service (PALS): 
 
Tel: 0800 015 3367 
 
Website: www.pals.nhs.uk (for general information only) 
 
 
Thank you for taking the time to read this information sheet and for considering taking 
part in the study. Please retain this information sheet for future reference.
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Appendix G: Consent form for studies 2 and 3 (transgender participants)  
 
  
                                                   
INFORMED CONSENT 
 
To be completed after the Participant Information Sheet has been read 
 
Clinical correlates and outcomes of treatment for trans people  
 
Please read the following carefully. Please initial each box and sign at the bottom to show 
you have read and understood what is expected of you. 
 
I hereby give my consent to participate in the questionnaire study clinical correlates and 
outcomes of treatment at the Nottingham Centre for Transgender Health. I confirm that: 
 
• I understand that this study is designed to further scientific knowledge and that all 
procedures have been approved by the regional Ethics Committee. 
 
• I have read and understood the Participant Information Sheet (version 4. Dated 8/03/17). 
 
• I have been informed that my participation in the study will involve completing a set of 
questionnaires and that my responses will be kept anonymous and confidential. 
 
• I understand that relevant sections of my medical notes and data collected during my 
assessment may be looked at by individuals from the Nottingham Centre for Transgender 
Health where it is relevant to my taking part in this research. I give permission for these 
individuals to have access to my records. 
 
• I understand that I am under no obligation to take part in the study; I have the right to 
withdraw at any stage for any reason; and that I will not be required to explain my reasons 
for withdrawing. 
 
 
 
Your name 
 
 
Your Signature 
 
 
Signature of Investigator 
 
 
Date 
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Appendix H: Information sheet for study 2 (cisgender participants)  
 
 
 
 
 
The differences and predictors of physical activity in trans and cisgender people 
 
Participant Information Sheet  
 
What is the purpose of the study? To explore physical activity levels in males and females.  
 
What will I be asked to do? You will be asked to complete an online survey that should take 
approximately 10 minutes.  
 
Will me taking part in this study be kept confidential? Loughborough University ethical approval 
for this study has been granted. Procedures for handling, processing, storing and destroying your data 
meet the requirements of the Data Protection Act, 1998. All information which is collected about you 
during the course of the research will be kept strictly confidential. All your data will be stored on a 
password protected memory stick. All data will be kept securely for 10 years.  After this time your 
data will be disposed of securely.   
 
I have some more questions, who should I contact? If you have any questions please do not hesitate 
to contact the study investigator, Bethany Jones (B.Jones@lboro.ac.uk) or her supervisors, Dr Emma 
Haycraft (Email: E.Haycraft@lboro.ac.uk, Phone: 01509 228160), Professor Jon Arcelus (Email: 
Jon.Arcelus@nottshc.nhs.uk Phone: 0115 8760160) or Dr Walter Bouman (Email: 
Walter.Bouman@nottshc.nhs.uk Phone: 0115  8760160)  
Further support: If you are concerned about your activity level or your ability to engage in physical 
activity then please contact your GP.  
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Appendix I: Consent form for study 2 (cisgender participants)  
 
 
 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
Please ensure that you have read the information sheet prior to completing this consent form. 
I give my consent to participate in the above study.  I understand that I do not have to complete the 
questionnaires and that I can withdraw from the study at any time by closing the web page. 
Name:……………………… 
Date:………………………. 
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Appendix J: Information sheet for study 4 when transgender people were recruited 
from the transgender health service 
 
 
Information Sheet: Validation of the Nottingham Gender and Body Dysphoria Scale 
Bethany Jones, Study Investigator 
What is the purpose of the study? This study aims to test how well a newly-develop measure 
(the Nottingham Gender and Body Dysphoria Scale) assesses feelings about gender, the body 
and quality of life. We hope that this scale will help those involved in the care of transgender people 
to determine how good treatment available through the NHS is. A summary of the finding will be 
available at the end of the study. 
 
What will I be asked to do? You will be invited to complete a series of questionnaires relating to how 
you feel about your gender, body and quality of life. You will also be asked to complete a 
questionnaire about gaming behaviour to determine whether this questionnaire is different to the 
Nottingham Gender and Body Dysphoria Scale. Completion of these questionnaires should take no 
longer than 20 minutes. Please return your questionnaire pack, either in the designated box at 
Nottingham Centre for Gender Dysphoria or by post. You do not have to answer any question that 
you do not want to. Taking part in the study is completely voluntary. 
How will information about me be stored and will I be identifiable? You will not be asked to 
provide any information that would make you identifiable (e.g., your name). Unidentifiable information 
collected from this study will be stored securely for 5 years (under your unique identifier code) on a 
password protected computer or in a locked filing cabinet at the NHS premises.  
What if I change my mind after I have taken part? You can withdraw you data within three months 
of taking part in the study by providing your unique identifier code (given at the top of the 
questionnaire pack). Withdrawing from the study, will not affect your care at the Nottingham Centre for 
Gender Dysphoria. 
 
I have some questions, who should I contact? The study investigator, Bethany Jones (Email: 
B.Jones@lboro.ac.uk Phone: 07541054823), or her supervisors: 
• Dr Emma Haycraft (Email: E.Haycraft@lboro.ac.uk, Phone: 01509 228160),  
• Professor Jon Arcelus (Email: jon.arcelus@nottingham.ac.uk, Phone: 0115 8760160) 
• Dr Walter Bouman (Email: walter.bouman@nottshc.nhs.uk, Phone: 0115  8760160)  
 
If you would like independent advice about taking part in research, you may wish to contact Patient 
Advice Liaison Service (PALS): Phone: 0800 015 3367, Email: PALS@nottshc.nhs.uk, Website: 
www.pals.nhs.uk (for general information only).  
Further support: There are no anticipated risks. This study has been reviewed by the regional NHS 
Research and Ethics Committee. However, if you feel distressed or upset during or after the study 
then please raise these issues with your clinician, contact your local GP or contact: 
 
MIND Email: info@mind.org.uk, Telephone: 0300 123 3393, Text: 86463, Website: 
http://www.mind.org.uk/  
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Appendix K: Information sheet for study 4 when transgender and cisgender 
participants were recruited from the community 
 
 
 
Validation of the Nottingham Gender and Body Dysphoria Scale 
What is the purpose of the study? This study aims to test how well a newly-develop measure 
(the Nottingham Gender and Body Dysphoria Scale) assesses feelings about gender, the body 
and quality of life. We hope that this scale will help those involved in the care of transgender people 
to determine how good treatment available through the NHS is. A summary of the finding will be 
available at the end of the study. 
What will I be asked to do? If you are age 18 or over and identify as cisgender (content with the 
gender you were assigned at birth) or transgender, you will be invited to complete a series of 
questionnaires relating to how you feel about your gender, body and quality of life. You will also be 
asked to complete a questionnaire about gaming behaviour to determine whether this questionnaire is 
different to the Nottingham Gender and Body Dysphoria Scale. Completion of these questionnaires 
should take no longer than 20 minutes. Taking part in the study is completely voluntary. 
How will information about me be stored and will I be identifiable? Loughborough University 
ethical approval for this study has been granted. All information which is collected about you during 
the course of the research will be kept confidential and stored anonymously. All data will be kept 
securely for 10 years. After this time your data will be disposed of securely.   
What if I change my mind after I have taken part? You can stop the study at any time by exiting the 
webpage and your responses will be destroyed. After completion of the questionnaires, you can 
withdraw you data within one month of taking part in the study by providing your unique identifier code 
to Bethany Jones.  
I have some questions, who should I contact? The study investigator, Bethany Jones (Email: 
B.Jones@lboro.ac.uk, Phone: 07541054823), or her supervisors: 
• Dr Emma Haycraft (Email: E.Haycraft@lboro.ac.uk, Phone: 01509 228160),  
• Professor Jon Arcelus (Email: jon.arcelus@nottingham.ac.uk, Phone: 0115 8760160) 
• Dr Walter Bouman (Email: walter.bouman@nottshc.nhs.uk, Phone: 0115  8760160)  
 
Further support: There are no anticipated risks. However, if you feel distressed or upset during or 
after the study then please raise these issues with your GP or contact: 
 
The Samaritans Email: jo@samaritans.org Telephone:  08457 90 90 90 Website: 
http://www.samaritans.org/  
 
MIND Email: info@mind.org.uk, Telephone: 0300 123 3393, Text: 86463, Website: 
http://www.mind.org.uk/ 
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Appendix L: Consent form for study 4 when transgender and cisgender participants 
were recruited from the community 
 
 
 
 
CONSENT FORM: Gender and body dysphoria study 
Important –Please ensure that you have read the information sheet before providing consent. 
Please read and the consent form and indicate whether or not you agree with each statement by 
ticking ‘yes’ or ‘no’. By ticking ‘yes’ to all the statements, you will be providing informed consent.  
The purpose and details of this study have been explained to me. I 
understand that this study is designed to further scientific knowledge and that 
all procedures have been approved by the Loughborough University Ethics 
Approvals (Human Participants) Sub-Committee. 
 
 
Yes □ 
 
 
No □ 
I have read and understood the information sheet and this consent form. Yes □ No □ 
I have had an opportunity to ask questions about my participation. Yes □ No □ 
I understand that I am under no obligation to take part in the study. Yes □ No □ 
I understand that I have the right to withdraw from this study within a month 
of taking part, without providing a reason.  
 
 
Yes □ 
 
No □ 
I understand that all the information I provide will be treated in strict 
confidence and will be kept anonymous and confidential to the researchers 
unless (under the statutory obligations of the agencies which the researchers 
are working with), it is judged that confidentiality will have to be breached for 
the safety of the participant or others.  
 
 
Yes □ 
 
 
No □ 
I agree to participate in this study. Yes □ No □ 
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Appendix M: Evidence of ethical approval for studies 1, 2, 3 and 4 
Study 1: NHS ethical approval for transgender participants 
 
 
 
 
 
National Research Ethics Service 
NRES Committee North West - Liverpool Central 
3rd floor 
Barlow House 
4 Minshull Street 
Manchester 
M1 3 DZ 
 
Telephone: 0161 625 7819 
 
26 May 2015 
 
Miss Bethany Jones 
School of Sport, Exercise and Health 
Sciences Epinal Way 
Loughborough 
LE11 3TU 
 
Dear Miss Jones 
 
Study title: Physical activity, exercise and sport participation in 
trans people: A qualitative study 
REC reference: 15/NW/0473 
IRAS project ID: 179989 
 
Thank you for your e-mail of 26 May 2015. I can confirm the REC has received the 
documents listed below and that these comply with the approval conditions detailed in 
our letter dated 26 May 2015 
 
Documents received 
 
The documents received were as follows: 
 
Document Version Date 
Participant consent form 6.0 26 May 2015 
Participant information sheet (PIS) 6.0 26 May 2015 
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Approved documents 
 
The final list of approved documentation for the study is therefore as follows: 
 
Document Version Date 
Interview schedules or topic guides for participants [Schedule] version 5.0 20 May 2015 
Other [Debrief Sheet] 5 20 May 2015 
Participant consent form 6.0 26 May 2015 
Participant information sheet (PIS) 6.0 26 May 2015 
REC Application Form [REC_Form_22052015]  22 May 2015 
Research protocol or project proposal [Proposal] Version 5.0 20 May 2015 
Summary CV for Chief Investigator (CI) [Jones CV] version 1.0 21 May 2015 
Summary CV for supervisor (student research) [Arcelus]   
Summary CV for supervisor (student research) [Bouman]   
Summary CV for supervisor (student research) [Haycraft]   
 
You should ensure that the sponsor has a copy of the final documentation for the 
study. It is the sponsor's responsibility to ensure that the documentation is made 
available to R&D offices at all participating sites. 
 
15/NW/0473 Please quote this number on all correspondence 
 
Yours sincerely 
 
Miss Regina Caden 
REC Assistant  
E-mail: nrescommittee.northwest-liverpoolcentral@nhs.net 
 
Copy to: Ms Shirley Mitchell, Nottinghamshire Healthcare Trust 
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Study 2: Loughborough University approval for cisgender participants 
 
From: ssehs res ent 
To: Emma Haycraft 
Cc: Beth Jones 
Subject: Ethical Clearance 
Date: 09 November 2015 11:07:42 
Attachments: image001.png 
 
Reference Number: SSEHS-1891 
Dear Dr Haycraft, 
I can confirm that your ethics checklist: Exploring physical activity levels in community participants 
has been approved.  The reference number is SSEHS-1891 
 
Kind regards 
Charlotte Barradell 
Finance and Research Office,  JB0.16 
School of Sport, Exercise and Health Sciences 
Loughborough  University 
Loughborough 
Leicestershire LE11 
3TU Tel: +44 (0) 1509 
226416 
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Studies 2 and 3: NHS ethical approval for clinical transgender participants (2012-2014) 
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Studies 2 and 3: NHS ethical approval for clinical transgender participants (2014-2016) 
 
 
 
NRES Committee East Midlands - Nottingham 1 
The Old Chapel 
Royal Standard Place 
Nottingham  
NG1 6FS 
Telephone: 0115 8839695 
31 March 2014 
 
Dr Walter Pierre Bouman 
Nottingham Gender Clinic  
Gregory Boulevard 
Nottingham  
NG7 6LB 
 
Dear Dr Bouman 
 
Study title: Nottingham Study of Transgender Individuals (NOSTI). Clinical 
correlates and outcomes of the treatment pathway for people 
with gender dysphoria in the United Kingdom. 
REC reference: 14/EM/0092 
IRAS project ID: 142544 
 
Thank you for your email of 27 March 2014.   I can confirm the REC has received the 
documents listed below and that these comply with the approval conditions detailed 
in our letter dated 20 March 2014 
 
Documents received 
 
The documents received were as follows: 
 
Document Version Date 
Participant Information Sheet: For patients 6 months after chest 
reconstructive surgery 
2 24 March 2014 
Participant Information Sheet: For patients 6 months after genital 
surgery 
2 24 March 2014 
Participant Information Sheet: For patients on hormone treatment 
for more than 1yr 
2 24 March 2014 
 
Approved documents 
The final list of approved documentation for the study is therefore as follows: 
 
Document Version Date 
Covering Letter  11 February 2014 
Investigator CV Dr Walter Pierre Bouman 27 January 2014 
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Participant Consent Form: For patients on hormone 
treatment for more than 1 year 
1 27 January 2014 
Participant Consent Form: For patients 6 months after 
genital surgery 
1 27 January 2014 
Participant Consent Form: For patients 6 months after 
chest reconstructive surgery 
1 27 January 2014 
Participant Information Sheet: For patients 6 months 
after chest reconstructive surgery 
2 24 March 2014 
Participant Information Sheet: For patients 6 months 
after genital surgery 
2 24 March 2014 
Participant Information Sheet: For patients on hormone 
treatment for more than 1yr 
2 24 March 2014 
Protocol 1 27 January 2014 
Questionnaire: Questionnaire Pack 1 27 January 2014 
REC application 142544/563097/1/617 10 February 2014 
 
You should ensure that the sponsor has a copy of the final documentation for the study. It 
is the sponsor's responsibility to ensure that the documentation is made available to R&D 
offices at all participating sites. 
 
14/EM/0092 Please quote this number on all correspondence 
 
Yours sincerely 
 
 
 
Miss Helen Wakefield  
REC Manager  
E-mail: nrescommittee.eastmidlands-nottingham1@nhs.net 
 
Copy to: Dr Walter Pierre Bouman, Nottingham Gender Clinic 
Dr Gopi Krishnan, Nottinghamshire Healthcare NHS Trust 
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Study 4: Loughborough University ethical approval for transgender people and cisgender 
people recruited from the community  
 
Research Office 
Loughborough  University  Leicestershire   LE11  3TU UK 
Switchboard: +44 (0 )1509  222222  Department: +44 (0) 15 0 9 222451 
 
Loughborough 
University 
Beth Jones 
School of Sport, Health and Exercise Sciences  
Loughborough University 
Loughborough  
Leicestershire LE11 3TU 
Direct Line: 01509 222423 
Fax: 01509 223953 
E-mail: J.A.Green@lboro.ac.uk 
 http://www.lboro.ac.uk/committees/ethics·-  
approvals-human-participants/ 
 
 
16 May 2016 
 
Dear Beth, 
 
Research Project: R16-P0GG: Validation of the Nottingham Gender and Body Dysphoria 
Scale 
 
Main Investigator: 
Emma Haycraft  
Other Researchers: 
Beth Jones 
I can confirm that the Loughborough University's Ethics Approvals (Human Participants) Sub- 
Committee has considered the ethical implications of this research proposal and has confirmed 
that the research is acceptable.  The Sub-Committee has issued clearance to proceed. 
 
· Yours sincerely, 
 
Jacqueline Green 
Secretary, Ethical Approvals (Human Participants) Subcommittee 
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Study 4: NHS ethical approval for clinical transgender participants  
 
 
 
 
 
East Midlands - Nottingham 1 Research Ethics Committee 
: 
 
 
03 June 2016 
 
Miss Bethany Jones 
School of Sport, Exercise & Health Sciences 
Loughborough Universality 
Loughborough  
LE11 3TU 
 
 
Dear Miss Jones, 
 
Study title: Validation of the Nottingham Gender and Body Dysphoria 
Scale 
REC reference: 16/EM/0183 
Protocol number: 2 
IRAS project ID: 201989 
 
Thank you for your letter of 27 May 2016, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter. Should you wish to provide a substitute contact point, require 
further information, or wish to make a request to postpone publication, please contact the 
REC Manager, Ms Rachel Nelson, NRESCommittee.EastMidlands-Nottingham1@nhs.net. 
 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
The REC favourable opinion is subject to the following conditions being met prior to the start 
of the study. 
 
Please note: This is the 
favourable opinion of the 
REC only and does not allow 
you to start your study at 
NHS sites in England until 
you receive HRA Approval 
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Management permission must be obtained from each host organisation prior to the start of 
the study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study 
in accordance with NHS research governance arrangements. Each NHS organisation must 
confirm through the signing of agreements and/or other documents that it has given 
permission for the research to proceed (except where explicitly specified otherwise). 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database within 6 weeks of recruitment of the first 
participant (for medical device studies, within the timeline determined by the current 
registration and publication trees). 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment. We will audit the registration details as part 
of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered 
but for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. 
Guidance on where to register is provided within IRAS. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
 
NHS sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below). 
 
Non-NHS sites 
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Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
Document Version Date 
Covering letter on headed paper [Covering letter] 1 26 May 2016 
IRAS Application Form [IRAS_Form_19042016]  19 April 2016 
IRAS Application Form [IRAS_Form_27052016]  27 May 2016 
IRAS Checklist XML [Checklist_27052016]  27 May 2016 
Non-validated questionnaire 2 23 May 2016 
Other [Debrief] 1 15 April 2016 
Other [PIS for community] 1 22 April 2016 
Other [Ethical approval from LU] 1 16 May 2016 
Participant information sheet (PIS) 2 23 May 2016 
Research protocol or project proposal 2 23 May 2016 
Response to Request for Further Information  27 May 2016 
Summary CV for Chief Investigator (CI) 1 15 April 2016 
Summary CV for student 1 15 April 2016 
Summary CV for supervisor (student research) 1 15 April 2016 
Summary CV for supervisor (student research) 1 15 April 2016 
Validated questionnaire 2  
 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures 
for Research Ethics Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures. 
 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have 
received and the application procedure. If you wish to make your views known please use 
the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/ 
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HRA Training 
We are pleased to welcome researchers and R&D staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/ 
 
 
 
With the Committee’s best wishes for the success of the project,  
Yours sincerely, 
 
 
Dr Carl Edwards 
Chair  
 
Email: NRESCommittee.EastMidlands-Nottingham1@nhs.net 
 
Enclosures: “After ethical review – 
guidance for researchers” 
 
Copy to: Ms Shirley Mitchell 
16/EM/0183 Please quote this number on all correspondence 
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Appendix N: Interview schedule for study 1 
 
Interview Schedule 
1. Do you currently engage in any exercise, physical activity or sport?  
 
2. If so… 
• How frequently do you engage in exercise, physical activity or sport? 
• Is this at a group or individual level?  
• What is it like being a trans person in your sports group? (or doing exercise, 
physical activity?) 
• What do you perceive other people’s attitudes to be like in relation to you 
engaging in exercise, physical activity or sport? (e.g., team 
players/coaches/other users of the facilities) 
• Can you discuss the barriers (personal and societal) regarding sport, exercise 
and physical activity participation? 
• What can be done to help address these barriers? 
 
3. If not… 
• Why not? 
• Can you discuss the barriers (personal and societal) regarding sport, 
exercise and physical activity participation? 
• What can be done to help address these barriers? 
 
4. Can you explain why you might be motivated to participate in physical activity, 
exercise or sport? (even if you do not always engage in this behaviour) 
• Can you explain whether you feel engaging in sport, exercise or physical 
activity can help the way you feel about your body?  
• Can you explain whether you feel engaging in sport, exercise or physical 
activity to have any benefits regarding your physical health?  
• Can you explain whether you feel engaging in sport, exercise of physical 
activity to have any benefits regarding your well-being? (for instance, your 
confidence or self-esteem) 
 
5. How do you feel about changing facilities?  
 
6. How do you feel about going swimming?  
 
7. Can you discuss if hormone treatment has changed the amount you participate in 
physical activity sport or exercise? 
• Compared to before your social transition, do you engage in more or less 
sport, physical activity or exercise?  
 
8.  Can you discuss how dysphoric you feel when you engage in sport/exercise?  
 
9.  How would you describe body dysphoria?  
 
10.  Can you discuss whether you ever attend sporting events? 
• Have you had any negative experiences? 
• Have you done this in the past? 
• Why don’t you do it now? 
• Do you think it would be easier or harder at different stages of your 
transition?
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Appendix O: Socio-demographic questionnaires used in studies 1, 2, 3 and 4 
Study 1: 
Demographic Information 
 
1. Age:…… 
  
2. What gender where you assigned at birth:           □  Male   □ Female 
 
3. Ethnic origin: (please tick the appropriate) 
□ White                                  
□ Black Caribbean                 
□ Black African                      
□ Indian  
□ Pakistani  
□ Bangladeshi 
□ Chinese 
□ Other Ethnic Group (please specify)……………………………………………………. 
 
4. Employment status: 
□ Employed full-time 
□ Employed part-time 
□ Unemployed 
□ Student  
□ Retired  
□ Other (please specify)……………… 
 
If employed (or previously employed) please specify your 
occupation:…………………………………………………………………………… 
 
5. Do you have any children:      □ Yes      □ No 
 
If yes, how many:……………. 
 
6. Living situation:  
□ With family 
□ Alone 
□ Shared (non-partner(s)) 
□ With partner only 
□ With children only 
□ Other (please specify)……………… 
 
7. How do you identify yourself in relation to gender:……………………………… 
 
8. Have you socially transitioned?  □ Yes     □ No 
 
If yes, when did you socially transition:……………………………………………   
 
9. Are you currently using cross-sex hormones?     □ Yes     □ No 
 
If yes, when did you start using cross-sex hormones:…………………………... 
 
10. Are you current using blockers?    □ Yes     □ No 
 
If yes, when did you start using blockers?.......................................................       
 
11. Have you undergone any sex reassignment surgery?    □ Yes     □ No 
 
If yes, what type of surgery:………………………………………………………………………….. 
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Studies 2 and 3:  
 
Personal Details 
1. Age: ……... 
 
2. Biological Gender 
□ Male 
□ Female 
 
3. Ethnic  origin: (Please  tick the appropriate box) 
□ White 
□ Black Caribbean 
□ Black African 
□ Black Other 
□ Indian 
□ Pakistani 
□ Bangladeshi 
□ Chinese 
□ Other Ethnic Group (Please specify) 
  
4. Employment  status: (Please tick the appropriate box) 
□ Employed full-time 
□ Employed part-time 
□ Student 
□ Volunteer work 
□ Housewife/husband 
□ Disabled 
□ Unemployed 
□ Retired 
□ Other (Please specify) 
 
If in work, please state how many weekly hours undertaken:…….. 
 
5. Civil status: (Please tick the appropriate box) 
□ Single, never married 
□ Married/Civil partnership 
□ Separated / Divorced 
□ Co-habiting I partner 
□ Widowed 
□ Other (Please specify) 
 
6. Do you have any children? 
□ Yes  
□ No 
If Yes, how many? ………….. 
Please state their ages ………………….. 
 
7. Living situation: (Please tick the appropriate box) 
□ With family of origin 
□ Alone 
□ Share with non-partner/s 
□ With partner only 
□ With partner and child/ren 
□ With child/ren only 
□ Other (Please specify) 
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8. Religion (please  specify): ................................................... 
 
9. Do you smoke?  
□ Yes 
□ No 
 
10. Age when you were first referred to any gender clinic:……………………….. 
  
11. Age of coming out:……………………………………. 
 
12. Age of transition:………………………….. 
 
13. How would you describe  your gender identity? 
□ I identify as a man 
□ I identify as a woman 
□ I identify partly as a man, and partly as a woman 
□ I identify neither as a man, nor as a woman 
□ I don't know what my gender identity is (yet) or I am questioning my gender identity 
□ Other (please specify):…………………………. 
 
14. How do you identify yourself? 
□ Trans*  
□ Gender neutral / neutrois 
□ Trans  
□ Non-binary gender 
□ Transvestite  
□ Pangender 
□ Transgender  
□ Bigender 
□ Transsexual  
□ Genderqueer 
□ Androgynous  
□ I don't know 
□ Cisgender   (you are content to remain the gender  you were assigned at birth) Other  (please  
specify) .............................................................................................. 
 
15. Current stage of gender  programme: (Please  tick all that apply)) 
□ Assessment  period 
□ Post-surgery 
□ In 'Real Life Experience'/ treatment program 
□  
16. Are you currently using any hormones? 
□ Yes 
□ No 
If yes: how did you obtain the hormones? 
□ Internet  
□ Friends/family  
□ From a doctor (Dr Name:………………………………….) 
□ Other..................................................... 
 
17. Have you undergone any sex reassignment surgery? (Please tick the appropriate box) 
□ Yes (Please give details in the box below)  
□ No 
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Study 4: 
Background questions 
UNIQUE IDENTIFIER NUMBER (e.g., 250991):…………….  
1. Age:…….. 
 
2. Country of residents:………………… 
 
□ When you were born, what gender were you assigned based on your sex characteristics?      
□  Male   □ Female 
 
3. How do you identify yourself in relation to gender? 
□ Male 
□ Female 
□ Trans male 
□ Trans female 
□ Androgynous 
□ Gender neutral 
□ Non-binary gender 
□ Pangender 
□ Bigender 
□ Genderqueer 
□ Gender fluid 
□ Other……………………………………… 
 
Note: if the gender you were assigned at birth (based on your sex characteristics) and your gender 
identity are the same, then please move on to the next questionnaire (Nottingham Gender and Body 
Dysphoria Scale).  
 
If your gender identity is different to the gender you were assigned at birth:  
 
4. How much of your time do you spend living (socially, at work or education, with friends and 
family, outside the house) as your gender identity: 
 
□ Less than 50% of the time 
□ More than 50% of the time (but not all the time) 
□ All the time (100%) 
 
5. Are you currently using cross-sex hormones?     □ Yes     □ No 
 
6. Are you current using blockers?    □ Yes     □ No 
 
7. If you see yourself as a trans man, have you undergone chest reconstructive surgery?  □ Yes     
□ No    □ Not relevant to me 
 
8. Have you undergone any gender confirming surgery?    □ Yes     □ No 
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Appendix P: Transgender Congruence Scale (TCS; Kozee, Tylka, & Bauerband, 2012) 
 
Transgender Congruence Scale 
Gender identity is defined as the gender(s) that you experience yourself as; it is not necessarily 
related to your assigned gender at birth. For the following items, please indicate the response that 
best describes your experience over the past two weeks. 
 
[Items removed for copyright reasons] 
 
Scoring:  
• Items are scored as follows: ‘strong disagree’ = 1, ‘somewhat disagree’ = 2, ‘neither agree nor 
disagree’ = 3, ‘somewhat agree’ = 4, ‘strongly agree’ = 5.  
• Items 6, 8 and 10 are reversed scored (where 1 = 5, 2 = 4, 3 = 3, 4 = 2, 5 = 1).  
• A total scale score is calculated using the mean of the responses to all 12 items.  
• The Appearance Congruence subscale comprises items 1, 2, 3, 4, 5, 6, 7, 8 and 9.  
• The Gender Identity Acceptance subscale comprised of items 10, 11 and 12.  
• Mean scores are calculated for each subscale. 
• A higher score indicates a higher level of transgender congruence. 
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Appendix Q: Experience of Transphobia Scale (Clements-Nolle, Marx, & Katz, 2006; 
Nuttbrock et al., 2010) 
 
 
Experience of transphobia scale 
The following questions ask you about your experience of discrimination or victimisation on the basis 
of your gender identity or gender expression. Please indicate the response that best describes your 
experience.  
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1. Have you ever been verbally abused or harassed 
due to your gender identity or presentation?  
0 1 2 3 
2. Have you ever been physically abused or beaten 
due to your gender identity or presentation 
0 1 2 3 
 
Scoring:  
• Items are scored as follows: ‘never’ = 0, ‘once’ = 1, ‘a few times’ = 2, ‘several times’ = 3 
• Each question is analysed separately.  
• A higher score indicates a higher experience of transphobia. 
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Appendix R: Hamburg Body Drawing Scale (HBDS; Becker et al., 2016) 
 
Hamburg Body Drawing Scale  
 
 
How satisfied are you currently with the following of your body features? 
 
Please give each body part one of the following scores by circling your response: 
 
1= very dissatisfied, 2=dissatisfied, 3=average, 4=satisfied, 5=very satisfied, NA=Not applicable 
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1. Hair 1 2 3 4 5 NA 
2. Ears 1 2 3 4 5 NA 
3. Beard/facial hair 1 2 3 4 5 NA 
4. Jaw 1 2 3 4 5 NA 
5. Shoulders 1 2 3 4 5 NA 
6. Axillary hair (under arm hair) 1 2 3 4 5 NA 
7. Arms 1 2 3 4 5 NA 
8. Pubic hair 1 2 3 4 5 NA 
9. Hands 1 2 3 4 5 NA 
10. Feet 1 2 3 4 5 NA 
11. Forehead 1 2 3 4 5 NA 
12. Nose 1 2 3 4 5 NA 
13. Chin 1 2 3 4 5 NA 
14. Adam’s apple 1 2 3 4 5 NA 
15. Upper arms 1 2 3 4 5 NA 
16. Chest/breasts 1 2 3 4 5 NA 
17. Stomach 1 2 3 4 5 NA 
18. Waist 1 2 3 4 5 NA 
19. Hips 1 2 3 4 5 NA 
20. Bottom 1 2 3 4 5 NA 
21. Thighs 1 2 3 4 5 NA 
22. Calves 1 2 3 4 5 NA 
23. Height 1 2 3 4 5 NA 
24. Weight 1 2 3 4 5 NA 
25. Clitoris 1 2 3 4 5 NA 
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26. Vagina 1 2 3 4 5 NA 
27. Inner labia 1 2 3 4 5 NA 
28. Outer labia 1 2 3 4 5 NA 
29. Penis 1 2 3 4 5 NA 
30. Testicles 1 2 3 4 5 NA 
31. Body hair 1 2 3 4 5 NA 
32. Voice 1 2 3 4 5 NA 
33. Skin 1 2 3 4 5 NA 
34. Body odor 1 2 3 4 5 NA 
35. Satisfaction with overall 
appearance 
1 2 3 4 5 NA 
36. Other (please 
specify)……………. 
1 2 3 4 5 NA 
 
Scoring:  
• For this thesis, only question 35 was used. It was scored as follows: ‘very dissatisfied’ = 1, 
‘dissatisfied’ = 2, ‘average’ = 3, ‘satisfied’ = 4, ‘very satisfied’ = 5, ‘not applicable’ = 9.  
• A higher score indicates low body dissatisfaction (i.e. greater body satisfaction). 
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Appendix S: Eating Disorder Inventory-2 (EDI-2; Garner, 1991) 
 
Eating Disorder Inventory-2 
The following items ask about your attitudes, feelings and behaviour.  Some of the items relate to food 
or eating.  Other items ask about your feelings about yourself. 
 
For each item, decide if the item is true about you ALWAYS (A), USUALLY (U), OFTEN (O), 
SOMETIMES (S), RARELY (R), or NEVER (N).  Circle the letter that corresponds to your rating.  For 
example, if your rating for an item is OFTEN, you would circle the (O) for that item.  Respond to all of 
the items, making sure that you circle the letter for the rating that is true about you.  If you need to 
change an answer, make an 'X' through the incorrect letter and then circle the correct one. 
 
[Items removed for copyright reasons] 
 
Scoring:  
• Items are scored as follows: ‘Always’ = 3, ‘usually’ = 2, ‘often’ = 1, ‘sometimes’ = 0, ‘rarely’ = 
0, ‘never’ = 0. 
• Items 1, 8, 10, 11, 13, 14, 18, 19, 31, 32 and 35 are reverse scored (where 3 = 0, 2 = 0, 1 = 0, 
0 = 1, 0 = 2, 0 = 3).  
• The Drive for Thinness subscale comprises items 1, 5, 7, 11, 15, 20 and 27 
• The Bulimia subscale comprises items 3, 4, 16, 23, 26, 29 and 34 
• The Body Dissatisfaction subscale comprises items 2, 6, 8, 13, 19, 25, 31, 33 and 35 
• The Perfectionism subscale comprises items 9, 17, 22, 24 28 and 36 
• The Interpersonal Distrust subscale comprises items 10, 12, 14, 18, 21, 30 and 32.  
• Subscale scores are calculated using the sum of all relevant items. 
• A higher score indicates a higher level of eating psychopathology.  
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Appendix T: Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
 
Hospital Anxiety and Depression Scale 
 
Please answer the questions below by circling the number that relates it you. 
 
[Items removed for copyright reasons] 
 
Scoring:  
• Items are scored as follows: ‘Most of the time’ = 3, ‘A lot of the time’ = 2, ‘Occasionally’ = 1, 
‘Not at all’ = 0.  
• Items 2, 4, 6, 7, 12 and 14 are reverse scored (where 3 = 0, 2 = 1, 1 = 2, 0 = 3) 
• Responses to items 1, 3, 5, 7, 9, 11, 13 are summed to comprise the anxiety subscale. 
• Responses to items 2, 4, 6, 8, 10, 12, 14 are summed to comprise the depression subscale. 
• Higher scores indicate higher levels of anxiety and depression.   
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Appendix U: Rosenberg Self-Esteem Scale (Rosenberg, 1965) 
 
Rosenberg Self-esteem Scale 
 
Below is a list of statements dealing with your general feelings about yourself.  
• If you strongly agree, circle Strongly Agree 
• If you agree with the statement, circle Agree 
• If you disagree, circle disagree 
• If you strongly disagree, circle Strongly Disagree.  
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1. On the whole, I am satisfied with myself  3 2 1 0 
2. At times, I think I am no good at all 3 2 1 0 
3. I feel that I have a number of good qualities  3 2 1 0 
4. I am able to do good things as well as most other 
people 
3 2 1 0 
5. I feel I do not have much to be proud of  3 2 1 0 
6. I certainly feel useless at times 3 2 1 0 
7. I feel that I’m a person of worth, at least on an equal 
plane with others 
3 2 1 0 
8. I wish I could have more respect for myself 3 2 1 0 
9. All in all, I am inclined to feel that I am a failure  3 2 1 0 
10. I take a positive attitude towards myself  3 2 1 0 
 
Scoring:  
• Items are scored as follows: ‘Strongly agree’ = 3, ‘Agree’ = 2, ‘Disagree’ = 1, ‘Strongly 
disagree’ = 0  
• Items 2, 5, 6, 8 and 9 are reverse scored (where 3 = 0, 2 = 1, 1 = 2, 0 = 3).  
• The 10 items are summed to obtain the total score.  
• A higher score indicates a higher self-esteem.  
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Appendix V: World Health Organisation Quality of Life-BREF (WHOQOL-BREF; 
Harper, 1998) 
WHOQOL-BRIEF 
The following questions ask how you feel about your quality of life, health, or other areas of your life. 
Please circle the answer that appears most appropriate. If you are unsure about which response 
to give to a question, the first response you think of is often the best one.  
 
Please keep in mind your standards, hopes, pleasures and concerns. We ask that you think about 
your life in the last two weeks: 
[Items removed for copyright reasons] 
 
Scoring:  
• Items 3, 4 and 26 are reverse scored (where 1= 5, 2 = 4, 3 = 3, 4 = 2, 5 = 1).  
• Item 1 assesses overall quality of life. 
• Item 2 assesses overall health.  
• Items 3, 4, 10, 15, 16, 17 and 18 comprise the physical health subscale.  
• Items 5, 6, 7, 11, 19 and 26 comprise the psychological subscale. 
• Items 20, 21 and 22 comprise the relationships subscale. 
• Items 8, 9, 12, 13, 14, 23, 24 and 25 comprise the environment subscale.  
• To calculate the subscale scores, calculate the mean for the items involved and multiply by 
four.  
• A higher score indicates a higher quality of life. 
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Appendix W: Rapid Assessment of Physical Activity (Topolski et al., 2006) 
Rapid Assessment of Physical Activity 
 
Physical activities are activities where you move and increase your heart rate above its resting rate, 
whether you do them for pleasure, work, or transportation. 
 
The following questions ask about the amount and intensity of physical activity you usually do. The 
intensity of the activity is related to the amount of energy you use to do these activities. 
 
Examples of physical activity intensity levels: 
Light activities: walking leisurely, stretching etc. 
Moderate activities fast walking, aerobic class, strength training, swimming gently etc. 
Vigorous activates: jogging, running, tennis, badminton, football etc.  
 
How physically active are you? (Check one answer on each line) 
 
Does this accurately 
describe you? 
 
 
* a form of exercise, often rhythmical movements, generally without using equipment or apparatus 
(e.g. sit-ups, pull-ups, planks) 
 
Aerobic physical activity subscale scoring 
• To score, choose the question with the highest score with an affirmative response. Any 
number less than 6 is suboptimal.  
Aerobic physical activity subscale  
1. I rarely or never do any physical activities.   
2. I do some light or moderate physical activities, but not every 
week. 
  
3. I do some light physical activity every week.   
4. I do moderate physical activities every week, but less than 30 
minutes every day or less than 5 days a week. 
  
5. I do vigorous physical activities every week, but less than 20 
minutes a day or less than 3 days a week. 
  
6. I do 30 minutes or more a day of moderate physical activities, 5 or 
more days a week. 
  
7. I do 20 minutes or more a day of vigorous physical activities, 3 or 
more days a week. 
  
Yes No 
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Appendix X: Internet Gaming Disorder Scale-Short Form (IGDS9-SF; Pontes & 
Griffiths, 2015) 
 
Internet Gaming Disorder Scale 
The following questions will ask you about your gaming activity during the past year (i.e., the past 12 
months). By gaming activity we understand any gaming-related activity that has been played either 
from a computer/laptop or from a gaming console or any kind of device (e.g., mobile phone, tablet, 
etc.) both online and/or offline.  
 
Scoring:  
• Items are scored as follows: ‘Never’ = 1, ‘Rarely’ = 2, ‘Sometimes’ = 3, ‘Often’ = 4, ‘Very often’ 
= 5. 
• No items are reverse scored.  
• For the total score, sum the responses from all nine questions.  
• A higher score indicates a higher level of problematic gaming behaviour. 
 
 
N
ev
er
 
R
ar
el
y 
So
m
et
im
es
 
O
fte
n 
Ve
ry
 o
fte
n 
1. Do you feel preoccupied with your gaming behaviour? 
(Some examples: Do you think about previous gaming 
activity or anticipate the next gaming session? Do you 
think gaming has become the dominant activity in your 
daily life?) 
1 2 3 4 5 
2. Do you feel more irritability, anxiety or even sadness 
when you try to either reduce or stop your gaming 
activity? 
1 2 3 4 5 
3. Do you feel the need to spend increasing amounts of time 
engaged gaming in order to achieve satisfaction or 
pleasure? 
1 2 3 4 5 
4. Do you systematically fail when trying to control or cease 
your gaming activity? 1 2 3 4 5 
5. Have you lost interests in previous hobbies and other 
entertainment activities as a result of your engagement 
with the game? 
1 2 3 4 5 
6. Have you continued your gaming activity despite knowing 
it was causing problems between you and other people? 1 2 3 4 5 
7. Have you deceived any of your family members, 
therapists or others because the amount of your gaming 
activity? 
1 2 3 4 5 
8. Do you play in order to temporarily escape or relieve a 
negative mood (e.g., helplessness, guilt, anxiety)? 1 2 3 4 5 
9. Have you jeopardised or lost an important relationship, 
job or an educational or career opportunity because of 
your gaming activity? 
1 2 3 4 5 
